القرارات والوثائق التكميلية, جنيف ٦ - ١٧ شباط/ فبراير ٢٠٠٦

‫‪COP/1/2006/CD‬‬

‫ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ‬

‫ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ‬ ‫ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ‬ ‫ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬ ‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ‬ ‫ﺠﻨﻴﻑ‪ ١٧ - ٦ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪٢٠٠٦‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬ ‫ﻭﺍﻟﻭﺜﺎﺌﻕ ﺍﻟﺘﻜﻤﻴﻠﻴﺔ‬

‫ﺠﻨﻴﻑ‬ ‫‪٢٠٠٦‬‬

‫ﻤﻘﺩﻤﺔ‬ ‫ﻴﺤﺘﻭﻱ ﻫﺫﺍ ﺍﻟﻘﺴﻡ ﻤﻥ ﻤﺩﺍﻭﻻﺕ ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟـﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴـﺔ‬ ‫ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ﻋﻠﻰ ﺍﻟﻤﺤﺎﻀﺭ ﺍﻟﺤﺭﻓﻴﺔ ﻟﻠﺠﻠﺴﺎﺕ ﺍﻟﻌﺎﻤﺔ‪.‬‬ ‫ﻭﺘﺭﺩ ﺍﻟﻜﻠﻤﺎﺕ ﺍﻟﺘﻲ ﺃﻟﻘﻴﺕ ﺒﺎﻟﻌﺭﺒﻴﺔ ﺃﻭ ﺍﻟﺼﻴﻨﻴﺔ ﺃﻭ ﺍﻹﻨﻜﻠﻴﺯﻴﺔ ﺃﻭ ﺍﻟﻔﺭﻨﺴﻴﺔ ﺃﻭ ﺍﻟﺭﻭﺴﻴﺔ ﺃﻭ ﺍﻷﺴﺒﺎﻨﻴﺔ ﻓـﻲ‬ ‫ﻫﺫﻩ ﺍﻟﻤﺤﺎﻀﺭ ﺍﻟﺤﺭﻓﻴﺔ ﺒﺎﻟﻠﻐﺔ ﺍﻟﺘﻲ ﺘﻜﻠﻡ ﺒﻬﺎ ﺍﻟﻤﺘﺤﺩﺙ؛ ﻭﻫﻲ ﺘﺘـﻀﻤﻥ ﺍﻟﺘـﺼﻭﻴﺒﺎﺕ ﺍﻟﺘـﻲ ﺘـﻡ ﺘﻠﻘﻴﻬـﺎ ﺤﺘـﻰ‬ ‫‪ ٣٠‬ﺤﺯﻴﺭﺍﻥ‪ /‬ﻴﻭﻨﻴﻭ ‪ ،٢٠٠٦‬ﻭﻫﻭ ﺍﻟﻤﻭﻋﺩ ﺍﻟﻨﻬﺎﺌﻲ ﺍﻟﻤﻌﻠﻥ ﻓﻲ ﺍﻟﻨﺴﺨﺔ ﺍﻟﻤﺅﻗﺘﺔ‪ ،‬ﻭﻫﻲ ﺒﺎﻟﺘﺎﻟﻲ ﺘﻌﺘﺒﺭ ﻨﻬﺎﺌﻴﺔ‪.‬‬ ‫ــــــــــــــ‬

‫‪- iii -‬‬

‫ﺍﻟﻤﺤﺘﻭﻴﺎﺕ‬ ‫ﺍﻟﺼﻔﺤﺔ‬ ‫‪iii‬‬ ‫‪vii‬‬ ‫‪ix‬‬

‫ﻤﻘﺩﻤﺔ ‪.............................................................................................‬‬ ‫ﺠﺩﻭل ﺍﻷﻋﻤﺎل ‪....................................................................................‬‬ ‫ﻗﺎﺌﻤﺔ ﺒﺎﻟﻭﺜﺎﺌﻕ ‪.....................................................................................‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬ ‫ﺍﻨﺘﺨﺎﺏ ﺃﻋﻀﺎﺀ ﻤﻜﺘﺏ ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ‬ ‫ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ‪١ ..........................................‬‬ ‫‪١‬‬ ‫‪٢‬‬ ‫‪٢‬‬ ‫‪٢‬‬ ‫ﺇﻨﺸﺎﺀ ﺍﻟﻠﺠﻨﺘﻴﻥ ﺍﻟﺭﺌﻴﺴﻴﺘﻴﻥ ‪.....................................................‬‬ ‫ﺍﻨﺘﺨﺎﺏ ﺃﻋﻀﺎﺀ ﻤﻜﺘﺒﻲ ﺍﻟﻠﺠﻨﺘﻴﻥ ﺍﻟﺭﺌﻴﺴﻴﺘﻴﻥ ‪.....................................‬‬ ‫ﺇﻗﺭﺍﺭ ﺠﺩﻭل ﺍﻷﻋﻤﺎل ‪.........................................................‬‬ ‫‪‬ﺩﺓ ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ ﺒﺸﻜل ﻤﺅﻗﺕ ‪....................................‬‬ ‫ﺘﻁﺒﻴﻕ ﻤﺴﻭ‬ ‫)‪FCTC/COP1(1‬‬

‫)‪FCTC/COP1(2‬‬ ‫)‪FCTC/COP1(3‬‬ ‫)‪FCTC/COP1(4‬‬ ‫)‪FCTC/COP1(5‬‬ ‫)‪FCTC/COP1(6‬‬

‫ﻤﺩﺓ ﻭﻻﻴﺔ ﺃﻋﻀﺎﺀ ﻤﻜﺘﺏ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟـﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴـﺔ‬ ‫ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ‪٣ ..................................................‬‬ ‫‪٣‬‬ ‫ﺃﻭﺭﺍﻕ ﺍﻋﺘﻤﺎﺩ ﺍﻷﻁﺭﺍﻑ ‪......................................................‬‬

‫)‪FCTC/COP1(7‬‬ ‫)‪FCTC/COP1(8‬‬

‫ﺍﻋﺘﻤﺎﺩ ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤـﺔ ﺍﻟـﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴـﺔ‬ ‫ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ‪٤ ..................................................‬‬ ‫‪١٩‬‬ ‫‪٢٠‬‬ ‫‪٢١‬‬ ‫ﺍﻋﺘﻤﺎﺩ ﺍﻟﻨﻅﺎﻡ ﺍﻟﻤﺎﻟﻲ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴـﺔ ﻤﻨﻅﻤـﺔ ﺍﻟـﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴـﺔ‬ ‫ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ‪..................................................‬‬ ‫ﺇﻨﺸﺎﺀ ﺃﻤﺎﻨﺔ ﺩﺍﺌﻤﺔ ﻟﻼﺘﻔﺎﻗﻴﺔ ‪....................................................‬‬ ‫ﻤﻴﺯﺍﻨﻴﺔ ﻭﺨﻁﺔ ﻋﻤل ‪.......................................... ٢٠٠٧-٢٠٠٦‬‬

‫)‪FCTC/COP1(9‬‬

‫)‪FCTC/COP1(10‬‬ ‫)‪FCTC/COP1(11‬‬

‫‪-v-‬‬

‫ﺍﻟﺼﻔﺤﺔ‬ ‫ﺍﻟﺘﻭﺼﻴﺔ ﺍﻟﻤﻘﺩﻤﺔ ﺇﻟﻰ ﺠﻤﻌﻴﺔ ﺍﻟﺼﺤﺔ ‪٢٥ ...........................................‬‬ ‫ﺍﻟﻤﻭﺍﺭﺩ ﻭﺍﻵﻟﻴﺎﺕ ﺍﻟﻤﺎﻟﻴﺔ ﺍﻟﺨﺎﺼﺔ ﺒﺎﻟﻤﺴﺎﻋﺩﺓ ‪٢٥ ....................................‬‬ ‫ﺍﻟﺘﺒﻠﻴﻎ ﻭﺘﺒﺎﺩل ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ‪٢٨ ......................................................‬‬ ‫ﻭﻀﻊ ﻤﺒﺎﺩﺉ ﺘﻭﺠﻴﻬﻴﺔ ﻟﺘﻨﻔﻴﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ ‪٤٥ ...........................................‬‬ ‫ﻭﻀﻊ ﺍﻟﺒﺭﻭﺘﻭﻜﻭﻻﺕ ‪٦٠ ..........................................................‬‬ ‫ﺇﻨﺸﺎﺀ ﻤﺠﻤﻭﻋﺔ ﺩﺭﺍﺴﺔ ﻤﻌﻨﻴﺔ ﺒﺎﻟﻤﺤﺎﺼﻴل ﺍﻟﺒﺩﻴﻠﺔ ‪٦١ ................................‬‬ ‫ﻤﻭﻋﺩ ﻭﻤﻜﺎﻥ ﺍﻨﻌﻘﺎﺩ ﺍﻟﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟـﺼﺤﺔ‬ ‫ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ‪٦٢ ..........................................‬‬ ‫)‪FCTC/COP1(12‬‬ ‫)‪FCTC/COP1(13‬‬ ‫)‪FCTC/COP1(14‬‬ ‫)‪FCTC/COP1(15‬‬ ‫)‪FCTC/COP1(16‬‬ ‫)‪FCTC/COP1(17‬‬ ‫)‪FCTC/COP1(18‬‬

‫‪٦٣ ............................................................................... List of Participants‬‬

‫ـــــــــــــــ‬

‫‪- vi -‬‬

‫‪١‬‬

‫ﺠﺩﻭل ﺍﻷﻋﻤﺎل‬ ‫ﺍﻓﺘﺘﺎﺡ ﺃﻋﻤﺎل ﺍﻟﺩﻭﺭﺓ‬ ‫ﺍﻨﺘﺨﺎﺏ ﺃﻋﻀﺎﺀ ﺍﻟﻤﻜﺘﺏ‬ ‫ﺇﻗﺭﺍﺭ ﺠﺩﻭل ﺍﻷﻋﻤﺎل ﻭﺘﻨﻅﻴﻡ ﺍﻷﻋﻤﺎل‬ ‫ﻤﻨﺎﻗﺸﺔ ﻋﺎﻤﺔ )ﺍﻟﺠﺯﺀ ﺍﻟﺭﻓﻴﻊ ﺍﻟﻤﺴﺘﻭﻯ(‬ ‫ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ ﺍﻟﻤﺅﻗﺕ‬ ‫ﺃﻭﺭﺍﻕ ﺍﻋﺘﻤﺎﺩ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ ‫‪١-١‬‬ ‫‪٢-١‬‬ ‫‪٣-١‬‬ ‫‪٤-١‬‬ ‫‪٥-١‬‬ ‫‪-٢‬‬ ‫‪-٣‬‬ ‫‪-٤‬‬ ‫‪-١‬‬

‫ﺘﻘﺭﻴﺭ ﺍﻷﻤﺎﻨﺔ ﺍﻟﻤﺅﻗﺘﺔ ﻭﺤﺎﻟﺔ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬ ‫ﺘﻘﺭﻴﺭ ﺍﻟﻔﺭﻴﻕ ﺍﻟﻌﺎﻤل ﺍﻟﺤﻜﻭﻤﻲ ﺍﻟﺩﻭﻟﻲ ﺍﻟﻤﻔﺘﻭﺡ ﺍﻟﻌﻀﻭﻴﺔ ﺍﻟﻤﻌﻨﻲ ﺒﺎﺘﻔﺎﻗﻴـﺔ ﻤﻨﻅﻤـﺔ ﺍﻟـﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴـﺔ‬ ‫ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬ ‫ﻤﺴﺎﺌل ﺤﺩﺩﺕ ﻓﻲ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻟﻴﺘﺨﺫ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺇﺠﺭﺍﺀﺍﺕ ﺒﺸﺄﻨﻬﺎ ﻓﻲ ﺩﻭﺭﺘﻪ ﺍﻷﻭﻟﻰ‬ ‫ﺍﻋﺘﻤﺎﺩ ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ )ﺍﻟﻤﺎﺩﺓ ‪ ٢٣‬ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﺍﻟﻔﻘﺭﺓ ‪(٣‬‬ ‫ﺘﻌﻴﻴﻥ ﺍﻷﻤﺎﻨﺔ ﺍﻟﺩﺍﺌﻤﺔ ﻭﻭﻀﻊ ﺍﻟﺘﺭﺘﻴﺒﺎﺕ ﺍﻟﻼﺯﻤﺔ ﻟﻌﻤﻠﻬﺎ )ﺍﻟﻤﺎﺩﺓ ‪ ٢٤‬ﺍﻷﻤﺎﻨﺔ‪ ،‬ﺍﻟﻔﻘﺭﺓ ‪(١‬‬ ‫ﺍﻋﺘﻤﺎﺩ ﺍﻟﻨﻅﺎﻡ ﺍﻟﻤﺎﻟﻲ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﻭﺍﻷﺤﻜﺎﻡ ﺍﻟﻤﺎﻟﻴﺔ ﺍﻟﺘﻲ ﺘﻨﻁﺒﻕ ﻋﻠﻰ ﻋﻤل ﺍﻷﻤﺎﻨﺔ )ﺍﻟﻤﺎﺩﺓ‬ ‫‪ ٢٣‬ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﺍﻟﻔﻘﺭﺓ ‪ ،٤‬ﻭﺍﻟﻤﺎﺩﺓ ‪ ٢٤‬ﺍﻷﻤﺎﻨﺔ(‬ ‫ﺍﻋﺘﻤﺎﺩ ﻤﻴﺯﺍﻨﻴﺔ ﺍﻟﻔﺘﺭﺓ ﺍﻟﻤﺎﻟﻴﺔ ﺍﻷﻭﻟﻰ )ﺍﻟﻤﺎﺩﺓ ‪ ٢٣‬ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﺍﻟﻔﻘﺭﺓ ‪(٤‬‬ ‫ﺍﺴﺘﻌﺭﺍﺽ ﻤﺼﺎﺩﺭ ﻭﺁﻟﻴﺎﺕ ﺍﻟﻤﺴﺎﻋﺩﺓ ﺍﻟﻘﺎﺌﻤﺔ ﻭﺍﻟﻤﺤﺘﻤﻠﺔ )ﺍﻟﻤﺎﺩﺓ ‪ ٢٦‬ﺍﻟﻤﻭﺍﺭﺩ ﺍﻟﻤﺎﻟﻴﺔ‪ ،‬ﺍﻟﻔﻘﺭﺓ ‪(٥‬‬ ‫‪١-٤‬‬ ‫‪٢-٤‬‬ ‫‪٣-٤‬‬ ‫‪٤-٤‬‬ ‫‪٥-٤‬‬

‫ﻤﺴﺎﺌل ﺃﺨﺭﻯ ﺤﺩﺩﺕ ﻓﻲ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻟﻴﻨﻅﺭ ﻓﻴﻬﺎ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ ‫ﺍﻟﺘﺒﻠﻴﻎ )ﺍﻟﻤﺎﺩﺓ ‪ ٢١‬ﺍﻟﺘﺒﻠﻴﻎ ﻭﺘﺒﺎﺩل ﺍﻟﻤﻌﻠﻭﻤﺎﺕ(‬ ‫‪١-٥‬‬

‫‪-٥‬‬

‫ﺒﺎﻟﺼﻴﻐﺔ ﺍﻟﻤﻌﺘﻤﺩﺓ ﻓﻲ ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻷﻭﻟﻰ‪.‬‬ ‫‪- vii -‬‬

‫‪١‬‬

‫ﻭﻀﻊ ﺩﻻﺌل ﻟﺘﻁﺒﻴﻕ ﺃﺤﻜﺎﻡ ﺍﻟﻤﺎﺩﺓ ‪ ) ٧‬ﺍﻟﺘﺩﺍﺒﻴﺭ ﻏﻴﺭ ﺍﻟﺴﻌﺭﻴﺔ ﺍﻟﺭﺍﻤﻴﺔ ﺇﻟﻰ ﺍﻟﺤﺩ ﻤﻥ ﺍﻟﻁﻠﺏ ﻋﻠﻰ‬ ‫ﺍﻟﺘﺒﻎ( ﻭﺍﻟﻤﺎﺩﺓ ‪ ) ٩‬ﺘﻨﻅﻴﻡ ﻤﺤﺘﻭﻴﺎﺕ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ (‬ ‫ﻭﻀﻊ ﺍﻟﺒﺭﻭﺘﻭﻜﻭﻻﺕ‬

‫‪٢-٥‬‬ ‫‪٣-٥‬‬ ‫‪-٦‬‬ ‫‪-٧‬‬ ‫‪-٨‬‬

‫ﺍﻟﻨﻅﺭ ﻓﻲ ﺒﺭﻨﺎﻤﺞ ﻟﻌﻤل ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ ‫ﻤﻭﻋﺩ ﻭﻤﻜﺎﻥ ﺍﻨﻌﻘﺎﺩ ﺍﻟﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ ‫ﺍﺨﺘﺘﺎﻡ ﺃﻋﻤﺎل ﺍﻟﺩﻭﺭﺓ‬

‫ــــــــــــ‬

‫‪- viii -‬‬

‫ﻗﺎﺌﻤﺔ ﺒﺎﻟﻭﺜﺎﺌﻕ‬ ‫ﺠﺩﻭل ﺍﻷﻋﻤﺎل‪١‬‬ ‫‪A/FCTC/COP/1/1 Rev.1‬‬ ‫)‪A/FCTC/COP/1/1 (annotated‬‬ ‫‪A/FCTC/COP/1/2‬‬

‫ﺠﺩﻭل ﺍﻷﻋﻤﺎل ﺍﻟﻤﺅﻗﺕ )ﺍﻟﻤﺸﺭﻭﺡ(‬ ‫ﺘﻘﺭﻴﺭ ﺍﻟﻔﺭﻴﻕ ﺍﻟﻌﺎﻤل ﺍﻟﺤﻜﻭﻤﻲ ﺍﻟﺩﻭﻟﻲ ﺍﻟﻤﻔﺘﻭﺡ ﺍﻟﻌﻀﻭﻴﺔ ﺍﻟﻤﻌﻨـﻲ‬ ‫ﺒﺎﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬ ‫ﺘﻘﺭﻴﺭ ﺍﻷﻤﺎﻨﺔ ﺍﻟﻤﺅﻗﺘﺔ ﻭﺤﺎﻟﺔ ﺍﺘﻔﺎﻗﻴـﺔ ﻤﻨﻅﻤـﺔ ﺍﻟـﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴـﺔ‬ ‫ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬ ‫ﺍﺴﺘﻌﺭﺍﺽ ﻤﺼﺎﺩﺭ ﻭﺁﻟﻴﺎﺕ ﺍﻟﻤﺴﺎﻋﺩﺓ ﺍﻟﻘﺎﺌﻤﺔ ﻭﺍﻟﻤﺤﺘﻤﻠﺔ‬ ‫ﺘﻌﻴﻴﻥ ﺍﻷﻤﺎﻨﺔ ﺍﻟﺩﺍﺌﻤﺔ ﻭﻭﻀﻊ ﺍﻟﺘﺭﺘﻴﺒﺎﺕ ﺍﻟﻼﺯﻤﺔ ﻟﻌﻤﻠﻬﺎ‬ ‫‪‬ﺩﺓ [ ﺍﻟﺘﻘﺭﻴﺭ ﺍﻟﺨﺎﺹ ﺒﺄﻭﺭﺍﻕ ﺍﻻﻋﺘﻤﺎﺩ‬ ‫] ﻤﺴﻭ‬ ‫‪‬ﺩﺓ(‬ ‫ﺍﻟﺘﻘﺭﻴﺭ ﺍﻷﻭل ﻟﻠﺠﻨﺔ "ﺏ" )ﻤﺴﻭ‬ ‫ﺍﻟﺘﻘﺭﻴﺭ ﺍﻷﻭل ﻟﻠﺠﻨﺔ "ﺃ"‬ ‫‪‬ﺩﺓ(‬ ‫ﺍﻟﺘﻘﺭﻴﺭ ﺍﻟﺜﺎﻨﻲ ﻟﻠﺠﻨﺔ "ﺏ" )ﻤﺴﻭ‬ ‫‪‬ﺩﺓ(‬ ‫ﺍﻟﺘﻘﺭﻴﺭ ﺍﻟﺜﺎﻨﻲ ﻟﻠﺠﻨﺔ "ﺃ" )ﻤﺴﻭ‬ ‫‪‬ﺩﺓ(‬ ‫ﺍﻟﺘﻘﺭﻴﺭ ﺍﻟﺜﺎﻟﺙ ﻟﻠﺠﻨﺔ "ﺃ" )ﻤﺴﻭ‬ ‫‪‬ﺩﺓ(‬ ‫ﺍﻟﺘﻘﺭﻴﺭ ﺍﻟﺜﺎﻟﺙ ﻟﻠﺠﻨﺔ "ﺏ" )ﻤﺴﻭ‬ ‫‪‬ﺩﺓ(‬ ‫ﺍﻟﺘﻘﺭﻴﺭ ﺍﻟﺭﺍﺒﻊ ﻟﻠﺠﻨﺔ "ﺃ" )ﻤﺴﻭ‬ ‫‪‬ﺩﺓ [ ﺍﻟﺘﻘﺭﻴﺭ ﺍﻟﺜﺎﻨﻲ ﺒﺸﺄﻥ ﺃﻭﺭﺍﻕ ﺍﻻﻋﺘﻤﺎﺩ‬ ‫] ﻤﺴﻭ‬ ‫‪‬ﺩﺓ(‬ ‫ﺍﻟﺘﻘﺭﻴﺭ ﺍﻟﺨﺎﻤﺱ ﻟﻠﺠﻨﺔ "ﺃ" )ﻤﺴﻭ‬

‫‪A/FCTC/COP/1/3‬‬

‫‪A/FCTC/COP/1/4‬‬ ‫‪A/FCTC/COP/1/5 and‬‬ ‫‪A/FCTC/COP/1/5 Corr.1‬‬ ‫‪A/FCTC/COP/1/6‬‬ ‫‪A/FCTC/COP/1/7‬‬ ‫‪A/FCTC/COP/1/8‬‬ ‫‪A/FCTC/COP/1/9‬‬ ‫‪A/FCTC/COP/1/10‬‬ ‫‪A/FCTC/COP/1/11‬‬ ‫‪A/FCTC/COP/1/12‬‬ ‫‪A/FCTC/COP/1/13‬‬ ‫‪A/FCTC/COP/1/14‬‬ ‫‪A/FCTC/COP/1/15‬‬

‫‪ ١‬ﺍﻨﻅﺭ ﺍﻟﺼﻔﺤﺔ ‪.vii‬‬ ‫‪- ix -‬‬

‫ﻭﺜﺎﺌﻕ ﺍﻟﻤﻌﻠﻭﻤﺎﺕ‬ ‫ﺤﺎﻟﺔ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤـﺔ‬ ‫ﺍﻟﺘﺒﻎ‬ ‫ﺎ ﻟﻠﻤﺎﺩﺓ ‪ ٢١‬ﻤﻥ ﺍﺘﻔﺎﻗﻴـﺔ‬ ‫ﺘﻘﺩﻴﻡ ﺍﻟﺘﻘﺎﺭﻴﺭ ﻭﺘﺒﺎﺩل ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﻭﻓﻘﹰ‬ ‫ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬ ‫‪‬ﺩﺩﺕ ﻓﻲ ﺍﻻﺘﻔﺎﻗﻴـﺔ ﻟﻴﻨﻅـﺭ ﻓﻴﻬـﺎ ﻤـﺅﺘﻤﺭ‬ ‫ﻤﺴﺎﺌل ﺃﺨﺭﻯ ﺤ‬ ‫ﺍﻷﻁﺭﺍﻑ‪ .‬ﻭﻀﻊ ﺩﻻﺌل ﻟﺘﻨﻔﻴﺫ ﺃﺤﻜﺎﻡ ﺍﻟﻤﺎﺩﺘﻴﻥ ‪ ٧‬ﻭ‪ ٩‬ﻭﻭﻀـﻊ‬ ‫ﺍﻟﺒﺭﻭﺘﻭﻜﻭﻻﺕ‬ ‫ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ ﺍﻟﻤﺅﻗﺕ‬ ‫ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ ﺍﻟﻤﺅﻗﺕ‪ .‬ﺍﻟﻁﺭﺍﺌﻕ ﺍﻟﻌﻤﻠﻴﺔ ﻟﻤﺸﺎﺭﻜﺔ ﺍﻟﻤـﺭﺍﻗﺒﻴﻥ‬ ‫ﻓﻲ ﺃﻋﻤﺎل ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ ‫ﺃﺴﺎﻟﻴﺏ ﺘﺼﺭﻴﻑ ﺍﻷﻋﻤﺎل ﻓﻲ ﺍﻟﻔﺘﺭﺍﺕ ﺍﻟﻔﺎﺼﻠﺔ ﺒﻴﻥ ﺍﻟـﺩﻭﺭﺍﺕ‬ ‫ﻟﻭﻀﻊ ﺍﻟﺩﻻﺌل‬ ‫ﻗﺎﺌﻤﺔ ﺒﺎﻟﻤﻨﻅﻤﺎﺕ ﻏﻴﺭ ﺍﻟﺤﻜﻭﻤﻴـﺔ ﺍﻟﺘـﻲ ﺸـﺎﺭﻜﺕ ﻓـﻲ ﺃﻱ‬ ‫ﻤﻔﺎﻭﻀﺎﺕ ﺃﻭ ﺃﻓﺭﻗﺔ ﻋﺎﻤﻠﺔ ﺘﺤﻀﻴﺭﻴﺔ ﺘﺘﻌﻠﻕ ﺒﺎﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤـﺔ‬ ‫ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬ ‫‪A/FCTC/COP/1/INF.DOC./1‬‬

‫‪A/FCTC/COP/1/INF.DOC./2‬‬

‫‪A/FCTC/COP/1/INF.DOC./3‬‬

‫‪A/FCTC/COP/1/INF.DOC./4 Rev.1‬‬ ‫‪A/FCTC/COP/1/INF.DOC./5‬‬

‫‪A/FCTC/COP/1/INF.DOC./6‬‬

‫‪A/FCTC/COP/1/INF.DOC./7‬‬

‫ﻭﺜﺎﺌﻕ ﺍﻟﻤﺘﻨﻭﻋﺎﺕ‬ ‫ﺩﻟﻴل ﺍﻟﺴﺎﺩﺓ ﺍﻟﻤﻨﺩﻭﺒﻴﻥ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ ﻓﻲ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ ‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ ] ﺒﺎﻹﻨﻜﻠﻴﺯﻴﺔ ﻭﺍﻟﻔﺭﻨﺴﻴﺔ ﻓﻘﻁ [‬ ‫ﺍﻟﺠﺩﻭل ﺍﻟﺯﻤﻨﻲ ﺍﻟﻴﻭﻤﻲ ﺍﻟﻤﺅﻗﺕ ] ﻭﺜﻴﻘﺔ ﻟﻡ ﺘﺼﺩﺭ [‬ ‫ﻤﺸﺎﺭﻜﺔ ﺍﻟﻤﻨﻅﻤﺎﺕ ﻏﻴﺭ ﺍﻟﺤﻜﻭﻤﻴﺔ ﻓﻲ ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ‬ ‫ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒـﺸﺄﻥ‬ ‫ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬ ‫ﻤﻼﺤﻅﺎﺕ ﺍﺴﺘﻬﻼﻟﻴﺔ ﻟﻠﻤﺩﻴﺭ ﺍﻟﻌﺎﻡ ﺃﻤﺎﻡ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓـﻲ‬ ‫ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒـﻎ‬ ‫ﻓﻲ ﺩﻭﺭﺘﻪ ﺍﻷﻭﻟﻰ‬ ‫ﺘﻘﺭﻴﺭ ﺍﻟﻔﺭﻴﻕ ﺍﻟﻌﺎﻤل ﺍﻟﺤﻜﻭﻤﻲ ﺍﻟﺩﻭﻟﻲ ﺍﻟﻤﻔﺘـﻭﺡ ﺍﻟﻌـﻀﻭﻴﺔ‬ ‫ﺍﻟﻤﻌﻨﻲ ﺒﺎﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ‬ ‫ﺍﻟﺘﺒﻎ‬ ‫‪A/FCTC/COP/1/DIV/1‬‬ ‫‪A/FCTC/COP/1/DIV/2 Rev.1‬‬ ‫‪A/FCTC/COP/1/DIV/3‬‬ ‫‪A/FCTC/COP/1/DIV/4‬‬

‫‪A/FCTC/COP/1/DIV/5‬‬

‫‪A/FCTC/COP/1/DIV/6‬‬

‫‪-x-‬‬

‫ﺃﻋﻀﺎﺀ ﻤﻜﺘﺏ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤـﺔ ﺍﻟـﺼﺤﺔ‬ ‫ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬ ‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬ ‫ﻗﺎﺌﻤﺔ ﺒﺎﻟﻭﺜﺎﺌﻕ‬

‫‪A/FCTC/COP/1/DIV/7‬‬

‫‪A/FCTC/COP/1/DIV/8‬‬ ‫‪A/FCTC/COP/1/DIV/9‬‬

‫ـــــــــــــــ‬

‫‪- xi -‬‬

‫اﻟﻘﺮارات‬ ‫ﺍﻨﺘﺨﺎﺏ ﺃﻋﻀﺎﺀ ﻤﻜﺘﺏ ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ‬ ‫ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬ ‫)‪FCTC/COP1(1‬‬

‫ﺍﻨﺘﺨﺒﺕ ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒـﺸﺄﻥ ﻤﻜﺎﻓﺤـﺔ‬ ‫ﺍﻟﺘﺒﻎ‪ ،‬ﺒﻌﺩ ﻤﺸﺎﻭﺭﺍﺕ ﻏﻴﺭ ﺭﺴﻤﻴﺔ‪ ،‬ﺃﻋﻀﺎﺀ ﻤﻜﺘﺒﻬﺎ ﺍﻟﺘﺎﻟﻴﺔ ﺃﺴﻤﺎﺅﻫﻡ‪:‬‬ ‫ﺍﻟﺴﻔﻴﺭ ﺝ‪ .‬ﻤﺎﺭﺘﺎﺒﻴﺕ )ﺸﻴﻠﻲ(‬ ‫ﺍﻟﺭﺌﻴﺱ‪:‬‬

‫ﻨﻭﺍﺏ ﺍﻟﺭﺌﻴﺱ‪ :‬ﺍﻟﺴﻴﺩﺓ ﺩ‪ .‬ﻤﺎﻓﻭﺒﻴﻠﻭ )ﺠﻨﻭﺏ ﺃﻓﺭﻴﻘﻴﺎ(‬ ‫ﺍﻟﺴﻴﺩ ﺭ‪ .‬ﺒﺎﻴﺎﺕ ﻤﺨﺘﺎﺭﻱ )ﺠﻤﻬﻭﺭﻴﺔ ﺇﻴﺭﺍﻥ ﺍﻹﺴﻼﻤﻴﺔ(‬ ‫ﺍﻟﺩﻜﺘﻭﺭ ﻙ‪ .‬ﻻﺴﻤﺎﻥ )ﺍﻟﻨﻤﺴﺎ(‬ ‫ﺍﻟﺩﻜﺘﻭﺭ ﻫﺎﺘﺎﻱ ﺸﻴﺘﺎﻨﻭﻨﺩﻩ )ﺘﺎﻴﻠﻨﺩ(‬ ‫ﺍﻟﺴﻔﻴﺭ ﺸﺎ ﺯﻭﻜﺎﻨﻎ )ﺍﻟﺼﻴﻥ(‬ ‫)ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻷﻭﻟﻰ‪ ٦ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪(٢٠٠٦‬‬ ‫ﺎ ﻟﻠﻤﺎﺩﺓ ‪٢١‬‬ ‫ﻭﺒﻌﺩ ﺫﻟﻙ‪ ،‬ﻗﺭﺭﺕ ﺍﻟﺩﻭﺭﺓ ﺍﺨﺘﻴﺎﺭ ﺃﺤﺩ ﻨﻭﺍﺏ ﺍﻟﺭﺌﻴﺱ ﺍﻟﺨﻤﺴﺔ ﻟﻼﻀﻁﻼﻉ ﺒﺄﻋﺒﺎﺀ ﺍﻟﻤﻘﺭﺭ ﻭﻓﻘﹰ‬ ‫ﻤﻥ ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ﻜﺎﻟﺘﺎﻟﻲ‪:‬‬ ‫ﺍﻟﺩﻜﺘﻭﺭ ﻙ‪ .‬ﻻﺴﻤﺎﻥ )ﺍﻟﻨﻤﺴﺎ(‬ ‫)ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻟﺭﺍﺒﻌﺔ‪ ١٥ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪(٢٠٠٦‬‬ ‫ﺍﻟﻤﻘﺭﺭ‪:‬‬

‫ﺇﻨﺸﺎﺀ ﺍﻟﻠﺠﻨﺘﻴﻥ ﺍﻟﺭﺌﻴﺴﻴﺘﻴﻥ‬

‫)‪FCTC/COP1(2‬‬

‫ﺃﻨﺸﺄﺕ ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪،‬‬ ‫ُﺴـﻨﺩﺕ‬ ‫ﺒﻌﺩ ﺍﻟﻨﻅﺭ ﻓﻲ ﺍﻗﺘﺭﺍﺡ ﺍﻷﻤﺎﻨﺔ ﺍﻟﻤﺅﻗﺘﺔ ﺤﻭل ﺃﺴﻠﻭﺏ ﺍﻟﻌﻤل ﻭﺘﻭﺯﻴﻌﻪ‪ ،‬ﻟﺠﻨﺘﻴﻥ ﺘﺠﺘﻤﻌﺎﻥ ﻓﻲ ﺍﻟﻭﻗﺕ ﺫﺍﺘﻪ‪ .‬ﻭﺃ‬ ‫ُﺴﻨﺩﺕ ﺇﻟﻰ ﺍﻟﻠﺠﻨﺔ "ﺏ" ﺍﻟﻘﻀﺎﻴﺎ ﺍﻹﺠﺭﺍﺌﻴﺔ ﻭﺍﻟﻤﺅﺴﺴﻴﺔ‪.‬‬ ‫ﺇﻟﻰ ﺍﻟﻠﺠﻨﺔ "ﺃ" ﺍﻟﻘﻀﺎﻴﺎ ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﺠﻭﻫﺭ ﺍﻟﻤﻭﻀﻭﻉ ﻓﻲ ﺤﻴﻥ ﺃ‬ ‫ﻭﺘﻘـﺭﺭ ﺃﻥ ﺘﻌﻤﺩ ﻜل ﻟﺠﻨﺔ ﻤﻥ ﺍﻟﻠﺠﻨﺘﻴﻥ‪ ،‬ﺒﺎﻟﻨﺴﺒﺔ ﺇﻟﻰ ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﺇﻟﻰ ﺍﺨﺘﻴﺎﺭ ﺭﺌﻴﺱ ﻭﻨﺎﺌﺒﻴﻥ‬ ‫ﻟﻠﺭﺌﻴﺱ‪.‬‬ ‫)ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻷﻭﻟﻰ‪ ٦ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪(٢٠٠٦‬‬

‫‪-1-‬‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪2‬‬

‫ﺍﻨﺘﺨﺎﺏ ﺃﻋﻀﺎﺀ ﻤﻜﺘﺒﻲ ﺍﻟﻠﺠﻨﺘﻴﻥ ﺍﻟﺭﺌﻴﺴﻴﺘﻴﻥ‬

‫)‪FCTC/COP1(3‬‬

‫ﺍﻨﺘﺨﺒﺕ ﺍﻟﻠﺠﻨﺘﺎﻥ ﺍﻟﺭﺌﻴﺴﻴﺘﺎﻥ ﺃﻋﻀﺎﺀ ﻤﻜﺘﺒﻴﻬﻤﺎ ﺍﻟﺘﺎﻟﻴﺔ ﺃﺴﻤﺎﺅﻫﻡ‪:‬‬ ‫ﺍﻟﺩﻜﺘﻭﺭ ﻙ‪ .‬ﺱ‪ .‬ﺭﻴﺩﻱ )ﺍﻟﻬﻨﺩ(‬ ‫ﺍﻟﺩﻜﺘﻭﺭ ﺇﻱ‪ .‬ﻜﻭﺭﻜﻭﺭﺍﻥ )ﺃﻴﺭﻟﻨﺩﺍ(‬ ‫ﺍﻟﺩﻜﺘﻭﺭ ﻙ‪ .‬ﺕ‪ .‬ﺃﻭﺘﻭ )ﺒﺎﻻﻭ(‬ ‫ﺍﻟﺴﻴﺩ ﻡ‪ .‬ﺴﻴﻙ )ﺍﻟﺴﻨﻐﺎل(‬ ‫ﺍﻟﺴﻴﺩ ﺏ‪ .‬ﺃﻭﻟﺩﻫﺎﻡ )ﻜﻨﺩﺍ(‬ ‫ﺍﻟﺴﻴﺩ ﺡ‪ .‬ﺍﻟﺤﺴﻴﻨﻲ )ﺍﻷﺭﺩﻥ(‬ ‫)ﺍﻟﺠﻠﺴﺘﺎﻥ ﺍﻷﻭﻟﻴﺎﻥ ﻟﻠﺠﻨﺔ "ﺃ" ﻭﺍﻟﻠﺠﻨﺔ "ﺏ"‪ ٧ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪(٢٠٠٦‬‬ ‫ﺍﻟﺭﺌﻴﺱ‬ ‫ﻨﺎﺌﺒﺎ ﺍﻟﺭﺌﻴﺱ‬ ‫ﺍﻟﺭﺌﻴﺱ‬ ‫ﻨﺎﺌﺒﺎ ﺍﻟﺭﺌﻴﺱ‬ ‫ﺍﻟﻠﺠﻨﺔ "ﺃ"‪:‬‬

‫ﺍﻟﻠﺠﻨﺔ "ﺏ"‪:‬‬

‫ﺇﻗﺭﺍﺭ ﺠﺩﻭل ﺍﻷﻋﻤﺎل‬

‫)‪FCTC/COP1(4‬‬

‫ﺃﻗﺭﺕ ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬ ‫ﺠﺩﻭل ﺍﻷﻋﻤﺎل ﺍﻟﻤﺅﻗﺕ ﺍﻟﺫﻱ ﺃﻋﺩﺘﻪ ﺍﻷﻤﺎﻨﺔ ﺍﻟﻤﺅﻗﺘﺔ‪.‬‬ ‫)ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻷﻭﻟﻰ‪ ٦ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪(٢٠٠٦‬‬

‫‪‬ﺩﺓ ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ ﺒﺸﻜل ﻤﺅﻗﺕ‬ ‫ﺘﻁﺒﻴﻕ ﻤﺴﻭ‬

‫)‪FCTC/COP1(5‬‬

‫ﻗﺭﺭﺕ ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬ ‫‪‬ﺩﺓ ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ ﺍﻟﺘﻲ ﻁﺭﺤﻬﺎ ﺍﻟﻔﺭﻴﻕ ﺍﻟﻌﺎﻤل ﺍﻟﺤﻜﻭﻤﻲ ﺍﻟـﺩﻭﻟﻲ ﺍﻟﻤﻔﺘـﻭﺡ‬ ‫ﺍﻟﺒﺕ ﻓﻲ ﺸﺄﻥ ﺍﻟﺘﻁﺒﻴﻕ ﺍﻟﻤﺅﻗﺕ ﻟﻤﺴﻭ‬ ‫ﺍﻟﻌﻀﻭﻴﺔ ﻭﺍﻟﻤﻌﻨﻲ ﺒﺎﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ﻋﻠﻰ ﺍﻟﻨﺤﻭ ﺍﻟﺘﺎﻟﻲ‪١:‬‬ ‫ﺘﻁﺒﻴﻕ ﻤﺸﺎﺭﻴﻊ ﺍﻟﻤﻭﺍﺩ ﺍﻟﺘﻲ ﻻ ﺘﺤﺘﻭﻱ ﻋﻠﻰ ﺃﻗﻭﺍﺱ ﺒﺸﻜل ﻤﺅﻗﺕ؛‬ ‫ﺒﺎﻟﻨﺴﺒﺔ ﺇﻟﻰ ﻤﺸﺎﺭﻴﻊ ﺍﻟﻤﻭﺍﺩ ‪ ١٠-٢‬ﻭ‪ ١١-٢‬ﻭ‪ ١٢-٢‬ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﻤﺼﻁﻠﺤﺎﺕ ﺍﻟـﺩﻭﺭﺍﺕ ﺃﻭ ﺍﻻﺠﺘﻤﺎﻋـﺎﺕ‬ ‫"ﺍﻟﻌﻠﻨﻴﺔ" ﻭ"ﺍﻟﻤﻔﺘﻭﺤﺔ" ﻭ"ﺍﻟﺴﺭﻴﺔ"‪ ،‬ﺍﻟﺘﻁﺒﻴﻕ ﺍﻟﻤﺅﻗﺕ ﻟﻸﺤﻜﺎﻡ ﺫﺍﺕ ﺍﻟﺼﻠﺔ ﺍﻟﻭﺍﺭﺩﺓ ﻓﻲ ﺍﻟﻤﺎﺩﺓ ‪ ٧‬ﻤﻥ ﺍﻟﻨﻅﺎﻡ ﺍﻟـﺩﺍﺨﻠﻲ‬ ‫ﻟﻠﻤﺠﻠﺱ ﺍﻟﺘﻨﻔﻴﺫﻱ ﻟﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻟﺘﻲ ﺍﺴﺘﻤﺩﺕ ﻤﻨﻬﺎ ﺍﻟﻌﺒﺎﺭﺍﺕ ﺍﻟﻤﺩﺭﺠﺔ ﺒﻴﻥ ﺃﻗﻭﺍﺱ؛‬ ‫ﺒﺎﻟﻨﺴﺒﺔ ﺇﻟﻰ ﻤﺸﺎﺭﻴﻊ ﺍﻟﻤﻭﺍﺩ ﻤﻥ ‪ ٦١‬ﺇﻟﻰ ‪ ٦٤‬ﺒﺸﺄﻥ ﻤﺤﺎﻀﺭ ﺍﻻﺠﺘﻤﺎﻋﺎﺕ‪ ،‬ﺍﻟﺘﻁﺒﻴﻕ ﺍﻟﻤﺅﻗﺕ ﻟﻸﺤﻜﺎﻡ ﺫﺍﺕ‬ ‫ﺍﻟﺼﻠﺔ ﺍﻟﻭﺍﺭﺩﺓ ﻓﻲ ﺍﻟﻤﻭﺍﺩ ‪ ٩٣‬ﺇﻟﻰ ‪ ٩٦‬ﻤﻥ ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ ﻟﺠﻤﻌﻴﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻟﺘﻲ ﺍﺴﺘﻤﺩﺕ ﻤﻨﻬﺎ ﺍﻟﻌﺒـﺎﺭﺍﺕ‬ ‫ﺍﻟﻭﺍﺭﺩﺓ ﺒﻴﻥ ﺃﻗﻭﺍﺱ؛‬

‫‪ ١‬ﺍﻨﻅﺭ ﺍﻟﻭﺜﻴﻘﺔ ‪.A/FCTC/COP/1/2‬‬

‫‪3‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺒﺎﻟﻨﺴﺒﺔ ﺇﻟﻰ ﻤﺸﺎﺭﻴﻊ ﺍﻟﻤﻭﺍﺩ ﻤﻥ ‪ ٧‬ﺇﻟﻰ ‪ ٩‬ﺒﺸﺄﻥ ﺒﻨﻭﺩ ﺠﺩﻭل ﺍﻷﻋﻤﺎل ﺍﻟﻤﺅﻗﺕ ﻓﻴﻤـﺎ ﻴﺘﻌﻠـﻕ ﺒﺎﻟـﺩﻭﺭﺍﺕ‬ ‫ﺍﻟﻌﺎﺩﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﺍﻟﺘﻁﺒﻴﻕ ﺍﻟﻤﺅﻗﺕ ﻟﻸﺠﺯﺍﺀ ﺍﻟﻤﺘﻀﻤﻨﺔ ﻓﻲ ﺍﻟﻤﻭﺍﺩ ﻤﻥ ‪ ٧‬ﺇﻟﻰ ‪ ٩‬ﻭﺍﻟﺘﻲ ﻻ ﺘﺭﺩ ﺒﻴﻥ ﺃﻗﻭﺍﺱ؛‬ ‫ﺒﺎﻟﻨﺴﺒﺔ ﺇﻟﻰ ﻤﺸﺭﻭﻋﻲ ﺍﻟﻤﺎﺩﺘﻴﻥ ‪ ٢-٢٧‬ﻭ‪ ٣١‬ﺒﺸﺄﻥ ﻋﻘﺩ ﺩﻭﺭﺍﺕ ﺃﻭ ﺍﺠﺘﻤﺎﻋﺎﺕ ﺍﻟﻬﻴﺌﺎﺕ ﺍﻟﻔﺭﻋﻴﺔ ﻭﻤﺅﺘﻤﺭ‬ ‫ﺍﻷﻁﺭﺍﻑ‪ ،‬ﺍﻟﺘﻁﺒﻴﻕ ﺍﻟﻤﺅﻗﺕ ﻟﻠﻤﻭﺍﺩ ﻭﺍﻟﻤﻤﺎﺭﺴﺎﺕ ﺫﺍﺕ ﺍﻟﺼﻠﺔ ﺍﻟﻭﺍﺭﺩﺓ ﻓﻲ ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ ﻟﻠﻤﺠﻠﺱ ﺍﻟﺘﻨﻔﻴﺫﻱ ﻟﻤﻨﻅﻤﺔ‬ ‫ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ؛‬ ‫ﻋﻘﺩ ﺍﻟﺠﻠﺴﺎﺕ ﺍﻟﻌﻠﻨﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻭﺠﻠﺴﺎﺕ ﺍﻟﻠﺠﻨﺘﻴﻥ ﻜﺠﻠﺴﺎﺕ ﻋﻠﻨﻴﺔ ﺒﻐـﺭﺽ ﺘـﺴﻬﻴل ﻤـﺸﺎﺭﻜﺔ‬ ‫ﺍﻟﻤﺭﺍﻗﺒﻴﻥ ﻤﺸﺎﺭﻜﺔ ﻜﺎﻤﻠﺔ ﻤﺎ ﻟﻡ ﻴﻘﺭﺭ ﺍﻟﻤﺅﺘﻤﺭ ﻏﻴﺭ ﺫﻟﻙ ﻷﺴﺒﺎﺏ ﻤﻌﻴﻨﺔ؛‬ ‫ﺒﺎﻟﻨﺴﺒﺔ ﺇﻟﻰ ﻤﺸﺭﻭﻉ ﺍﻟﻤﺎﺩﺓ ‪ ٢-٢٨‬ﺒﺸﺄﻥ ﺠﻭﺍﺯ ﻤﻤﺎﺭﺴﺔ ﺭﺌﻴﺱ ﻫﻴﺌﺔ ﻓﺭﻋﻴﺔ ﻤﺎ ﺤﻕ ﺍﻟﺘﺼﻭﻴﺕ‪ ،‬ﺍﻟﺘﻁﺒﻴﻕ‬ ‫ﺍﻟﻤﺅﻗﺕ ﻟﻠﻤﺎﺩﺓ ‪ ٣٨‬ﻤﻥ ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ ﻟﺠﻤﻌﻴﺔ ﺍﻟﺼﺤﺔ ﻤﻊ ﺇﺩﺨﺎل ﻤﺎ ﻴﻠﺯﻡ ﻤﻥ ﺘﻌﺩﻴﻼﺕ ﻋﻠﻴﻬﺎ؛‬ ‫ﺒﺎﻟﻨﺴﺒﺔ ﺇﻟﻰ ﻤﺸﺭﻭﻋﻲ ﺍﻟﻤﺎﺩﺘﻴﻥ ‪ ٢٩‬ﻭ‪ ٣٠‬ﺒﺸﺄﻥ ﺩﻋﻭﺓ ﺍﻟﻤﺭﺍﻗﺒﻴﻥ ﻭﺤـﻀﻭﺭﻫﻡ ﻭﻤـﺸﺎﺭﻜﺘﻬﻡ‪ ،‬ﺍﻟﺘﻁﺒﻴـﻕ‬ ‫ﹰ‪،‬‬ ‫ﺍﻟﻤﺅﻗﺕ ﻟﻠﻤﻭﺍﺩ ﻭﺍﻟﻤﻤﺎﺭﺴﺎﺕ ﺫﺍﺕ ﺍﻟﺼﻠﺔ ﺒﺠﻤﻌﻴﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺤﻭل ﻤﺸﺎﺭﻜﺔ ﺍﻟﺩﻭل ﺍﻟﺘـﻲ ﻟﻴـﺴﺕ ﺃﻁﺭﺍﻓـﺎ‬ ‫ﻭﺍﻟﻤﻨﻅﻤﺎﺕ ﺍﻟﺤﻜﻭﻤﻴﺔ ﺍﻟﺩﻭﻟﻴﺔ ﻭﺍﻟﻤﻨﻅﻤﺎﺕ ﻏﻴﺭ ﺍﻟﺤﻜﻭﻤﻴﺔ ﻭﺴﺎﺌﺭ ﺍﻟﻤﺭﺍﻗﺒﻴﻥ؛‬ ‫ﺒﺎﻟﻨﺴﺒﺔ ﺇﻟﻰ ﻤﺸﺭﻭﻉ ﺍﻟﻤﺎﺩﺓ ‪ ٤٩‬ﺒﺸﺄﻥ ﻁﺭﺍﺌﻕ ﻋﻤﻠﻴﺔ ﺍﺘﺨﺎﺫ ﺍﻟﻘﺭﺍﺭﺍﺕ‪ ،‬ﺍﻋﺘﻤﺎﺩ ﻜل ﺍﻟﻘﺭﺍﺭﺍﺕ ﺒﺘﻭﺍﻓﻕ ﺍﻵﺭﺍﺀ‬ ‫ﺭﻴﺜﻤﺎ ﻴﺘﻡ ﻭﻀﻊ ﺍﻟﻠﻤﺴﺎﺕ ﺍﻷﺨﻴﺭﺓ ﻋﻠﻰ ﺍﻟﻤﺎﺩﺓ ‪.٤٩‬‬ ‫)ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻟﺜﺎﻨﻴﺔ‪ ٧ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪(٢٠٠٦‬‬

‫ﻤﺩﺓ ﻭﻻﻴﺔ ﺃﻋﻀﺎﺀ ﻤﻜﺘﺏ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟـﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴـﺔ‬ ‫ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬

‫)‪FCTC/COP1(6‬‬

‫ﻗﺭﺭﺕ ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒـﺸﺄﻥ ﻤﻜﺎﻓﺤـﺔ‬ ‫‪‬ﺩﺓ ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ‪ ،‬ﺃﻥ ﻴﻅل ﺃﻋﻀﺎﺀ ﺍﻟﻤﻜﺘﺏ ﺍﻟﺫﻴﻥ ﺍﻨﺘﺨﺒﻭﺍ ﻓـﻲ ﺍﻟـﺩﻭﺭﺓ‬ ‫ﺍﻟﺘﺒﻎ‪ ،‬ﺒﻌﺩ ﺍﻟﻨﻅﺭ ﻓﻲ ﺍﻟﻤﺎﺩﺓ ‪ ٢١‬ﻤﻥ ﻤﺴﻭ‬ ‫ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ﻓﻲ ﻤﻨﺎﺼـﺒﻬﻡ ﺤﺘـﻰ‬ ‫ﺍﻨﺘﻬﺎﺀ ﺍﻟﺩﻭﺭﺓ ﺍﻟﻌﺎﺩﻴﺔ ﺍﻟﺜﺎﻨﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪.‬‬ ‫)ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻟﺜﺎﻟﺜﺔ‪ ٧ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪(٢٠٠٦‬‬

‫ﺃﻭﺭﺍﻕ ﺍﻋﺘﻤﺎﺩ ﺍﻷﻁﺭﺍﻑ‬

‫)‪FCTC/COP1(7‬‬

‫ﺍﻋﺘﺭﻓﺕ ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒـﺸﺄﻥ ﻤﻜﺎﻓﺤـﺔ‬ ‫ﺍﻟﺘﺒﻎ ﺒﺼﻼﺤﻴﺔ ﺃﻭﺭﺍﻕ ﺍﻋﺘﻤﺎﺩ ﻤﻤﺜﻠﻲ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﺎﻟﻴﻥ‪ :‬ﺃﺭﻤﻴﻨﻴﺎ؛ ﺃﺴـﺘﺭﺍﻟﻴﺎ؛ ﺍﻟﻨﻤـﺴﺎ؛ ﺁﺫﺭﺒﻴﺠـﺎﻥ؛ ﺒـﻨﻐﻼﺩﻴﺵ؛‬ ‫ﺒﺭﺒﺎﺩﻭﺱ؛ ﺒﻠﺠﻴﻜﺎ؛ ﺒﻨﻥ؛ ﺒﻭﺘﺎﻥ؛ ﺒﻭﻟﻴﻔﻴﺎ؛ ﺒﻭﺘﺴﻭﺍﻨﺎ؛ ﺍﻟﺒﺭﺍﺯﻴل؛ ﺒﺭﻭﻨﻲ ﺩﺍﺭ ﺍﻟﺴﻼﻡ؛ ﺒﻠﻐﺎﺭﻴﺎ؛ ﻜﻤﺒﻭﺩﻴﺎ؛ ﻜﻨﺩﺍ؛ ﺍﻟﺭﺃﺱ‬ ‫ﺍﻷﺨﻀﺭ؛ ﺠﻤﻬﻭﺭﻴﺔ ﺃﻓﺭﻴﻘﻴﺎ ﺍﻟﻭﺴﻁﻰ؛ ﺸﻴﻠﻲ؛ ﺍﻟﺼﻴﻥ؛ ﺠﺯﺭ ﻜﻭﻙ؛ ﻗﺒـﺭﺹ؛ ﺠﻤﻬﻭﺭﻴـﺔ ﻜﻭﺭﻴـﺎ ﺍﻟﺩﻴﻤﻘﺭﺍﻁﻴـﺔ‬ ‫ﺍﻟﺸﻌﺒﻴﺔ؛ ﺠﻤﻬﻭﺭﻴﺔ ﺍﻟﻜﻭﻨﻐﻭ ﺍﻟﺩﻴﻤﻘﺭﺍﻁﻴﺔ ﺍﻟﺸﻌﺒﻴﺔ؛ ﺍﻟﺩﺍﻨﻤﺭﻙ؛ ﺠﻴﺒﻭﺘﻲ؛ ﻤﺼﺭ؛ ﺇﺴـﺘﻭﻨﻴﺎ؛ ﺍﻟﺠﻤﺎﻋـﺔ ﺍﻷﻭﺭﻭﺒﻴـﺔ؛‬ ‫ﻓﻴﺠﻲ؛ ﻓﻨﻠﻨﺩﺍ؛ ﻓﺭﻨﺴﺎ؛ ﺃﻟﻤﺎﻨﻴﺎ؛ ﻏﺎﻨﺎ؛ ﻏﻭﺍﺘﻴﻤﺎﻻ؛ ﻫﻨﺩﻭﺭﺍﺱ؛ ﻫﻨﻐﺎﺭﻴﺎ؛ ﺃﻴﺴﻠﻨﺩﺍ؛ ﺍﻟﻬﻨﺩ؛ ﺠﻤﻬﻭﺭﻴﺔ ﺇﻴﺭﺍﻥ ﺍﻹﺴـﻼﻤﻴﺔ؛‬ ‫ﺃﻴﺭﻟﻨﺩﺍ؛ ﺇﺴﺭﺍﺌﻴل؛ ﺠﺎﻤﺎﻴﻜﺎ؛ ﺍﻟﻴﺎﺒﺎﻥ؛ ﺍﻷﺭﺩﻥ؛ ﻜﻴﻨﻴﺎ؛ ﻜﻴﺭﻴﺒﺎﺘﻲ؛ ﻻﺘﻔﻴﺎ؛ ﻟﻴﺴﻭﺘﻭ؛ ﻟﻴﺘﻭﺍﻨﻴﺎ؛ ﻟﻜـﺴﻤﺒﺭﻍ؛ ﻤﺩﻏـﺸﻘﺭ؛‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪4‬‬

‫ﻤﺎﻟﻴﺯﻴﺎ؛ ﻤﺎﻟﻁﺔ؛ ﺠﺯﺭ ﻤﺎﺭﺸﺎل؛ ﻤﻭﺭﻴﺘﺎﻨﻴﺎ؛ ﻤﻭﺭﻴﺸﻴﻭﺱ؛ ﺍﻟﻤﻜﺴﻴﻙ؛ ﻭﻻﻴﺎﺕ ﻤﻴﻜﺭﻭﻨﻴﺯﻴـﺎ ﺍﻟﻤﻭﺤـﺩﺓ؛ ﻤﻨﻐﻭﻟﻴـﺎ؛‬ ‫‪‬ﻤﺎﻥ؛ ﺒﺎﻜﺴﺘﺎﻥ؛ ﺒﺎﻻﻭ؛ ﺒﻴـﺭﻭ؛‬ ‫ﻤﻴﺎﻨﻤﺎﺭ؛ ﻨﺎﻤﻴﺒﻴﺎ؛ ﻨﺎﻭﺭﻭ؛ ﻫﻭﻟﻨﺩﺍ؛ ﻨﻴﻭﺯﻴﻠﻨﺩﺍ؛ ﺍﻟﻨﻴﺠﺭ؛ ﻨﻴﺠﻴﺭﻴﺎ؛ ﻨﻴﻭﻭﻱ؛ ﺍﻟﻨﺭﻭﻴﺞ؛ ﻋ‬ ‫ﺍﻟﻔﻠﺒﻴﻥ؛ ﺍﻟﺒﺭﺘﻐﺎل؛ ﻗﻁﺭ؛ ﺠﻤﻬﻭﺭﻴﺔ ﻜﻭﺭﻴﺎ؛ ﺭﻭﺍﻨﺩﺍ؛ ﺴﺎﻨﺕ ﻟﻭﺴﻴﺎ؛ ﺴﺎﻤﻭﺍ؛ ﺍﻟﻤﻤﻠﻜﺔ ﺍﻟﻌﺭﺒﻴﺔ ﺍﻟﺴﻌﻭﺩﻴﺔ؛ ﺍﻟـﺴﻨﻐﺎل؛‬ ‫ﺴﻴﺸﻴل؛ ﺴﻨﻐﺎﻓﻭﺭﺓ؛ ﺴﻠﻭﻓﺎﻜﻴﺎ؛ ﺴﻠﻭﻓﻴﻨﻴﺎ؛ ﺠﺯﺭ ﺴﻠﻴﻤﺎﻥ؛ ﺠﻨﻭﺏ ﺃﻓﺭﻴﻘﻴﺎ؛ ﺇﺴﺒﺎﻨﻴﺎ؛ ﺴﺭﻱ ﻻﻨﻜﺎ؛ ﺍﻟﺴﻭﺩﺍﻥ؛ ﺍﻟـﺴﻭﻴﺩ؛‬ ‫ﺘﺎﻴﻠﻨﺩ؛ ﺘﻭﻏﻭ؛ ﺘﻭﻨﻐﺎ؛ ﺘﺭﻜﻴﺎ؛ ﺘﻭﻓﺎﻟﻭ؛ ﺍﻟﻤﻤﻠﻜﺔ ﺍﻟﻤﺘﺤﺩﺓ ﻟﺒﺭﻴﻁﺎﻨﻴﺎ ﺍﻟﻌﻅﻤﻰ ﻭﺃﻴﺭﻟﻨﺩﺍ ﺍﻟﺸﻤﺎﻟﻴﺔ؛ ﺃﻭﺭﻭﻏﻭﺍﻱ؛ ﻓـﺎﻨﻭﺍﺘﻭ؛‬ ‫ﻓﻴﻴﺕ ﻨﺎﻡ‪.‬‬ ‫ﻭﻗﺩ ﻤﻨﺢ ﻤﻤﺜﻠﻭ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﺭﺩ ﺃﺴﻤﺎﺅﻫﺎ ﺃﺩﻨﺎﻩ ﺇﻤﻜﺎﻨﻴﺔ ﺍﻟﻤﺸﺎﺭﻜﺔ ﻓﻲ ﺍﻟﺩﻭﺭﺓ ﺒﺸﻜل ﻤﺅﻗﺕ ﺒﺘﺨﻭﻴﻠﻬﻡ ﻤﻤﺎﺭﺴـﺔ‬ ‫ﻜل ﺍﻟﺤﻘﻭﻕ ﻓﻲ ﺍﻟﻤﺅﺘﻤﺭ ﻓﻲ ﺍﻨﺘﻅﺎﺭ ﻭﺭﻭﺩ ﺃﻭﺭﺍﻕ ﺍﻋﺘﻤﺎﺩﻫﻡ ﺍﻟﺭﺴﻤﻴﺔ‪:‬‬ ‫ﺒﻴﻼﺭﻭﺱ؛ ﺍﻟﺠﻤﺎﻫﻴﺭﻴﺔ ﺍﻟﻌﺭﺒﻴﺔ ﺍﻟﻠﻴﺒﻴﺔ؛ ﻤﻠﺩﻴﻑ؛ ﻤﺎﻟﻲ؛ ﺒﻨﻤﺎ؛ ﺍﻟﺠﻤﻬﻭﺭﻴﺔ ﺍﻟﻌﺭﺒﻴﺔ ﺍﻟـﺴﻭﺭﻴﺔ؛ ﺍﻹﻤـﺎﺭﺍﺕ ﺍﻟﻌﺭﺒﻴـﺔ‬ ‫ﺍﻟﻤﺘﺤﺩﺓ‪.‬‬ ‫)ﺍﻟﺠﻠﺴﺘﺎﻥ ﺍﻟﻌﺎﻤﺘﺎﻥ ﺍﻟﺜﺎﻟﺜﺔ ﻭﺍﻟﺨﺎﻤﺴﺔ‪ ٧ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪(٢٠٠٦‬‬

‫ﺍﻋﺘﻤﺎﺩ ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤـﺔ ﺍﻟـﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴـﺔ‬ ‫ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬

‫)‪FCTC/COP1(8‬‬

‫ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ ﺍﻟﻤﺒﻴﻥ ﻓﻲ ﺍﻟﻤﺭﻓﻕ‪.‬‬

‫ﺍﻋﺘﻤﺩ‬

‫ﺍﻟﻤﺭﻓﻕ‬ ‫ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ ‫ﺍﻻﻨﻁﺒﺎﻕ‬ ‫ﺍﻟﻤﺎﺩﺓ ‪١‬‬ ‫ﻴﺴﺭﻱ ﻫﺫﺍ ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ ﻋﻠﻰ ﺩﻭﺭﺍﺕ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪.‬‬

‫ﺍﻟﺘﻌﺎﺭﻴﻑ‬ ‫ﺍﻟﻤﺎﺩﺓ ‪٢‬‬ ‫ﻷﻏﺭﺍﺽ ﻫﺫﺍ ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ‪:‬‬ ‫ﺘﻌﻨﻲ ﻜﻠﻤﺔ "ﺍﻻﺘﻔﺎﻗﻴﺔ" ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪ ،‬ﺍﻟﻤﻌﺘﻤﺩﺓ ﻓﻲ ﺠﻨﻴـﻑ‬ ‫‪-١‬‬ ‫ﺒﺘﺎﺭﻴﺦ ‪ ٢١‬ﺃﻴﺎﺭ‪ /‬ﻤﺎﻴﻭ ‪٢٠٠٣‬؛‬ ‫ﺘﻌﻨﻲ ﻜﻠﻤﺔ "ﺍﻷﻁﺭﺍﻑ" ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﻻﺘﻔﺎﻗﻴﺔ؛‬ ‫‪-٢‬‬

‫‪5‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬ ‫ﺘﻌﻨﻲ ﻋﺒﺎﺭﺓ "ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ" ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺍﻟﻤﻨﺸﺄ ﺒﻤﻭﺠﺏ ﺍﻟﻤﺎﺩﺓ ‪ ٢٣‬ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ؛‬ ‫‪-٣‬‬

‫ﺎ ﻟﻠﻤﺎﺩﺓ ‪ ٢٣‬ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴـﺔ‬ ‫ﺘﻌﻨﻲ ﻜﻠﻤﺔ "ﺍﻟﺩﻭﺭﺓ" ﺃﻴﺔ ﺩﻭﺭﺓ ﻋﺎﺩﻴﺔ ﺃﻭ ﺍﺴﺘﺜﻨﺎﺌﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺘﻨﻌﻘﺩ ﻭﻓﻘﹰ‬ ‫‪-٤‬‬ ‫ﻭﻫﺫﺍ ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ؛‬ ‫ﺘﻌﻨﻲ ﻋﺒﺎﺭﺓ "ﻤﻨﻅﻤﺔ ﺍﻟﺘﻜﺎﻤل ﺍﻻﻗﺘﺼﺎﺩﻱ ﺍﻹﻗﻠﻴﻤﻲ" ﺃﻴﺔ ﻤﻨﻅﻤﺔ ﻭﺭﺩ ﺘﻌﺭﻴﻔﻬـﺎ ﻓـﻲ ﺍﻟﻤـﺎﺩﺓ ‪)١‬ﺏ( ﻤـﻥ‬ ‫ﺎ ﻟﻠﻔﻘﺭﺓ ‪ ١‬ﻤﻥ ﺍﻟﻤﺎﺩﺓ ‪ ٢١‬ﻤﻥ ﻫـﺫﺍ ﺍﻟﻨﻅـﺎﻡ‬ ‫ﺘﻌﻨﻲ ﻜﻠﻤﺔ "ﺍﻟﺭﺌﻴﺱ" ﺭﺌﻴﺱ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺍﻟﻤﻨﺘﺨﺏ ﻭﻓﻘﹰ‬ ‫ﺘﻌﻨﻲ ﻜﻠﻤﺔ "ﺍﻷﻤﺎﻨﺔ" ﺍﻷﻤﺎﻨﺔ ﺍﻟﻤﻨﺸﺄﺓ ﺒﻤﻭﺠﺏ ﺍﻟﻔﻘﺭﺓ ‪ ١‬ﻤﻥ ﺍﻟﻤﺎﺩﺓ ‪ ٢٤‬ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ؛‬ ‫ﺘﻌﻨﻲ ﻋﺒﺎﺭﺓ "ﺍﻟﻬﻴﺌﺔ ﺍﻟﻔﺭﻋﻴﺔ" ﺃﻴﺔ ﻫﻴﺌﺔ ﻴﺘﻡ ﺘﺸﻜﻴﻠﻬﺎ ﻋﻤ ﹰ‬ ‫ﻼ ﺒﺄﺤﻜﺎﻡ ﺍﻟﻔﻘﺭﺓ ‪)٥‬ﻭ( ﻤﻥ ﺍﻟﻤﺎﺩﺓ ‪ ٢٣‬ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ؛‬ ‫‪-٥‬‬ ‫ﺍﻻﺘﻔﺎﻗﻴﺔ؛‬ ‫‪-٦‬‬ ‫ﺍﻟﺩﺍﺨﻠﻲ؛‬ ‫‪-٧‬‬ ‫‪-٨‬‬

‫ﺘﻌﻨﻲ ﻋﺒﺎﺭﺓ "ﺍﻷﻁﺭﺍﻑ ﺍﻟﺤﺎﻀﺭﺓ ﻭﺍﻟﻤﺼﻭﺘﺔ" ﺍﻷﻁﺭﺍﻑ ﺍﻟﺤﺎﻀﺭﺓ ﻓﻲ ﺃﻱ ﺍﺠﺘﻤﺎﻉ ﻴﺠﺭﻱ ﻓﻴﻪ ﺘـﺼﻭﻴﺕ‬ ‫‪-٩‬‬ ‫ﻭﺍﻟﺘﻲ ﺘﺩﻟﻲ ﺒﺼﻭﺕ ﻤﺅﻴﺩ ﺃﻭ ﻤﻌﺎﺭﺽ ﺼﺎﻟﺢ ﺤﺴﺏ ﺍﻷﺼﻭل‪ .‬ﻭﺘﻌﺘﺒﺭ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻤﺘﻨـﻊ ﻋـﻥ ﺍﻟﺘـﺼﻭﻴﺕ‬ ‫ﺎ ﻏﻴﺭ ﻤﺼﻭﺘﺔ؛‬ ‫ﺃﻁﺭﺍﻓﹰ‬ ‫‪ -١٠‬ﺘﻌﻨﻲ ﻋﺒﺎﺭﺓ ﺍﻟﺩﻭﺭﺍﺕ ﺃﻭ ﺍﻻﺠﺘﻤﺎﻋﺎﺕ "ﺍﻟﻌﻠﻨﻴﺔ" ﺍﻟﺩﻭﺭﺍﺕ ﺃﻭ ﺍﻻﺠﺘﻤﺎﻋﺎﺕ ﺍﻟﺘﻲ ﻴﺘﺎﺡ ﺤﻀﻭﺭﻫﺎ ﻟﻸﻁﺭﺍﻑ‪،‬‬ ‫ﹰ‪ ،‬ﻭﺍﻷﻤﺎﻨﺔ ﻭﺍﻟﻤﻨﻅﻤﺎﺕ ﺍﻟﺤﻜﻭﻤﻴﺔ ﺍﻟﺩﻭﻟﻴﺔ ﻭﻏﻴﺭ‬ ‫ﻭﺍﻟﺩﻭل ﻭﻤﻨﻅﻤﺎﺕ ﺍﻟﺘﻜﺎﻤل ﺍﻻﻗﺘﺼﺎﺩﻱ ﺍﻹﻗﻠﻴﻤﻲ ﺍﻟﺘﻲ ﻟﻴﺴﺕ ﺃﻁﺭﺍﻓﺎ‬ ‫ﻼ ﺒﺎﻟﻤﺎﺩﺓ ‪ ،٣١‬ﻭﻋﺎﻤﺔ ﺍﻟﺠﻤﻬﻭﺭ؛‬ ‫ﺍﻟﺤﻜﻭﻤﻴﺔ ﺍﻟﻤﻌﺘﻤﺩﺓ ﻤﻥ ﻗﺒل ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻋﻤ ﹰ‬ ‫ﹸﻌﻘﺩ ﻟﻐﺭﺽ ﻤﺤﺩﺩ ﻭﻓـﻲ‬ ‫‪ -١١‬ﺘﻌﻨﻲ ﻋﺒﺎﺭﺓ ﺍﻟﺩﻭﺭﺍﺕ ﺃﻭ ﺍﻻﺠﺘﻤﺎﻋﺎﺕ "ﺍﻟﺴﺭﻴﺔ" ﺍﻟﺩﻭﺭﺍﺕ ﺃﻭ ﺍﻻﺠﺘﻤﺎﻋﺎﺕ ﺍﻟﺘﻲ ﺘ‬ ‫ﻅﺭﻭﻑ ﺍﺴﺘﺜﻨﺎﺌﻴﺔ‪ ،‬ﻭﻴﺘﺎﺡ ﺤﻀﻭﺭﻫﺎ ﻟﻸﻁﺭﺍﻑ ﻭﻤﻭﻅﻔﻲ ﺍﻷﻤﺎﻨﺔ ﺍﻷﺴﺎﺴﻴﻴﻥ‪.‬‬

‫ﺍﻟﺩﻭﺭﺍﺕ‬ ‫ﺍﻟﻤﺎﺩﺓ ‪٣‬‬ ‫ﺘﻌﻘﺩ ﺩﻭﺭﺍﺕ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﻤﻘﺭ ﺍﻷﻤﺎﻨﺔ‪ ،‬ﺇﻻ ﺇﺫﺍ ﻗﺭﺭ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻏﻴﺭ ﺫﻟﻙ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٤‬‬ ‫ﺎ ﺇﻻ ﺇﺫﺍ ﻗﺭﺭ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻏﻴﺭ ﺫﻟﻙ‪،‬‬ ‫ﺘﻌﻘﺩ ﺍﻟﺩﻭﺭﺘﺎﻥ ﺍﻟﻌﺎﺩﻴﺘﺎﻥ ﺍﻟﺜﺎﻨﻴﺔ ﻭﺍﻟﺜﺎﻟﺜﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺴﻨﻭﻴﹰ‬ ‫‪-١‬‬ ‫ﻭﺒﻌﺩ ﺫﻟﻙ‪ ،‬ﺘﻌﻘﺩ ﺍﻟﺩﻭﺭﺍﺕ ﺍﻟﻌﺎﺩﻴﺔ ﻜل ﺴﻨﺘﻴﻥ‪.‬‬ ‫ﻴﻘﺭﺭ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﻓﻲ ﻜل ﺩﻭﺭﺓ ﻋﺎﺩﻴﺔ‪ ،‬ﺘﺎﺭﻴﺦ ﻭﻤﺩﺓ ﺍﻟﺩﻭﺭﺓ ﺍﻟﻌﺎﺩﻴـﺔ ﺍﻟﺘﺎﻟﻴـﺔ‪ .‬ﻭﻴـﺴﻌﻰ ﻤـﺅﺘﻤﺭ‬ ‫‪-٢‬‬ ‫ﺍﻷﻁﺭﺍﻑ ﺇﻟﻰ ﻋﺩﻡ ﻋﻘﺩ ﺩﻭﺭﺍﺕ ﻤﻥ ﻫﺫﺍ ﺍﻟﻘﺒﻴل ﻓﻲ ﻭﻗﺕ ﻴﺼﻌﺏ ﻓﻴﻪ ﺤﻀﻭﺭﻫﺎ ﻋﻠﻰ ﻋﺩﺩ ﻫﺎﻡ ﻤﻥ ﺍﻟﻭﻓﻭﺩ‪.‬‬ ‫ﺘﻌﻘﺩ ﺍﻟﺩﻭﺭﺍﺕ ﺍﻻﺴﺘﺜﻨﺎﺌﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺃﻴﺔ ﺃﻭﻗﺎﺕ ﺃﺨﺭﻯ ﻴﺭﻯ ﺍﻟﻤﺅﺘﻤﺭ ﺃﻨﻬﺎ ﻀﺭﻭﺭﻴﺔ‪ ،‬ﺃﻭ ﺒﻨﺎﺀ‬ ‫‪-٣‬‬ ‫ﻋﻠﻰ ﻁﻠﺏ ﺨﻁﻲ ﻴﻘﺩﻤﻪ ﺃﻱ ﻁﺭﻑ‪ ،‬ﺸﺭﻴﻁﺔ ﺃﻥ ﻴﺅﻴﺩ ﻫﺫﺍ ﺍﻟﻁﻠﺏ‪ ،‬ﻓﻲ ﻏﻀﻭﻥ ﺴﺘﺔ ﺃﺸﻬﺭ ﻤﻥ ﺇﺭﺴﺎل ﺍﻟﻁﻠﺏ ﺇﻟﻴﻬﺎ‬ ‫ﻤﻥ ﻗﺒل ﺍﻷﻤﺎﻨﺔ‪ ،‬ﺜﻠﺙ ﺍﻷﻁﺭﺍﻑ ﻋﻠﻰ ﺍﻷﻗل‪.‬‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪6‬‬

‫ﺎ‬ ‫ﺀ ﻋﻠﻰ ﻁﻠﺏ ﺨﻁﻲ ﻴﻘﺩﻤﻪ ﺃﺤﺩ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﻤﻭﻋﺩ ﻻ ﻴﺘﺠﺎﻭﺯ ﺴﺘﻴﻥ ﻴﻭﻤـﹰ‬ ‫ﺘﻌﻘﺩ ﺍﻟﺩﻭﺭﺍﺕ ﺍﻻﺴﺘﺜﻨﺎﺌﻴﺔ ﺒﻨﺎ ‪‬‬ ‫‪-٤‬‬ ‫ﻼ ﺒﺎﻟﻔﻘﺭﺓ ‪ ٣‬ﺃﻋﻼﻩ‪.‬‬ ‫ﻤﻥ ﺘﺎﺭﻴﺦ ﺘﺄﻴﻴﺩ ﺜﻠﺙ ﺍﻷﻁﺭﺍﻑ ﻋﻠﻰ ﺍﻷﻗل ﻟﻬﺫﺍ ﺍﻟﻁﻠﺏ ﻋﻤ ﹰ‬

‫ﺍﻟﻤﺎﺩﺓ ‪٥‬‬ ‫ﺎ ﻋﻠﻰ ﺍﻷﻗـل‬ ‫ﺘﻘﻭﻡ ﺍﻷﻤﺎﻨﺔ ﺒﺈﺒﻼﻍ ﺠﻤﻴﻊ ﺍﻷﻁﺭﺍﻑ ﺒﻤﻭﺍﻋﻴﺩ ﻭﻤﻜﺎﻥ ﺍﻨﻌﻘﺎﺩ ﺍﻟﺩﻭﺭﺍﺕ ﺍﻟﻌﺎﺩﻴﺔ ﻗﺒل ﺴﺘﻴﻥ ﻴﻭﻤﹰ‬ ‫ﺎ ﻋﻠﻰ ﺍﻷﻗل ﻤﻥ ﺘﺎﺭﻴﺦ ﺍﻨﻌﻘﺎﺩ ﺍﻟﺩﻭﺭﺍﺕ ﺍﻻﺴﺘﺜﻨﺎﺌﻴﺔ‪.‬‬ ‫ﻤﻥ ﺘﺎﺭﻴﺦ ﺍﻨﻌﻘﺎﺩﻫﺎ‪ ،‬ﻭﻗﺒل ﺜﻼﺜﻴﻥ ﻴﻭﻤﹰ‬

‫ﺠﺩﻭل ﺍﻷﻋﻤﺎل‬ ‫ﺍﻟﻤﺎﺩﺓ ‪٦‬‬ ‫ﺘﻘﻭﻡ ﺍﻷﻤﺎﻨﺔ‪ ،‬ﺒﺎﻟﺘﺸﺎﻭﺭ ﻤﻊ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ‪ ،‬ﺒﺈﻋﺩﺍﺩ ﺠﺩﻭل ﺍﻷﻋﻤﺎل ﺍﻟﻤﺅﻗﺕ ﻟﻜل ﺩﻭﺭﺓ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٧‬‬ ‫ﻴﺘﻀﻤﻥ ﺠﺩﻭل ﺍﻷﻋﻤﺎل ﺍﻟﻤﺅﻗﺕ ﻟﻜل ﺩﻭﺭﺓ ﻋﺎﺩﻴﺔ‪ ،‬ﺤﺴﺏ ﺍﻻﻗﺘﻀﺎﺀ‪ ،‬ﻤﺎ ﻴﻠﻲ‪:‬‬ ‫ﺍﻟﺒﻨﻭﺩ ﺍﻟﻨﺎﺸﺌﺔ ﻋﻥ ﻤﻭﺍﺩ ﺍﻻﺘﻔﺎﻗﻴﺔ‪ ،‬ﺒﻤﺎ ﻓﻴﻬﺎ ﺍﻟﺒﻨﻭﺩ ﺍﻟﻤﺤﺩﺩﺓ ﻓﻲ ﺍﻟﻤﺎﺩﺓ ‪ ٢٣‬ﻤﻨﻬﺎ؛‬ ‫ﺍﻟﺒﻨﻭﺩ ﺍﻟﺘﻲ ﺘﻘﺭﺭ ﺇﺩﺭﺍﺠﻬﺎ ﻓﻲ ﺩﻭﺭﺓ ﺴﺎﺒﻘﺔ؛‬ ‫ﺍﻟﺒﻨﻭﺩ ﺍﻟﻭﺍﺭﺩ ﺫﻜﺭﻫﺎ ﻓﻲ ﺍﻟﻤﺎﺩﺓ ‪١٣‬؛‬ ‫ﺍﻟﻤﻴﺯﺍﻨﻴﺔ ﺍﻟﻤﻘﺘﺭﺤﺔ ﻭﻜﺫﻟﻙ ﺠﻤﻴﻊ ﺍﻟﻤﺴﺎﺌل ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﺎﻟﺤﺴﺎﺒﺎﺕ ﻭﺍﻟﺘﺭﺘﻴﺒﺎﺕ ﺍﻟﻤﺎﻟﻴﺔ؛‬ ‫ﻼ ﺒﺎﻹﺠﺭﺍﺀﺍﺕ ﺍﻟﺘﻲ ﻴﻘﺭﻫﺎ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ؛‬ ‫ﺘﻘﺎﺭﻴﺭ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻘﺩﻡ ﻋﻤ ﹰ‬ ‫ﺍﻟﺘﻘﺎﺭﻴﺭ ﺍﻟﻤﻘﺩﻤﺔ ﻤﻥ ﺍﻟﻬﻴﺌﺎﺕ ﺍﻟﻔﺭﻋﻴﺔ؛‬ ‫)ﺃ(‬ ‫)ﺏ(‬ ‫)ﺝ(‬ ‫)ﺩ(‬ ‫)ﻫ(‬ ‫)ﻭ(‬

‫ﺃﻱ ﺒﻨﺩ ﺁﺨﺭ ﺫﻱ ﺼﻠﺔ ﺒﺘﻨﻔﻴﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻴﻘﺘﺭﺤﻪ ﺃﺤﺩ ﺍﻷﻁﺭﺍﻑ ﻭﺘﺘﻠﻘﺎﻩ ﺍﻷﻤﺎﻨﺔ ﻗﺒل ﺘﻌﻤﻴﻡ ﺠـﺩﻭل‬ ‫)ﺯ(‬ ‫ﺍﻷﻋﻤﺎل ﺍﻟﻤﺅﻗﺕ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٨‬‬ ‫ﻓﻴﻤﺎ ﻴﺨﺹ ﻜل ﺩﻭﺭﺓ ﻋﺎﺩﻴﺔ ﺘﻭﺯﻉ ﺍﻷﻤﺎﻨﺔ ﻋﻠﻰ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﻭﻋﻠﻰ ﺍﻟﻤﺭﺍﻗﺒﻴﻥ ﺍﻟﻤﺩﻋﻭﻴﻥ ﻟﺤﻀﻭﺭ ﺍﻟـﺩﻭﺭﺓ‬ ‫ﻼ ﺒﺎﻟﻤﻭﺍﺩ ‪ ٢٩‬ﻭ‪ ٣٠‬ﻭ‪ ،٣١‬ﺠﺩﻭل ﺍﻷﻋﻤﺎل ﺍﻟﻤﺅﻗﺕ ﻤﻊ ﻭﺜﺎﺌﻕ ﺍﻟﻤﺅﺘﻤﺭ ﺍﻷﺨﺭﻯ ﺒﺎﻟﻠﻐﺎﺕ ﺍﻟﺭﺴﻤﻴﺔ‪ ،‬ﻗﺒل ﻤﻭﻋـﺩ‬ ‫ﻋﻤ ﹰ‬ ‫ﺎ ﻋﻠﻰ ﺍﻷﻗل‪.‬‬ ‫ﺍﻓﺘﺘﺎﺡ ﺃﻋﻤﺎل ﺍﻟﺩﻭﺭﺓ ﺒﺴﺘﻴﻥ ﻴﻭﻤﹰ‬

‫‪7‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺍﻟﻤﺎﺩﺓ ‪٩‬‬ ‫ﺘﺩﺭﺝ ﺍﻷﻤﺎﻨﺔ ﻓﻲ ﺠﺩﻭل ﺃﻋﻤﺎل ﻤﺅﻗﺕ ﺘﻜﻤﻴﻠﻲ‪ ،‬ﺒﺎﻟﺘﺸﺎﻭﺭ ﻤﻊ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ‪ ،‬ﺃﻱ ﺒﻨﺩ ﻴﻘﺘﺭﺤﻪ ﺃﺤﺩ ﺍﻷﻁﺭﺍﻑ‬ ‫ﻭﺘﺘﻠﻘﺎﻩ ﺍﻷﻤﺎﻨﺔ ﺒﻌﺩ ﺇﺭﺴﺎل ﺠﺩﻭل ﺍﻷﻋﻤﺎل ﺍﻟﻤﺅﻗﺕ ﻟﻠﺩﻭﺭﺓ ﺍﻟﻌﺎﺩﻴﺔ‪ ،‬ﻋﻠﻰ ﺃﻥ ﻴﻜﻭﻥ ﺫﻟﻙ ﻗﺒل ‪ ١٠‬ﺃﻴﺎﻡ ﻤﻥ ﻴﻭﻡ ﺍﻓﺘﺘﺎﺡ‬ ‫ﺃﻋﻤﺎل ﺍﻟﺩﻭﺭﺓ‪ ،‬ﺸﺭﻴﻁﺔ ﺃﻥ ﻴﻨﺩﺭﺝ ﺍﻟﺒﻨﺩ ﻀﻤﻥ ﻨﻁﺎﻕ ﺍﻟﻤﺎﺩﺓ ‪ ٧‬ﻤﻥ ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪١٠‬‬ ‫ﻴﺒﺤﺙ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺠﺩﻭل ﺍﻷﻋﻤﺎل ﺍﻟﻤﺅﻗﺕ ﺒﺎﻹﻀﺎﻓﺔ ﺇﻟﻰ ﺃﻱ ﺠﺩﻭل ﺃﻋﻤﺎل ﻤﺅﻗﺕ ﺘﻜﻤﻴﻠﻲ ﻭﻴﺠـﻭﺯ‬ ‫ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﻟﺩﻯ ﺇﻗﺭﺍﺭ ﺠﺩﻭل ﺍﻷﻋﻤﺎل ﻷﻴﺔ ﺩﻭﺭﺓ ﻋﺎﺩﻴﺔ‪ ،‬ﺃﻥ ﻴﻘﺭﺭ ﺇﻀﺎﻓﺔ ﺒﻨﻭﺩ ﺃﻭ ﺤﺫﻓﻬﺎ ﺃﻭ ﺘﺄﺠﻴﻠﻬـﺎ ﺃﻭ‬ ‫ﺘﻌﺩﻴﻠﻬﺎ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪١١‬‬

‫ﻻ ﻴﺘﻀﻤﻥ ﺠﺩﻭل ﺍﻷﻋﻤﺎل ﺍﻟﻤﺅﻗﺕ ﻷﻴﺔ ﺩﻭﺭﺓ ﺍﺴﺘﺜﻨﺎﺌﻴﺔ ﺇﻻ ﺍﻟﺒﻨﻭﺩ ﺍﻟﺘﻲ ﻴﻘﺘﺭﺡ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺍﻟﻨﻅـﺭ‬ ‫‪‬ﻉ ﺠﺩﻭل‬ ‫ﻓﻴﻬﺎ ﻓﻲ ﺩﻭﺭﺓ ﻋﺎﺩﻴﺔ ﺃﻭ ﺍﻟﺒﻨﻭﺩ ﺍﻟﻭﺍﺭﺩﺓ ﻓﻲ ﻁﻠﺏ ﻜﺘﺎﺒﻲ ﻤﻥ ﺃﺤﺩ ﺍﻷﻁﺭﺍﻑ ﺒﻌﻘﺩ ﺍﻟﺩﻭﺭﺓ ﺍﻻﺴﺘﺜﻨﺎﺌﻴﺔ‪ .‬ﻭﻴﻭﺯ‬ ‫ﺍﻷﻋﻤﺎل ﺍﻟﻤﺅﻗﺕ ﻋﻠﻰ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﻟﻭﻗﺕ ﺫﺍﺘﻪ ﺍﻟﺫﻱ ﻴﻭﺯﻉ ﻓﻴﻪ ﺍﻹﺨﻁﺎﺭ ﻟﺤﻀﻭﺭ ﺍﻟﺩﻭﺭﺓ ﺍﻻﺴﺘﺜﻨﺎﺌﻴﺔ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪١٢‬‬ ‫ﺍ ﻋﻥ ﺍﻵﺜﺎﺭ ﺍﻹﺩﺍﺭﻴﺔ ﻭﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﺎﻟﻤﻴﺯﺍﻨﻴﺔ ﺍﻟﻤﺘﺭﺘﺒﺔ ﻋﻠﻰ ﺠﻤﻴـﻊ‬ ‫ﺘﻘﺩﻡ ﺍﻷﻤﺎﻨﺔ ﺇﻟﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺘﻘﺭﻴﺭﹰ‬ ‫‪-١‬‬ ‫ﺒﻨﻭﺩ ﺠﺩﻭل ﺍﻷﻋﻤﺎل ﺍﻟﻤﻭﻀﻭﻋﻴﺔ ﺍﻟﻤﻌﺭﻭﻀﺔ ﻋﻠﻰ ﺍﻟﺩﻭﺭﺓ ﻗﺒل ﺃﻥ ﻴﺘﻭﻟﻰ ﺍﻟﻤﺅﺘﻤﺭ ﺍﻟﻨﻅﺭ ﻓﻴﻬﺎ‪.‬‬ ‫ﻻ ﻴﻨﻅﺭ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﻫﺫﻩ ﺍﻟﺒﻨﻭﺩ ﺇﻻ ﺒﻌﺩ ﻤﻀﻲ ﺜﻤﺎﻥ ﻭﺃﺭﺒﻌﻴﻥ ﺴﺎﻋﺔ ﻋﻠﻰ ﺍﻷﻗل ﻤـﻥ ﺘـﺎﺭﻴﺦ‬ ‫‪-٢‬‬ ‫ﺍﺴﺘﻼﻤﻪ ﺘﻘﺭﻴﺭ ﺍﻷﻤﺎﻨﺔ ﻋﻥ ﺍﻵﺜﺎﺭ ﺍﻹﺩﺍﺭﻴﺔ ﻭﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﺎﻟﻤﻴﺯﺍﻨﻴﺔ‪ ،‬ﻤﺎ ﻟﻡ ﻴﻘﺭﺭ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻏﻴﺭ ﺫﻟﻙ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪١٣‬‬ ‫ﺎ ﻓﻲ ﺠﺩﻭل ﺍﻷﻋﻤﺎل ﺍﻟﻤﺅﻗﺕ ﻟﻠﺩﻭﺭﺓ ﺍﻟﻌﺎﺩﻴﺔ ﺍﻟﺘﺎﻟﻴﺔ ﺃﻱ ﺒﻨﺩ ﻤﻥ ﺒﻨﻭﺩ ﺠﺩﻭل ﺍﻷﻋﻤﺎل ﻟﻠـﺩﻭﺭﺓ‬ ‫ﻴﺩﺭﺝ ﺘﻠﻘﺎﺌﻴﹰ‬ ‫ﺍﻟﻌﺎﺩﻴﺔ ﺍﻟﺘﻲ ﻟﻡ ﺘﻨﻅﺭ ﻓﻴﻪ ﺃﻭ ﻟﻡ ﺘﻨﺘﻪ ﻤﻥ ﺍﻟﻨﻅﺭ ﻓﻴﻪ ﺨﻼل ﺍﻟﺩﻭﺭﺓ‪ ،‬ﻤﺎ ﻟﻡ ﻴﻘﺭﺭ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻏﻴﺭ ﺫﻟﻙ‪.‬‬

‫ﺍﻷﻤﺎﻨﺔ‬ ‫ﺍﻟﻤﺎﺩﺓ ‪١٤‬‬ ‫ﻴﻌﻤل ﺭﺌﻴﺱ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ‪ ،‬ﺃﻭ ﻤﻤﺜل ﺭﺌﻴﺱ ﺍﻷﻤﺎﻨﺔ‪ ،‬ﺒﻬﺫﻩ ﺍﻟﺼﻔﺔ ﻓﻲ ﺠﻤﻴﻊ ﺩﻭﺭﺍﺕ ﻤﺅﺘﻤﺭ ﺍﻷﻁـﺭﺍﻑ‬ ‫‪-١‬‬ ‫ﻭﻫﻴﺌﺎﺘﻪ ﺍﻟﻔﺭﻋﻴﺔ‪.‬‬ ‫ﻴﺘﻭﻟﻰ ﺭﺌﻴﺱ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺃﻤﺭ ﺘﺩﺒﻴﺭ ﺍﻟﻤﻭﻅﻔﻴﻥ ﻭﺍﻟﺨﺩﻤﺎﺕ ﺍﻟﻼﺯﻤﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻭﻫﻴﺌﺎﺘﻪ ﺍﻟﻔﺭﻋﻴﺔ‪،‬‬ ‫‪-٢‬‬ ‫ﻓﻲ ﺤﺩﻭﺩ ﺍﻟﻤﻭﺍﺭﺩ ﺍﻟﻤﺘﺎﺤﺔ‪ .‬ﻭﻴﺩﻴﺭ ﺭﺌﻴﺱ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻭﻴﻭﺠﻪ ﻫﺅﻻﺀ ﺍﻟﻤﻭﻅﻔﻴﻥ ﻭﺘﻠﻙ ﺍﻟﺨﺩﻤﺎﺕ ﻭﻴـﻭﻓﺭ ﺍﻟـﺩﻋﻡ‬ ‫ﻭﺍﻟﻤﺸﻭﺭﺓ ﺍﻟﻤﻨﺎﺴﺒﻴﻥ ﻟﻤﻜﺘﺏ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻭﻫﻴﺌﺎﺘﻪ ﺍﻟﻔﺭﻋﻴﺔ‪.‬‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪8‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪١٥‬‬ ‫ﺎ ﻟﻬﺫﺍ ﺍﻟﻨﻅـﺎﻡ‪ ،‬ﺍﻟﻤﻬـﺎﻡ‬ ‫ﺒﺎﻹﻀﺎﻓﺔ ﺇﻟﻰ ﺍﻟﻭﻅﺎﺌﻑ ﺍﻟﻤﺤﺩﺩﺓ ﻓﻲ ﺍﻟﻤﺎﺩﺓ ‪ ٢٤‬ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺘﺘﻭﻟﻰ ﺍﻷﻤﺎﻨﺔ‪ ،‬ﻭﻓﻘﹰ‬ ‫ﺍﺘﺨﺎﺫ ﺍﻟﺘﺭﺘﻴﺒﺎﺕ ﺍﻟﺨﺎﺼﺔ ﺒﺘﻭﻓﻴﺭ ﺍﻟﺘﺭﺠﻤﺔ ﺍﻟﻔﻭﺭﻴﺔ ﻓﻲ ﺍﻟﺩﻭﺭﺓ؛‬ ‫ﹼﻘﻲ ﻭﺜﺎﺌﻕ ﺍﻟﺩﻭﺭﺓ ﻭﺘﺭﺠﻤﺘﻬﺎ ﻭﺍﺴﺘﻨﺴﺎﺨﻬﺎ ﻭﺘﻭﺯﻴﻌﻬﺎ؛‬ ‫ﺘﻠ‬ ‫ﻨﺸﺭ ﺍﻟﻭﺜﺎﺌﻕ ﺍﻟﺭﺴﻤﻴﺔ ﻟﻠﺩﻭﺭﺓ ﻭﺘﻭﺯﻴﻌﻬﺎ؛‬ ‫ﺇﻋﺩﺍﺩ ﺍﻟﺴﺠﻼﺕ ﺍﻟﺨﺎﺼﺔ ﺒﺎﻟﺩﻭﺭﺓ ﻭﺍﺘﺨﺎﺫ ﺍﻟﺘﺭﺘﻴﺒﺎﺕ ﻟﺤﻔﻅﻬﺎ؛‬ ‫ﺍﺘﺨﺎﺫ ﺍﻟﺘﺭﺘﻴﺒﺎﺕ ﻹﻴﺩﺍﻉ ﻭﺜﺎﺌﻕ ﺍﻟﺩﻭﺭﺓ ﻭﺤﻔﻅﻬﺎ؛‬ ‫ﺃﺩﺍﺀ ﻜل ﺍﻟﻤﻬﺎﻡ ﺍﻷﺨﺭﻯ ﺍﻟﺘﻲ ﻗﺩ ﻴﻁﻠﺒﻬﺎ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪.‬‬ ‫)ﺃ(‬ ‫)ﺏ(‬ ‫)ﺝ(‬ ‫)ﺩ(‬ ‫)ﻫ(‬ ‫)ﻭ(‬ ‫ﺍﻟﺘﺎﻟﻴﺔ‪:‬‬

‫ﺍﻟﺘﻤﺜﻴل ﻭﻭﺜﺎﺌﻕ ﺍﻟﺘﻔﻭﻴﺽ‬ ‫ﺍﻟﻤﺎﺩﺓ ‪١٦‬‬ ‫ﻴﻤﺜل ﻜل ﻁﺭﻑ ﻤﺸﺘﺭﻙ ﻓﻲ ﺩﻭﺭﺓ ﻤﻥ ﺍﻟﺩﻭﺭﺍﺕ ﺒﻭﻓﺩ ﻴﺘﺄﻟﻑ ﻤﻥ ﺭﺌﻴﺱ ﺍﻟﻭﻓﺩ ﻭﺴﺎﺌﺭ ﻤـﻥ ﺘـﺩﻋﻭ ﺇﻟﻴـﻪ‬ ‫ﺍﻟﺤﺎﺠﺔ ﻤﻥ ﺍﻟﻤﻤﺜﻠﻴﻥ ﻭﺍﻟﻤﻤﺜﻠﻴﻥ ﺍﻟﻤﻨﺎﻭﺒﻴﻥ ﻭﺍﻟﻤﺴﺘﺸﺎﺭﻴﻥ ﺍﻟﻤﻌﺘﻤﺩﻴﻥ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪١٧‬‬ ‫ﻴﺠﻭﺯ ﻟﻤﻤﺜل ﻤﻨﺎﻭﺏ ﺃﻭ ﻤﺴﺘﺸﺎﺭ ﺃﻥ ﻴﻌﻤل ﺒﺼﻔﺔ ﻤﻤﺜل ﺒﻨﺎﺀ ﻋﻠﻰ ﺘﻌﻴﻴﻥ ﺭﺌﻴﺱ ﺍﻟﻭﻓﺩ ﻟﻪ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪١٨‬‬ ‫ﺘﻘﺩﻡ ﻭﺜﺎﺌﻕ ﺘﻔﻭﻴﺽ ﺍﻟﻤﻤﺜﻠﻴﻥ ﻭﻜﺫﻟﻙ ﺃﺴﻤﺎﺀ ﺍﻟﻤﻤﺜﻠﻴﻥ ﺍﻟﻤﻨﺎﻭﺒﻴﻥ ﻭﺍﻟﻤﺴﺘﺸﺎﺭﻴﻥ ﺇﻟﻰ ﺍﻷﻤﺎﻨـﺔ ﻓـﻲ ﻤﻭﻋـﺩ‬ ‫ﹼﻎ ﺃﻱ ﺘﻐﻴﻴﺭ ﻻﺤﻕ ﻓﻲ ﺘﻜﻭﻴﻥ ﺍﻟﻭﻓـﻭﺩ ﺇﻟـﻰ‬ ‫ﻻ ﻴﺘﺠﺎﻭﺯ ﺃﺭﺒﻊ ﻭﻋﺸﺭﻴﻥ ﺴﺎﻋﺔ ﻤﻥ ﺍﻓﺘﺘﺎﺡ ﺍﻟﺩﻭﺭﺓ ﺇﻥ ﺃﻤﻜﻥ‪ .‬ﻜﻤﺎ ﻴﺒﻠ‬ ‫‪‬ﺎ ﻋﻥ ﻭﺯﻴﺭ ﺍﻟﺨﺎﺭﺠﻴﺔ ﺃﻭ ﻭﺯﻴﺭ ﺍﻟـﺼﺤﺔ‬ ‫‪‬ﺎ ﻋﻥ ﺭﺌﻴﺱ ﺍﻟﺩﻭﻟﺔ ﺃﻭ ﺍﻟﺤﻜﻭﻤﺔ ﻭﺇﻤ‬ ‫ﺍﻷﻤﺎﻨﺔ‪ .‬ﻭﺘﺼﺩﺭ ﻭﺜﺎﺌﻕ ﺍﻟﺘﻔﻭﻴﺽ ﺇﻤ‬ ‫ﺃﻭ ﺃﻱ ﺴﻠﻁﺔ ﺤﻜﻭﻤﻴﺔ ﻤﺨﺘﺼﺔ ﺃﺨﺭﻯ ﺃﻭ ﺇﺫﺍ ﻜﺎﻥ ﺍﻷﻤﺭ ﻴﺘﻌﻠﻕ ﺒﺈﺤﺩﻯ ﻤﻨﻅﻤﺎﺕ ﺍﻟﺘﻜﺎﻤل ﺍﻻﻗﺘﺼﺎﺩﻱ ﺍﻹﻗﻠﻴﻤﻲ‪ ،‬ﻋﻥ‬ ‫ﺍﻟﺴﻠﻁﺔ ﺍﻟﻤﺨﺘﺼﺔ ﻓﻲ ﺘﻠﻙ ﺍﻟﻤﻨﻅﻤﺔ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪١٩‬‬ ‫ﺘﻔﺤﺹ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ ﻭﺜﺎﺌﻕ ﺍﻟﺘﻔﻭﻴﺽ ﻭﺘﻘﺩﻡ ﺘﻘﺭﻴﺭﻫﺎ ﺇﻟﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪.‬‬

‫‪9‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺍﻟﻤﺎﺩﺓ ‪٢٠‬‬ ‫‪‬ﺕ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﻗﺒﻭل ﻭﺜﺎﺌﻕ ﺘﻔﻭﻴﻀﻬﻡ‪.‬‬ ‫ﻴﺤﻕ ﻟﻠﻤﻤﺜﻠﻴﻥ ﺍﻻﺸﺘﺭﺍﻙ ﻓﻲ ﺍﻟﺩﻭﺭﺓ ﺒﺼﻔﺔ ﻤﺅﻗﺘﺔ ﺭﻴﺜﻤﺎ ﻴﺒ‬

‫ﺃﻋﻀﺎﺀ ﺍﻟﻤﻜﺘﺏ‬ ‫ﺍﻟﻤﺎﺩﺓ ‪٢١‬‬ ‫ﻴﺘﻡ‪ ،‬ﻓﻲ ﺍﻟﺩﻭﺭﺓ ﺍﻟﻌﺎﺩﻴﺔ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﺍﻨﺘﺨﺎﺏ ﺭﺌﻴﺱ ﻭﺨﻤﺴﺔ ﻨﻭﺍﺏ ﻟﻠﺭﺌﻴﺱ‪ ،‬ﻴﻘﻭﻡ ﺃﺤـﺩﻫﻡ‬ ‫‪-١‬‬ ‫ﺒﺩﻭﺭ ﺍﻟﻤﻘﺭﺭ‪ ،‬ﻤﻥ ﺒﻴﻥ ﻤﻤﺜﻠﻲ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺤﺎﻀﺭﺓ ﻓﻲ ﺍﻟﺩﻭﺭﺓ‪ .‬ﻭﻴﺸﻜل ﺃﻋﻀﺎﺀ ﺍﻟﻤﻜﺘﺏ ﻫﺅﻻﺀ ﻫﻴﺌﺔ ﻤﻜﺘﺏ ﻤﺅﺘﻤﺭ‬ ‫ﱠل ﻜل ﺇﻗﻠﻴﻡ ﻤﻥ ﺃﻗﺎﻟﻴﻡ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺒﻌﻀﻭ ﻭﺍﺤﺩ ﻤﻥ ﺃﻋﻀﺎﺀ ﻫﻴﺌـﺔ ﺍﻟﻤﻜﺘـﺏ‪ .‬ﻭﻴﻅـل‬ ‫ﺍﻷﻁﺭﺍﻑ‪ .‬ﻭﻴﻤﺜ‬ ‫ﺍﻟﺭﺌﻴﺱ ﻭﻨﻭﺍﺏ ﺍﻟﺭﺌﻴﺱ ﻓﻲ ﻤﻨﺎﺼﺒﻬﻡ ﺤﺘﻰ ﺍﺨﺘﺘﺎﻡ ﺃﻋﻤﺎل ﺍﻟﺩﻭﺭﺓ ﺍﻟﻌﺎﺩﻴﺔ ﺍﻟﺜﺎﻨﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﺒﻤﺎ ﻓﻲ ﺫﻟﻙ ﺃﻴﺔ‬ ‫ﺩﻭﺭﺍﺕ ﺍﺴﺘﺜﻨﺎﺌﻴﺔ ﻴﺘﻡ ﻋﻘﺩﻫﺎ‪.‬‬ ‫ﻴﺘﻡ‪ ،‬ﻗﺒل ﻨﻬﺎﻴﺔ ﺩﻭﺭﺓ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺍﻟﻌﺎﺩﻴﺔ ﺍﻟﺜﺎﻨﻴﺔ ﻭﺩﻭﺭﺘﻪ ﺍﻟﻌﺎﺩﻴﺔ ﺍﻟﺘﻲ ﺘﻠﻴﻬﺎ‪ ،‬ﺍﻨﺘﺨﺎﺏ ﺃﻋﻀﺎﺀ ﺍﻟﻤﻜﺘﺏ‬ ‫‪-٢‬‬ ‫ﺍ‬ ‫ﻤﻥ ﺒﻴﻥ ﺍﻷﻁﺭﺍﻑ ﻟﻜﻲ ﻴﺸﻜﻠﻭﺍ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ ﻓﻲ ﺍﻟﺩﻭﺭﺓ ﺍﻟﺘﺎﻟﻴﺔ‪ .‬ﻭﺘﺒﺩﺃ ﻤﺩﺓ ﻋﻀﻭﻴﺔ ﺃﻋﻀﺎﺀ ﺍﻟﻤﻜﺘﺏ ﻫﺅﻻﺀ ﺍﻋﺘﺒﺎﺭﹰ‬ ‫ﻤﻥ ﺘﺎﺭﻴﺦ ﺍﺨﺘﺘﺎﻡ ﺃﻋﻤﺎل ﺍﻟﺩﻭﺭﺓ ﻭﻴﺴﺘﻤﺭ ﻋﻤﻠﻬﻡ ﺤﺘﻰ ﺍﺨﺘﺘﺎﻡ ﺃﻋﻤﺎل ﺍﻟﺩﻭﺭﺓ ﺍﻟﻌﺎﺩﻴﺔ ﺍﻟﺘﺎﻟﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻋﻠﻰ‬ ‫ﺃﻥ ﺘﺸﻤل ﻤﺩﺓ ﻋﻀﻭﻴﺘﻬﻡ ﺃﻴﺔ ﺩﻭﺭﺍﺕ ﺍﺴﺘﺜﻨﺎﺌﻴﺔ ﻴﺘﻡ ﻋﻘﺩﻫﺎ‪.‬‬ ‫ﻴﻨﻁﺒﻕ ﺍﻟﺘﻨﺎﻭﺏ ﻓﻴﻤﺎ ﺒﻴﻥ ﺃﻗﺎﻟﻴﻡ ﺍﻟﻤﻨﻅﻤﺔ ﻋﻠﻰ ﻤﻨﺼﺒﻲ ﺍﻟﺭﺌﻴﺱ ﻭﺍﻟﻤﻘﺭﺭ‪.‬‬ ‫‪-٣‬‬

‫ﻴﺸﺎﺭﻙ ﺍﻟﺭﺌﻴﺱ ﻓﻲ ﺩﻭﺭﺍﺕ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺒﺼﻔﺘﻪ ﺘﻠﻙ‪ ،‬ﻭﻻ ﻴﻤﺎﺭﺱ ﻓﻲ ﺍﻟﻭﻗﺕ ﻨﻔﺴﻪ ﺍﻟﺤﻘـﻭﻕ ﺍﻟﺘـﻲ‬ ‫‪-٤‬‬ ‫ﻴﺘﻤﺘﻊ ﺒﻬﺎ ﻤﻤﺜل ﺃﻱ ﻁﺭﻑ ﻤﻥ ﺍﻷﻁﺭﺍﻑ‪ .‬ﻭﻴﻘﻭﻡ ﺍﻟﻁﺭﻑ ﺍﻟﻤﻌﻨﻲ ﺒﺘﻌﻴﻴﻥ ﺸﺨﺹ ﺁﺨﺭ ﻴﻤﺜﻠﻪ ﻓﻲ ﺍﻟـﺩﻭﺭﺍﺕ ﻜـﻲ‬ ‫ﻴﻤﺎﺭﺱ ﺤﻘﻪ ﻓﻲ ﺍﻟﺘﺼﻭﻴﺕ‪.‬‬ ‫ﺎ ﻟﻐﺭﺽ ﻤﺤﺩﺩ‪.‬‬ ‫ﻴﺠﻭﺯ ﺃﻥ ﺘﺩﻋﻭ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ ﺭﺌﻴﺱ ﺃﻴﺔ ﻫﻴﺌﺔ ﻓﺭﻋﻴﺔ ﺘﺤﻘﻴﻘﹰ‬ ‫‪-٥‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٢٢‬‬ ‫ﻴﻘﻭﻡ ﺍﻟﺭﺌﻴﺱ‪ ،‬ﺒﺎﻹﻀﺎﻓﺔ ﺇﻟﻰ ﺍﻟﺼﻼﺤﻴﺎﺕ ﺍﻟﺘﻲ ﻴﻤﻨﺤﻪ ﺇﻴﺎﻫﺎ ﻫﺫﺍ ﺍﻟﻨﻅﺎﻡ ﻓﻲ ﻤﻭﺍﻀﻊ ﺃﺨﺭﻯ‪ ،‬ﺒﺈﻋﻼﻥ ﺍﻓﺘﺘﺎﺡ‬ ‫‪-١‬‬ ‫ﺃﻋﻤﺎل ﺍﻟﺩﻭﺭﺓ ﻭﺍﺨﺘﺘﺎﻤﻬﺎ‪ ،‬ﻭﻴﺘﺭﺃﺱ ﺍﻟﺠﻠﺴﺎﺕ ﻭﻴﻜﻔل ﻤﺭﺍﻋﺎﺓ ﻤﺎ ﻴﻘﻀﻲ ﺒﻪ ﻫﺫﺍ ﺍﻟﻨﻅﺎﻡ‪ ،‬ﻭﻴﻌﻁـﻲ ﺤـﻕ ﺍﻟﺘﺤـﺩﺙ‪،‬‬ ‫ﺎ ﺒﺄﺤﻜﺎﻡ ﻫﺫﺍ ﺍﻟﻨﻅـﺎﻡ‪،‬‬ ‫ﻭﻴﻁﺭﺡ ﺍﻟﻤﺴﺎﺌل ﻟﻠﺘﺼﻭﻴﺕ‪ ،‬ﻭﻴﻌﻠﻥ ﺍﻟﻘﺭﺍﺭﺍﺕ‪ .‬ﻭﻴﺒﺕ ﺍﻟﺭﺌﻴﺱ ﻓﻲ ﻨﻘﺎﻁ ﺍﻟﻨﻅﺎﻡ‪ ،‬ﻭﻴﻘﻭﻡ‪ ،‬ﺭﻫﻨﹰ‬ ‫ﺒﻀﺒﻁ ﺍﻟﻤﺩﺍﻭﻻﺕ ﻭﺍﻟﻤﺤﺎﻓﻅﺔ ﻋﻠﻰ ﺍﻟﻨﻅﺎﻡ ﻓﻴﻬﺎ‪.‬‬ ‫‪‬ـﺴﻤﺢ ﺒﻬـﺎ ﻟﻜـل‬ ‫ﻟﻠﺭﺌﻴﺱ ﺃﻥ ﻴﻘﺘﺭﺡ ﻋﻠﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺇﻗﻔﺎل ﻗﺎﺌﻤﺔ ﺍﻟﻤﺘﺤﺩﺜﻴﻥ ﻭﺘﺤﺩﻴﺩ ﺍﻟﻤﺩﺓ ﺍﻟﺘﻲ ﻴ‬ ‫‪-٢‬‬ ‫‪‬ﺴﻤﺢ ﺒﻬﺎ ﻟﻜل ﻤﻤﺜل ﺒﺸﺄﻥ ﺃﻴﺔ ﻤﺴﺄﻟﺔ‪ ،‬ﻭﺘﺄﺠﻴل ﺍﻟﻤﻨﺎﻗﺸﺔ ﺃﻭ ﺇﻗﻔﺎل ﺒﺎﺒﻬﺎ‪،‬‬ ‫ﻤﺘﺤﺩﺙ ﻭﺘﺤﺩﻴﺩ ﻋﺩﺩ ﻤﺭﺍﺕ ﺍﻟﺘﺤﺩﺙ ﺍﻟﺘﻲ ﻴ‬ ‫ﻭﺘﻌﻠﻴﻕ ﺍﻟﺠﻠﺴﺔ ﺃﻭ ﺭﻓﻌﻬﺎ‪.‬‬ ‫ﹼل ﺍﻟﺭﺌﻴﺱ‪ ،‬ﻓﻲ ﻤﻤﺎﺭﺴﺘﻪ ﻤﻬﺎﻡ ﺫﻟﻙ ﺍﻟﻤﻨﺼﺏ‪ ،‬ﺨﺎﻀﻌﹰ‬ ‫ﺎ ﻟﺴﻠﻁﺔ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪.‬‬ ‫ﻴﻅ‬ ‫‪-٣‬‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪10‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٢٣‬‬ ‫ﺎ ﻋﻥ ﺠﻠﺴﺔ ﻤﺎ ﺃﻭ ﻋﻥ ﺠﺯﺀ ﻤﻨﻬﺎ ﻓﻌﻠﻴﻪ ﺃﻥ ﻴﻌﻴﻥ ﺃﺤﺩ ﻨﻭﺍﺏ ﺍﻟﺭﺌﻴﺱ ﻟﻠﻘﻴﺎﻡ ﺒﻤﻬﺎﻤﻪ‪.‬‬ ‫ﺇﺫﺍ ﺘﻐﻴﺏ ﺍﻟﺭﺌﻴﺱ ﻤﺅﻗﺘﹰ‬ ‫‪-١‬‬ ‫‪‬ﻥ ﻋﻠﻰ ﻫﺫﺍ ﺍﻟﻨﺤﻭ ﺃﻥ ﻴﻤﺎﺭﺱ ﻓﻲ ﺍﻟﻭﻗﺕ ﺫﺍﺘﻪ ﻤﺎ ﻟﻤﻤﺜل ﺃﻱ ﻁﺭﻑ ﻤﻥ ﺍﻟﺤﻘﻭﻕ‪.‬‬ ‫‪‬ﻌﻴ‬ ‫ﻭﻻ ﻴﺤﻕ ﻟﻨﺎﺌﺏ ﺍﻟﺭﺌﻴﺱ ﺍﻟﺫﻱ ﻴ‬ ‫ﻟﻨﺎﺌﺏ ﺍﻟﺭﺌﻴﺱ ﺍﻟﺫﻱ ﻴﻘﻭﻡ ﺒﻤﻬﺎﻡ ﺍﻟﺭﺌﻴﺱ ﺍﻟﺼﻼﺤﻴﺎﺕ ﺍﻟﺘﻲ ﻟﻪ ﻭﺍﻟﻭﺍﺠﺒﺎﺕ ﺍﻟﺘﻲ ﻋﻠﻴﻪ‪.‬‬ ‫‪-٢‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٢٤‬‬ ‫ﺇﺫﺍ ﺍﺴﺘﻘﺎل ﺃﺤﺩ ﺃﻋﻀﺎﺀ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ ﻤﻥ ﻤﻨﺼﺒﻪ‪ ،‬ﺃﻭ ﺘﻌﺫﺭ ﻋﻠﻴﻪ ﻟﺴﺒﺏ ﺁﺨﺭ ﺇﻜﻤﺎل ﻤﺩﺓ ﻋﻀﻭﻴﺘﻪ ﺍﻟﻤﺤﺩﺩﺓ‬ ‫‪-١‬‬ ‫ﺃﻭ ﺘﻌﺫﺭ ﻋﻠﻴﻪ ﺍﻻﻀﻁﻼﻉ ﺒﻤﻬﺎﻡ ﻤﻨﺼﺒﻪ‪ ،‬ﻴﻘﻭﻡ ﺍﻟﻁﺭﻑ ﺍﻟﻤﻌﻨﻲ ﺒﺘﻌﻴﻴﻥ ﻤﻤﺜل ﻟﻠﻁﺭﻑ ﻨﻔﺴﻪ ﻴﺤل ﻤﺤﻠﻪ ﺨﻼل ﺍﻟﻔﺘﺭﺓ‬ ‫ﺍﻟﻤﺘﺒﻘﻴﺔ ﻤﻥ ﻤﺩﺓ ﻋﻀﻭﻴﺘﻪ ﺍﻷﺼﻠﻴﺔ‪.‬‬ ‫ﺇﺫﺍ ﺘﻌﺫﺭ ﻋﻠﻰ ﺍﻟﺭﺌﻴﺱ ﺍﻟﻘﻴﺎﻡ ﺒﻤﻬﺎﻤﻪ ﻓﻲ ﺍﻟﻔﺘﺭﺍﺕ ﺍﻟﻔﺎﺼﻠﺔ ﺒﻴﻥ ﺍﻟﺩﻭﺭﺍﺕ ﻴﺘﻭﻟﻰ ﺃﺤﺩ ﻨﻭﺍﺏ ﺍﻟﺭﺌﻴﺱ ﺍﻟﻘﻴـﺎﻡ‬ ‫‪-٢‬‬ ‫ﺎ ﻟﻪ ﺇﻟﻰ ﺘﻭﻟﻲ ﻤﻬﺎﻡ ﺍﻟﺭﺌﻴﺱ ﻋﻥ ﻁﺭﻴﻕ ﺍﻟﻘﺭﻋﺔ ﻓﻲ ﺍﻟﺩﻭﺭﺓ‬ ‫‪‬ﺩﻋﻰ ﻨﻭﺍﺏ ﺍﻟﺭﺌﻴﺱ ﻭﻓﻘﹰ‬ ‫ﺒﻤﻬﺎﻤﻪ‪ .‬ﻭﻴﺤﺩﺩ ﺍﻟﺘﺭﺘﻴﺏ ﺍﻟﺫﻱ ﻴ‬ ‫ﺍﻟﺘﻲ ﻴﺠﺭﻱ ﻓﻴﻬﺎ ﺍﻻﻨﺘﺨﺎﺏ‪.‬‬

‫ﺍﻟﻬﻴﺌﺎﺕ ﺍﻟﻔﺭﻋﻴﺔ‬ ‫ﺍﻟﻤﺎﺩﺓ ‪٢٥‬‬ ‫‪‬ﻨﺸﺊ ﻤﺎ ﻴﻠﺯﻡ ﻤﻥ ﻫﺫﻩ ﺍﻟﻬﻴﺌﺎﺕ ﺍﻟﻔﺭﻋﻴﺔ ﻟﺒﻠﻭﻍ‬ ‫ﺎ ﻟﻠﻤﺎﺩﺓ ‪)٥-٢٣‬ﻭ( ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ‪ ،‬ﺃﻥ ﻴ‬ ‫ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻁﺒﻘﹰ‬ ‫‪-١‬‬ ‫ﺍﻟﻐﺭﺽ ﺍﻟﻤﺘﻭﺨﻰ ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ‪.‬‬ ‫ﻴﺤﺩﺩ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺍﻟﻤﺴﺎﺌل ﺍﻟﺘﻲ ﺘﻨﻅﺭ ﻓﻴﻬﺎ ﻜل ﻫﻴﺌﺔ ﻤﻥ ﺘﻠﻙ ﺍﻟﻬﻴﺌﺎﺕ ﺍﻟﻔﺭﻋﻴﺔ‪ ،‬ﺒﻤﺎ ﻓﻲ ﺫﻟﻙ ﻭﻻﻴﺘﻬﺎ‬ ‫‪-٢‬‬ ‫ﺀ ﻋﻠﻰ ﻁﻠﺏ ﻤﻥ ﺭﺌﻴﺱ ﺍﻟﻬﻴﺌﺔ ﺍﻟﻔﺭﻋﻴـﺔ‪ ،‬ﺇﺠـﺭﺍﺀ‬ ‫ﻭﻏﺎﻴﺎﺘﻬﺎ ﻭﻤﺩﺘﻬﺎ ﻭﻤﻴﺯﺍﻨﻴﺘﻬﺎ‪ ،‬ﻭﻟﻪ ﺃﻥ ﻴﺨﻭل ﺭﺌﻴﺱ ﺍﻟﻤﺅﺘﻤﺭ‪ ،‬ﺒﻨﺎ ‪‬‬ ‫ﺍﻟﺘﻌﺩﻴﻼﺕ ﺍﻟﻤﻨﺎﺴﺒﺔ ﻋﻠﻰ ﺘﻘﺴﻴﻡ ﺍﻟﻌﻤل‪.‬‬ ‫ﺒﺎﺴﺘﺜﻨﺎﺀ ﻤﺎ ﻫﻭ ﻤﻨﺼﻭﺹ ﻋﻠﻴﻪ ﻓﻲ ﺍﻟﻤﻭﺍﺩ ﻤﻥ ‪ ٢٦‬ﺇﻟﻰ ‪ ٢٨‬ﺘﺴﺭﻱ ﻫﺫﻩ ﺍﻟﻤﻭﺍﺩ ﻤﻊ ﺘﻌﺩﻴل ﻤﺎ ﻴﻠﺯﻡ ﻋﻠـﻰ‬ ‫‪-٣‬‬ ‫ﺎ ﺒﺄﻴﺔ ﺘﻌﺩﻴﻼﺕ ﻴﻘﺭﺭﻫﺎ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪.‬‬ ‫ﺃﻋﻤﺎل ﺃﻴﺔ ﻫﻴﺌﺔ ﻓﺭﻋﻴﺔ‪ ،‬ﺭﻫﻨﹰ‬

‫ﺍﻟﻤﺎﺩﺓ ‪٢٦‬‬ ‫ﺇﺫﺍ ﻟﻡ ﺘﻜﻥ ﺍﻟﻬﻴﺌﺔ ﺍﻟﻔﺭﻋﻴﺔ ﻤﻔﺘﻭﺤﺔ ﺍﻟﻌﻀﻭﻴﺔ ﺘﺸﻜل ﺃﻏﻠﺒﻴﺔ ﺍﻷﻁﺭﺍﻑ ﺍﻟﻤﺴﻤﺎﺓ ﻤﻥ ﻗﺒل ﺍﻟﻤﺅﺘﻤﺭ ﻟﻠﻤﺸﺎﺭﻜﺔ‬ ‫ﻓﻲ ﺍﻟﻬﻴﺌﺔ ﺍﻟﻨﺼﺎﺏ ﺍﻟﻘﺎﻨﻭﻨﻲ‪ .‬ﺃﻤﺎ ﺇﺫﺍ ﻜﺎﻨﺕ ﺍﻟﻬﻴﺌﺔ ﺍﻟﻔﺭﻋﻴﺔ ﻤﻔﺘﻭﺤﺔ ﺍﻟﻌﻀﻭﻴﺔ ﻓﺈﻥ ﺭﺒﻊ ﻋﺩﺩ ﺍﻷﻁـﺭﺍﻑ ﻴـﺸﻜﻠﻭﻥ‬ ‫ﺍﻟﻨﺼﺎﺏ ﺍﻟﻘﺎﻨﻭﻨﻲ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٢٧‬‬ ‫ﻴﻘﺭﺭ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻤﻭﺍﻋﻴﺩ ﺩﻭﺭﺍﺕ ﺍﻟﻬﻴﺌﺎﺕ ﺍﻟﻔﺭﻋﻴﺔ ﻭﻤﻜﺎﻥ ﺍﻨﻌﻘﺎﺩﻫﺎ‪ ،‬ﻤﻊ ﺍﻟﻤﺭﺍﻋﺎﺓ ﺍﻟﻭﺍﺠﺒـﺔ ﻟﻤـﺩﻯ‬ ‫‪-١‬‬ ‫ﺍﺴﺘﺼﻭﺍﺏ ﻋﻘﺩ ﻫﺫﻩ ﺍﻟﺩﻭﺭﺍﺕ ﺒﺎﻟﺘﺯﺍﻤﻥ ﻤﻊ ﺩﻭﺭﺍﺕ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪.‬‬

‫‪11‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺎ ﻤﺎ ﻟﻡ ﻴﻘﺭﺭ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺃﻭ ﺍﻟﻬﻴﺌﺔ ﺍﻟﻔﺭﻋﻴﺔ ﺍﻟﻤﻌﻨﻴﺔ‬ ‫ﹸﻌﻘﺩ ﺩﻭﺭﺍﺕ ﺃﻭ ﺍﺠﺘﻤﺎﻋﺎﺕ ﺍﻟﻬﻴﺌﺎﺕ ﺍﻟﻔﺭﻋﻴﺔ ﻋﻠﻨﹰ‬ ‫ﺘ‬ ‫‪-٢‬‬ ‫ﺃﻥ ﺘﻜﻭﻥ ﺴﺭﻴﺔ‪ .‬ﻭﺘﻨﻔﺫ ﻫﺫﻩ ﺍﻟﻤﺎﺩﺓ ﻋﻠﻰ ﻨﺤﻭ ﻴﺘﺴﻕ ﻤﻊ ﺍﻟﻤﺎﺩﺓ ‪ ٣-٥‬ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٢٨‬‬ ‫‪‬ﻨﺘﺨﺏ ﺭﺌﻴﺱ ﺍﻟﻬﻴﺌﺔ ﺍﻟﻔﺭﻋﻴﺔ ﻤﻥ ﻗﺒل ﺍﻟﻬﻴﺌﺔ ﺍﻟﻔﺭﻋﻴﺔ ﻤﺎ ﻟﻡ ﻴﻘﺭﺭ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻏﻴﺭ ﺫﻟﻙ‪ .‬ﻭﺘﻨﺘﺨـﺏ‬ ‫ﻴ‬ ‫‪-١‬‬ ‫ﻜل ﻫﻴﺌﺔ ﻓﺭﻋﻴﺔ ﺃﻋﻀﺎﺀ ﻤﻜﺘﺒﻬﺎ ﻤﻊ ﺍﻟﻤﺭﺍﻋﺎﺓ ﺍﻟﻭﺍﺠﺒﺔ ﻟﻤﺒﺩﺃ ﺍﻟﺘﻤﺜﻴل ﺍﻟﺠﻐﺭﺍﻓﻲ ﺍﻟﻌﺎﺩل ﻭﺍﻟﺘﻤﺜﻴل ﺍﻟﻤﺘﻭﺍﺯﻥ ﻟﻠﺒﻠـﺩﺍﻥ‬ ‫ﺍﻟﻨﺎﻤﻴﺔ ﻭﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻤﺘﻘﺩﻤﺔ ﻭﻤﺭﺍﻋﺎﺓ ﺍﻟﺘﻭﺍﺯﻥ ﺒﻴﻥ ﺍﻟﺠﻨﺴﻴﻥ ﻭﻻ ﻴﻌﻤل ﺃﻋﻀﺎﺀ ﺍﻟﻤﻜﺘﺏ ﻷﻜﺜﺭ ﻤﻥ ﻤـﺩﺘﻲ ﻋـﻀﻭﻴﺔ‬ ‫ﻤﺘﺘﺎﻟﻴﺘﻴﻥ‪.‬‬ ‫ﻻ ﻴﺠﻭﺯ ﻟﺭﺌﻴﺱ ﺃﻴﺔ ﻫﻴﺌﺔ ﻓﺭﻋﻴﺔ ﻭﻻ ﻟﻨﺎﺌﺏ ﺭﺌﻴﺴﻬﺎ ﺍﻟﺘﺼﻭﻴﺕ‪ ،‬ﻤﺎ ﻟﻡ ﻴﻜﻭﻨﺎ ﺍﻟﻌﻀﻭﻴﻥ ﺍﻟﻭﺤﻴـﺩﻴﻥ ﻓـﻲ‬ ‫‪-٢‬‬ ‫ﺎ ﻟﻠﻤﺎﺩﺓ ‪.١-٤٩‬‬ ‫ﻭﻓﺩﻴﻬﻤﺎ ﺍﻟﻤﻌﻨﻴﻴﻥ‪ .‬ﻭﻓﻲ ﺘﻠﻙ ﺍﻟﺤﺎﻟﺔ ﺘﺠﻭﺯ ﻟﻬﻤﺎ ﻤﻤﺎﺭﺴﺔ ﺍﻟﺤﻕ ﻓﻲ ﺍﻟﺘﺼﻭﻴﺕ ﻭﻓﻘﹰ‬

‫ﺍﻟﻤﺭﺍﻗﺒﻭﻥ‬ ‫ﺍﻟﻤﺎﺩﺓ ‪٢٩‬‬ ‫ﺎ ﻓﻲ ﺍﻻﺘﻔﺎﻗﻴﺔ‪ ،‬ﺃﻭ ﺃﻴﺔ ﺩﻭﻟﺔ ﻋﻀﻭ ﻤﻨﺘﺴﺒﺔ ﻓﻲ‬ ‫ﻷﻴﺔ ﺩﻭﻟﺔ ﻋﻀﻭ ﻓﻲ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﻭﻟﻴﺴﺕ ﻁﺭﻓﹰ‬ ‫‪-١‬‬ ‫ﺎ ﻓﻲ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻭﻟﻜﻨﻬﺎ ﺩﻭﻟﺔ ﻋﻀﻭ ﻓﻲ ﺍﻷﻤﻡ ﺍﻟﻤﺘﺤﺩﺓ ﺃﻭ ﻓﻲ‬ ‫ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ‪ ،‬ﺃﻭ ﺃﻴﺔ ﺩﻭﻟﺔ ﺃﺨﺭﻯ ﻟﻴﺴﺕ ﻁﺭﻓﹰ‬ ‫ﻭﻜﺎﻻﺘﻬﺎ ﺍﻟﻤﺘﺨﺼﺼﺔ ﺃﻭ ﻓﻲ ﺍﻟﻭﻜﺎﻟﺔ ﺍﻟﺩﻭﻟﻴﺔ ﻟﻠﻁﺎﻗﺔ ﺍﻟﺫﺭﻴﺔ‪ ،‬ﻭﻷﻴﺔ ﻤﻨﻅﻤﺔ ﺘﻜﺎﻤل ﺍﻗﺘﺼﺎﺩﻱ ﺇﻗﻠﻴﻤﻲ‪ ،‬ﺤﺴﺏ ﺍﻟﺘﻌﺭﻴﻑ‬ ‫ﺎ ﻓﻲ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺃﻥ ﺘﺤﻀﺭ ﺍﻟﺠﻠﺴﺎﺕ ﺍﻟﻌﻠﻨﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺃﻭ‬ ‫ﺍﻟﻭﺍﺭﺩ ﻓﻲ ﺍﻟﻤﺎﺩﺓ ‪)١‬ﺏ( ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ‪ ،‬ﻭﻟﻴﺴﺕ ﻁﺭﻓﹰ‬ ‫ﺍﺠﺘﻤﺎﻋﺎﺕ ﻫﻴﺌﺎﺘﻪ ﺍﻟﻔﺭﻋﻴﺔ ﺒﺼﻔﺔ ﻤﺭﺍﻗﺏ‪.‬‬ ‫ﻟﻠﻤﺭﺍﻗﺒﻴﻥ ﺍﻟﺤﻕ‪ ،‬ﺒﻤﻭﺠﺏ ﻫﺫﻩ ﺍﻟﻤﺎﺩﺓ‪ ،‬ﻓﻲ ﺍﻟﻤﺸﺎﺭﻜﺔ ﺩﻭﻥ ﺍﻟﺤﻕ ﻓﻲ ﺍﻟﺘﺼﻭﻴﺕ ﻓـﻲ ﺍﻟﺠﻠـﺴﺎﺕ ﺍﻟﻌﻠﻨﻴـﺔ‬ ‫‪-٢‬‬ ‫ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻭﻫﻴﺌﺎﺘﻪ ﺍﻟﻔﺭﻋﻴﺔ‪ ،‬ﻭﻟﻴﺱ ﻟﻬﻡ ﺍﻟﺤﻕ ﻓﻲ ﺍﻟﺘﺤﺩﺙ ﺇﻻ ﺒﻌﺩ ﺍﻷﻁﺭﺍﻑ‪ .‬ﻭﻟﻴﺱ ﻟﻤﻨﻅﻤـﺎﺕ ﺍﻟﺘﻜﺎﻤـل‬ ‫ﺍﻻﻗﺘﺼﺎﺩﻱ ﺍﻹﻗﻠﻴﻤﻲ ﺍﻟﺤﻕ ﻓﻲ ﺍﻟﺘﺤﺩﺙ ﺇﻻ ﺒﺸﺄﻥ ﺍﻟﻤﺴﺎﺌل ﺍﻟﺘﻲ ﺘﺩﺨل ﻀﻤﻥ ﺍﺨﺘﺼﺎﺼﻬﺎ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٣٠‬‬ ‫ﻴﺠﻭﺯ ﻷﻴﺔ ﻤﻨﻅﻤﺔ ﺤﻜﻭﻤﻴﺔ ﺩﻭﻟﻴﺔ‪ ،‬ﺃﻥ ﺘﻁﻠﺏ ﺇﻟﻰ ﺍﻷﻤﺎﻨﺔ ﺍﻟﺤﺼﻭل ﻋﻠﻰ ﻤﺭﻜﺯ ﺍﻟﻤﺭﺍﻗﺏ ﺍﻟﺫﻱ ﻴﻤﻜـﻥ ﺃﻥ‬ ‫‪-١‬‬ ‫ﻴﻤﻨﺤﻪ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﻤﻊ ﻤﺭﺍﻋﺎﺓ ﺍﻟﻔﻘﺭﺘﻴﻥ ‪ ١٧‬ﻭ‪ ١٨‬ﻤﻥ ﺍﻟﺩﻴﺒﺎﺠﺔ ﻭﻜﺫﻟﻙ ﺍﻟﻤﺎﺩﺓ ‪ ٣-٥‬ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ‪.‬‬ ‫ﻟﻠﻤﺭﺍﻗﺒﻴﻥ ﺍﻟﺤﻕ‪ ،‬ﺒﻤﻭﺠﺏ ﻫﺫﻩ ﺍﻟﻤﺎﺩﺓ‪ ،‬ﻓﻲ ﺍﻟﻤﺸﺎﺭﻜﺔ‪ ،‬ﺩﻭﻥ ﺍﻟﺤﻕ ﻓﻲ ﺍﻟﺘﺼﻭﻴﺕ‪ ،‬ﻓﻲ ﺍﻻﺠﺘﻤﺎﻋﺎﺕ ﺍﻟﻌﻠﻨﻴـﺔ‬ ‫‪-٢‬‬ ‫ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻭﻫﻴﺌﺎﺘﻪ ﺍﻟﻔﺭﻋﻴﺔ‪ ،‬ﻭﺍﻟﺘﺤﺩﺙ ﺒﻌﺩ ﺍﻟﻤﺭﺍﻗﺒﻴﻥ ﺍﻟﻤﺸﺎﺭ ﺇﻟﻴﻬﻡ ﻓﻲ ﺍﻟﻤﺎﺩﺓ ‪.٢٩‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٣١‬‬ ‫ﹸﻌﺘﻤﺩ ﻜﻤﺭﺍﻗﺒﻴﻥ ﻓﻲ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺍﻟﻤﻨﻅﻤﺎﺕ ﻏﻴﺭ ﺍﻟﺤﻜﻭﻤﻴﺔ ﺍﻟﺘﻲ ﺸـﺎﺭﻜﺕ ﻓـﻲ ﻫﻴﺌـﺔ ﺍﻟﺘﻔـﺎﻭﺽ‬ ‫ﺘ‬ ‫‪-١‬‬ ‫ﺍﻟﺤﻜﻭﻤﻴﺔ ﺍﻟﺩﻭﻟﻴﺔ ﺍﻟﻤﻌﻨﻴﺔ ﺒﺎﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ﻭﻓـﻲ ﺍﻟﻔﺭﻴـﻕ ﺍﻟﻌﺎﻤـل‬ ‫ﺍﻟﺤﻜﻭﻤﻲ ﺍﻟﺩﻭﻟﻲ ﺍﻟﻤﻔﺘﻭﺡ ﺍﻟﻌﻀﻭﻴﺔ ﺍﻟﻤﻌﻨﻲ ﺒﺎﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪.‬‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪12‬‬

‫ﻴﺠﻭﺯ ﻟﻠﻤﻨﻅﻤﺎﺕ ﻏﻴﺭ ﺍﻟﺤﻜﻭﻤﻴﺔ‪ ،‬ﺍﻟﺩﻭﻟﻴﺔ ﻤﻨﻬﺎ ﻭﺍﻹﻗﻠﻴﻤﻴﺔ‪ ،‬ﺍﻟﺘﻲ ﺘﺘﻔﻕ ﻤﻘﺎﺼـﺩﻫﺎ ﻭﺃﻨـﺸﻁﺘﻬﺎ ﻤـﻊ ﺭﻭﺡ‬ ‫‪-٢‬‬ ‫ﺍﻻﺘﻔﺎﻗﻴﺔ ﻭﻏﺭﻀﻬﺎ ﻭﻤﺒﺎﺩﺌﻬﺎ‪ ،‬ﺃﻥ ﺘﻁﻠﺏ ﺍﻟﺤﺼﻭل ﻋﻠﻰ ﻤﺭﻜﺯ ﺍﻟﻤﺭﺍﻗﺏ ﺍﻟﺫﻱ ﻴﻤﻜﻥ ﺃﻥ ﻴﻤﻨﺤﻪ ﻤﺅﺘﻤﺭ ﺍﻷﻁـﺭﺍﻑ‪،‬‬ ‫ﺀ ﻋﻠﻰ ﺘﻘﺭﻴﺭ ﻤﻥ ﺍﻷﻤﺎﻨﺔ‪ ،‬ﻭﻤﻊ ﻤﺭﺍﻋﺎﺓ ﺍﻟﻔﻘﺭﺘﻴﻥ ‪ ١٧‬ﻭ‪ ١٨‬ﻤﻥ ﺍﻟﺩﻴﺒﺎﺠﺔ ﻭﺍﻟﻤﺎﺩﺓ ‪ ٣-٥‬ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ‪ .‬ﻭﻴﻨﺒﻐﻲ ﺃﻥ‬ ‫ﺒﻨﺎ ‪‬‬ ‫ﺎ ﻗﺒل ﺍﻓﺘﺘﺎﺡ ﺃﻋﻤﺎل ﺍﻟﺩﻭﺭﺓ‪.‬‬ ‫ﺘﻘﺩﻡ ﺘﻠﻙ ﺍﻟﻁﻠﺒﺎﺕ ﺇﻟﻰ ﺍﻷﻤﺎﻨﺔ ﻓﻲ ﻤﻭﻋﺩ ﺃﻗﺼﺎﻩ ﺘﺴﻌﻭﻥ ﻴﻭﻤﹰ‬ ‫ﻴﺴﺘﻌﺭﺽ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺘﻔﻭﻴﺽ ﻜل ﻤﻨﻅﻤﺔ ﻤﻥ ﺍﻟﻤﻨﻅﻤﺎﺕ ﻏﻴﺭ ﺍﻟﺤﻜﻭﻤﻴﺔ ﻓـﻲ ﺃﻱ ﻤـﻥ ﺩﻭﺭﺍﺘـﻪ‬ ‫‪-٣‬‬ ‫ﺍﻟﻌﺎﺩﻴﺔ‪ ،‬ﻭﻤﻥ ﺜﻡ ﻴﺤﺩﺩ ﻤﺩﻯ ﺍﺴﺘﺼﻭﺍﺏ ﺍﻹﺒﻘﺎﺀ ﻋﻠﻰ ﻤﺭﻜﺯﻫﺎ ﻜﻤﺭﺍﻗﺏ‪.‬‬ ‫ﻟﻠﻤﺭﺍﻗﺒﻴﻥ ﺍﻟﺤﻕ‪ ،‬ﺒﻤﻭﺠﺏ ﻫﺫﻩ ﺍﻟﻤﺎﺩﺓ‪ ،‬ﻓﻲ ﺍﻟﻤﺸﺎﺭﻜﺔ ﺩﻭﻥ ﺍﻟﺤﻕ ﻓﻲ ﺍﻟﺘﺼﻭﻴﺕ ﻓﻲ ﺍﻻﺠﺘﻤﺎﻋـﺎﺕ ﺍﻟﻌﻠﻨﻴـﺔ‬ ‫‪-٤‬‬ ‫ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻭﻫﻴﺌﺎﺘﻪ ﺍﻟﻔﺭﻋﻴﺔ‪ ،‬ﻭﺍﻟﺘﺤﺩﺙ ﺒﻌﺩ ﺍﻟﻤﺭﺍﻗﺒﻴﻥ ﺍﻟﻤﺸﺎﺭ ﺇﻟﻴﻬﻡ ﻓﻲ ﺍﻟﻤﺎﺩﺘﻴﻥ ‪ ٢٩‬ﻭ‪.٣٠‬‬

‫ﺘﺼﺭﻴﻑ ﺍﻷﻋﻤﺎل‬ ‫ﺍﻟﻤﺎﺩﺓ ‪٣٢‬‬ ‫ﺎ ﻤﺎ ﻟﻡ ﻴﻘﺭﺭ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺃﻥ ﺘﻜﻭﻥ ﺴﺭﻴﺔ‪ .‬ﻭﺘﻨﻔﺫ ﻫﺫﻩ ﺍﻟﻤﺎﺩﺓ ﻋﻠﻰ‬ ‫ﹸﻌﻘﺩ ﺠﻠﺴﺎﺕ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻋﻠﻨﹰ‬ ‫ﺘ‬ ‫ﻨﺤﻭ ﻴﺘﺴﻕ ﻤﻊ ﺍﻟﻤﺎﺩﺓ ‪ ٣-٥‬ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٣٣‬‬ ‫ﱠﻡ ﺇﻟـﻰ‬ ‫ﺘﻘﺩﻡ ﺍﻷﻁﺭﺍﻑ ﺍﻻﻗﺘﺭﺍﺤﺎﺕ ﻭﺍﻟﺘﻌﺩﻴﻼﺕ‪ ،‬ﻓﻲ ﺍﻷﺤﻭﺍل ﺍﻟﻌﺎﺩﻴﺔ‪ ،‬ﻜﺘﺎﺒﺔ ﺒﺈﺤﺩﻯ ﺍﻟﻠﻐﺎﺕ ﺍﻟﺭﺴﻤﻴﺔ ﻭﺘﺴﻠ‬ ‫ﺎ ﻤﻨﻬﺎ ﻋﻠﻰ ﺍﻟﻭﻓﻭﺩ‪ .‬ﻭﻻ ﻴﺠﻭﺯ ﺍﻟﻨﻅﺭ ﻓﻲ ﺍﻻﻗﺘﺭﺍﺤﺎﺕ ﻭﺍﻟﺘﻌﺩﻴﻼﺕ ﺇﻻ ﺇﺫﺍ ﻜﺎﻥ ﻗـﺩ ﺴـﺒﻕ‬ ‫ﺍﻷﻤﺎﻨﺔ ﺍﻟﺘﻲ ﺘﻌﻤﻡ ﻨﺴﺨﹰ‬ ‫ﺘﻌﻤﻴﻡ ﻨﺴﺦ ﻤﻨﻬﺎ ﻋﻠﻰ ﺍﻟﻭﻓﻭﺩ ﺒﻔﺘﺭﺓ ﺯﻤﻨﻴﺔ ﻻ ﺘﻘل ﻋﻥ ‪ ٢٤‬ﺴﺎﻋﺔ ﻗﺒل ﺍﻻﺠﺘﻤﺎﻉ‪ .‬ﻋﻠﻰ ﺃﻨﻪ ﻴﺠﻭﺯ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ ‫ﺃﻥ ﻴﺴﻤﺢ ﺒﻤﻨﺎﻗﺸﺔ ﺍﻻﻗﺘﺭﺍﺤﺎﺕ ﺃﻭ ﺍﻟﺘﻌﺩﻴﻼﺕ ﻋﻠﻰ ﺍﻻﻗﺘﺭﺍﺤﺎﺕ ﺃﻭ ﺍﻟﻤﻘﺘﺭﺤﺎﺕ ﺍﻹﺠﺭﺍﺌﻴﺔ ﻭﺍﻟﻨﻅﺭ ﻓﻴﻬﺎ ﺤﺘﻰ ﻭﺇﻥ ﻟﻡ‬ ‫‪‬ﻤﻤﺕ ﻓﻲ ﺍﻟﻴـﻭﻡ‬ ‫‪‬ﻤﻤﺕ ﺃﻭ ﺇﺫﺍ ﻜﺎﻨﺕ ﻗﺩ ﻋ‬ ‫ﺘﻜﻥ ﻫﺫﻩ ﺍﻻﻗﺘﺭﺍﺤﺎﺕ ﺃﻭ ﺍﻟﺘﻌﺩﻴﻼﺕ ﻋﻠﻰ ﺍﻻﻗﺘﺭﺍﺤﺎﺕ ﺃﻭ ﺍﻟﻤﻘﺘﺭﺤﺎﺕ ﻗﺩ ﻋ‬ ‫ﺫﺍﺘﻪ ﻓﻘﻁ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٣٤‬‬ ‫ﺎ ﻟﺘﺼﺭﻴﻑ ﺍﻷﻋﻤﺎل ﻓﻲ ﺍﻟﺠﻠﺴﺎﺕ ﺍﻟﻌﺎﻤﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪.‬‬ ‫ﺎ ﻗﺎﻨﻭﻨﻴﹰ‬ ‫ﺘﺸﻜل ﺃﻏﻠﺒﻴﺔ ﺍﻟﺩﻭل ﺍﻷﻁﺭﺍﻑ ﻨﺼﺎﺒﹰ‬ ‫‪-١‬‬ ‫ﻭﻴﺸﺘﺭﻁ ﺤﻀﻭﺭ ﺜﻠﺜﻲ ﺍﻟﺩﻭل ﺍﻷﻁﺭﺍﻑ ﻻﺘﺨﺎﺫ ﺃﻱ ﻗﺭﺍﺭ‪.‬‬ ‫ﻷﻏﺭﺍﺽ ﺘﺤﺩﻴﺩ ﻨﺼﺎﺏ ﻗﺎﻨﻭﻨﻲ ﻻﺘﺨﺎﺫ ﺃﻱ ﻗﺭﺍﺭ ﺒﺸﺄﻥ ﺃﻴﺔ ﻤﺴﺄﻟﺔ ﺘﺩﺨل ﻓﻲ ﻨﻁـﺎﻕ ﺍﺨﺘـﺼﺎﺼﺎﺕ ﺃﻴـﺔ‬ ‫‪-٢‬‬ ‫ﻭ ﻟﻌﺩﺩ ﺍﻷﺼﻭﺍﺕ ﺍﻟﺘﻲ‬ ‫‪‬ﺤﺴﺏ ﻟﺘﻠﻙ ﺍﻟﻤﻨﻅﻤﺔ ﻋﺩﺩ ﺃﺼﻭﺍﺕ ﻤﺴﺎ ﹴ‬ ‫ﻤﻨﻅﻤﺔ ﻤﻥ ﻤﻨﻅﻤﺎﺕ ﺍﻟﺘﻜﺎﻤل ﺍﻻﻗﺘﺼﺎﺩﻱ ﺍﻹﻗﻠﻴﻤﻲ ﻴ‬ ‫ﺎ ﻷﺤﻜﺎﻡ ﺍﻟﻤﺎﺩﺓ ‪ ٢-٣٢‬ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ‪.‬‬ ‫ﻴﺤﻕ ﻟﻬﺎ ﺇﻋﻁﺎﺅﻩ ﻁﺒﻘﹰ‬

‫ﺍﻟﻤﺎﺩﺓ ‪٣٥‬‬ ‫ﺎ ﺒﺄﺤﻜﺎﻡ‬ ‫ﺎ ﻋﻠﻰ ﺇﺫﻥ ﻤﻥ ﺍﻟﺭﺌﻴﺱ‪ .‬ﻭﺭﻫﻨﹰ‬ ‫ﻻ ﻴﺤﻕ ﻷﻱ ﻤﻤﺜل ﺃﻥ ﻴﺘﺤﺩﺙ ﻓﻲ ﺃﻱ ﺠﻠﺴﺔ ﺩﻭﻥ ﺍﻟﺤﺼﻭل ﻤﺴﺒﻘﹰ‬ ‫‪-١‬‬ ‫ﺍﻟﻤﻭﺍﺩ ‪ ٣٦‬ﻭ‪ ٣٨‬ﻭ‪ ٤٢‬ﻴﻌﻁﻲ ﺍﻟﺭﺌﻴﺱ ﺍﻟﻜﻠﻤﺔ ﻟﻠﻤﺘﺤﺩﺜﻴﻥ ﺤﺴﺏ ﺘﺭﺘﻴﺏ ﺇﺒﺩﺍﺀ ﺭﻏﺒﺘﻬﻡ ﻓﻲ ﺍﻟﺘﺤﺩﺙ‪ .‬ﻭﺘﺤﺘﻔﻅ ﺍﻷﻤﺎﻨﺔ‬

‫‪13‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺒﻘﺎﺌﻤﺔ ﻟﻠﻤﺘﺤﺩﺜﻴﻥ‪ .‬ﻭﻟﻠﺭﺌﻴﺱ ﺃﻥ ﻴﻁﻠﺏ ﻤﻥ ﺃﻱ ﻤﺘﺤﺩﺙ ﻤﺭﺍﻋﺎﺓ ﺍﻟﻨﻅﺎﻡ ﺇﺫﺍ ﻜﺎﻨﺕ ﻤﻼﺤﻅﺎﺘﻪ ﻻ ﻋﻼﻗﺔ ﻟﻬﺎ ﺒﺎﻟﻤﻭﻀﻭﻉ‬ ‫ﻗﻴﺩ ﺍﻟﺒﺤﺙ‪.‬‬ ‫ﻭﻟﻠﺭﺌﻴﺱ ﺃﺜﻨﺎﺀ ﺍﻟﻤﻨﺎﻗﺸﺔ ﺃﻥ ﻴﻌﻠﻥ ﻗﺎﺌﻤﺔ ﺍﻟﻤﺘﺤﺩﺜﻴﻥ ﻭﻟﻪ‪ ،‬ﺒﻤﻭﺍﻓﻘﺔ ﺍﻟﻤﺅﺘﻤﺭ‪ ،‬ﺃﻥ ﻴﻌﻠﻥ ﺇﻗﻔﺎل ﻫـﺫﻩ ﺍﻟﻘﺎﺌﻤـﺔ‪.‬‬ ‫‪-٢‬‬ ‫ﻋﻠﻰ ﺃﻥ ﻟﻠﺭﺌﻴﺱ ﺃﻥ ﻴﻌﻁﻲ ﺤﻕ ﺍﻟﺭ‬ ‫‪‬ﺩ ﻷﻱ ﻤﻤﺜل ﺇﺫﺍ ﻭﺠﺩ ﻤﺎ ﻴﺒﺭﺭ ﺫﻟﻙ ﻓﻲ ﻜﻠﻤﺔ ﺃﻟﻘﻴﺕ ﺒﻌﺩ ﺇﻗﻔﺎل ﺍﻟﻘﺎﺌﻤﺔ‪.‬‬ ‫‪‬ﺴﻤﺢ ﺒﻬﺎ ﻟﻜـل‬ ‫ﺀ ﻋﻠﻰ ﺍﻗﺘﺭﺍﺡ ﻤﻥ ﺍﻟﺭﺌﻴﺱ ﺃﻭ ﻤﻥ ﺃﻱ ﻁﺭﻑ‪ ،‬ﺃﻥ ﻴﺤﺩﺩ ﺍﻟﻤﺩﺓ ﺍﻟﺘﻲ ﻴ‬ ‫ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﺒﻨﺎ ‪‬‬ ‫‪-٣‬‬ ‫‪‬ﺴﻤﺢ ﺒﻬﺎ ﻟﻜل ﻤﻤﺜل ﺒﺸﺄﻥ ﺃﻴﺔ ﻤﺴﺄﻟﺔ‪ .‬ﻭﻗﺒل ﺍﺘﺨﺎﺫ ﺃﻱ ﻗﺭﺍﺭ ﻴﺠﻭﺯ ﻻﺜﻨﻴﻥ ﻤﻥ‬ ‫ﻤﺘﺤﺩﺙ ﻭﻋﺩﺩ ﻤﺭﺍﺕ ﺍﻟﺘﺤﺩﺙ ﺍﻟﺘﻲ ﻴ‬ ‫‪‬ﺙ ﻤﻌﺎﺭﻀﺔ ﻟﻬﺫﺍ ﺍﻻﻗﺘﺭﺍﺡ‪ .‬ﻭﺇﺫﺍ‬ ‫ﺍ ﻟﻼﻗﺘﺭﺍﺡ ﺍﻟﺨﺎﺹ ﺒﺫﻟﻙ ﺍﻟﺘﺤﺩﻴﺩ ﻭﻻﺜﻨﻴﻥ ﻤﻥ ﺍﻟﻤﻤﺜﻠﻴﻥ ﺍﻟﺘﺤﺩ‬ ‫‪‬ﺙ ﺘﺄﻴﻴﺩﹰ‬ ‫ﺍﻟﻤﻤﺜﻠﻴﻥ ﺍﻟﺘﺤﺩ‬ ‫ﺘﻡ ﻫﺫﺍ ﺍﻟﺘﺤﺩﻴﺩ ﻭﺘﺠﺎﻭﺯ ﺃﺤﺩ ﺍﻟﻤﺘﺤﺩﺜﻴﻥ ﺍﻟﻭﻗﺕ ﺍﻟﻤﺨﺼﺹ ﻴﻨﺒﻬﻪ ﺍﻟﺭﺌﻴﺱ ﻋﻠﻰ ﺍﻟﻔﻭﺭ ﺇﻟﻰ ﻀﺭﻭﺭﺓ ﺍﻟﺘﻘﻴﺩ ﺒﺎﻟﻨﻅﺎﻡ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٣٦‬‬ ‫ﹸﺼﺕ ﺇﻟﻴﻬـﺎ‬ ‫ﻴﺠﻭﺯ ﻤﻨﺢ ﺍﻷﺴﺒﻘﻴﺔ ﻓﻲ ﺍﻟﺘﺤﺩﺙ ﻟﺭﺌﻴﺱ ﺃﻭ ﻤﻘﺭﺭ ﻫﻴﺌﺔ ﻓﺭﻋﻴﺔ ﻤﻥ ﺃﺠل ﺸﺭﺡ ﺍﻟﻨﺘﺎﺌﺞ ﺍﻟﺘﻲ ﺨﻠ‬ ‫‪-١‬‬ ‫ﺘﻠﻙ ﺍﻟﻬﻴﺌﺔ ﺍﻟﻔﺭﻋﻴﺔ‪.‬‬ ‫ﺀ ﻋﻠﻰ ﺩﻋـﻭﺓ ﻤـﻥ ﺍﻟـﺭﺌﻴﺱ‬ ‫ﻟﺭﺌﻴﺱ ﺍﻷﻤﺎﻨﺔ ﺃﻭ ﺃﻱ ﻋﻀﻭ ﻓﻲ ﺍﻷﻤﺎﻨﺔ ﻴﻌﻴﻨﻪ ﺭﺌﻴﺱ ﺍﻷﻤﺎﻨﺔ ﺃﻥ ﻴﺩﻟﻲ ﺒﻨﺎ ‪‬‬ ‫‪-٢‬‬ ‫ﺒﺒﻴﺎﻨﺎﺕ ﺸﻔﻭﻴﺔ ﺃﻭ ﻜﺘﺎﺒﻴﺔ ﺒﺸﺄﻥ ﺃﻴﺔ ﻤﺴﺄﻟﺔ ﻤﻁﺭﻭﺤﺔ ﻟﺘﻘﺩﻴﻡ ﻤﻌﻠﻭﻤﺎﺕ ﺃﻭ ﺘﻭﻀﻴﺤﺎﺕ ﺃﻭ ﺘﻔﺴﻴﺭﺍﺕ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٣٧‬‬ ‫ﻴﻌﻁﻲ ﺍﻟﺭﺌﻴﺱ ﺤﻕ ﺍﻟﺭﺩ ﻷﻱ ﻤﻤﺜل ﻴﻁﻠﺒﻪ‪ .‬ﻭﻓﻲ ﻤﻤﺎﺭﺴﺔ ﻫﺫﺍ ﺍﻟﺤﻕ ﻴﺤﺎﻭل ﺍﻟﻤﻤﺜﻠـﻭﻥ ﺍﻹﻴﺠـﺎﺯ ﺒﻘـﺩﺭ‬ ‫‪‬ل ﺃﻥ ﻴﺩﻟﻭﺍ ﺒﺒﻴﺎﻨﺎﺘﻬﻡ ﻓﻲ ﻨﻬﺎﻴﺔ ﺍﻟﺠﻠﺴﺔ ﺍﻟﺘﻲ ﻴﻁﻠﺏ ﻓﻴﻬﺎ ﻫﺫﺍ ﺍﻟﺤﻕ‪.‬‬ ‫ﺍﻹﻤﻜﺎﻥ‪ ،‬ﻭﻴﻔﻀ‬

‫ﺍﻟﻤﺎﺩﺓ ‪٣٨‬‬ ‫ﻴﺠﻭﺯ ﻟﻠﻤﻤﺜل‪ ،‬ﻋﻨﺩ ﻤﻨﺎﻗﺸﺔ ﺃﻱ ﻤﺴﺄﻟﺔ‪ ،‬ﺃﻥ ﻴﺜﻴﺭ ﻨﻘﻁﺔ ﻨﻅﺎﻡ ﻓﻲ ﺃﻱ ﻭﻗﺕ‪ ،‬ﻭﻴﺘﻌﻴﻥ ﻋﻠﻰ ﺍﻟﺭﺌﻴﺱ ﺃﻥ ﻴﺒـﺕ‬ ‫ﺍ ﻟﻠﺘﺼﻭﻴﺕ‪،‬‬ ‫ﺍ ﺒﻤﻘﺘﻀﻰ ﻫﺫﺍ ﺍﻟﻨﻅﺎﻡ‪ .‬ﻭﻴﺠﻭﺯ ﺃﻥ ﻴﻁﻌﻥ ﺍﻟﻤﻤﺜل ﻓﻲ ﻗﺭﺍﺭ ﺍﻟﺭﺌﻴﺱ‪ .‬ﻭﻴﻁﺭﺡ ﺍﻟﻁﻌﻥ ﻓﻭﺭﹰ‬ ‫ﻓﻲ ﺫﻟﻙ ﻓﻭﺭﹰ‬ ‫ﺍ ﻤﺎ ﻟﻡ ﺘﻠﻐﻪ ﺃﻏﻠﺒﻴﺔ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺤﺎﻀﺭﺓ ﻭﺍﻟﻤﺼﻭﺘﺔ‪ .‬ﻭﻻ ﻴﺠﻭﺯ ﺃﻥ ﻴﺘﺤﺩﺙ ﺍﻟﻤﻤﺜل ﺍﻟـﺫﻱ ﺃﺜـﺎﺭ‬ ‫ﻭﻴﻜﻭﻥ ﺍﻟﻘﺭﺍﺭ ﻨﺎﻓﺫﹰ‬ ‫ﻨﻘﻁﺔ ﻨﻅﺎﻡ ﻋﻥ ﻤﻀﻤﻭﻥ ﺍﻟﻤﺴﺄﻟﺔ ﻗﻴﺩ ﺍﻟﻤﻨﺎﻗﺸﺔ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٣٩‬‬ ‫ﻴﺠﻭﺯ‪ ،‬ﺃﺜﻨﺎﺀ ﻤﻨﺎﻗﺸﺔ ﺃﻴﺔ ﻤﺴﺄﻟﺔ‪ ،‬ﺃﻥ ﻴﻘﺘﺭﺡ ﺍﻟﻤﻤﺜل ﺘﻌﻠﻴﻕ ﺃﻭ ﺘﺄﺠﻴل ﺍﻟﺠﻠﺴﺔ‪ .‬ﻭﻻ ﺘﻨﺎﻗﺵ ﻫﺫﻩ ﺍﻻﻗﺘﺭﺍﺤـﺎﺕ‬ ‫‪-١‬‬ ‫ﺍ ﻟﻠﺘﺼﻭﻴﺕ‪.‬‬ ‫ﺒل ﺘﻁﺭﺡ ﻓﻭﺭﹰ‬ ‫ﻴﻌﻨﻲ "ﺘﻌﻠﻴﻕ ﺍﻟﺠﻠﺴﺔ"‪ ،‬ﻷﻏﺭﺍﺽ ﻫﺫﺍ ﺍﻟﻨﻅﺎﻡ‪ ،‬ﺍﻹﺭﺠﺎﺀ ﺍﻟﻤﺅﻗﺕ ﻷﻋﻤﺎل ﺍﻟﺠﻠﺴﺔ ﻭﻴﻌﻨﻲ "ﺘﺄﺠﻴل ﺍﻟﺠﻠـﺴﺔ"‬ ‫‪-٢‬‬ ‫ﺇﻨﻬﺎﺀ ﺠﻤﻴﻊ ﺃﻋﻤﺎﻟﻬﺎ ﺇﻟﻰ ﺤﻴﻥ ﻋﻘﺩ ﺠﻠﺴﺔ ﺃﺨﺭﻯ‪.‬‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪14‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٤٠‬‬ ‫ﻴﺠﻭﺯ‪ ،‬ﺃﺜﻨﺎﺀ ﻤﻨﺎﻗﺸﺔ ﺃﻱ ﻤﺴﺄﻟﺔ‪ ،‬ﺃﻥ ﻴﻘﺘﺭﺡ ﺃﺤﺩ ﺍﻟﻤﻤﺜﻠﻴﻥ ﺘﺄﺠﻴل ﻤﻨﺎﻗﺸﺔ ﺍﻟﻤﺴﺄﻟﺔ ﻗﻴـﺩ ﺍﻟﻨﻅـﺭ‪ .‬ﻭﻴﺠـﻭﺯ‬ ‫ﻟﻤﺘﺤﺩﺜﻴﻥ ﺍﺜﻨﻴﻥ ﺒﺎﻹﻀﺎﻓﺔ ﺇﻟﻰ ﻤﻘﺩﻡ ﺍﻟﻤﻘﺘﺭﺡ‪ ،‬ﺃﻥ ﻴﺅﻴﺩﺍ ﺍﻟﻤﻘﺘﺭﺡ ﻭﻟﻤﺘﺤﺩﺜﻴﻥ ﺍﺜﻨﻴﻥ ﺃﻥ ﻴﻌﺎﺭﻀـﺎ ﻭﺒﻌـﺩﻩ ﻴﻁـﺭﺡ‬ ‫ﺍ‪.‬‬ ‫ﺍﻟﻤﻘﺘﺭﺡ ﻟﻠﺘﺼﻭﻴﺕ ﻓﻭﺭﹰ‬

‫ﺍﻟﻤﺎﺩﺓ ‪٤١‬‬ ‫ﻴﺠﻭﺯ ﻷﻱ ﻤﻤﺜل‪ ،‬ﻓﻲ ﺃﻱ ﻭﻗﺕ‪ ،‬ﺃﻥ ﻴﻘﺘﺭﺡ ﺇﻨﻬﺎﺀ ﺍﻟﻤﻨﺎﻗﺸﺔ ﺍﻟﺠﺎﺭﻴﺔ ﺴﻭﺍﺀ ﺃﻋﺭﺏ ﻤﻤﺜل ﺁﺨﺭ ﻋﻥ ﺭﻏﺒﺘـﻪ‬ ‫ﹸﻠﺏ ﺍﻹﺫﻥ ﻓﻲ ﺍﻟﺘﺤﺩﺙ ﻟﻤﻌﺎﺭﻀﺔ ﺍﻹﻨﻬﺎﺀ‪ ،‬ﻓﻘﺩ ﻴﻤﻨﺢ ﺍﻹﺫﻥ ﻻﺜﻨﻴﻥ ﻤﻥ ﺍﻟﻤﺘﺤﺩﺜﻴﻥ ﻻ ﻏﻴﺭ‪،‬‬ ‫ﻓﻲ ﺍﻟﺘﺤﺩﺙ ﺃﻭ ﻻ‪ .‬ﻭﺇﺫﺍ ﻁ‬ ‫‪‬ﻌﻠﻥ ﺍﻟـﺭﺌﻴﺱ ﺫﻟـﻙ‬ ‫ﺍ‪ .‬ﻭﺇﺫﺍ ﻗﺭﺭ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺇﻗﻔﺎل ﺒﺎﺏ ﺍﻟﻤﻨﺎﻗﺸﺔ ﻴ‬ ‫‪‬ﻁﺭﺡ ﺍﻻﻗﺘﺭﺍﺡ ﻟﻠﺘﺼﻭﻴﺕ ﻓﻭﺭﹰ‬ ‫ﻭﺒﻌﺩ ﺫﻟﻙ ﻴ‬ ‫‪‬ﺕ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺇﻻ ﻋﻠﻰ ﺍﻻﻗﺘﺭﺍﺤﺎﺕ ﺍﻟﻤﻘﺩﻤﺔ ﻗﺒل ﺍﻹﻗﻔﺎل‪.‬‬ ‫ﻭﺒﻌﺩﻫﺎ ﻻ ﻴﺼﻭ‬

‫ﺍﻟﻤﺎﺩﺓ ‪٤٢‬‬ ‫ﺘﻜﻭﻥ ﻟﻼﻗﺘﺭﺍﺤﺎﺕ ﺍﻟﺘﺎﻟﻴﺔ ﺃﺴﺒﻘﻴﺔ ﺒﺎﻟﺘﺭﺘﻴﺏ ﺍﻟﻤﺒﻴﻥ ﺃﺩﻨﺎﻩ ﻋﻠﻰ ﺠﻤﻴﻊ ﺍﻟﻤﻘﺘﺭﺤﺎﺕ ﺃﻭ ﺍﻻﻗﺘﺭﺍﺤﺎﺕ ﺒﺎﺴـﺘﺜﻨﺎﺀ‬ ‫ﻨﻘﻁﺔ ﺍﻟﻨﻅﺎﻡ‪:‬‬ ‫ﺘﻌﻠﻴﻕ ﺍﻟﺠﻠﺴﺔ؛‬ ‫ﺘﺄﺠﻴل ﺍﻟﺠﻠﺴﺔ؛‬ ‫ﺘﺄﺠﻴل ﻤﻨﺎﻗﺸﺔ ﺍﻟﻤﺴﺄﻟﺔ ﺍﻟﻤﻁﺭﻭﺤﺔ؛‬ ‫ﺇﻨﻬﺎﺀ ﻤﻨﺎﻗﺸﺔ ﺍﻟﻤﺴﺄﻟﺔ ﺍﻟﻤﻁﺭﻭﺤﺔ‪.‬‬ ‫)ﺃ(‬ ‫)ﺏ(‬ ‫)ﺝ(‬ ‫)ﺩ(‬

‫ﺍﻟﻤﺎﺩﺓ ‪٤٣‬‬ ‫ﺎ ﺒﺎﻟﻤﺎﺩﺓ ‪ ٤٢‬ﻴﻁﺭﺡ ﻟﻠﺘﺼﻭﻴﺕ ﺃﻱ ﺍﻗﺘﺭﺍﺡ ﻴﺩﻋﻭ ﺇﻟﻰ ﺍﻟﺒﺕ ﻓﻲ ﺍﺨﺘﺼﺎﺹ ﻤـﺅﺘﻤﺭ ﺍﻷﻁـﺭﺍﻑ ﻓـﻲ‬ ‫ﺭﻫﻨﹰ‬ ‫ﻤﻨﺎﻗﺸﺔ ﺃﻱ ﻤﺴﺄﻟﺔ ﺃﻭ ﻓﻲ ﺇﻗﺭﺍﺭ ﻤﻘﺘﺭﺡ ﺃﻭ ﺘﻌﺩﻴل ﻟﻤﻘﺘﺭﺡ ﻤﻘﺩﻡ ﺇﻟﻴﻪ‪ ،‬ﻗﺒل ﺍﻟﺘﺼﻭﻴﺕ ﻋﻠـﻰ ﺍﻟﻤﻘﺘـﺭﺡ ﺃﻭ ﺍﻟﺘﻌـﺩﻴل‬ ‫ﺍﻟﻤﻁﺭﻭﺡ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٤٤‬‬ ‫ﻴﺠﻭﺯ ﻷﻱ ﻤﻤﺜل ﺃﻥ ﻴﻘﺘﺭﺡ ﺍﻟﺘﺼﻭﻴﺕ ﻋﻠﻰ ﺃﺠﺯﺍﺀ ﻤﻥ ﺍﻗﺘﺭﺍﺤﻪ ﺃﻭ ﺃﺠﺯﺍﺀ ﻤﻥ ﺍﻟﺘﻌﺩﻴل ﺒﺸﻜل ﻤﻨﻔـﺼل‪.‬‬ ‫ﹼﻠﻴﻥ ﺍﺜﻨﻴﻥ ﺒﺎﻟﺘﺤﺩﺙ‪ ،‬ﺃﺤﺩﻫﻤﺎ ﻤﺅﻴـﺩ ﻟﻠﻁﻠـﺏ ﻭﺍﻵﺨـﺭ‬ ‫‪‬ﻡ ﺍﻋﺘﺭﺍﺽ ﻋﻠﻰ ﻁﻠﺏ ﺍﻟﺘﺠﺯﺌﺔ‪ ،‬ﻴﺄﺫﻥ ﺍﻟﺭﺌﻴﺱ ﻟﻤﻤﺜ‬ ‫ﻗﺩ‬ ‫ﻭﺇﺫﺍ ﹸ‬ ‫ﺍ‪ .‬ﻭﻴﺠﻭﺯ ﻟﻠﺭﺌﻴﺱ ﺃﻥ ﻴﺤﺩﺩ ﺍﻟﻭﻗﺕ ﺍﻟﻤﺴﻤﻭﺡ ﺒﻪ ﻟﻜل ﻤﺘﺤـﺩﺙ‪.‬‬ ‫ﻤﻌﺎﺭﺽ ﻟﻪ‪ ،‬ﺒﻌﺩﻫﺎ ﻴﻁﺭﺡ ﺍﻟﻁﻠﺏ ﻟﻠﺘﺼﻭﻴﺕ ﻓﻭﺭﹰ‬ ‫‪‬ﻭﻓﻕ ﻋﻠﻰ ﺍﻗﺘﺭﺍﺡ ﺍﻟﺘﺠﺯﺌﺔ‪ ،‬ﺘﻁﺭﺡ ﺃﺠﺯﺍﺀ ﺍﻻﻗﺘﺭﺍﺡ ﺃﻭ ﺍﻟﺘﻌﺩﻴل ﺍﻟﺘﻲ ﻴﻭﺍﻓﻕ ﻋﻠﻴﻬﺎ ﻟﻠﺘـﺼﻭﻴﺕ ﺠﻤﻠـﺔ‪ .‬ﻭﺇﺫﺍ‬ ‫ﻭﺇﺫﺍ ﻭ‬ ‫ﺎ ﺒﺭﻤﺘﻪ‪.‬‬ ‫ﺭﻓﻀﺕ ﻜل ﺃﺠﺯﺍﺀ ﺍﻟﻤﻨﻁﻭﻕ ﻓﻲ ﺍﻻﻗﺘﺭﺍﺡ ﺃﻭ ﺍﻟﺘﻌﺩﻴل‪ ،‬ﻴﻌﺘﺒﺭ ﺍﻻﻗﺘﺭﺍﺡ ﺃﻭ ﺍﻟﺘﻌﺩﻴل ﻤﺭﻓﻭﻀﹰ‬

‫‪15‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺍﻟﻤﺎﺩﺓ ‪٤٥‬‬ ‫ﻻ‪ .‬ﻭﺇﺫﺍ ﺍﻗﺘﺭﺡ ﺘﻌـﺩﻴﻼﻥ ﺃﻭ ﺃﻜﺜـﺭ ﻋﻠـﻰ‬ ‫ﻋﻨﺩﻤﺎ ﻴﻘﺘﺭﺡ ﺘﻌﺩﻴل ﺍﻗﺘﺭﺍﺡ ﻴﺠﺭﻱ ﺍﻟﺘﺼﻭﻴﺕ ﻋﻠﻰ ﺍﻟﺘﻌﺩﻴل ﺃﻭ ﹰ‬ ‫ﻻ ﻋﻠﻰ ﺍﻟﺘﻌﺩﻴل ﺍﻟﺫﻱ ﻴﺭﻯ ﺍﻟﺭﺌﻴﺱ ﺃﻨﻪ ﺍﻷﺒﻌـﺩ ﻓـﻲ ﻤـﻀﻤﻭﻨﻪ ﻋـﻥ‬ ‫ﺍﻻﻗﺘﺭﺍﺡ ﻓﺈﻥ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻴﺼﻭﺕ ﺃﻭ ﹰ‬ ‫ﹰ‪ ،‬ﻭﻫﻜﺫﺍ ﺩﻭﺍﻟﻴﻙ ﺇﻟﻰ ﺃﻥ ﻴﺘﻡ ﻁﺭﺡ ﺠﻤﻴﻊ ﺍﻟﺘﻌﺩﻴﻼﺕ ﻟﻠﺘـﺼﻭﻴﺕ‪.‬‬ ‫ﺍﻻﻗﺘﺭﺍﺡ ﺍﻷﺼﻠﻲ‪ ،‬ﺜﻡ ﻋﻠﻰ ﺍﻟﺘﻌﺩﻴل ﺍﻟﺫﻱ ﻴﻠﻴﻪ ﺒﻌﺩﺍ‬ ‫ﻏﻴﺭ ﺃﻨﻪ ﺇﺫﺍ ﺍﻨﻁﻭﻯ ﺃﺤﺩ ﺍﻟﺘﻌﺩﻴﻼﺕ ﺒﺎﻟﻀﺭﻭﺭﺓ ﻋﻠﻰ ﺭﻓﺽ ﺘﻌﺩﻴل ﺁﺨﺭ‪ ،‬ﻓﻼ ﻴﻁﺭﺡ ﺍﻟﺘﻌﺩﻴل ﺍﻷﺨﻴﺭ ﻟﻠﺘﺼﻭﻴﺕ‪.‬‬ ‫ﹸﺒل ﺍﻗﺘـﺭﺍﺡ ﻤـﻥ‬ ‫ﻭﺇﺫﺍ ﺍﻋﺘﻤﺩ ﺘﻌﺩﻴل ﺃﻭ ﺃﻜﺜﺭ‪ ،‬ﻓﺤﻴﻨﺌﺫ ﻴﻁﺭﺡ ﺍﻻﻗﺘﺭﺍﺡ ﺒﺼﻴﻐﺘﻪ ﺍﻟﻤﻌﺩﻟﺔ ﻟﻠﺘﺼﻭﻴﺕ‪ .‬ﻭﺇﺫﺍ ﻗ‬ ‫ﺎ ﻤﻥ ﺍﻻﻗﺘﺭﺍﺡ ﺍﻷﺼﻠﻲ‪ ،‬ﻭﻻ ﻴﺠﺭﻱ ﺤﻴﻨﺌـﺫ ﺘـﺼﻭﻴﺕ‬ ‫ﺍ ﺃﺴﺎﺴﻴﹰ‬ ‫ﺼﺎﺤﺏ ﺍﻻﻗﺘﺭﺍﺡ ﺍﻷﺼﻠﻲ ﺍﻋﺘﺒﺭ ﺫﻟﻙ ﺍﻟﺘﻌﺩﻴل ﺠﺯﺀﹰ‬ ‫ﻼ ﻋﻠﻰ ﺍﻗﺘﺭﺍﺡ ﺇﺫﺍ ﺍﻗﺘﺼﺭ ﻋﻠﻰ ﻤﺠﺭﺩ ﺇﻀﺎﻓﺔ ﺃﻭ ﺤﺫﻑ ﺃﻭ ﺘﻨﻘﻴﺢ ﻟﺠـﺯﺀ ﻤـﻥ‬ ‫ﻤﺴﺘﻘل ﻋﻠﻴﻪ‪ .‬ﻭﻴﻌﺘﺒﺭ ﺍﻻﻗﺘﺭﺍﺡ ﺘﻌﺩﻴ ﹰ‬ ‫ﺍﻻﻗﺘﺭﺍﺡ‪.‬‬ ‫ﺎ ﺒﺤﺩ ﺫﺍﺘﻪ‪.‬‬ ‫ﻼ ﻋﻥ ﺍﻗﺘﺭﺍﺡ‪ ،‬ﺍﻗﺘﺭﺍﺤﹰ‬ ‫‪‬ﻌﺘﺒﺭ ﺃﻱ ﺍﻗﺘﺭﺍﺡ ﺇﺠﺭﺍﺌﻲ ﻴﺸﻜل ﺒﺩﻴ ﹰ‬ ‫ﻭﻴ‬

‫ﺍﻟﻤﺎﺩﺓ ‪٤٦‬‬ ‫ﺇﺫﺍ ﺘﻌﻠﻕ ﺍﻗﺘﺭﺍﺤﺎﻥ ﺃﻭ ﺃﻜﺜﺭ ﺒﻤﺴﺄﻟﺔ ﻭﺍﺤﺩﺓ ﻓﺈﻥ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻴﺼﻭﺕ ﻋﻠﻰ ﺍﻻﻗﺘﺭﺍﺤﺎﺕ ﺒﺎﻟﺘﺭﺘﻴﺏ ﺍﻟﺫﻱ‬ ‫ﺘﻘﺩﻡ ﺒﻪ‪ ،‬ﻤﺎ ﻟﻡ ﻴﻘﺭﺭ ﺍﻟﻤﺅﺘﻤﺭ ﻏﻴﺭ ﺫﻟﻙ‪ .‬ﻭﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺃﻥ ﻴﻘﺭﺭ ﺒﻌﺩ ﻜل ﺘﺼﻭﻴﺕ ﻋﻠﻰ ﺍﻗﺘﺭﺍﺡ ﻤﺎ ﺇﺫﺍ ﻜـﺎﻥ‬ ‫ﻴﺼﻭﺕ ﻋﻠﻰ ﺍﻻﻗﺘﺭﺍﺡ ﺍﻟﺫﻱ ﻴﻠﻴﻪ ﺃﻭ ﻻ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٤٧‬‬ ‫ﻴﺠﻭﺯ ﻟﺼﺎﺤﺏ ﺍﻻﻗﺘﺭﺍﺡ ﺍﻹﺠﺭﺍﺌﻲ ﺃﻭ ﺍﻻﻗﺘﺭﺍﺡ ﺃﻥ ﻴﺴﺤﺒﻪ ﻓﻲ ﺃﻱ ﻭﻗﺕ ﻗﺒل ﺒﺩﺀ ﺍﻟﺘﺼﻭﻴﺕ ﻋﻠﻴﻪ‪ ،‬ﺸﺭﻴﻁﺔ‬ ‫‪‬ل‪ .‬ﻭﻴﺠﻭﺯ ﻷﻱ ﻁﺭﻑ ﺃﻥ ﻴﻌﻴﺩ ﺘﻘـﺩﻴﻡ ﺍﻻﻗﺘـﺭﺍﺡ ﺃﻭ ﺍﻻﻗﺘـﺭﺍﺡ‬ ‫ﻋﺩ‬ ‫ﺃﻻ ﻴﻜﻭﻥ ﺍﻻﻗﺘﺭﺍﺡ ﺍﻹﺠﺭﺍﺌﻲ ﺃﻭ ﺍﻻﻗﺘﺭﺍﺡ ﻗﺩ ‪‬‬ ‫ﺍﻹﺠﺭﺍﺌﻲ ﺍﻟﻤﺴﺤﻭﺏ ﻋﻠﻰ ﻫﺫﺍ ﺍﻟﻨﺤﻭ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٤٨‬‬ ‫‪‬ﺭ ﻤﺅﺘﻤﺭ‬ ‫ﺇﺫﺍ ﺍﻋﺘﻤﺩ ﺃﻭ ﺭﻓﺽ ﺍﻗﺘﺭﺍﺡ ﺇﺠﺭﺍﺌﻲ ﻤﺎ‪ ،‬ﻻ ﻴﺠﻭﺯ ﺇﻋﺎﺩﺓ ﺍﻟﻨﻅﺭ ﻓﻴﻪ ﻓﻲ ﺍﻟﺠﻠﺴﺔ ﻨﻔﺴﻬﺎ‪ ،‬ﻤﺎ ﻟﻡ ﻴﻘﺭ‬ ‫‪‬ﻭﺘﺔ‪ .‬ﻭﻻ ﻴﻤﻨﺢ ﺍﻹﺫﻥ ﺒﺎﻟﺘﺤﺩﺙ ﺒﺸﺄﻥ ﺍﻗﺘﺭﺍﺡ ﺒﺈﻋﺎﺩﺓ ﺍﻟﻨﻅﺭ‬ ‫ﺍﻷﻁﺭﺍﻑ ﺫﻟﻙ ﺒﺄﻏﻠﺒﻴﺔ ﺜﻠﺜﻲ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺤﺎﻀﺭﺓ ﻭﺍﻟﻤﺼ‬ ‫ﺇﻻ ﻟﺼﺎﺤﺏ ﺍﻻﻗﺘﺭﺍﺡ ﻭﻻﺜﻨﻴﻥ ﻤﻥ ﺍﻟﻤﺅﻴﺩﻴﻥ ﻭﺍﺜﻨﻴﻥ ﻤﻥ ﺍﻟﻤﻌﺎﺭﻀﻴﻥ ﻟﻼﻗﺘﺭﺍﺡ ﻭﺒﻌﺩ ﺫﻟﻙ ﻴﻁﺭﺡ ﻟﻠﺘﺼﻭﻴﺕ ﻓـﻭﺭﹰ‬ ‫ﺍ‪.‬‬ ‫ﻭﻻ ﻴﻌﺘﺒﺭ ﺃﻥ ﺃﻱ ﺘﺼﻭﻴﺏ ﻟﺨﻁﺄ ﻜﺘﺎﺒﻲ ﺃﻭ ﺤﺴﺎﺒﻲ ﻓﻲ ﺃﻱ ﻭﺜﻴﻘﺔ ﺘﺘﻌﻠﻕ ﺒﺎﻗﺘﺭﺍﺡ ﺇﺠﺭﺍﺌﻲ ﺴﺒﻕ ﺍﻋﺘﻤﺎﺩﻩ‪ ،‬ﺃﻨﻪ ﻴﻘﺘﻀﻲ‬ ‫ﺇﻋﺎﺩﺓ ﻤﻨﺎﻗﺸﺔ ﺫﻟﻙ ﺍﻻﻗﺘﺭﺍﺡ ﺍﻹﺠﺭﺍﺌﻲ ﺒﺄﻏﻠﺒﻴﺔ ﺍﻟﺜﻠﺜﻴﻥ‪.‬‬

‫ﺍﻟﺘﺼﻭﻴﺕ‬ ‫ﺍﻟﻤﺎﺩﺓ ‪٤٩‬‬ ‫ﺹ ﻋﻠﻴﻪ ﻓﻲ ﺍﻟﻔﻘﺭﺓ ‪.٢‬‬ ‫ﻟﻜل ﻁﺭﻑ ﺼﻭﺕ ﻭﺍﺤﺩ ﺒﺎﺴﺘﺜﻨﺎﺀ ﻤﺎ ﻨ ‪‬‬ ‫‪-١‬‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪16‬‬

‫ﺘﻤﺎﺭﺱ ﻤﻨﻅﻤﺎﺕ ﺍﻟﺘﻜﺎﻤل ﺍﻻﻗﺘﺼﺎﺩﻱ ﺍﻹﻗﻠﻴﻤﻲ‪ ،‬ﻓﻲ ﺍﻟﻤﺴﺎﺌل ﺍﻟﺩﺍﺨﻠﺔ ﻓـﻲ ﺍﺨﺘـﺼﺎﺼﺎﺘﻬﺎ‪ ،‬ﺤﻘﻬـﺎ ﻓـﻲ‬ ‫‪-٢‬‬ ‫ﻭ ﻟﻌﺩﺩ ﺩﻭﻟﻬﺎ ﺍﻷﻋﻀﺎﺀ ﺍﻟﺘﻲ ﻫﻲ ﺃﻁﺭﺍﻑ ﻓﻲ ﺍﻻﺘﻔﺎﻗﻴﺔ‪ .‬ﻭﻻ ﺘﻤﺎﺭﺱ ﺃﻱ ﻤﻨﻅﻤﺔ‬ ‫ﺍﻟﺘﺼﻭﻴﺕ ﺒﻌﺩﺩ ﻤﻥ ﺍﻷﺼﻭﺍﺕ ﻤﺴﺎ ﹴ‬ ‫ﻤﻥ ﻫﺫﺍ ﺍﻟﻘﺒﻴل ﺤﻘﻬﺎ ﻓﻲ ﺍﻟﺘﺼﻭﻴﺕ ﺇﺫﺍ ﻤﺎﺭﺴﺕ ﺃﻱ ﻤﻥ ﺩﻭﻟﻬﺎ ﺍﻷﻋﻀﺎﺀ ﺤﻘﻬﺎ‪ ،‬ﻭﺍﻟﻌﻜﺱ ﺒﺎﻟﻌﻜﺱ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٥٠‬‬ ‫ﺎ ﻟﻠﻨﻅﺎﻡ ﺍﻟﻤﺎﻟﻲ ﺍﻟﻤـﺸﺎﺭ ﺇﻟﻴـﻪ ﻓـﻲ‬ ‫ﹸﺘﺨﺫ ﺍﻟﻘﺭﺍﺭﺍﺕ ﺒﺸﺄﻥ ﺍﻟﻤﺴﺎﺌل ﺍﻟﻤﻴﺯﻨﻴﺔ ﻭﺍﻟﻤﺎﻟﻴﺔ ﺒﺘﻭﺍﻓﻕ ﺍﻵﺭﺍﺀ ﻭﻭﻓﻘﹰ‬ ‫ﺘ‬ ‫‪-١‬‬ ‫ﺍﻟﻤﺎﺩﺓ ‪ ٤-٢٣‬ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ‪.‬‬ ‫ﻓﻴﻤﺎ ﻴﺨﺹ ﺠﻤﻴﻊ ﺍﻟﻘﺭﺍﺭﺍﺕ ﺍﻷﺨﺭﻯ ﻴﺒﺫل ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻗﺼﺎﺭﻯ ﺠﻬﺩﻩ ﻟﻠﺘﻭﺼل ﺇﻟﻰ ﺍﺘﻔﺎﻕ ﺒﺘﻭﺍﻓـﻕ‬ ‫‪-٢‬‬ ‫ﺍﻵﺭﺍﺀ‪.‬‬

‫ﺇﺫﺍ ﺍﺴﺘﻨﻔﺩﺕ ﺠﻤﻴﻊ ﺍﻟﺠﻬﻭﺩ ﺍﻟﺭﺍﻤﻴﺔ ﺇﻟﻰ ﺍﻟﺘﻭﺼل ﺇﻟﻰ ﺘﻭﺍﻓﻕ ﻓﻲ ﺍﻵﺭﺍﺀ ﺒﺸﺄﻥ ﺍﻟﻘﺭﺍﺭﺍﺕ ﺍﻟﻤﺸﺎﺭ ﺇﻟﻴﻬﺎ ﻓـﻲ‬ ‫‪-٣‬‬ ‫‪‬ﺭ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺍﻷﻋﻤﺎل ﻋﻠﻰ ﺍﻟﻨﺤﻭ ﺍﻟﺘﺎﻟﻲ‪ ،‬ﻜﻤﻼﺫ ﺃﺨﻴﺭ‪:‬‬ ‫ﺍﻟﻔﻘﺭﺓ ‪ ٢‬ﻭﺘﻌﺫﺭ ﺍﻟﺘﻭﺼل ﺇﻟﻰ ﺃﻱ ﺍﺘﻔﺎﻕ‪ ،‬ﻴﺴﻴ‬ ‫ﺘﺘﺨﺫ ﺍﻟﻘﺭﺍﺭﺍﺕ ﺒﺸﺄﻥ ﺍﻟﻤﺴﺎﺌل ﺍﻟﺠﻭﻫﺭﻴﺔ‪ ،‬ﺒﺄﻏﻠﺒﻴﺔ ﺜﻼﺜﺔ ﺃﺭﺒﺎﻉ ﺃﺼﻭﺍﺕ ﺍﻷﻁـﺭﺍﻑ ﺍﻟﺤﺎﻀـﺭﺓ‬ ‫)ﺃ(‬ ‫ﻭﺍﻟﻤﺼﻭﺘﺔ‪ ،‬ﻤﺎ ﻟﻡ ﻴﻨﺹ ﻋﻠﻰ ﻏﻴﺭ ﺫﻟﻙ ﻓﻲ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺃﻭ ﻓﻲ ﻤﻭﺍﺩ ﻫﺫﺍ ﺍﻟﻨﻅﺎﻡ؛‬ ‫ﹸﺘﺨﺫ ﺍﻟﻘﺭﺍﺭﺍﺕ ﺒﺸﺄﻥ ﺍﻟﻤﺴﺎﺌل ﺍﻹﺠﺭﺍﺌﻴﺔ ﺒﺄﻏﻠﺒﻴﺔ ﺃﺼﻭﺍﺕ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺤﺎﻀﺭﺓ ﻭﺍﻟﻤﺼﻭﺘﺔ‪.‬‬ ‫ﺘ‬ ‫)ﺏ(‬

‫‪‬ﻁﺭﺡ ﺃﻱ ﻁﻌﻥ ﻓـﻲ‬ ‫ﻴﺒﺕ ﺍﻟﺭﺌﻴﺱ ﻓﻲ ﺃﻴﺔ ﻨﻘﻁﺔ ﺒﺨﺼﻭﺹ ﻤﺎ ﺇﺫﺍ ﻜﺎﻨﺕ ﺍﻟﻤﺴﺄﻟﺔ ﺇﺠﺭﺍﺌﻴﺔ ﺃﻭ ﺠﻭﻫﺭﻴﺔ‪ .‬ﻭﻴ‬ ‫‪-٤‬‬ ‫‪‬ﻠﻎ ﺒﺄﻏﻠﺒﻴﺔ ﺃﺼـﻭﺍﺕ ﺍﻷﻁـﺭﺍﻑ ﺍﻟﺤﺎﻀـﺭﺓ‬ ‫ﺍ ﻤﺎ ﻟﻡ ﻴ‬ ‫‪‬ﻌﺘﺒﺭ ﻗﺭﺍﺭ ﺍﻟﺭﺌﻴﺱ ﻨﺎﻓﺫﹰ‬ ‫ﻫﺫﺍ ﺍﻟﻘﺭﺍﺭ ﻟﻠﺘﺼﻭﻴﺕ ﻋﻠﻰ ﺍﻟﻔﻭﺭ‪ .‬ﻭﻴ‬ ‫ﻭﺍﻟﻤﺼﻭﺘﺔ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٥١‬‬ ‫ﻴﻜﻭﻥ ﺍﻟﺘﺼﻭﻴﺕ‪ ،‬ﻓﻲ ﻏﻴﺭ ﺍﻻﻨﺘﺨﺎﺒﺎﺕ‪ ،‬ﺒﺭﻓﻊ ﺍﻷﻴﺩﻱ‪ .‬ﻭﻴﺠﺭﻱ ﺍﻟﺘﺼﻭﻴﺕ ﺒﻨﺩﺍﺀ ﺍﻷﺴﻤﺎﺀ ﺒﻨﺎﺀ ﻋﻠﻰ ﻁﻠـﺏ‬ ‫‪-١‬‬ ‫ﺃﻱ ﻁﺭﻑ‪ .‬ﻭﻴﺠﺭﻱ ﺍﻟﺘﺼﻭﻴﺕ ﺒﻨﺩﺍﺀ ﺍﻷﺴﻤﺎﺀ ﺒﺎﻟﺘﺭﺘﻴﺏ ﺍﻟﻬﺠﺎﺌﻲ ﺍﻹﻨﻜﻠﻴﺯﻱ ﻷﺴﻤﺎﺀ ﺍﻷﻁﺭﺍﻑ‪ .‬ﻭﻴﺤﺩﺩ ﺍﺴﻡ ﺍﻟﻁﺭﻑ‬ ‫ﻻ ﺒﺎﻟﻘﺭﻋﺔ‪.‬‬ ‫ﺍﻟﺫﻱ ﻴﺼﻭﺕ ﺃﻭ ﹰ‬ ‫ﺎ ﺒﺄﻏﻠﺒﻴـﺔ‬ ‫‪‬ﺕ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻋﻠﻰ ﺃﻱ ﻤﺴﺄﻟﺔ ﺒﺎﻻﻗﺘﺭﺍﻉ ﺍﻟﺴﺭﻱ ﺇﺫﺍ ﻗـﺭﺭ ﺫﻟـﻙ ﻤـﺴﺒﻘﹰ‬ ‫ﻴﺠﻭﺯ ﺃﻥ ﻴﺼﻭ‬ ‫‪-٢‬‬ ‫ﺍﻷﻁﺭﺍﻑ ﺍﻟﺤﺎﻀﺭﺓ ﻭﺍﻟﻤﺼﻭﺘﺔ‪ ،‬ﺸﺭﻴﻁﺔ ﻋﺩﻡ ﺇﺠﺭﺍﺀ ﺍﻗﺘﺭﺍﻉ ﺴﺭﻱ ﻓﻲ ﺍﻟﻤﺴﺎﺌل ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﺎﻟﻤﻴﺯﺍﻨﻴﺔ‪ .‬ﻭﻻ ﻴﺘﺨﺫ ﺃﻱ‬ ‫ﻗﺭﺍﺭ ﺒﻤﻭﺠﺏ ﻫﺫﻩ ﺍﻟﻤﺎﺩﺓ ﺒﺸﺄﻥ ﻤﺎ ﺇﺫﺍ ﻜﺎﻥ ﺍﻟﺘﺼﻭﻴﺕ ﺒﺎﻻﻗﺘﺭﺍﻉ ﺍﻟﺴﺭﻱ‪ ،‬ﺇﻻ ﺒﺭﻓﻊ ﺍﻷﻴـﺩﻱ؛ ﻭﺇﺫﺍ ﻗـﺭﺭ ﻤـﺅﺘﻤﺭ‬ ‫ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﺼﻭﻴﺕ ﻋﻠﻰ ﻤﺴﺄﻟﺔ ﺒﻌﻴﻨﻬﺎ ﺒﺎﻻﻗﺘﺭﺍﻉ ﺍﻟﺴﺭﻱ ﻓﻼ ﻴﺠﻭﺯ ﻁﻠﺏ ﺇﺠﺭﺍﺀ ﻁﺭﻴﻘﺔ ﺃﺨﺭﻯ ﻟﻠﺘﺼﻭﻴﺕ ﺃﻭ ﺍﻟﺒﺕ‬ ‫ﻓﻴﻪ‪.‬‬ ‫ﺎ ﺒﺎﻟﻭﺴﺎﺌل ﺍﻟﻤﻴﻜﺎﻨﻴﻜﻴﺔ ﻴﺤل ﺍﻟﺘﺼﻭﻴﺕ ﻏﻴﺭ ﺍﻟﻤﺴﺠل ﻤﺤل ﺍﻟﺘﺼﻭﻴﺕ‬ ‫ﺤﻴﻥ ﻴﺠﺭﻱ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺘﺼﻭﻴﺘﹰ‬ ‫‪-٣‬‬ ‫ﺒﺭﻓﻊ ﺍﻷﻴﺩﻱ ﻭﻴﺤل ﺍﻟﺘﺼﻭﻴﺕ ﺍﻟﻤﺴﺠل ﻤﺤل ﺍﻟﺘﺼﻭﻴﺕ ﺒﻨﺩﺍﺀ ﺍﻷﺴﻤﺎﺀ‪.‬‬ ‫‪‬ﺩﺭﺝ ﻓﻲ ﻤﺤﺎﻀﺭ ﺍﻟﺠﻠﺴﺎﺕ ﺼﻭﺕ ﻜل ﻁﺭﻑ ﻤﺸﺎﺭﻙ ﻓﻲ ﺍﻟﺘﺼﻭﻴﺕ ﺒﻨـﺩﺍﺀ ﺍﻷﺴـﻤﺎﺀ ﺃﻭ ﺍﻟﺘـﺼﻭﻴﺕ‬ ‫ﻴ‬ ‫‪-٤‬‬ ‫ﺍﻟﻤﺴﺠل‪.‬‬

‫‪17‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺍﻟﻤﺎﺩﺓ ‪٥٢‬‬ ‫ﺒﻌﺩ ﺇﻋﻼﻥ ﺍﻟﺭﺌﻴﺱ ﺒﺩﺍﻴﺔ ﺍﻟﺘﺼﻭﻴﺕ ﻻ ﻴﻘﺎﻁﻊ ﺃﻱ ﻤﻤﺜل ﻋﻤﻠﻴﺔ ﺍﻟﺘﺼﻭﻴﺕ ﺇﻻ ﻟﻨﻘﻁﺔ ﻨﻅﺎﻡ ﺘﺘﺼل ﺒﻤـﺴﺎﺭ‬ ‫‪-١‬‬ ‫ﺍﻟﺘﺼﻭﻴﺕ ﺍﻟﻔﻌﻠﻲ‪.‬‬ ‫ﺒﻌﺩ ﺍﻜﺘﻤﺎل ﻋﻤﻠﻴﺔ ﺍﻟﺘﺼﻭﻴﺕ ﻴﺠﻭﺯ ﻟﻠﺭﺌﻴﺱ ﺍﻟﺴﻤﺎﺡ ﻟﻸﻁﺭﺍﻑ ﺒﺎﻹﺩﻻﺀ ﺒﺒﻴﺎﻥ ﻤﻭﺠﺯ ﻴﻘﺘﺼﺭ ﻋﻠﻰ ﺘﻌﻠﻴل‬ ‫‪-٢‬‬ ‫ﺍﻟﺘﺼﻭﻴﺕ‪ .‬ﻭﻻ ﻴﺘﺤﺩﺙ ﺭﺍﻋﻲ ﺍﻻﻗﺘﺭﺍﺡ ﺘﻌﻠﻴ ﹰ‬ ‫ﻼ ﻟﻠﺘﺼﻭﻴﺕ ﻋﻠﻴﻪ ﺇﻻ ﺇﺫﺍ ﻁﺭﺃ ﻋﻠﻴﻪ ﺘﻌﺩﻴل‪ .‬ﻭﻴﺠﻭﺯ ﻟﻠﺭﺌﻴﺱ ﺃﻥ ﻴﻀﻊ‬ ‫ﺍ ﻟﻠﻭﻗﺕ ﺍﻟﺫﻱ ﺴﻴﺘﺎﺡ ﻟﺫﻜﺭ ﻫﺫﻩ ﺍﻟﺘﻌﻠﻴﻼﺕ‪.‬‬ ‫ﺤﺩﻭﺩﹰ‬

‫ﺍﻟﻤﺎﺩﺓ ‪٥٣‬‬ ‫ﺭﺭ ﻤـﺅﺘﻤﺭ‬ ‫ﺘﺠﺭﻯ ﺍﻻﻨﺘﺨﺎﺒﺎﺕ ﺒﺎﻻﻗﺘﺭﺍﻉ ﺍﻟﺴﺭﻱ‪ ،‬ﺇﻻ ﺃﻨﻪ ﻓﻲ ﺤﺎﻟﺔ ﻋﺩﻡ ﺇﺒﺩﺍﺀ ﺃﻱ ﺍﻋﺘﺭﺍﺽ ﻴﺠـﻭﺯ ﺃﻥ ﻴﻘـ ‪‬‬ ‫ﺍﻷﻁﺭﺍﻑ ﻋﺩﻡ ﺍﻟﻠﺠﻭﺀ ﺇﻟﻰ ﺇﺠﺭﺍﺀ ﺍﻗﺘﺭﺍﻉ ﻋﻠﻰ ﻤﺭﺸﺢ ﻤﺘﻔﻕ ﻋﻠﻴﻪ ﺃﻭ ﻗﺎﺌﻤﺔ ﻤﺭﺸﺤﻴﻥ ﻤﺘﻔﻕ ﻋﻠﻴﻬﺎ‪ .‬ﻭﺇﺫﺍ ﻟﺯﻡ ﺇﺠـﺭﺍﺀ‬ ‫ﺍﻗﺘﺭﺍﻉ ﻴﻘﻭﻡ ﺸﺨﺼﺎﻥ ﻴﻌﻴﻨﻬﻤﺎ ﺍﻟﺭﺌﻴﺱ‪ ،‬ﻤﻥ ﺒﻴﻥ ﺍﻟﻭﻓﻭﺩ ﺍﻟﺤﺎﻀﺭﺓ ﺒﺎﻟﻤﺴﺎﻋﺩﺓ ﻓﻲ ﻋﺩ ﺍﻷﺼﻭﺍﺕ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٥٤‬‬ ‫ﻋﻨﺩﻤﺎ ﻴﺘﻌﻴﻥ ﺍﻨﺘﺨﺎﺏ ﺸﺨﺹ ﻭﺍﺤﺩ ﺃﻭ ﻁﺭﻑ ﻭﺍﺤﺩ ﻓﻘﻁ‪ ،‬ﻭﻻ ﻴﺤﺼل ﺃﻱ ﻤﺭﺸﺢ ﻓﻲ ﺍﻻﻗﺘﺭﺍﻉ ﺍﻷﻭل ﻋﻠﻰ‬ ‫‪-١‬‬ ‫‪‬ﺠﺭﻯ ﺍﻗﺘﺭﺍﻉ ﺜﺎﻥ ﻴﻘﺘﺼﺭ ﻋﻠﻰ ﺍﻟﻤﺭﺸﺤﻴﻥ ﺍﻟﻠﺫﻴﻥ ﺤﺼﻼ ﻋﻠـﻰ‬ ‫ﺃﻏﻠﺒﻴﺔ ﺃﺼﻭﺍﺕ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺤﺎﻀﺭﺓ ﻭﺍﻟﻤﺼﻭﺘﺔ‪ ،‬ﻴ‬ ‫ﺃﻜﺒﺭ ﻋﺩﺩ ﻤﻥ ﺍﻷﺼﻭﺍﺕ‪ .‬ﻭﺇﺫﺍ ﺘﺴﺎﻭﺕ ﺍﻷﺼﻭﺍﺕ ﻓﻲ ﺍﻻﻗﺘﺭﺍﻉ ﺍﻟﺜﺎﻨﻲ ﻴﺤﺴﻡ ﺍﻟـﺭﺌﻴﺱ ﺍﻷﻤـﺭ ﺒـﻴﻥ ﺍﻟﻤﺭﺸـﺤﻴﻥ‬ ‫ﺒﺎﻟﻘﺭﻋﺔ‪.‬‬ ‫ﺇﺫﺍ ﺃﺭﻴﺩ ﺸﻐل ﻤﻨﺼﺒﻴﻥ ﺃﻭ ﺃﻜﺜﺭ ﺒﺎﻻﻨﺘﺨﺎﺏ ﻓﻲ ﻭﻗﺕ ﻭﺍﺤﺩ ﻭﻓﻲ ﺍﻟﻅﺭﻭﻑ ﻨﻔﺴﻬﺎ‪ ،‬ﻓﺈﻥ ﺍﻟﻤﺭﺸﺤﻴﻥ ﺍﻟـﺫﻴﻥ‬ ‫‪-٢‬‬ ‫ﻴﺤﺼﻠﻭﻥ ﻓﻲ ﺍﻻﻗﺘﺭﺍﻉ ﺍﻷﻭل ﻋﻠﻰ ﺃﻜﺒﺭ ﻋﺩﺩ ﻤﻥ ﺍﻷﺼﻭﺍﺕ ﻭﻋﻠﻰ ﺃﻏﻠﺒﻴﺔ ﺃﺼﻭﺍﺕ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺤﺎﻀﺭﺓ ﻭﺍﻟﻤﺼﻭﺘﺔ‬ ‫ﻫﻡ ﺍﻟﺫﻴﻥ ﻴﻨﺘﺨﺒﻭﻥ‪.‬‬ ‫ﹼل ﻋﺩﺩ ﺍﻟﻤﺭﺸﺤﻴﻥ ﺍﻟﺤﺎﺼﻠﻴﻥ ﻋﻠﻰ ﻫﺫﻩ ﺍﻷﻏﻠﺒﻴﺔ ﻋﻥ ﻋﺩﺩ ﺍﻷﺸﺨﺎﺹ ﺃﻭ ﺍﻷﻁـﺭﺍﻑ ﺍﻟـﺫﻴﻥ ﻴﺘﻌـﻴﻥ‬ ‫‪-٣‬‬ ‫ﺇﺫﺍ ﻗ‬ ‫ﹼﺤﻴﻥ ﺍﻟﺤﺎﺼﻠﻴﻥ‬ ‫ﺍﻨﺘﺨﺎﺒﻬﻡ ﺘﺠﺭﻯ ﻋﻤﻠﻴﺎﺕ ﺍﻗﺘﺭﺍﻉ ﺇﻀﺎﻓﻴﺔ ﻟﺸﻐل ﺍﻟﻤﻨﺎﺼﺏ ﺍﻟﻤﺘﺒﻘﻴﺔ‪ ،‬ﻭﻴﻘﺘﺼﺭ ﺍﻟﺘﺼﻭﻴﺕ ﻋﻠﻰ ﺍﻟﻤﺭﺸ‬ ‫ﻋﻠﻰ ﺃﻜﺒﺭ ﻋﺩﺩ ﻤﻥ ﺍﻷﺼﻭﺍﺕ ﻓﻲ ﺍﻻﻗﺘﺭﺍﻉ ﺍﻟﺴﺎﺒﻕ ﻋﻠﻰ ﻋﺩﺩ ﻻ ﻴﺘﺠﺎﻭﺯ ﻀﻌﻑ ﻋﺩﺩ ﺍﻟﻤﻨﺎﺼﺏ ﺍﻟﻤﺘﺒﻘﻴﺔ ﺍﻟﺘﻲ ﻴﺘﻌﻴﻥ‬ ‫ﺸﻐﻠﻬﺎ؛ ﻭﺫﻟﻙ ﺸﺭﻴﻁﺔ ﺠﻭﺍﺯ ﺇﻋﻁﺎﺀ ﺍﻷﺼﻭﺍﺕ‪ ،‬ﺒﻌﺩ ﺍﻻﻗﺘـﺭﺍﻉ ﺍﻟﺜﺎﻟـﺙ ﻏﻴـﺭ ﺍﻟﺤﺎﺴـﻡ‪ ،‬ﺇﻟـﻰ ﺃﻱ ﺸـﺨﺹ ﺃﻭ‬ ‫ﻁﺭﻑ ﺫﻱ ﺃﻫﻠﻴﺔ‪.‬‬ ‫ﺇﺫﺍ ﻜﺎﻨﺕ ﻋﻤﻠﻴﺎﺕ ﺍﻻﻗﺘﺭﺍﻉ ﺍﻟﺜﻼﺙ ﻏﻴﺭ ﺍﻟﻤﻘﻴﺩﺓ ﻫﺫﻩ ﻏﻴﺭ ﺤﺎﺴﻤﺔ‪ ،‬ﺘﻘﺘﺼﺭ ﻋﻤﻠﻴﺎﺕ ﺍﻻﻗﺘﺭﺍﻉ ﺍﻟﺜﻼﺙ ﺍﻟﺘﺎﻟﻴﺔ‬ ‫‪-٤‬‬ ‫ﻋﻠﻰ ﺍﻟﻤﺭﺸﺤﻴﻥ ﺍﻟﺫﻴﻥ ﻴﺤﺼﻠﻭﻥ ﻋﻠﻰ ﺃﻜﺒﺭ ﻋﺩﺩ ﻤﻥ ﺍﻷﺼﻭﺍﺕ ﻓﻲ ﺜﺎﻟﺙ ﻋﻤﻠﻴﺎﺕ ﺍﻻﻗﺘﺭﺍﻉ ﻏﻴﺭ ﺍﻟﻤﻘﻴـﺩﺓ ﺒﻤـﺎ ﻻ‬ ‫ﻴﺘﺠﺎﻭﺯ ﻀﻌﻑ ﺍﻟﻤﻨﺎﺼﺏ ﺍﻟﻤﺘﺒﻘﻴﺔ ﺍﻟﺘﻲ ﻴﺘﻌﻴﻥ ﺸﻐﻠﻬﺎ‪ ،‬ﻭﺘﺼﺒﺢ ﻋﻤﻠﻴﺎﺕ ﺍﻻﻗﺘﺭﺍﻉ ﺍﻟﺜﻼﺙ ﺍﻟﺘﺎﻟﻴﺔ ﻏﻴﺭ ﻤﻘﻴﺩﺓ‪ ،‬ﻭﻴﺴﺘﻤﺭ‬ ‫ﺍﻷﻤﺭ ﻋﻠﻰ ﻫﺫﺍ ﺍﻟﻤﻨﻭﺍل ﺇﻟﻰ ﺃﻥ ﺘﺸﻐل ﺠﻤﻴﻊ ﺍﻟﻤﻨﺎﺼﺏ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٥٥‬‬ ‫ﻓﻲ ﺃﻱ ﺍﻨﺘﺨﺎﺏ ﻴﺼﻭﺕ ﻜل ﻤﻤﺜل‪ ،‬ﺇﻻ ﺇﺫﺍ ﺍﻤﺘﻨﻊ ﻋﻥ ﺍﻟﺘﺼﻭﻴﺕ‪ ،‬ﻟﻌﺩﺩ ﺍﻟﻤﺭﺸﺤﻴﻥ ﺍﻟﻤﺴﺎﻭﻱ ﻟﻌﺩﺩ ﺍﻟﻤﻨﺎﺼﺏ‬ ‫ﺍﻟﻤﺭﺍﺩ ﺸﻐﻠﻬﺎ ﺒﺎﻻﻨﺘﺨﺎﺏ‪ .‬ﻭﺃﻱ ﺒﻁﺎﻗﺔ ﺍﻗﺘﺭﺍﻉ ﺘﺤﻤل ﺃﺴﻤﺎﺀ ﺘﺯﻴﺩ ﺃﻭ ﺘﻘل ﻋﻥ ﺍﻟﻤﻨﺎﺼﺏ ﺍﻟﻤﺭﺍﺩ ﺸـﻐﻠﻬﺎ ﺒﺎﻻﻨﺘﺨـﺎﺏ‬ ‫ﺘﻌﺘﺒﺭ ﻻﻏﻴﺔ ﻭﺒﺎﻁﻠﺔ‪.‬‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪18‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٥٦‬‬ ‫ﹼﺭ ﺸﻐل ﻤﻨﺼﺏ ﺃﻭ ﺃﻜﺜﺭ ﻴﺭﺍﺩ ﺸﻐﻠﻪ ﺒﺎﻻﻨﺘﺨﺎﺏ ﺒﺴﺒﺏ ﺘﺴﺎﻭﻱ ﺍﻷﺼﻭﺍﺕ‬ ‫ﺇﺫﺍ ﺤﺩﺙ ﻓﻲ ﺃﻱ ﺍﻨﺘﺨﺎﺏ ﺃﻥ ﺘﻌﺫ‬ ‫‪‬ﻨﺘﺨﺏ ﻤﻨﻬﻡ‪ .‬ﻭﻴﺠﻭﺯ ﺘﻜﺭﺍﺭ ﻫﺫﻩ‬ ‫ﺍﻟﺘﻲ ﺤﺼل ﻋﻠﻴﻬﺎ ﻤﺭﺸﺤﺎﻥ ﺃﻭ ﺃﻜﺜﺭ‪ ،‬ﻴﺠﺭﻯ ﺍﻗﺘﺭﺍﻉ ﺒﻴﻥ ﺍﻟﻤﺭﺸﺤﻴﻥ ﻟﺘﺤﺩﻴﺩ ﻤﻥ ﻴ‬ ‫ﺍﻟﻌﻤﻠﻴﺔ ﻋﻨﺩ ﺍﻟﻀﺭﻭﺭﺓ‪.‬‬

‫ﺍﻟﻠﻐﺎﺕ ﻭﺍﻟﻤﺤﺎﻀﺭ‬ ‫ﺍﻟﻤﺎﺩﺓ ‪٥٧‬‬ ‫ﺍﻟﻠﻐﺎﺕ ﺍﻟﺭﺴﻤﻴﺔ ﻭﻟﻐﺎﺕ ﺍﻟﻌﻤل ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻋﻠﻰ ﺍﻟﺴﻭﺍﺀ ﻫـﻲ ﺍﻟﻌﺭﺒﻴـﺔ ﻭﺍﻟـﺼﻴﻨﻴﺔ ﻭﺍﻹﻨﻜﻠﻴﺯﻴـﺔ‬ ‫ﻭﺍﻟﻔﺭﻨﺴﻴﺔ ﻭﺍﻟﺭﻭﺴﻴﺔ ﻭﺍﻷﺴﺒﺎﻨﻴﺔ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٥٨‬‬ ‫ﹸﻠﻘﻰ ﺒﺄﻱ ﻤﻥ ﺍﻟﻠﻐﺎﺕ ﺍﻟﺭﺴﻤﻴﺔ ﺘﺭﺠﻤﺔ ﻓﻭﺭﻴﺔ ﺇﻟﻰ ﺴﺎﺌﺭ ﺍﻟﻠﻐﺎﺕ ﺍﻟﺭﺴﻤﻴﺔ‪.‬‬ ‫ﺘﺘﺭﺠﻡ ﺍﻟﺒﻴﺎﻨﺎﺕ ﺍﻟﺘﻲ ﺘ‬ ‫‪-١‬‬

‫ﻴﺠﻭﺯ ﺃﻥ ﻴﺘﺤﺩﺙ ﻤﻤﺜل ﺃﻱ ﻁﺭﻑ ﺒﻠﻐﺔ ﻏﻴﺭ ﺍﻟﻠﻐﺎﺕ ﺍﻟﺭﺴﻤﻴﺔ ﺇﺫﺍ ﻭﻓﺭ ﻫﺫﺍ ﺍﻟﻁﺭﻑ ﺍﻟﺘﺭﺠﻤﺔ ﺍﻟﻔﻭﺭﻴﺔ ﺇﻟﻰ‬ ‫‪-٢‬‬ ‫ﺇﺤﺩﻯ ﺍﻟﻠﻐﺎﺕ ﺍﻟﺭﺴﻤﻴﺔ‪ .‬ﻭﻴﺠﻭﺯ ﺃﻥ ﺘﺴﺘﻨﺩ ﺍﻟﺘﺭﺠﻤﺔ ﺍﻟﻔﻭﺭﻴﺔ ﺍﻟﺘﻲ ﻴﻘﻭﻡ ﺒﻬﺎ ﺍﻟﻤﺘﺭﺠﻤﻭﻥ ﺍﻟﺘﺎﺒﻌﻭﻥ ﻟﻸﻤﺎﻨﺔ ﺇﻟﻰ ﺴـﺎﺌﺭ‬ ‫ﺍﻟﻠﻐﺎﺕ ﺍﻟﺭﺴﻤﻴﺔ ﺇﻟﻰ ﺍﻟﺘﺭﺠﻤﺔ ﺍﻟﻔﻭﺭﻴﺔ ﻤﻥ ﺍﻟﻠﻐﺔ ﺍﻟﺭﺴﻤﻴﺔ ﺍﻷﻭﻟﻰ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٥٩‬‬ ‫ﺘﺘﺎﺡ ﺒﺠﻤﻴﻊ ﻟﻐﺎﺕ ﺍﻟﻌﻤل ﺠﻤﻴﻊ ﺍﻟﻭﺜﺎﺌﻕ ﺍﻟﺭﺴﻤﻴﺔ ﺫﺍﺕ ﺍﻟﺼﻠﺔ ﺒﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٦٠‬‬ ‫ﺘﻌﺩ ﺍﻷﻤﺎﻨﺔ ﺍﻟﻤﺤﺎﻀﺭ ﺍﻟﺤﺭﻓﻴﺔ ﻟﺠﻠﺴﺎﺕ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻭﺍﻟﻤﺤﺎﻀﺭ ﺍﻟﻤﻭﺠﺯﺓ ﻟﺠﻠﺴﺎﺕ ﺍﻟﻬﻴﺌﺎﺕ ﺍﻟﻔﺭﻋﻴﺔ‬ ‫ﺒﻠﻐﺎﺕ ﺍﻟﻌﻤل ﺍﻟﺴﺕ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٦١‬‬ ‫ﺘﺤﺘﻔﻅ ﺍﻷﻤﺎﻨﺔ ﺒﺘﺴﺠﻴﻼﺕ ﺠﻠﺴﺎﺕ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﻭﺒﺘﺴﺠﻴﻼﺕ ﺠﻠﺴﺎﺕ ﺍﻟﻬﻴﺌﺎﺕ ﺍﻟﻔﺭﻋﻴﺔ ﻜﻠﻤﺎ ﺃﻤﻜـﻥ‬ ‫ﺫﻟﻙ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٦٢‬‬ ‫ﹸﺴﺦ ﺍﻟﻤﺅﻗﺘﺔ ﻤﻥ ﺍﻟﻤﺤﺎﻀﺭ ﺍﻟﻤﻭﺠﺯﺓ ﺍﻟﻤﺸﺎﺭ ﺇﻟﻴﻬﺎ ﻓﻲ ﺍﻟﻤﺎﺩﺓ ‪ ٦٠‬ﻓﻲ ﺃﺴﺭﻉ ﻭﻗﺕ ﻤﻤﻜـﻥ ﺇﻟـﻰ‬ ‫ﺘﺭﺴل ﺍﻟﻨ‬ ‫ﺎ ﻤـﻥ ﺘـﺎﺭﻴﺦ‬ ‫ﹰ‪ ،‬ﻓﻲ ﻏﻀﻭﻥ ﻓﺘﺭﺓ ﻻ ﺘﺘﺠﺎﻭﺯ ﺨﻤﺴﺔ ﻋـﺸﺭ ﻴﻭﻤـﹰ‬ ‫ﺍﻟﻭﻓﻭﺩ‪ ،‬ﺍﻟﺘﻲ ﺘﻘﻭﻡ ﺒﺩﻭﺭﻫﺎ ﺒﺈﺒﻼﻍ ﺍﻷﻤﺎﻨﺔ ﻜﺘﺎﺒﻴﺎ‬ ‫ﺍﻻﺴﺘﻼﻡ‪ ،‬ﺒﺄﻴﺔ ﺘﺼﻭﻴﺒﺎﺕ ﺘﺭﻏﺏ ﻓﻲ ﺇﺩﺨﺎﻟﻬﺎ ﻋﻠﻴﻬﺎ‪.‬‬

‫‪19‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺍﻟﻤﺎﺩﺓ ‪٦٣‬‬ ‫ﺎ ﻤﻥ ﺠﻤﻴﻊ ﺍﻟﻤﺤﺎﻀـﺭ ﺍﻟﺤﺭﻓﻴـﺔ‬ ‫ﻴﺭﺴل ﺭﺌﻴﺱ ﺍﻷﻤﺎﻨﺔ ﻓﻲ ﺃﻗﺭﺏ ﻭﻗﺕ ﻤﻤﻜﻥ ﺒﻌﺩ ﺍﺨﺘﺘﺎﻡ ﻜل ﺩﻭﺭﺓ ﻨﺴﺨﹰ‬ ‫ﻭﺍﻟﻤﺤﺎﻀﺭ ﺍﻟﻤﻭﺠﺯﺓ ﻭﺍﻟﻘﺭﺍﺭﺍﺕ ﻭﺍﻟﺘﻭﺼﻴﺎﺕ ﻭﻏﻴﺭﻫﺎ ﻤﻥ ﺍﻟﻤﻘﺭﺭﺍﺕ ﺍﻟﺭﺴﻤﻴﺔ ﺍﻟﺘﻲ ﺃﻗﺭﻫﺎ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺇﻟـﻰ‬ ‫ﺍﻷﻁﺭﺍﻑ ﻭﺇﻟﻰ ﺍﻟﺩﻭل ﻭﻤﻨﻅﻤﺎﺕ ﺍﻟﺘﻜﺎﻤل ﺍﻻﻗﺘﺼﺎﺩﻱ ﺍﻹﻗﻠﻴﻤﻲ ﺍﻟﺘﻲ ﺩﻋﻴﺕ ﻟﺤﻀﻭﺭ ﺍﻟﺩﻭﺭﺓ‪ .‬ﻭﺘﺭﺴـل ﻤﺤﺎﻀـﺭ‬ ‫ﺍﻟﺠﻠﺴﺎﺕ ﺍﻟﺴﺭﻴﺔ ﺇﻟﻰ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ ﻓﻴﻬﺎ ﻓﻘﻁ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٦٤‬‬

‫ﻴﺘﻌﻴﻥ ﻨﺸﺭ ﺍﻟﻤﺤﺎﻀﺭ ﺍﻟﺤﺭﻓﻴﺔ ﻭﺍﻟﻤﺤﺎﻀﺭ ﺍﻟﻤﻭﺠﺯﺓ ﻟﻠﺠﻠﺴﺎﺕ ] ﺍﻟﻌﻠﻨﻴﺔ [ ﻭﺘﻘﺎﺭﻴﺭ ﺠﻤﻴﻊ ﺍﻟﻬﻴﺌﺎﺕ ﺍﻟﻔﺭﻋﻴﺔ‪.‬‬

‫ﺍﻟﻤﺎﺩﺓ ‪٦٥‬‬ ‫ﻴﺼﺩﺭ ﺭﺌﻴﺱ ﺍﻷﻤﺎﻨﺔ‪ ،‬ﺒﻠﻐﺎﺕ ﺍﻟﻌﻤل‪ ،‬ﻋﻠﻰ ﺴﺒﻴل ﺘﻴﺴﻴﺭ ﺃﻤﻭﺭ ﺍﻟﻭﻓﻭﺩ ﺍﻟﻤﺸﺎﺭﻜﺔ‪ ،‬ﺠﺭﻴـﺩﺓ ﻴﻭﻤﻴـﺔ ﻋـﻥ‬ ‫ﺍ ﻋﻥ ﺃﻋﻤﺎل ﺍﻟﺠﻠﺴﺎﺕ ﺍﻟﻌﺎﻤﺔ ﻭﺍﻟﺠﻠﺴﺎﺕ ﺍﻟﻌﻠﻨﻴﺔ ﻟﻠﺠﺎﻥ ﻭﺍﻟﻠﺠﺎﻥ ﺍﻟﻔﺭﻋﻴﺔ‪.‬‬ ‫ﺎ ﻤﻭﺠﺯﹰ‬ ‫ﺍﻟﺩﻭﺭﺓ‪ ،‬ﻭﺒﻴﺎﻨﹰ‬

‫ﺘﻌﺩﻴل ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ‬ ‫ﺍﻟﻤﺎﺩﺓ ‪٦٦‬‬ ‫ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺃﻥ ﻴﻌﺩل ﻫﺫﺍ ﺍﻟﻨﻅﺎﻡ ﺍﻟﺩﺍﺨﻠﻲ ﺒﺘﻭﺍﻓﻕ ﺍﻵﺭﺍﺀ‪.‬‬

‫ﺃﺴﺒﻘﻴﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ‬ ‫ﺍﻟﻤﺎﺩﺓ ‪٦٧‬‬ ‫ﺇﺫﺍ ﺤﺩﺙ ﺃﻱ ﺘﻌﺎﺭﺽ ﺒﻴﻥ ﺃﻱ ﻤﻥ ﺃﺤﻜﺎﻡ ﻫﺫﺍ ﺍﻟﻨﻅﺎﻡ ﻭﺃﻱ ﻤﻥ ﺃﺤﻜﺎﻡ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺘﻜﻭﻥ ﺍﻷﺴـﺒﻘﻴﺔ ﻷﺤﻜـﺎﻡ‬ ‫)ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻟﺭﺍﺒﻌﺔ‪ ١٥ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪-٢٠٠٦‬‬ ‫ﺍﻟﻠﺠﻨﺔ "ﺏ"‪ ،‬ﺍﻟﺘﻘﺭﻴﺭ ﺍﻟﺭﺍﺒﻊ(‬ ‫ﺍﻻﺘﻔﺎﻗﻴﺔ‪.‬‬

‫ﺍﻋﺘﻤﺎﺩ ﺍﻟﻨﻅﺎﻡ ﺍﻟﻤـﺎﻟﻲ ﻟﻤـﺅﺘﻤﺭ ﺍﻷﻁـﺭﺍﻑ ﻓ ﻲ اﺗﻔﺎﻗﻴ ﺔ ﻣﻨﻈﻤ ﺔ اﻟ ﺼﺤﺔ اﻟﻌﺎﻟﻤﻴ ﺔ‬ ‫اﻹﻃﺎرﻳﺔ ﺑﺸﺄن ﻣﻜﺎﻓﺤﺔ اﻟﺘﺒﻎ‬

‫)‪FCTC/COP1(9‬‬

‫ﻗﺭﺭ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺍﺴﺘﻌﻤﺎل ﺍﻟﻼﺌﺤﺔ ﺍﻟﻤﺎﻟﻴﺔ ﻭﺍﻟﻨﻅﺎﻡ ﺍﻟﻤﺎﻟﻲ ﻟﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ‪ ١‬ﻭﻜﺫﻟﻙ ﺍﻟﻨﻅﺎﻡ‬ ‫ﺍﻟﻤﺎﻟﻲ ﺍﻟﻤﺸﺎﺭ ﺇﻟﻴﻪ ﻓﻲ ﺍﻟﻤﺎﺩﺓ ‪ ٤-٢٣‬ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ‪.‬‬ ‫)ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻟﺭﺍﺒﻌﺔ‪ ١٥ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪-٢٠٠٦‬‬ ‫ﺍﻟﻠﺠﻨﺔ "ﺏ"‪ ،‬ﺍﻟﺘﻘﺭﻴﺭ ﺍﻷﻭل(‬ ‫‪ ١‬ﺍﻟﻼﺌﺤﺔ ﺍﻟﻤﺎﻟﻴﺔ ﻟﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ‪ ،‬ﺍﻟﻭﺜﺎﺌﻕ ﺍﻷﺴﺎﺴﻴﺔ‪ ،‬ﺍﻟﻁﺒﻌﺔ ﺍﻟﺨﺎﻤﺴﺔ ﻭﺍﻷﺭﺒﻌﻭﻥ‪ ،‬ﺠﻨﻴـﻑ‪ ،‬ﻤﻨﻅﻤـﺔ ﺍﻟـﺼﺤﺔ‬ ‫ﺍﻟﻌﺎﻟﻤﻴﺔ‪٢٠٠٥ ،‬؛ ﺍﻟﻨﻅﺎﻡ ﺍﻟﻤﺎﻟﻲ ﺍﻟﺫﻱ ﺩﺨل ﺤﻴﺯ ﺍﻟﻨﻔﺎﺫ ﻓﻲ ﻋﺎﻡ ‪.٢٠٠١‬‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪20‬‬

‫ﺇﻨﺸﺎﺀ ﺃﻤﺎﻨﺔ ﺩﺍﺌﻤﺔ ﻟﻼﺘﻔﺎﻗﻴﺔ‬

‫)‪FCTC/COP1(10‬‬

‫ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪،‬‬

‫ﻗﺭﺭ‬

‫ﺒﻌﺩ ﺘﺄﻜﻴﺩ ﻏﺭﺽ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪ ،‬ﻜﻤﺎ ﻫﻭ ﻤﺒﻴﻥ ﻓﻲ ﺍﻟﻤﺎﺩﺓ‬ ‫‪ ٣‬ﻤﻨﻬﺎ ﻤﺎ ﻴﻠﻲ‪:‬‬ ‫ﺇﻨﺸﺎﺀ ﺃﻤﺎﻨﺔ ﺩﺍﺌﻤﺔ ﻟﻼﺘﻔﺎﻗﻴﺔ ﺩﺍﺨل ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﻴﻜﻭﻥ ﻤﻘﺭﻫﺎ ﻓﻲ ﺠﻨﻴﻑ )ﺘﺴﻤﻰ ﻓﻴﻤـﺎ‬ ‫‪-١‬‬ ‫ﻴﻠﻲ "ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ"(؛‬ ‫ﻗﻴﺎﻡ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ‪ ،‬ﺒﺎﻟﺘﺸﺎﻭﺭ ﻤﻊ ﺃﻤﺎﻨﺔ ﺍﻟﻤﻨﻅﻤﺔ‪ ،‬ﺒﺈﻋﺩﺍﺩ ﺘﻭﺼﻴﻑ ﻟﻭﻅﻴﻔﺔ ﺭﺌﻴﺱ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ‪،‬‬ ‫‪-٢‬‬ ‫ﻤﻊ ﻤﺭﺍﻋﺎﺓ ﺍﻟﺨﺒﺭﺍﺕ ﺍﻟﻤﺴﺘﺼﻭﺒﺔ ﻭﺍﻟﺨﺼﺎﺌﺹ ﺍﻟﻤﺤﺩﺩﺓ ﻓﻲ ﻤﺤﺎﻀﺭ ﺍﻟﻠﺠﻨﺔ "ﺏ" ﻟﻠﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤـﺅﺘﻤﺭ‬ ‫ﺍﻷﻁﺭﺍﻑ؛‪١‬‬ ‫ﺩﻋﻭﺓ ﺍﻟﻤﺩﻴﺭ ﺍﻟﻌﺎﻡ ﻟﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺇﻟﻰ ﺍﻹﻋﻼﻥ ﻋﻥ ﻭﻅﻴﻔﺔ ﺭﺌﻴﺱ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻋﻠﻰ‬ ‫‪-٣‬‬ ‫ﺍﻟﻨﺤﻭ ﺍﻟﺫﻱ ﺘﻌﺭﻀﻪ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ‪ ،‬ﻓﻲ ﺃﻗﺭﺏ ﻓﺭﺼﺔ‪ ،‬ﻭﺍﻻﺴﺘﻌﺎﻨﺔ ﺒﺨﺩﻤﺎﺕ ﺍﻟﺩﻋﻡ ﺍﻟﺘـﻲ ﺘﻘـﺩﻤﻬﺎ ﺃﻤﺎﻨـﺔ‬ ‫ﺍ ﻻ ﻴﺯﻴﺩ ﻋﻠﻰ ‪ ١٠‬ﻤﺭﺸﺤﻴﻥ‪ ،‬ﻭﺇﺭﺴﺎل‬ ‫ﺍﻟﻤﻨﻅﻤﺔ ﻟﻔﺤﺹ ﺍﻟﻁﻠﺒﺎﺕ‪ ،‬ﻭﺇﻋﺩﺍﺩ ﻗﺎﺌﻤﺔ ﻤﺨﺘﺼﺭﺓ ﺃﻭﻟﻴﺔ ﺘﻀﻡ ﻋﺩﺩﹰ‬ ‫ﻫﺫﻩ ﺍﻟﻁﻠﺒﺎﺕ ﺇﻟﻰ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ؛‬ ‫ﻗﻴﺎﻡ ﺨﺩﻤﺎﺕ ﺍﻟﺩﻋﻡ ﺍﻟﺘﻲ ﺘﻘﺩﻤﻬﺎ ﺃﻤﺎﻨﺔ ﺍﻟﻤﻨﻅﻤﺔ ﺒﺈﺭﺴﺎل ﻗﺎﺌﻤﺔ ﻜﺎﻤﻠﺔ ﺒﺠﻤﻴﻊ ﺍﻟﻁﻠﺒﺎﺕ ﺍﻟﻤﻔﺤﻭﺼﺔ‪،‬‬ ‫‪-٤‬‬ ‫ﺇﻟﻰ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ‪ ،‬ﻤﻊ ﻋﺭﺽ ﻤﻭﺠﺯ ﻷﺴﺒﺎﺏ ﺘﻭﺼﻴﺎﺘﻬﺎ؛‬ ‫ﺍ ﻻ ﻴﺯﻴﺩ‬ ‫ﻗﻴﺎﻡ ﻫﻴﺌﺔ ﻤﻜﺘﺏ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺒﺎﻟﻨﻅﺭ ﻓﻲ ﺍﻟﻘﺎﺌﻤﺔ ﺍﻟﻤﺨﺘﺼﺭﺓ ﺍﻷﻭﻟﻴﺔ ﺍﻟﺘﻲ ﺘﻀﻡ ﻋﺩﺩﹰ‬ ‫‪-٥‬‬ ‫ﻋﻠﻰ ‪ ١٠‬ﻤﺭﺸﺤﻴﻥ ﻟﺸﻐل ﻤﻨﺼﺏ ﺭﺌﻴﺱ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ‪ ،‬ﺒﺎﻟﺘﺸﺎﻭﺭ ﻤﻊ ﺃﻤﺎﻨﺔ ﺍﻟﻤﻨﻅﻤﺔ ﻭﺫﻟﻙ ﻤـﻥ ﺃﺠـل‬ ‫ﺍﻟﺘﻭﺼﻴﺔ‪ ،‬ﺒﻌﺩ ﺍﻟﺘﺸﺎﻭﺭ ﻤﻊ ﺍﻟﻤﺩﻴﺭ ﺍﻟﻌﺎﻡ ﻟﻠﻤﻨﻅﻤﺔ‪ ،‬ﺒﻤﺭﺸﺢ ﻭﺍﺤﺩ ﻻﺘﺨﺎﺫ ﻗﺭﺍﺭ ﻨﻬﺎﺌﻲ ﻓﻲ ﻫﺫﺍ ﺍﻟﺸﺄﻥ؛‬ ‫ﻗﻴﺎﻡ ﺍﻟﻤﺩﻴﺭ ﺍﻟﻌﺎﻡ ﻟﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺒﺘﻌﻴﻴﻥ ﺭﺌﻴﺱ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ؛‬ ‫‪-٦‬‬

‫ﺃﻥ ﻴﺸﻐل ﺭﺌﻴﺱ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻤﻨﺼﺒﻪ ﻟﻔﺘﺭﺓ ﺃﺭﺒﻊ ﺴﻨﻭﺍﺕ‪ ،‬ﻴﻤﻜﻥ ﺘﺠﺩﻴﺩﻫﺎ ﻟﻔﺘﺭﺓ ﻭﺍﺤـﺩﺓ ﺘﺒﻠـﻎ‬ ‫‪-٧‬‬ ‫ﺜﻼﺙ ﺴﻨﻭﺍﺕ ﺃﺨﺭﻯ؛‬ ‫ﻻ ﺃﻤﺎﻡ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻋﻥ ﺘﻨﻔﻴـﺫ ﺍﻟﻤﻌﺎﻫـﺩﺓ‬ ‫ﻻ ﻭﻤﺴﺎﺀ ﹰ‬ ‫ﺃﻥ ﻴﻜﻭﻥ ﺭﺌﻴﺱ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻤﺴﺅﻭ ﹰ‬ ‫‪-٨‬‬ ‫ﻭﺍﻷﻨﺸﻁﺔ ﺍﻟﺘﻘﻨﻴﺔ ﻋﻠﻰ ﺍﻟﻨﺤﻭ ﺍﻟﻤﺤﺩﺩ ﻓﻲ ﺍﻟﻔﻘﺭﺓ ‪ ،١٢‬ﻭﻴﻘﺩﻡ ﺘﻘﺎﺭﻴﺭ ﻋﻥ ﺠﻤﻴﻊ ﺃﻨـﺸﻁﺘﻬﺎ ﺇﻟـﻰ ﻤـﺅﺘﻤﺭ‬ ‫ﺎ ﻤﻨﻬﺎ ﺇﻟﻰ ﺍﻟﻤﺩﻴﺭ ﺍﻟﻌﺎﻡ ﻟﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ‪ ،‬ﺤﺴﺏ ﺍﻻﻗﺘﻀﺎﺀ؛‬ ‫ﺍﻷﻁﺭﺍﻑ‪ ،‬ﻭﻴﺭﺴل ﻨﺴﺨﹰ‬ ‫‪-٩‬‬ ‫ﻻ ﺃﻤﺎﻡ ﺍﻟﻤﺩﻴﺭ ﺍﻟﻌﺎﻡ ﻟﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﻋﻥ‬ ‫ﻻ ﻭﻤﺴﺎﺀ ﹰ‬ ‫ﺃﻥ ﻴﻜﻭﻥ ﺭﺌﻴﺱ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻤﺴﺅﻭ ﹰ‬ ‫ﺍﻟﺸﺅﻭﻥ ﺍﻹﺩﺍﺭﻴﺔ ﻭﺸﺅﻭﻥ ﺇﺩﺍﺭﺓ ﺍﻟﻤﻭﻅﻔﻴﻥ‪ ،‬ﻭﻜﺫﻟﻙ ﻋﻥ ﺍﻷﻨﺸﻁﺔ ﺍﻟﺘﻘﻨﻴﺔ‪ ،‬ﺤﺴﺏ ﺍﻻﻗﺘﻀﺎﺀ؛‬ ‫‪ -١٠‬ﻗﻴﺎﻡ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺒﺎﻟﺘﻌﺎﻭﻥ ﻭﺍﻟﺘﻨﺴﻴﻕ ﺒﺸﺄﻥ ﺘﻨﻔﻴﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻤﻊ ﻤﺒﺎﺩﺭﺓ ﺍﻟﺘﺤﺭﺭ ﻤﻥ ﺍﻟﺘﺒـﻎ ﻭﻤـﻊ‬ ‫ﺴﺎﺌﺭ ﺇﺩﺍﺭﺍﺕ ﺍﻟﻤﻨﻅﻤﺔ ﺍﻟﻤﻌﻨﻴﺔ‪ ،‬ﺒﻬﺩﻑ ﻀﻤﺎﻥ ﺍﻟﺸﻔﺎﻓﻴﺔ ﻭﺍﻟﻜﻔﺎﺀﺓ ﻭﺍﻟﻤﺭﺩﻭﺩﻴﺔ ﻭﺘﻔﺎﺩﻱ ﺍﻻﺯﺩﻭﺍﺠﻴﺔ؛‬ ‫‪ ١‬ﺍﻨﻅﺭ ﺍﻟﻤﺤﺎﻀﺭ ﺍﻟﻤﻭﺠﺯﺓ ﻟﺠﻠﺴﺎﺕ ﺍﻟﻠﺠﻨﺔ "ﺏ" ﺍﻟﺜﺎﻤﻨﺔ ﺇﻟﻰ ﺍﻟﺜﺎﻟﺜﺔ ﻋﺸﺭﺓ‪.‬‬

‫‪21‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺎ ﻟﻠﻨﻅﺎﻡ ﺍﻷﺴﺎﺴﻲ ﻟﻤﻭﻅﻔﻲ ﻤﻨﻅﻤﺔ ﺍﻟـﺼﺤﺔ‬ ‫‪ -١١‬ﺃﻥ ﻴﻌﻴﻥ ﺭﺌﻴﺱ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺠﻤﻴﻊ ﺍﻟﻤﻭﻅﻔﻴﻥ ﻭﻓﻘﹰ‬ ‫ﺎ ﺒﻬﻤﺎ‪ ،‬ﻭﻤﻊ ﻤﺭﺍﻋﺎﺓ ﺍﻟﺨﺼﺎﺌﺹ ﺍﻟﻤﺴﺘﺼﻭﺒﺔ ﺍﻟﻤﺤﺩﺩﺓ ﻓﻲ‬ ‫ﺍﻟﻌﺎﻟﻤﻴﺔ ﻭﻻﺌﺤﺔ ﺍﻟﻤﻭﻅﻔﻴﻥ ﺍﻟﺨﺎﺼﺔ ﺒﻬﺎ‪ ،‬ﻭﺭﻫﻨﹰ‬ ‫ﺘﻘﺭﻴﺭ ﺍﻟﻠﺠﻨﺔ "ﺏ" ﻟﻠﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ؛‪١‬‬ ‫‪ -١٢‬ﺃﻥ ﺘﻀﻁﻠﻊ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺒﺒﺭﻨﺎﻤﺞ ﻋﻤل ﻴﺴﺘﻨﺩ ﺇﻟﻰ ﺍﻟﻤﺎﺩﺓ ‪ ٣-٢٤‬ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻭﺍﻟﻤﻭﺍﺩ ‪٣-٢١‬‬ ‫ﺎ ﻟﻸﻭﻟﻭﻴﺎﺕ ﻭﻓﻲ ﺤﺩﻭﺩ‬ ‫ﻭ‪ ٢-٢٢‬ﻭ‪ ٥-٢٣‬ﻤﻨﻬﺎ‪ ،‬ﻭﺒﺄﻴﺔ ﻤﻬﺎﻡ ﺇﻀﺎﻓﻴﺔ ﻴﺴﻨﺩﻫﺎ ﺇﻟﻴﻬﺎ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﻭﻓﻘﹰ‬ ‫ﻤﺨﺼﺼﺎﺕ ﺍﻟﻤﻴﺯﺍﻨﻴﺔ ﺍﻟﺘﻲ ﻴﻭﺍﻓﻕ ﻋﻠﻴﻬﺎ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ؛‬ ‫‪ -١٣‬ﺃﻥ ﺘﻁﻠﺏ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻤﻥ ﺍﻟﻤﻨﻅﻤﺔ ﻓﺘﺢ ﻭﺍﺴﺘﺒﻘﺎﺀ ﺤﺴﺎﺒﺎﺕ ﻤﺎﻟﻴﺔ ﻟﺩﻋﻡ ﻋﻤﻠﻴﺎﺕ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ‬ ‫ﺎ ﻟﻠﻨﻅﺎﻡ ﺍﻟﻤﺎﻟﻲ؛‬ ‫ﻭﺃﻨﺸﻁﺘﻬﺎ‪ ،‬ﻭﻓﻘﹰ‬ ‫‪ -١٤‬ﺃﻥ ﺘﻭﺍﺼل ﺍﻷﻤﺎﻨﺔ ﺍﻟﻤﺅﻗﺘﺔ‪ ،‬ﺇﻟﻰ ﺃﻥ ﻴﺘﻡ ﺘﻌﻴﻴﻥ ﺃﻭل ﺭﺌﻴﺱ ﻷﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻭﺤﺘﻰ ﺘﺒـﺩﺃ ﺃﻤﺎﻨـﺔ‬ ‫ﺍﻻﺘﻔﺎﻗﻴﺔ ﻋﻤﻠﻬﺎ‪ ،‬ﺘﻘﺩﻴﻡ ﺍﻟﻤﺴﺎﻋﺩﺓ ﺒﺼﻔﺘﻬﺎ ﺍﻟﺤﺎﻟﻴﺔ ﻋﻠﻰ ﺍﻟﻨﺤﻭ ﺍﻟﻤﻨﺼﻭﺹ ﻋﻠﻴﻪ ﻓﻲ ﺍﻟﻤـﺎﺩﺓ ‪ ٢-٢٤‬ﻤـﻥ‬ ‫ﺍﻻﺘﻔﺎﻗﻴﺔ‪.‬‬ ‫)ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻟﺨﺎﻤﺴﺔ‪ ١٧ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪-٢٠٠٦‬‬ ‫ﺍﻟﻠﺠﻨﺔ "ﺏ"‪ ،‬ﺍﻟﺘﻘﺭﻴﺭ ﺍﻟﺜﺎﻨﻲ(‬

‫ﻤﻴﺯﺍﻨﻴﺔ ﻭﺨﻁﺔ ﻋﻤل ‪٢٠٠٧-٢٠٠٦‬‬

‫)‪FCTC/COP1(11‬‬

‫ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪:‬‬ ‫ﺍﻋﺘﻤﺎﺩ ﻤﻴﺯﺍﻨﻴﺔ ﺍﻟﻔﺘﺭﺓ ﺍﻟﻤﺎﻟﻴﺔ ‪ ٢٠٠٧-٢٠٠٦‬ﻋﻠﻰ ﺍﻟﻨﺤﻭ ﺍﻟﺘﺎﻟﻲ ‪:‬‬ ‫ﺒﺎﻟﺩﻭﻻﺭﺍﺕ ﺍﻷﻤﺭﻴﻜﻴﺔ‬ ‫‪٢ ١٠٠ ٠٠٠‬‬ ‫ﺩﻭﺭﺍﺕ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ) ﺍﻟﻤﺎﺩﺓ ‪)٣-٢٤‬ﺃ((‬ ‫ﻨﻅﺎﻡ ﺘﻘﺩﻴﻡ ﺍﻟﺘﻘﺎﺭﻴﺭ ﺒﻤﻭﺠﺏ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻭﺘﻘﺩﻴﻡ ﺍﻟﺩﻋﻡ ﺇﻟﻰ‬ ‫ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﻟﻭﻓﺎﺀ ﺒﻬﺫﺍ ﺍﻻﻟﺘﺯﺍﻡ‬ ‫) ﺍﻟﻤﺎﺩﺓ ‪)٣-٢٤‬ﺏ( ﻭ)ﺝ((‬ ‫ﺘﻘﺭﻴﺭ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ) ﺍﻟﻤﺎﺩﺓ ‪)٣-٢٤‬ﺩ((‬ ‫ﺍﻟﺘﻨﺴﻴﻕ ﻤﻊ ﺴﺎﺌﺭ ﺍﻟﻬﻴﺌﺎﺕ ﺍﻟﻤﻌﻨﻴﺔ ﻭﺍﻟﺘﺭﺘﻴﺒﺎﺕ ﺍﻹﺩﺍﺭﻴﺔ‬ ‫) ﺍﻟﻤﺎﺩﺓ ‪)٣-٢٤‬ﻫ( ﻭ)ﻭ((‬ ‫ﻭﻀﻊ ﻤﺒﺎﺩﺉ ﺘﻭﺠﻴﻬﻴﺔ ﻭﺒﺭﻭﺘﻭﻜﻭﻻﺕ‪ ،‬ﻭﻏﻴﺭ ﺫﻟﻙ ﻤﻥ‬ ‫ﺍﻷﻨﺸﻁﺔ ) ﺍﻟﻤﺎﺩﺓ ‪)٣-٢٤‬ﺯ((‬ ‫ﺍﻟﻤﺠﻤﻭﻉ‬ ‫ﻻ‪:‬‬ ‫ﺃﻭ ﹰ‬ ‫ﺎ‪:‬‬ ‫ﺜﺎﻨﻴﹰ‬

‫ﻗﺭﺭ‬ ‫)‪(١‬‬

‫‪٢ ٥٠٠ ٠٠٠‬‬ ‫‪٦٦٥ ٠٠٠‬‬ ‫‪١ ١٨٠ ٠٠٠‬‬ ‫‪١ ٥٦٥ ٠٠٠‬‬ ‫‪٨ ٠١٠ ٠٠٠‬‬

‫ﺎ‪:‬‬ ‫ﺜﺎﻟﺜﹰ‬ ‫ﺎ‪:‬‬ ‫ﺭﺍﺒﻌﹰ‬ ‫ﺎ‪:‬‬ ‫ﺨﺎﻤﺴﹰ‬

‫‪ ١‬ﺍﻟﻤﺤﻀﺭ ﺍﻟﻤﻭﺠﺯ ﻟﻤﺩﺍﻭﻻﺕ ﺍﻟﻠﺠﻨﺔ "ﺏ"‪.‬‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ ‫ﺍﻋﺘﻤﺎﺩ ﺨﻁﺔ ﻋﻤل ﺍﻟﻔﺘﺭﺓ ﺍﻟﻤﺎﻟﻴﺔ ‪ ،١٢٠٠٧-٢٠٠٦‬ﺒﺼﻴﻐﺘﻬﺎ ﺍﻟﻤﻌﺩﻟﺔ ﺒﺎﻟﻘﺭﺍﺭﺍﺕ ﺍﻟﺘﻲ ﺍﺘﺨـﺫﺘﻬﺎ‬ ‫)‪(٢‬‬ ‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ؛‬ ‫ﺍﻋﺘﻤﺎﺩ ﺠﺩﻭل ﻴﺒﻴﻥ ﺘﻭﺯﻴﻊ ﺍﻟﻤﺴﺎﻫﻤﺎﺕ ﺍﻟﻤﻘﺩﺭﺓ ﺍﻟﻁﻭﻋﻴﺔ ﻟﻠﻔﺘﺭﺓ ﺍﻟﻤﺎﻟﻴﺔ ‪ ٢٠٠٧-٢٠٠٦‬ﻜﻤﺎ ﻫﻭ‬ ‫)‪(٣‬‬ ‫ﻤﺒﻴﻥ ﻓﻲ ﻤﺭﻓﻕ ﻫﺫﺍ ﺍﻟﻘﺭﺍﺭ؛‬ ‫ﺘﻔﻭﻴﺽ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻓﻲ ﺘﻠﻘﻲ ﺍﻟﻤﺴﺎﻫﻤﺎﺕ ﺍﻟﻁﻭﻋﻴﺔ ﺍﻟﺨﺎﺭﺠﺔ ﻋﻥ ﺍﻟﻤﻴﺯﺍﻨﻴﺔ ﻟﻸﻨﺸﻁﺔ ﺍﻟﻤﻨﺩﺭﺠﺔ‬ ‫)‪(٤‬‬ ‫ﻀﻤﻥ ﺍﻟﻔﻘﺭﺘﻴﻥ ﺍﻟﻔﺭﻋﻴﺘﻴﻥ "ﺃﻭ ﹰ‬ ‫ﺎ" ﻤﻥ ﺍﻟﻔﻘﺭﺓ )‪ (١‬ﺃﻋﻼﻩ‪.‬‬ ‫ﻻ" ﻭ"ﺨﺎﻤﺴﹰ‬

‫‪22‬‬

‫ﺍﻟﻤﺭﻓﻕ‬ ‫ﺘﻭﺯﻴﻊ ﺍﻟﻤﺴﺎﻫﻤﺎﺕ ﺍﻟﻤﻘﺩﺭﺓ ﺍﻟﻁﻭﻋﻴﺔ ﻋﻠﻰ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ‬ ‫ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ﻟﻠﻔﺘﺭﺓ ﺍﻟﻤﺎﻟﻴﺔ ‪٢٢٠٠٧-٢٠٠٦‬‬ ‫ﺒﺎﻟﺩﻭﻻﺭﺍﺕ ﺍﻷﻤﺭﻴﻜﻴﺔ‬

‫‪٪‬‬ ‫‪٠‚٠٠٧٧٤‬‬ ‫‪٠‚٠١٧٠٤‬‬ ‫‪٠‚٠٠٣١٠‬‬ ‫‪٣‚٩٠٣١٣‬‬ ‫‪٢‚٤٦٥٧٩‬‬ ‫‪٠‚٠١٨٥٩‬‬ ‫‪٠‚٧٢٣٣٢‬‬ ‫‪١٣‚٤١٦٧٠‬‬ ‫‪٠‚٣٦٣٩٨‬‬ ‫‪٠‚٠٧٤٣٥‬‬ ‫‪٠‚٥٤٢١٠‬‬ ‫‪٠‚٠٥٢٦٦‬‬ ‫‪٠‚٠٨٥١٩‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٢‚٣٥٨٩١‬‬ ‫‪٠‚٠١٥٤٩‬‬ ‫‪٠‚٧٢٧٩٦‬‬ ‫‪٠‚٠٥٢٦٦‬‬ ‫‪١‚٦٥٥٧٣‬‬ ‫‪٠‚٠٢٦٣٣‬‬ ‫‪٠‚٠١٥٤٩‬‬

‫‪١‬‬ ‫‪٣١٢‬‬ ‫‪١٩٧‬‬ ‫‪١‬‬ ‫‪٥٧‬‬ ‫‪١ ٠٧٤‬‬ ‫‪٢٩‬‬ ‫‪٥‬‬ ‫‪٤٣‬‬ ‫‪٤‬‬ ‫‪٦‬‬ ‫‪١٨٨‬‬ ‫‪١‬‬ ‫‪٥٨‬‬ ‫‪٤‬‬ ‫‪١٣٢‬‬ ‫‪٢‬‬ ‫‪١‬‬

‫‪٦٢٠‬‬ ‫‪٣٦٥‬‬ ‫‪٢٤٨‬‬ ‫‪٦٤١‬‬ ‫‪٥٠٩‬‬ ‫‪٤٨٩‬‬ ‫‪٩٣٨‬‬ ‫‪٦٧٧‬‬ ‫‪١٥٥‬‬ ‫‪٩٥٥‬‬ ‫‪٤٢٢‬‬ ‫‪٢١٨‬‬ ‫‪٨٢٤‬‬ ‫‪١٢٤‬‬ ‫‪٩٤٩‬‬ ‫‪٢٤١‬‬ ‫‪٣١٠‬‬ ‫‪٢١٨‬‬ ‫‪٦٢٤‬‬ ‫‪١٠٩‬‬ ‫‪٢٤١‬‬

‫ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ‬ ‫ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ )ﻓﻲ ‪ ٢٠‬ﺘﺸﺭﻴﻥ ﺍﻟﺜﺎﻨﻲ‪ /‬ﻨﻭﻓﻤﺒﺭ ‪(٢٠٠٥‬‬

‫ﺁﺫﺭﺒﻴﺠﺎﻥ‬ ‫ﺍﻷﺭﺩﻥ‬ ‫ﺃﺭﻤﻴﻨﻴﺎ‬ ‫ﺃﺴﺒﺎﻨﻴﺎ‬ ‫ﺃﺴﺘﺭﺍﻟﻴﺎ‬ ‫ﺇﺴﺘﻭﻨﻴﺎ‬ ‫ﺇﺴﺭﺍﺌﻴل‬ ‫ﺃﻟﻤﺎﻨﻴﺎ‬ ‫ﺍﻹﻤﺎﺭﺍﺕ ﺍﻟﻌﺭﺒﻴﺔ ﺍﻟﻤﺘﺤﺩﺓ‬ ‫ﺃﻭﺭﻭﻏﻭﺍﻱ‬ ‫ﺃﻴﺭﻟﻨﺩﺍ‬ ‫ﺃﻴﺴﻠﻨﺩﺍ‬ ‫ﺒﺎﻜﺴﺘﺎﻥ‬ ‫ﺒﺎﻻﻭ‬ ‫ﺍﻟﺒﺭﺍﺯﻴل‬ ‫ﺒﺭﺒﺎﺩﻭﺱ‬ ‫ﺍﻟﺒﺭﺘﻐﺎل‬ ‫ﺒﺭﻭﻨﻲ ﺩﺍﺭ ﺍﻟﺴﻼﻡ‬ ‫ﺒﻠﺠﻴﻜﺎ‬ ‫ﺒﻠﻐﺎﺭﻴﺎ‬ ‫ﺒﻨﻐﻼﺩﻴﺵ‬

‫ﺎ ﻋﻠﻰ ﺘﻭﺯﻴﻊ ﺍﻟﻤﺴﺎﻫﻤﺎﺕ ﺍﻟﻤﻘﺩﺭﺓ ﺍﻟﻁﻭﻋﻴﺔ ﻟﻠﻔﺘﺭﺓ ﺍﻟﻤﺎﻟﻴﺔ ‪.٢٠٠٩-٢٠٠٨‬‬ ‫‪ ٢‬ﻻ ﻴﻨﻁﺒﻕ ﻫﺫﺍ ﺍﻟﻤﺭﻓﻕ ﻤﺴﺒﻘﹰ‬

‫‪ ١‬ﺍﻨﻅﺭ ﺍﻟﻭﺜﻴﻘﺔ ‪.A/FCTC/COP/1/5‬‬

‫‪23‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬ ‫ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ‬ ‫ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ )ﻓﻲ ‪ ٢٠‬ﺘﺸﺭﻴﻥ ﺍﻟﺜﺎﻨﻲ‪ /‬ﻨﻭﻓﻤﺒﺭ ‪(٢٠٠٥‬‬

‫ﺒﺎﻟﺩﻭﻻﺭﺍﺕ ﺍﻷﻤﺭﻴﻜﻴﺔ‬

‫‪٪‬‬ ‫‪٠‚٠٢٩٤٣‬‬ ‫‪٠‚٠٠٣١٠‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠‚٠١٨٥٩‬‬ ‫‪٠‚٠١٣٩٤‬‬ ‫‪٠‚١٤٢٥٠‬‬ ‫‪٠‚٠٢٧٨٨‬‬ ‫‪٠‚٣٢٣٧١‬‬ ‫‪٠‚٥٧٦١٨‬‬ ‫‪٠‚٠٣٤٠٧‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠‚٠١٢٣٩‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٣‚٨٧٢١٥‬‬ ‫‪٠‚٢٠٤٤٥‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠,٢٤٣١٧‬‬ ‫‪٠‚٠٥٨٨٦‬‬ ‫‪٠‚٠٠٤٦٥‬‬ ‫‪٢‚٧٨١٧٥‬‬ ‫‪٠‚٠١٥٤٩‬‬ ‫‪٠‚٤٥٢٢٧‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪١‚١١٢٠٨‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠‚٠٠٣١٠‬‬ ‫‪٠‚٠٠٤٦٥‬‬ ‫‪٠‚٠٢٦٣٣‬‬ ‫‪٠‚٠٧٨٩٩‬‬ ‫‪٠‚١٢٧٠١‬‬ ‫‪٠‚٦٠٠٩٦‬‬ ‫‪٠‚٠٠٧٧٤‬‬ ‫‪٠‚٠١٢٣٩‬‬

‫‪٢ ٣٥٧‬‬ ‫‪٢٤٨‬‬ ‫‪١٢٤‬‬ ‫‪١ ٤٨٩‬‬ ‫‪١ ١١٧‬‬ ‫‪١١ ٤١٤‬‬ ‫‪٢ ٢٣٣‬‬ ‫‪٢٥ ٩٢٩‬‬ ‫‪٤٦ ١٥٢‬‬ ‫‪٢ ٧٢٩‬‬ ‫‪١٢٤‬‬ ‫‪١٢٤‬‬ ‫‪١٢٤‬‬ ‫‪١٢٤‬‬ ‫‪٩٩٣‬‬ ‫‪١٢٤‬‬ ‫‪١٢٤‬‬ ‫‪١٢٤‬‬ ‫‪٣١٠ ١٥٩‬‬ ‫‪١٦ ٣٧٦‬‬ ‫‪١٢٤‬‬ ‫‪١٩ ٤٧٨‬‬ ‫‪٤ ٧١٤‬‬ ‫‪٣٧٢‬‬ ‫‪٢٢٢ ٨١٨‬‬ ‫‪١ ٢٤١‬‬ ‫‪٣٦ ٢٢٧‬‬ ‫‪١٢٤‬‬ ‫‪٨٩ ٠٧٨‬‬ ‫‪١٢٤‬‬ ‫‪١٢٤‬‬ ‫‪١٢٤‬‬ ‫‪٢٤٨‬‬ ‫‪٣٧٢‬‬ ‫‪٢ ١٠٩‬‬ ‫‪٦ ٣٢٧‬‬ ‫‪١٠ ١٧٣‬‬ ‫‪٤٨ ١٣٧‬‬ ‫‪٦٢٠‬‬ ‫‪٩٩٣‬‬

‫ﺒﻨﻤﺎ‬ ‫ﺒﻨﻥ‬ ‫ﺒﻭﺘﺎﻥ‬ ‫ﺒﻭﺘﺴﻭﺍﻨﺎ‬ ‫ﺒﻭﻟﻴﻔﻴﺎ‬ ‫ﺒﻴﺭﻭ‬ ‫ﺒﻴﻼﺭﻭﺱ‬ ‫ﺘﺎﻴﻠﻨﺩ‬ ‫ﺘﺭﻜﻴﺎ‬ ‫ﺘﺭﻴﻨﻴﺩﺍﺩ ﻭﺘﻭﺒﺎﻏﻭ‬ ‫ﺘﻭﻏﻭ‬ ‫ﺘﻭﻓﺎﻟﻭ‬ ‫ﺘﻭﻨﻐﺎ‬ ‫ﺘﻴﻤﻭﺭ ‪ -‬ﻟﺴﺘﻲ‬ ‫ﺠﺎﻤﺎﻴﻜﺎ‬ ‫ﺠﺯﺭ ﺴﻠﻴﻤﺎﻥ‬ ‫ﺠﺯﺭ ﻜﻭﻙ‬ ‫ﺠﺯﺭ ﻤﺎﺭﺸﺎل‬ ‫ﺍﻟﺠﻤﺎﻋﺔ ﺍﻷﻭﺭﻭﺒﻴﺔ‬ ‫ﺍﻟﺠﻤﺎﻫﻴﺭﻴﺔ ﺍﻟﻌﺭﺒﻴﺔ ﺍﻟﻠﻴﺒﻴﺔ‬ ‫ﺠﻤﻬﻭﺭﻴﺔ ﺃﻓﺭﻴﻘﻴﺎ ﺍﻟﻭﺴﻁﻰ‬ ‫ﺠﻤﻬﻭﺭﻴﺔ ﺇﻴﺭﺍﻥ ﺍﻹﺴﻼﻤﻴﺔ‬ ‫ﺍﻟﺠﻤﻬﻭﺭﻴﺔ ﺍﻟﻌﺭﺒﻴﺔ ﺍﻟﺴﻭﺭﻴﺔ‬ ‫ﺠﻤﻬﻭﺭﻴﺔ ﺍﻟﻜﻭﻨﻐﻭ ﺍﻟﺩﻴﻤﻘﺭﺍﻁﻴﺔ‬ ‫ﺠﻤﻬﻭﺭﻴﺔ ﻜﻭﺭﻴﺎ‬ ‫ﺠﻤﻬﻭﺭﻴﺔ ﻜﻭﺭﻴﺎ ﺍﻟﺩﻴﻤﻘﺭﺍﻁﻴﺔ ﺍﻟﺸﻌﺒﻴﺔ‬ ‫ﺠﻨﻭﺏ ﺃﻓﺭﻴﻘﻴﺎ‬ ‫ﺠﻴﺒﻭﺘﻲ‬ ‫ﺍﻟﺩﺍﻨﻤﺭﻙ‬ ‫ﺍﻟﺭﺃﺱ ﺍﻷﺨﻀﺭ‬ ‫ﺭﻭﺍﻨﺩﺍ‬ ‫ﺴﺎﻤﻭﺍ‬ ‫ﺴﺎﻨﺕ ﻟﻭﺴﻴﺎ‬ ‫ﺴﺎﻥ ﻤﺎﺭﻴﻨﻭ‬ ‫ﺴﺭﻱ ﻻﻨﻜﺎ‬ ‫ﺴﻠﻭﻓﺎﻜﻴﺎ‬ ‫ﺴﻠﻭﻓﻴﻨﻴﺎ‬ ‫ﺴﻨﻐﺎﻓﻭﺭﺓ‬ ‫ﺍﻟﺴﻨﻐﺎل‬ ‫ﺍﻟﺴﻭﺩﺍﻥ‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ ‫ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ‬ ‫ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ )ﻓﻲ ‪ ٢٠‬ﺘﺸﺭﻴﻥ ﺍﻟﺜﺎﻨﻲ‪ /‬ﻨﻭﻓﻤﺒﺭ ‪(٢٠٠٥‬‬

‫‪24‬‬

‫ﺒﺎﻟﺩﻭﻻﺭﺍﺕ ﺍﻷﻤﺭﻴﻜﻴﺔ‬

‫‪٪‬‬ ‫‪١‚٥٤٥٧٦‬‬ ‫‪٠‚٠٠٣١٠‬‬ ‫‪٠‚٣٤٥٤٠‬‬ ‫‪٣‚١٧٩٨١‬‬ ‫‪٠‚١٠٨٤٢‬‬ ‫‪٠‚٠٠٦٢٠‬‬ ‫‪٠‚٠٤٦٤٧‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠‚٠٠٣١٠‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٩‚٣٣٩٧٨‬‬ ‫‪٠‚١٤٧١٤‬‬ ‫‪٠‚٨٢٥٥٤‬‬ ‫‪٠‚٠٠٦٢٠‬‬ ‫‪٠‚٠٣٢٥٣‬‬ ‫‪٠‚٠٦٠٤١‬‬ ‫‪٠‚٠٩٩١٣‬‬ ‫‪٠‚٠٠٣١٠‬‬ ‫‪٤‚٣٥٦٩٤‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠‚٠١٣٩٤‬‬ ‫‪٠‚٠٢٣٢٣‬‬ ‫‪٠‚١١٩٢٦‬‬ ‫‪٠‚٠٣٧١٧‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠‚٠٢١٦٨‬‬ ‫‪٠‚٠٠٣١٠‬‬ ‫‪٠‚٣١٤٤٢‬‬ ‫‪٠‚٠٠٤٦٥‬‬ ‫‪٠‚١٨٥٨٦‬‬ ‫‪٢‚٩١٦٥٠‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪١‚١٠٤٣٤‬‬ ‫‪٩‚٤٩٠١٨‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠‚٠١٧٠٤‬‬ ‫‪٠‚٠١٥٤٩‬‬ ‫‪٠‚٠٠٩٢٩‬‬ ‫‪٠‚٠٠١٥٥‬‬

‫‪١٢٣ ٨١٦‬‬ ‫‪٢٤٨‬‬ ‫‪٢٧ ٦٦٦‬‬ ‫‪٢٥٤ ٧٠٣‬‬ ‫‪٨ ٦٨٤‬‬ ‫‪٤٩٦‬‬ ‫‪٣ ٧٢٢‬‬ ‫‪١٢٤‬‬ ‫‪٢٤٨‬‬ ‫‪١٢٤‬‬ ‫‪٧٤٨ ١١٧‬‬ ‫‪١١ ٧٨٦‬‬ ‫‪٦٦ ١٢٦‬‬ ‫‪٤٩٦‬‬ ‫‪٢ ٦٠٥‬‬ ‫‪٤ ٨٣٨‬‬ ‫‪٧ ٩٤٠‬‬ ‫‪٢٤٨‬‬ ‫‪٣٤٨ ٩٩١‬‬ ‫‪١٢٤‬‬ ‫‪١ ١١٧‬‬ ‫‪١ ٨٦١‬‬ ‫‪٩ ٥٥٣‬‬ ‫‪٢ ٩٧٨‬‬ ‫‪١٢٤‬‬ ‫‪١ ٧٣٧‬‬ ‫‪٢٤٨‬‬ ‫‪٢٥ ١٨٥‬‬ ‫‪٣٧٢‬‬ ‫‪١٤ ٨٨٨‬‬ ‫‪٢٣٣ ٦١٢‬‬ ‫‪١٢٤‬‬ ‫‪٨٨ ٤٥٧‬‬ ‫‪٧٦٠ ١٦٣‬‬ ‫‪١٢٤‬‬ ‫‪١٢٤‬‬ ‫‪١ ٣٦٥‬‬ ‫‪١ ٢٤١‬‬ ‫‪٧٤٤‬‬ ‫‪١٢٤‬‬

‫ﺍﻟﺴﻭﻴﺩ‬ ‫ﺴﻴﺸﻴل‬ ‫ﺸﻴﻠﻲ‬ ‫ﺍﻟﺼﻴﻥ‬ ‫‪‬ﻤﺎﻥ‬ ‫ﻋ‬ ‫ﻏﺎﻨﺎ‬ ‫ﻏﻭﺍﺘﻴﻤﺎﻻ‬ ‫ﻏﻴﺎﻨﺎ‬ ‫ﻏﻴﻨﻴﺎ ﺍﻻﺴﺘﻭﺍﺌﻴﺔ‬ ‫ﻓﺎﻨﻭﺍﺘﻭ‬ ‫ﻓﺭﻨﺴﺎ‬ ‫ﺍﻟﻔﻠﺒﻴﻥ‬ ‫ﻓﻨﻠﻨﺩﺍ‬ ‫ﻓﻴﺠﻲ‬ ‫ﻓﻴﻴﺕ ﻨﺎﻡ‬ ‫ﻗﺒﺭﺹ‬ ‫ﻗﻁﺭ‬ ‫ﻜﻤﺒﻭﺩﻴﺎ‬ ‫ﻜﻨﺩﺍ‬ ‫ﻜﻴﺭﻴﺒﺎﺘﻲ‬ ‫ﻜﻴﻨﻴﺎ‬ ‫ﻻﺘﻔﻴﺎ‬ ‫ﻟﻜﺴﻤﺒﺭﻍ‬ ‫ﻟﻴﺘﻭﺍﻨﻴﺎ‬ ‫ﻟﻴﺴﻭﺘﻭ‬ ‫ﻤﺎﻟﻁﺔ‬ ‫ﻤﺎﻟﻲ‬ ‫ﻤﺎﻟﻴﺯﻴﺎ‬ ‫ﻤﺩﻏﺸﻘﺭ‬ ‫ﻤﺼﺭ‬ ‫ﺍﻟﻤﻜﺴﻴﻙ‬ ‫ﻤﻠﺩﻴﻑ‬ ‫ﺍﻟﻤﻤﻠﻜﺔ ﺍﻟﻌﺭﺒﻴﺔ ﺍﻟﺴﻌﻭﺩﻴﺔ‬ ‫ﺍﻟﻤﻤﻠﻜﺔ ﺍﻟﻤﺘﺤﺩﺓ ﻟﺒﺭﻴﻁﺎﻨﻴﺎ ﺍﻟﻌﻅﻤﻰ ﻭﺃﻴﺭﻟﻨﺩﺍ ﺍﻟﺸﻤﺎﻟﻴﺔ‬ ‫ﻤﻨﻐﻭﻟﻴﺎ‬ ‫ﻤﻭﺭﻴﺘﺎﻨﻴﺎ‬ ‫ﻤﻭﺭﻴﺸﻴﻭﺱ‬ ‫ﻤﻴﺎﻨﻤﺎﺭ‬ ‫ﻨﺎﻤﻴﺒﻴﺎ‬ ‫ﻨﺎﻭﺭﻭ‬

‫‪25‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬ ‫ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ‬ ‫ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ )ﻓﻲ ‪ ٢٠‬ﺘﺸﺭﻴﻥ ﺍﻟﺜﺎﻨﻲ‪ /‬ﻨﻭﻓﻤﺒﺭ ‪(٢٠٠٥‬‬

‫ﺒﺎﻟﺩﻭﻻﺭﺍﺕ ﺍﻷﻤﺭﻴﻜﻴﺔ‬

‫‪٪‬‬ ‫‪١‚٠٥١٦٨‬‬ ‫‪١‚٣٣٠٤٧‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠‚٠٦٥٠٥‬‬ ‫‪٠‚٣٤٢٣٠‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٠‚٦٥٢٠٧‬‬ ‫‪٠‚٠٠٧٧٤‬‬ ‫‪٠‚١٩٥١٦‬‬ ‫‪٢‚٦١٧٥٧‬‬ ‫‪٠‚٠٠١٥٥‬‬ ‫‪٢٢‚٠٠٠٠٠‬‬ ‫‪١٠٠‚٠٠٠٠٠‬‬

‫‪٨٤ ٢٣٩‬‬ ‫‪١٠٦ ٥٧١‬‬ ‫‪١٢٤‬‬ ‫‪٥ ٢١١‬‬ ‫‪٢٧ ٤١٨‬‬ ‫‪١٢٤‬‬ ‫‪٥٢ ٢٣١‬‬ ‫‪٦٢٠‬‬ ‫‪١٥ ٦٣٢‬‬ ‫‪٢٠٩ ٦٦٨‬‬ ‫‪١٢٤‬‬ ‫‪١ ٧٦٢ ٢٠٠‬‬ ‫‪٨ ٠١٠ ٠٠٠‬‬

‫ﺍﻟﻤﺠﻤﻭﻉ‬

‫ﺍﻟﻨﺭﻭﻴﺞ‬ ‫ﺍﻟﻨﻤﺴﺎ‬ ‫ﺍﻟﻨﻴﺠﺭ‬ ‫ﻨﻴﺠﻴﺭﻴﺎ‬ ‫ﻨﻴﻭﺯﻴﻠﻨﺩﺍ‬ ‫ﻨﻴﻭﻭﻱ‬ ‫ﺍﻟﻬﻨﺩ‬ ‫ﻫﻨﺩﻭﺭﺍﺱ‬ ‫ﻫﻨﻐﺎﺭﻴﺎ‬ ‫ﻫﻭﻟﻨﺩﺍ‬ ‫ﻭﻻﻴﺎﺕ ﻤﻴﻜﺭﻭﻨﻴﺯﻴﺎ ﺍﻟﻤﻭﺤﺩﺓ‬ ‫ﺍﻟﻴﺎﺒﺎﻥ‬

‫)ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻟﺨﺎﻤﺴﺔ‪ ١٧ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪-٢٠٠٦‬‬ ‫ﺍﻟﻠﺠﻨﺔ "ﺏ"‪ ،‬ﺍﻟﺘﻘﺭﻴﺭ ﺍﻟﺜﺎﻟﺙ(‬

‫ﺍﻟﺘﻭﺼﻴﺔ ﺍﻟﻤﻘﺩﻤﺔ ﺇﻟﻰ ﺠﻤﻌﻴﺔ ﺍﻟﺼﺤﺔ‬

‫)‪FCTC/COP1(12‬‬

‫ﻗﺭﺭ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺘﻭﺼﻴﺔ ﺠﻤﻌﻴﺔ ﺍﻟﺼﺤﺔ ﺒﺎﻻﺴﺘﻤﺭﺍﺭ ﻓﻲ ﺩﻋﻡ ﻤﺒﺎﺩﺭﺓ ﺍﻟﺘﺤﺭﺭ ﻤﻥ ﺍﻟﺘﺒﻎ ﻓﻲ ﺍﻟﻔﺘﺭﺓ‬ ‫‪ ٢٠٠٩-٢٠٠٨‬ﻭﺘﻌﺯﻴﺯﻫﺎ‪ ،‬ﻋﻨﺩ ﺍﻻﻗﺘﻀﺎﺀ‪ ،‬ﺒﻬﺩﻑ ﻤﺴﺎﻋﺩﺓ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻋﻠﻰ ﺘﻨﻔﻴﺫ ﺃﺤﻜﺎﻤﻬﺎ‪.‬‬ ‫)ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻟﺨﺎﻤﺴﺔ‪ ١٧ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪-٢٠٠٦‬‬ ‫ﺍﻟﻠﺠﻨﺔ "ﺏ"‪ ،‬ﺍﻟﺘﻘﺭﻴﺭ ﺍﻟﺜﺎﻟﺙ(‬

‫ﺍﻟﻤﻭﺍﺭﺩ ﻭﺍﻵﻟﻴﺎﺕ ﺍﻟﻤﺎﻟﻴﺔ ﺍﻟﺨﺎﺼﺔ ﺒﺎﻟﻤﺴﺎﻋﺩﺓ‬

‫)‪FCTC/COP1(13‬‬

‫ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪،‬‬ ‫ﺇﺫ ﻴﻘﺭ ﺒﺎﻟﺤﺎﺠﺔ ﺍﻟﻤﻠﺤﺔ ﺍﻟﺘﻲ ﺘﻘﺘﻀﻲ ﺃﻥ ﺘﻨﻔﺫ ﺠﻤﻴﻊ ﺍﻷﻁﺭﺍﻑ ﺍﻟﻤﺘﻌﺎﻗﺩﺓ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟـﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴـﺔ‬ ‫ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ﺒﺄﻓﻀل ﻤﺴﺘﻭﻯ ﻤﻤﻜﻥ؛‬ ‫‪‬ﺔ ﺇﻟﻰ ﺘﻘﺩﻴﻡ ﺍﻟﻤﺴﺎﻋﺩﺓ ﺇﻟﻰ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻨﺎﻤﻴـﺔ ﺍﻷﻁـﺭﺍﻑ ﻭﺍﻷﻁـﺭﺍﻑ ﺍﻟﺘـﻲ ﺘﻤـﺭ‬ ‫ﻭﺇﺫ ﻴﻘﺭ ﺒﺎﻟﺤﺎﺠﺔ ﺍﻟﻤﻠﺤ‬ ‫ﺍﻗﺘﺼﺎﺩﺍﺘﻬﺎ ﺒﻤﺭﺤﻠﺔ ﺍﻨﺘﻘﺎﻟﻴﺔ‪ ،‬ﻟﺩﻋﻤﻬﺎ ﻓﻲ ﺘﻨﻔﻴﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ؛‬ ‫ﻭﺇﺫ ﻴﻘﺭ ﻜﺫﻟﻙ ﺒﺄﻥ ﻤﻥ ﺍﻟﺼﻌﺏ ﺘﻘﻴﻴﻡ ﻤﺴﺘﻭﻯ ﻭﻁﺒﻴﻌﺔ ﺍﻷﻤﻭﺍل ﺍﻟﻤﺨﺼﺼﺔ ﻷﻨﺸﻁﺔ ﺘﻨﻔﻴﺫ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒـﻎ‪،‬‬ ‫ﺎ ﻤﻘﺩﺍﺭ ﺍﻟﻤﻭﺍﺭﺩ ﺍﻟﻼﺯﻤﺔ ﻭﻻ ﺍﻟﺘﻭﻗﻴﺕ ﺍﻟﺫﻱ ﻴﺤﺘﺎﺝ ﻓﻴﻪ ﺇﻟﻰ ﺘﻘﺩﻴﻡ ﺍﻟﻤﻭﺍﺭﺩ‪ ،‬ﻭﺒﺄﻥ ﻤـﻥ‬ ‫ﻷﻥ ﻤﻥ ﻏﻴﺭ ﺍﻟﻤﻌﺭﻭﻑ ﺤﺎﻟﻴﹰ‬ ‫ﺍﻟﻀﺭﻭﺭﻱ ﺘﻘﻴﻴﻡ ﺘﻠﻙ ﺍﻻﺤﺘﻴﺎﺠﺎﺕ ﺒﺼﻭﺭﺓ ﺃﻓﻀل؛‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ ‫ﻭﺇﺫ ﻴﻀﻊ ﻓﻲ ﺍﻟﺤﺴﺒﺎﻥ ﺃﻥ ﺤﺸﺩ ﺍﻟﺘﻤﻭﻴل ﻴﻘﺘﻀﻲ ﺇﺠﺭﺍﺀ ﺘﻘﻴﻴﻡ ﻤﻔـﺼل ﻟﻼﺤﺘﻴﺎﺠـﺎﺕ ﻋﻠـﻰ ﺍﻟﻤـﺴﺘﻭﻯ‬

‫‪26‬‬

‫ﺍﻟﻘﻁﺭﻱ؛‬

‫ﺎ ﺒﺄﻥ ﺘﻘﺩﻴﻡ ﺍﻟﻤﻭﺍﺭﺩ ﻴﻌﺘﻤﺩ ﻋﻠﻰ ﻨﺸﺎﻁ ﺍﻟﺒﻠﺩﺍﻥ ﻓﻲ ﻁﻠﺏ ﺍﻟﺩﻋﻡ ﻓﻲ ﻫﺫﺍ ﺍﻟﻤﺠﺎل ﻭﺍﻟﻌﺜﻭﺭ ﻋﻠﻰ‬ ‫ﻭﺇﺫ ﻴﻘﺭ ﺃﻴﻀﹰ‬ ‫ﺠﻬﺎﺕ ﻤﺎﻨﺤﺔ ﻤﺴﺘﻌﺩﺓ ﻟﺘﻘﺩﻴﻡ ﺍﻟﻤﺴﺎﻋﺩﺓ ﺇﻟﻰ ﺒﺭﺍﻤﺞ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ؛‬ ‫ﻭﺇﺫ ﻴﻘﺭ ﺒﺄﻥ ﺘﺭﺘﻴﺒﺎﺕ ﺍﻟﺘﻤﻭﻴل ﺍﻟﻘﺎﺌﻤﺔ ﻓﻲ ﻜﺜﻴﺭ ﻤﻥ ﺍﻟﺒﻠﺩﺍﻥ ﺘﺭﺘﺒﻁ ﺒﺎﻟﻔﻌل ﺒﺒﺭﺍﻤﺞ ﺼﺤﻴﺔ ﺃﺨﺭﻯ؛‬ ‫ﺎ ﺃﻥ ﺍﻟﻤﺎﺩﺓ ‪)٥-٢٦‬ﺏ( ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺘﻨﺹ ﻋﻠﻰ ﻗﻴﺎﻡ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴـﺔ ﺒﺘﻘـﺩﻴﻡ‬ ‫ﻭﺇﺫ ﻴﻀﻊ ﻓﻲ ﺍﻟﺤﺴﺒﺎﻥ ﺃﻴﻀﹰ‬ ‫ﺍﻟﻤﺸﻭﺭﺓ ﻟﻠﺒﻠﺩﺍﻥ ﺍﻟﻨﺎﻤﻴﺔ ﺍﻷﻁﺭﺍﻑ ﻭﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻤﺭ ﺍﻗﺘﺼﺎﺩﺍﺘﻬﺎ ﺒﻤﺭﺤﻠﺔ ﺍﻨﺘﻘﺎﻟﻴﺔ‪ ،‬ﻟﺩﻯ ﺍﻟﻁﻠﺏ‪ ،‬ﺒﺸﺄﻥ ﻤـﺼﺎﺩﺭ‬ ‫ﺍﻟﺘﻤﻭﻴل ﺍﻟﻤﺘﺎﺤﺔ ﺒﻐﻴﺔ ﺘﻴﺴﻴﺭ ﺍﻟﻭﻓﺎﺀ ﺒﺎﻟﺘﺯﺍﻤﺎﺘﻬﺎ ﺒﻤﻭﺠﺏ ﺍﻻﺘﻔﺎﻗﻴﺔ؛‬ ‫ﻭﺇﺫ ﻴﻀﻊ ﻓﻲ ﺍﻟﺤﺴﺒﺎﻥ ﺃﻥ ﺍﻟﻤﺎﺩﺓ ‪)٥-٢٦‬ﺝ( ﺘﻁﻠﺏ ﺇﻟﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺃﻥ ﻴﻘﻭﻡ ﻓﻲ ﺩﻭﺭﺘـﻪ ﺍﻷﻭﻟـﻰ‬ ‫ﺍ ﺇﻟﻰ ﺩﺭﺍﺴﺔ ﺘﻌﺩﻫﺎ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴـﺔ‪ ،‬ﻭﻤﻌﻠﻭﻤـﺎﺕ‬ ‫ﺒﺎﺴﺘﻌﺭﺍﺽ ﻤﺼﺎﺩﺭ ﻭﺁﻟﻴﺎﺕ ﺍﻟﻤﺴﺎﻋﺩﺓ ﺍﻟﻘﺎﺌﻤﺔ ﻭﺍﻟﻤﺤﺘﻤﻠﺔ‪ ،‬ﺍﺴﺘﻨﺎﺩﹰ‬ ‫ﻤﻨﺎﺴﺒﺔ ﺃﺨﺭﻯ‪ ،‬ﻭﺍﻟﻨﻅﺭ ﻓﻲ ﻜﻔﺎﻴﺘﻬﺎ؛‬ ‫ﻭﺇﺫ ﻴﻀﻊ ﻓﻲ ﺍﻟﺤﺴﺒﺎﻥ ﺃﻥ ﺍﻟﻤﺎﺩﺓ ‪)٥-٢٦‬ﺩ( ﺘﻁﻠﺏ ﺇﻟﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺃﺨﺫ ﻨﺘﺎﺌﺞ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﺒﻌـﻴﻥ‬ ‫ﺍﻻﻋﺘﺒﺎﺭ ﻟﺩﻯ ﺍﻟﺒﺕ ﻓﻲ ﻀﺭﻭﺭﺓ ﺘﻌﺯﻴﺯ ﺍﻵﻟﻴﺎﺕ ﺍﻟﺤﺎﻟﻴﺔ ﺃﻭ ﺇﻨﺸﺎﺀ ﺼﻨﺩﻭﻕ ﻋﺎﻟﻤﻲ ﻁﻭﻋﻲ ﺃﻭ ﻏﻴﺭ ﺫﻟﻙ ﻤﻥ ﺍﻵﻟﻴﺎﺕ‬ ‫ﺍﻟﻤﺎﻟﻴﺔ ﺍﻟﻤﻨﺎﺴﺒﺔ ﻟﺘﻭﺠﻴﻪ ﺍﻟﻤﻭﺍﺭﺩ ﺍﻟﻤﺎﻟﻴﺔ ﺍﻹﻀﺎﻓﻴﺔ‪ ،‬ﺤﺴﺏ ﺍﻻﻗﺘﻀﺎﺀ‪ ،‬ﺇﻟﻰ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻨﺎﻤﻴﺔ ﺍﻷﻁﺭﺍﻑ ﻭﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ‬ ‫ﺘﻤﺭ ﺍﻗﺘﺼﺎﺩﺍﺘﻬﺎ ﺒﻤﺭﺤﻠﺔ ﺍﻨﺘﻘﺎﻟﻴﺔ ﻟﻤﺴﺎﻋﺩﺘﻬﺎ ﻋﻠﻰ ﺒﻠﻭﻍ ﻏﺎﻴﺎﺕ ﺍﻻﺘﻔﺎﻗﻴﺔ؛‬ ‫‪‬ﻌﺩ ﻏﺎﻴﺔ‬ ‫ﻭﺇﺫ ﻴﺭﻯ ﺃﻥ ﺇﺩﺭﺍﺝ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ﻓﻲ ﺍﻻﺘﺠﺎﻩ ﺍﻟﺭﺌﻴﺴﻲ ﻵﻟﻴﺎﺕ ﻤﻥ ﻗﺒﻴل ﺍﻻﺴﺘﺭﺍﺘﻴﺠﻴﺎﺕ ﺍﻟﻘﻁﺭﻴﺔ ﻴ‬ ‫ﺘﺘﺭﺍﻭﺡ ﺒﻴﻥ ﺍﻷﺠل ﺍﻟﻤﺘﻭﺴﻁ ﻭﺍﻷﺠل ﺍﻟﻁﻭﻴل‪ ،‬ﻭﺃﻥ ﻤﻥ ﺍﻟﻀﺭﻭﺭﻱ ﺍﺴﺘﺨﺩﺍﻡ ﻜل ﺍﻵﻟﻴﺎﺕ ﺍﻟﻤﻨﺎﺴـﺒﺔ ﻓـﻲ ﺘﺤﻘﻴـﻕ‬ ‫ﺍﻟﻐﺎﻴﺎﺕ ﺍﻟﻔﻭﺭﻴﺔ ﻭﺘﻠﺒﻴﺔ ﺍﻻﺤﺘﻴﺎﺠﺎﺕ ﺍﻟﻔﻭﺭﻴﺔ؛‬ ‫ﻭﺇﺫ ﻴﻀﻊ ﻓﻲ ﺍﻟﺤﺴﺒﺎﻥ ﺃﻥ ﺁﻟﻴﺎﺕ ﺍﻟﻤﺴﺎﻋﺩﺓ ﺍﻟﺩﻭﻟﻴﺔ ﺘﻠﻙ ﺴﺘﻌﺯﺯ ﺤﺸﺩ ﺍﻟﻤﺯﻴﺩ ﻤﻥ ﺍﻟﻤﻭﺍﺭﺩ ﺍﻟﻭﻁﻨﻴﺔ ﻤﻥ ﻗﺒل‬ ‫ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻨﺎﻤﻴﺔ ﺍﻷﻁﺭﺍﻑ ﻭﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻤﺭ ﺍﻗﺘﺼﺎﺩﺍﺘﻬﺎ ﺒﻤﺭﺤﻠﺔ ﺍﻨﺘﻘﺎﻟﻴﺔ؛‬

‫ﻗﺭﺭ ﻤﺎ ﻴﻠﻲ‪:‬‬ ‫ﺩﻋﻭﺓ ﺠﻤﻌﻴﺔ ﺍﻟﺼﺤﺔ ﺇﻟﻰ ﺘﻘﺩﻴﻡ ﺍﻟﺩﻋﻡ ﺍﻟﺘﺎﻡ ﻟﺘﺤﺩﻴﺩ ﺃﻭﻟﻭﻴﺎﺕ ﺤﺸﺩ ﺍﻟﻤﻭﺍﺭﺩ ﻤﻥ ﺃﺠل ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬ ‫)‪(١‬‬ ‫ﻋﻠﻰ ﺍﻟﻤﺴﺘﻭﻴﻴﻥ ﺍﻟﻭﻁﻨﻲ ﻭﺍﻟﺩﻭﻟﻲ؛‬ ‫ﺩﻋﻭﺓ ﺍﻷﻤﻴﻥ ﺍﻟﻌﺎﻡ ﻟﻸﻤﻡ ﺍﻟﻤﺘﺤﺩﺓ ﺇﻟﻰ ﺘﻘﺩﻴﻡ ﺘﻘﺭﻴﺭ ﺇﻟﻰ ﺍﻟﻤﺠﻠﺱ ﺍﻻﻗﺘﺼﺎﺩﻱ ﻭﺍﻻﺠﺘﻤﺎﻋﻲ ﺍﻟﺘـﺎﺒﻊ‬ ‫)‪(٢‬‬ ‫ﺍ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ﻭﻤﺎ ﻴﺘﺼل ﺒﻬﺎ ﻤﻥ‬ ‫ﻟﻸﻤﻡ ﺍﻟﻤﺘﺤﺩﺓ ﻟﻜﻲ ﻴﻌﺘﻤﺩ ﺍﻟﻤﺠﻠﺱ ﺍﻻﻗﺘﺼﺎﺩﻱ ﻭﺍﻻﺠﺘﻤﺎﻋﻲ ﻗﺭﺍﺭﹰ‬ ‫ﺤﺸﺩ ﺍﻟﻤﻭﺍﺭﺩ؛‬ ‫ﺩﻋﻭﺓ ﻓﺭﻗﺔ ﺍﻟﻌﻤل ﺍﻟﻤﺨﺼﺼﺔ ﺍﻟﻤﺸﺘﺭﻜﺔ ﺒﻴﻥ ﻭﻜﺎﻻﺕ ﺍﻷﻤﻡ ﺍﻟﻤﺘﺤﺩﺓ ﻭﺍﻟﻤﻌﻨﻴﺔ ﺒﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ﺇﻟﻰ‬ ‫)‪(٣‬‬ ‫ﺍ ﻋﻥ ﺃﻨﺸﻁﺘﻬﺎ ﻭﻤﺩﻯ ﻤﻼﺀﻤﺘﻬﺎ ﺍﻟﻤﺤﺘﻤﻠﺔ ﻟﺯﻴﺎﺩﺓ‬ ‫ﺃﻥ ﺘﻘﺩﻡ ﺇﻟﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﻓﻲ ﺩﻭﺭﺘﻪ ﺍﻟﺜﺎﻨﻴﺔ‪ ،‬ﺘﻘﺭﻴﺭﹰ‬ ‫ﺎ ﻟﻌﻤﻠﻬﺎ ﻓﻲ ﻤﺠﺎل ﺘﻜﺜﻴﻑ ﺍﺴﺘﺠﺎﺒﺔ ﺍﻷﻤـﻡ‬ ‫ﻓﺭﺹ ﺍﻟﺤﺼﻭل ﻋﻠﻰ ﺍﻟﺘﻤﻭﻴل ﺍﻟﺨﺎﺹ ﺒﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪ ،‬ﻭﻤﻠﺨﺼﹰ‬ ‫ﺍﻟﻤﺘﺤﺩﺓ ﻟﻤﻘﺘﻀﻴﺎﺕ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ؛‬

‫‪27‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺘﺸﺠﻴﻊ ﺍﻟﻤﻨﻅﻤﺎﺕ ﺍﻟﺩﻭﻟﻴﺔ ﻭﺍﻹﻗﻠﻴﻤﻴﺔ ﻜﺎﻓﺔ ﺒﻘﻭﺓ ﻋﻠﻰ ﺩﻋﻡ ﺍﻷﻨﺸﻁﺔ ﺫﺍﺕ ﺍﻟﺼﻠﺔ ﺒﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒـﻎ‪،‬‬ ‫)‪(٤‬‬ ‫ﻭﺍﻹﻗﺭﺍﺭ ﺒﺩﻭﺭﻫﺎ ﻓﻲ ﺒﻠﻭﻍ ﺍﻟﻤﺭﺍﻤﻲ ﺍﻹﻨﻤﺎﺌﻴﺔ ﻟﻸﻟﻔﻴﺔ‪ ،‬ﻭﻻﺴﻴﻤﺎ ﺍﻟﻤﺭﺍﻤﻲ ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﺎﻟﺤﺩ ﻤﻥ ﺍﻟﻔﻘﺭ‪ ،‬ﻭﺘﻤﻜﻴﻥ‬ ‫ﺍﻟﻤﺭﺃﺓ‪ ،‬ﻭﺘﺨﻔﻴﺽ ﻤﻌﺩل ﻭﻓﻴﺎﺕ ﺍﻷﻁﻔﺎل‪ ،‬ﻭﺍﻻﺴﺘﺩﺍﻤﺔ ﺍﻟﺒﻴﺌﻴﺔ‪ ،‬ﻭﺇﻗﺎﻤﺔ ﺸﺭﺍﻜﺔ ﻋﺎﻟﻤﻴﺔ ﻤﻥ ﺃﺠل ﺍﻟﺘﻨﻤﻴﺔ؛‬ ‫ﺩﻋﻭﺓ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻤﺘﻘﺩﻤﺔ ﺍﻷﻁﺭﺍﻑ ﺇﻟﻰ ﺘﻘﺩﻴﻡ ﺍﻟﺩﻋﻡ ﺍﻟﺘﻘﻨﻲ ﻭﺍﻟﻤﺎﻟﻲ ﻟﻬﺫﺍ ﺍﻟﻐﺭﺽ ﺇﻟﻰ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻨﺎﻤﻴﺔ‬ ‫)‪(٥‬‬ ‫ﺍﻷﻁﺭﺍﻑ ﻭﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻤﺭ ﺍﻗﺘﺼﺎﺩﺍﺘﻬﺎ ﺒﻤﺭﺤﻠﺔ ﺍﻨﺘﻘﺎﻟﻴﺔ‪ ،‬ﺒﻤﺎ ﻴﺘﻔﻕ ﻤﻊ ﺍﻟﺘﺯﺍﻤﺎﺘﻬﺎ ﺒﻤﻭﺠﺏ ﺍﻻﺘﻔﺎﻗﻴـﺔ‪،‬‬ ‫ﻭﺫﻟﻙ ﻤﻥ ﺨﻼل ﺍﻟﻘﻨﻭﺍﺕ ﺍﻟﺜﻨﺎﺌﻴﺔ ﺃﻭ ﺍﻹﻗﻠﻴﻤﻴﺔ ﺃﻭ ﺍﻟﺩﻭﻟﻴﺔ ﺃﻭ ﻏﻴﺭ ﺫﻟﻙ؛‬ ‫ﺘﺸﺠﻴﻊ ﺍﻟﻤﻨﻅﻤﺎﺕ ﺍﻟﺩﻭﻟﻴﺔ ﻭﺍﻹﻗﻠﻴﻤﻴﺔ ﻭﺩﻭﻥ ﺍﻹﻗﻠﻴﻤﻴﺔ ﻭﺍﻟﻤﺅﺴﺴﺎﺕ ﺍﻟﻤﺎﻟﻴﺔ ﺍﻟﺩﻭﻟﻴﺔ ﻭﺴﺎﺌﺭ ﺍﻟﺸﺭﻜﺎﺀ‬ ‫)‪(٦‬‬ ‫ﻓﻲ ﺍﻟﺘﻨﻤﻴﺔ ﺒﻘﻭﺓ ﻋﻠﻰ ﺘﺤﺩﻴﺩ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ﻜﻤﺠﺎل ﻴﺴﺘﺤﻕ ﺍﻟﺩﻋﻡ ﺍﻟﻤﺎﻟﻲ ﻭﺍﻟﻤﺴﺎﻋﺩﺓ ﺍﻟﺘﻘﻨﻴﺔ‪ ،‬ﻭﺍﻟﻤﺸﻭﺭﺓ ﻓﻲ‬ ‫ﻤﺠﺎل ﺍﻟﺘﺩﺍﺒﻴﺭ ﺍﻟﻀﺭﻴﺒﻴﺔ ﺍﻟﺭﺍﻤﻴﺔ ﺇﻟﻰ ﺍﻟﺤﺩ ﻤﻥ ﺍﻟﻁﻠﺏ ﻋﻠﻰ ﺍﻟﺘﺒﻎ‪ ،‬ﻤﻤﺎ ﻴﻤﻜﻥ ﺘﻘﺩﻴﻤﻪ ﺇﻟﻰ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻨﺎﻤﻴـﺔ‬ ‫ﺍﻷﻁﺭﺍﻑ ﻭﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻤﺭ ﺍﻗﺘﺼﺎﺩﺍﺘﻬﺎ ﺒﻤﺭﺤﻠﺔ ﺍﻨﺘﻘﺎﻟﻴﺔ ﻟﻤﺴﺎﻋﺩﺘﻬﺎ ﻋﻠﻰ ﺍﻟﻭﻓﺎﺀ ﺒﺎﻟﺘﺯﺍﻤﺎﺘﻬﺎ ﻓﻴﻤﺎ ﻴﺘﻌﻠﻕ‬ ‫ﺒﺎﻻﺘﻔﺎﻗﻴﺔ؛‬ ‫ﺩﻋﻭﺓ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻨﺎﻤﻴﺔ ﺍﻷﻁﺭﺍﻑ ﻭﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻤﺭ ﺍﻗﺘﺼﺎﺩﺍﺘﻬﺎ ﺒﻤﺭﺤﻠﺔ ﺍﻨﺘﻘﺎﻟﻴﺔ ﺇﻟـﻰ ﺇﺠـﺭﺍﺀ‬ ‫)‪(٧‬‬ ‫ﺘﻘﻴﻴﻤﺎﺕ ﻟﻼﺤﺘﻴﺎﺠﺎﺕ ﻋﻠﻰ ﻀﻭﺀ ﺍﻟﺘﺯﺍﻤﺎﺘﻬﺎ ﺍﻹﺠﻤﺎﻟﻴﺔ ﻓﻴﻤﺎ ﻴﺘﻌﻠﻕ ﺒﺘﻨﻔﻴﺫ ﺠﻤﻴﻊ ﺃﺤﻜﺎﻡ ﺍﻻﺘﻔﺎﻗﻴـﺔ‪ ،‬ﻭﺇﺒـﻼﻍ‬ ‫‪‬ﺩﺩﺕ ﺃﻭﻟﻭﻴﺎﺘﻬﺎ؛‬ ‫ﺍﻟﺸﺭﻜﺎﺀ ﺍﻹﻨﻤﺎﺌﻴﻴﻥ ﺒﺎﺤﺘﻴﺎﺠﺎﺘﻬﺎ ﺍﻟﺘﻲ ﺤ‬ ‫ﺩﻋﻭﺓ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻨﺎﻤﻴﺔ ﺍﻷﻁﺭﺍﻑ ﻭﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻤﺭ ﺍﻗﺘﺼﺎﺩﺍﺘﻬﺎ ﺒﻤﺭﺤﻠﺔ ﺍﻨﺘﻘﺎﻟﻴﺔ ﺇﻟﻰ ﺍﻟﻌﻤل ﻋﻠﻰ‬ ‫)‪(٨‬‬ ‫ﺇﻨﺸﺎﺀ ﺁﻟﻴﺎﺕ ﺘﻤﻭﻴل ﻤﺴﺘﺩﺍﻤﺔ ﺩﺍﺨل ﺍﻟﺒﻠﺩﺍﻥ ﻟﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ؛‬ ‫ﻤﻁﺎﻟﺒﺔ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺒﺎﻻﺴﺘﻤﺭﺍﺭ ﻓﻲ ﺘﻁﻭﻴﺭ ﻗﺎﻋـﺩﺓ ﺍﻟﺒﻴﺎﻨـﺎﺕ ﺍﻟﺨﺎﺼـﺔ ﺒﺎﻟﺘﻤﻭﻴـل ﺍﻟﻤﺘـﺎﺡ‬ ‫)‪(٩‬‬ ‫ﻭﺍﻟﻤﻨﺸﺄﺓ ﺨﻼل ﺍﻟﺩﺭﺍﺴﺔ ﺍﻟﻤﺠﺭﺍﺓ ﻤﻥ ﺃﺠل ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺩﻭﺭﺘﻪ ﺍﻷﻭﻟـﻰ‪ ،‬ﻭﻤﻭﺍﺼـﻠﺔ ﺘﺤـﺩﻴﺜﻬﺎ‪،‬‬ ‫ﻤﻊ ﻤﺭﺍﻋﺎﺓ ﺘﻘﺎﺭﻴﺭ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻤﻘﺩﻤﺔ ﺇﻟﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻋﻥ ﻫﺫﻩ ﺍﻟﺒﻨﻭﺩ‪ ،‬ﻭﺇﺘﺎﺤﺘﻬـﺎ ﻟﻸﻁـﺭﺍﻑ ﺒﻐﻴـﺔ‬ ‫ﻤﺴﺎﻋﺩﺘﻬﺎ ﻋﻠﻰ ﺘﺤﺩﻴﺩ ﻤﺼﺎﺩﺭ ﺍﻟﺘﻤﻭﻴل ﻭﺍﻟﻤﻭﺍﺭﺩ ﺍﻷﺨﺭﻯ؛‬ ‫)‪ (١٠‬ﻤﻁﺎﻟﺒﺔ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺒﻤﺴﺎﻋﺩﺓ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻨﺎﻤﻴﺔ ﺍﻷﻁﺭﺍﻑ ﻭﺍﻷﻁﺭﺍﻑ ﺍﻟﺘـﻲ ﺘﻤـﺭ ﺍﻗﺘـﺼﺎﺩﺍﺘﻬﺎ‬ ‫ﺒﻤﺭﺤﻠﺔ ﺍﻨﺘﻘﺎﻟﻴﺔ‪ ،‬ﻋﻨﺩ ﺍﻟﻁﻠﺏ‪ ،‬ﻓﻲ ﺇﺠﺭﺍﺀ ﺘﻘﻴﻴﻤﺎﺕ ﺍﻻﺤﺘﻴﺎﺠﺎﺕ‪ ،‬ﻭﺇﺴﺩﺍﺀ ﺍﻟﻤﺸﻭﺭﺓ ﺇﻟﻴﻬﺎ ﺒـﺸﺄﻥ ﺍﻵﻟﻴـﺎﺕ‬ ‫ﺍﻟﻘﺎﺌﻤﺔ ﻟﻠﺘﻤﻭﻴل ﻭﺍﻟﻤﺴﺎﻋﺩﺓ ﺍﻟﺘﻘﻨﻴﺔ‪ ،‬ﻭﺘﺯﻭﻴﺩ ﺍﻟﺸﺭﻜﺎﺀ ﺍﻹﻨﻤﺎﺌﻴﻴﻥ ﺒﺎﻟﻤﻌﻠﻭﻤﺎﺕ ﻋﻥ ﺍﻻﺤﺘﻴﺎﺠﺎﺕ ﺍﻟﻤﺤﺩﺩﺓ؛‬ ‫)‪ (١١‬ﻤﻁﺎﻟﺒﺔ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺒﺘﻠﻘﻲ ﺍﻗﺘﺭﺍﺤﺎﺕ ﺍﻟﻤﺸﺎﺭﻴﻊ ﺍﻟﻤﻘﺩﻤـﺔ ﻤـﻥ ﺍﻟﺒﻠـﺩﺍﻥ ﺍﻟﻨﺎﻤﻴـﺔ ﺍﻷﻁـﺭﺍﻑ‬ ‫ﻭﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻤﺭ ﺍﻗﺘﺼﺎﺩﺍﺘﻬﺎ ﺒﻤﺭﺤﻠﺔ ﺍﻨﺘﻘﺎﻟﻴﺔ‪ ،‬ﻓﻴﻤﺎ ﻴﺘﻌﻠﻕ ﺒﺘﻨﻔﻴﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ‪ ،‬ﻭﺘﻭﺠﻴﻪ ﻫﺫﻩ ﺍﻻﻗﺘﺭﺍﺤـﺎﺕ‬ ‫ﺇﻟﻰ ﻤﺼﺎﺩﺭ ﺍﻟﺘﻤﻭﻴل ﺍﻟﻤﺤﺘﻤﻠﺔ؛‬ ‫)‪ (١٢‬ﻤﻁﺎﻟﺒﺔ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺒﺘﻌﺯﻴﺯ ﺍﻟﺘﻌﺎﻭﻥ ﺒﻴﻥ ﺒﻠﺩﺍﻥ ﺍﻟﺠﻨﻭﺏ ﻓﻲ ﺘﺒﺎﺩل ﺍﻟﺨﺒﺭﺍﺕ ﺍﻟﻌﻠﻤﻴﺔ ﻭﺍﻟﺘﻘﻨﻴـﺔ‬ ‫ﻭﺍﻟﻘﺎﻨﻭﻨﻴﺔ‪ ،‬ﺤﺴﺒﻤﺎ ﻴﻨﺎﺴﺏ ﺘﻨﻔﻴﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ؛‬ ‫)‪ (١٣‬ﺤﺙ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻤﺘﻘﺩﻤﺔ ﻭﺍﻟﻤﺅﺴﺴﺎﺕ ﺍﻟﻤﺎﻟﻴﺔ ﺍﻟﺩﻭﻟﻴﺔ ﻭﺍﻟﻤﻨﻅﻤﺎﺕ ﺍﻟﺩﻭﻟﻴﺔ ﻭﺴﺎﺌﺭ ﺍﻟﺠﻬﺎﺕ ﺍﻟﻤﺎﻨﺤـﺔ‬ ‫ﺀ ﻋﻠﻰ ﻁﻠﺒﺎﺕ ﻤﺤـﺩﺩﺓ‪ ،‬ﺇﻟـﻰ ﺍﻟﺒﻠـﺩﺍﻥ‬ ‫ﻋﻠﻰ ﺘﻭﺠﻴﻪ ﺍﻟﻤﻭﺍﺭﺩ ﺍﻟﺘﻲ ﻻ ﻏﻨﻰ ﻋﻨﻬﺎ ﻟﻠﺘﻨﻔﻴﺫ ﺍﻟﺘﺎﻡ ﻟﻼﺘﻔﺎﻗﻴﺔ‪ ،‬ﺒﻨﺎ ‪‬‬ ‫ﺍﻟﻨﺎﻤﻴﺔ ﺍﻷﻁﺭﺍﻑ ﻭﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻤﺭ ﺍﻗﺘﺼﺎﺩﺍﺘﻬﺎ ﺒﻤﺭﺤﻠﺔ ﺍﻨﺘﻘﺎﻟﻴﺔ‪ ،‬ﺒﻐﻴﺔ ﺘﻨﻔﻴﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ؛‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ ‫)‪ (١٤‬ﻤﻁﺎﻟﺒﺔ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺒﺈﻁﻼﻕ ﺤﻤﻠﺔ ﻟﺘﻭﻋﻴﺔ ﺍﻟﺸﺭﻜﺎﺀ ﺍﻟﻤﺤﺘﻤﻠﻴﻥ ﻓﻲ ﻋﻤﻠﻴﺔ ﺍﻟﺘﻨﻤﻴﺔ ﻟﺤﺸﺩ ﺍﻟـﺩﻋﻡ‬ ‫ﺍﻟﻤﺎﻟﻲ ﻭﺍﻟﺘﻘﻨﻲ ﺍﻟﻼﺯﻡ ﻟﻠﺒﻠﺩﺍﻥ ﺍﻟﻨﺎﻤﻴﺔ ﺍﻷﻁﺭﺍﻑ ﻭﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻤﺭ ﺍﻗﺘﺼﺎﺩﺍﺘﻬﺎ ﺒﻤﺭﺤﻠﺔ ﺍﻨﺘﻘﺎﻟﻴﺔ‪ ،‬ﺒﻐﻴـﺔ‬ ‫ﻤﺴﺎﻋﺩﺘﻬﺎ ﻋﻠﻰ ﺘﻨﻔﻴﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ‪.‬‬ ‫)ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻟﺨﺎﻤﺴﺔ‪ ١٧ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪-٢٠٠٦‬‬ ‫ﺍﻟﻠﺠﻨﺔ "ﺃ"‪ ،‬ﺍﻟﺘﻘﺭﻴﺭ ﺍﻷﻭل(‬

‫‪28‬‬

‫ﺍﻟﺘﺒﻠﻴﻎ ﻭﺘﺒﺎﺩل ﺍﻟﻤﻌﻠﻭﻤﺎﺕ‬

‫)‪FCTC/COP1(14‬‬

‫ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪،‬‬ ‫ﺇﺫ ﻴﻀﻊ ﻓﻲ ﺍﻋﺘﺒﺎﺭﻩ ﺍﻟﻤﺎﺩﺓ ‪ ١-٢١‬ﻤﻥ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤـﺔ ﺍﻟﺘﺒـﻎ‪،‬‬ ‫ﻭﺍﻟﺘﻲ ﺘﻨﺹ ﻋﻠﻰ ﺃﻥ ﺘﻘﺩﻡ ﺍﻷﻁﺭﺍﻑ ﺘﻘﺎﺭﻴﺭ ﺩﻭﺭﻴﺔ ﻋﻥ ﻗﻀﺎﻴﺎ ﻤﺤﺩﺩﺓ ﺇﻟﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ؛‬ ‫ﺎ ﺍﻟﻤﺎﺩﺓ ‪ ٢-٢١‬ﺍﻟﺘﻲ ﺘﻔﻭﺽ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺘﺤﺩﻴـﺩ ﺘـﻭﺍﺘﺭ ﻭﺃﺸـﻜﺎل‬ ‫ﻭﺇﺫ ﻴﻀﻊ ﻓﻲ ﺍﻋﺘﺒﺎﺭﻩ ﺃﻴﻀﹰ‬ ‫ﺍﻟﺘﻘﺎﺭﻴﺭ‪ ،‬ﻭﺘﻨﺹ ﻋﻠﻰ ﺃﻥ ﻴﻘﺩﻡ ﻜل ﻁﺭﻑ ﺘﻘﺭﻴﺭﻩ ﺍﻷﻭﻟﻲ ﻓﻲ ﺤﺩﻭﺩ ﺴﻨﺘﻴﻥ ﻤﻥ ﺒﺩﺀ ﺴﺭﻴﺎﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺒﺎﻟﻨﺴﺒﺔ ﻟﻪ؛‬ ‫ﺎ ﻟﻠﻤﺎﺩﺓ ‪ ،٢-٢١‬ﺴﻴﻠﺯﻡ ﺃﻥ ﻴﻘﺩﻡ ﻋﺩﺩ ﻤﻥ ﺍﻷﻁﺭﺍﻑ ﺘﻘـﺎﺭﻴﺭﻩ ﺍﻷﻭﻟﻴـﺔ ﻗﺒـل ﺍﻨﻌﻘـﺎﺩ‬ ‫ﻭﺇﺫ ﻴﺩﺭﻙ ﺃﻨﻪ‪ ،‬ﻭﻓﻘﹰ‬ ‫ﺍﻻﺠﺘﻤﺎﻉ ﺍﻟﺜﺎﻨﻲ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ؛‬ ‫ﻭﺇﺫ ﻴﻀﻊ ﻓﻲ ﺍﻋﺘﺒﺎﺭﻩ ﺃﻥ ﺍﻟﺘﺒﻠﻴﻎ ﻋﻠﻰ ﺍﻟﻤﺴﺘﻭﻯ ﺍﻟﻭﻁﻨﻲ ﻻ ﻴﻨﺒﻐﻲ‪ ،‬ﻋﻠﻰ ﻀـﻭﺀ ﻤﺤﺩﻭﺩﻴـﺔ ﺍﻟﺨﺒـﺭﺍﺕ‬ ‫ﹴ؛‬ ‫ﻼ ﺩﻭﻥ ﺩﺍﻉ‬ ‫ﺎ ﺜﻘﻴ ﹰ‬ ‫ﻭﺍﻟﻤﻭﺍﺭﺩ‪ ،‬ﺃﻥ ﻴﺸﻜل ﻋﺒﺌﹰ‬ ‫ﺎ ﺍﻟﺘﻘﺎﺭﻴﺭ ﺍﻟﻭﻁﻨﻴﺔ ﻴﻨﺒﻐﻲ ﺃﻥ ﺘﻤﻜﻥ ﺍﻷﻁﺭﺍﻑ ﻤﻥ ﺍﻻﺴـﺘﻔﺎﺩﺓ ﻤـﻥ ﺘﺠـﺎﺭﺏ‬ ‫ﻭﺇﺫ ﻴﻀﻊ ﻓﻲ ﺍﻋﺘﺒﺎﺭﻩ ﺃﻴﻀﹰ‬ ‫ﺒﻌﻀﻬﺎ ﺍﻟﺒﻌﺽ ﻤﻥ ﺨﻼل ﺁﻟﻴﺔ ﻓﻌﺎﻟﺔ ﻹﺒﺩﺍﺀ ﺍﻟﺘﻌﻠﻴﻘﺎﺕ؛‬

‫ﻗﺭﺭ ﻤﺎ ﻴﻠﻲ‪:‬‬ ‫ﺎ ﺍﻟﻨﻤﻭﺫﺝ ﺍﻟﺨﺎﺹ ﺒﺘﻘﺩﻴﻡ ﺍﻟﺘﻘﺎﺭﻴﺭ ﺍﻟﻭﻁﻨﻴﺔ ﻋﻠﻰ ﺍﻟﻨﺤﻭ ﺍﻟﻤﺒﻴﻥ ﻓﻲ ﺍﺴﺘﻤﺎﺭﺓ ﺍﻟﺘﺒﻠﻴﻎ‬ ‫ﺃﻥ ﻴﻌﺘﻤﺩ ﻤﺅﻗﺘﹰ‬ ‫)‪(١‬‬ ‫ﺍﻟﻭﺍﺭﺩﺓ ﻓﻲ ﺍﻟﻤﺭﻓﻕ‪ ،‬ﺇﻟﻰ ﺃﻥ ﻴﺘﻡ ﺍﻟﻨﻅﺭ ﻓﻴﻪ ﻤﺭﺓ ﺃﺨﺭﻯ ﻓﻲ ﺩﻭﺭﺘﻪ ﺍﻟﺘﺎﻟﻴﺔ؛‬ ‫ﺃﻥ ﻴﻁﻠﺏ ﺘﻘﺩﻴﻡ ﺍﻟﺘﻘﺎﺭﻴﺭ ﺍﻟﻭﻁﻨﻴﺔ ﺒﻁﺭﻴﻘﺔ ﺘﺩﺭﺠﻴﺔ‪ /‬ﻤﺘﺩﺭﺠﺔ‪ ،‬ﻤﺜﻠﻤـﺎ ﻫـﻭ ﻤﺒـﻴﻥ ﻓـﻲ ﺍﻟﻘـﺴﻡ‬ ‫)‪(٢‬‬ ‫ﺍﻟﻤﺨﺼﺹ ﻟﺩﻭﺭﻴﺔ ﺍﻟﺘﻘﺎﺭﻴﺭ ﻭﺘﻭﻗﻴﺘﻬﺎ ﺍﻟﻭﺍﺭﺩ ﻓﻲ ﺍﻟﻤﺭﻓﻕ؛‬ ‫ﺃﻥ ﻴﻁﻠﺏ ﺇﻟﻰ ﺘﻠﻙ ﺍﻷﻁﺭﺍﻑ ﺍﻟﻤﻁﻠﻭﺏ ﻤﻨﻬﺎ ﺃﻥ ﺘﻘﺩﻡ ﺘﻘﺎﺭﻴﺭﻫﺎ ﺍﻷﻭﻟﻴﺔ ﻓﻲ ﻋﺎﻡ ‪ ،٢٠٠٧‬ﺒﻤﻭﺠﺏ‬ ‫)‪(٣‬‬ ‫ﺍﻟﺤﻜﻡ ﺍﻟﻭﺍﺭﺩ ﻓﻲ ﺍﻟﻤﺎﺩﺓ ‪ ،٢-٢١‬ﺃﻥ ﺘﺴﺘﺨﺩﻡ ﺍﻟﻨﻤﻭﺫﺝ ﺍﻟﻤﺅﻗﺕ ﻓﻲ ﺍﺴﺘﻴﻔﺎﺀ ﺘﻘﺎﺭﻴﺭﻫﺎ ﺍﻷﻭﻟﻴﺔ؛‬ ‫ﺘﺤﺩﻴﺩ ﺜﻼﺙ ﻓﺌﺎﺕ ﻤﻥ ﺍﻟﻘﻀﺎﻴﺎ ﺍﻟﺘﻲ ﻴﺠﺏ ﺃﻥ ﺘﻘﺩﻡ ﻋﻨﻬﺎ ﺍﻟﺘﻘﺎﺭﻴﺭ ﺍﻟﻭﻁﻨﻴﺔ‪ ،‬ﻜﻤﺎ ﻫﻭ ﻤﺤـﺩﺩ ﻓـﻲ‬ ‫)‪(٤‬‬ ‫ﺍﻟﻤﺭﻓﻕ؛‬

‫‪29‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺃﻥ ﻴﻁﻠﺏ ﺇﻟﻰ ﻜل ﻁﺭﻑ ﺃﻥ ﻴﻘﺩﻡ ﺘﻘﺭﻴﺭﻩ ﺍﻷﻭﻟﻲ ﻋﻥ ﺍﻟﻔﺌﺔ ‪ ،١‬ﻭﺍﻷﺴﺌﻠﺔ ﺍﻻﺨﺘﻴﺎﺭﻴﺔ ﺇﺫﺍ ﺭﻏـﺏ‬ ‫)‪(٥‬‬ ‫ﻓﻲ ﺫﻟﻙ‪ ،‬ﻓﻲ ﻏﻀﻭﻥ ﺴﻨﺘﻴﻥ ﻤﻥ ﺒﺩﺀ ﺍﻟﻨﻔﺎﺫ ﺒﺎﻟﻨﺴﺒﺔ ﻟﻪ؛‬ ‫ﺇﻋﺩﺍﺩ ﻨﻤﺎﺫﺝ ﺨﺎﺼﺔ ﺒﺎﻟﻔﺌﺘﻴﻥ ‪ ٢‬ﻭ‪ ٣‬ﻓﻲ ﺩﻭﺭﺘﻪ ﺍﻟﺜﺎﻨﻴﺔ؛‬ ‫)‪(٦‬‬

‫)‪(٧‬‬ ‫ﺃﻥ ﻴﻁﻠﺏ ﺇﻟﻰ ﻜل ﻁﺭﻑ ﺃﻥ ﻴﻘﺩﻡ ﺘﻘﺭﻴﺭﻩ ﺍﻟﺜﺎﻨﻲ ﻋﻥ ﺍﻟﻔﺌﺔ ‪ ٢‬ﻓﻲ ﻏﻀﻭﻥ ﺨﻤﺱ ﺴﻨﻭﺍﺕ ﻤﻥ ﺒﺩﺀ‬ ‫ﺍﻟﻨﻔﺎﺫ ﺒﺎﻟﻨﺴﺒﺔ ﻟﻪ؛‬ ‫ﺃﻥ ﻴﻁﻠﺏ ﺇﻟﻰ ﻜل ﻁﺭﻑ ﺃﻥ ﻴﻘﺩﻡ ﺘﻘﺭﻴﺭﻩ ﺍﻟﺜﺎﻟﺙ ﻋﻥ ﺍﻟﻔﺌﺔ ‪ ٣‬ﻓﻲ ﻏﻀﻭﻥ ﺜﻤﺎﻨﻲ ﺴﻨﻭﺍﺕ ﻤﻥ ﺒﺩﺀ‬ ‫)‪(٨‬‬ ‫ﺍﻟﻨﻔﺎﺫ ﺒﺎﻟﻨﺴﺒﺔ ﻟﻪ؛‬ ‫ﻼ ﻟﺘﺭﺘﻴﺒﺎﺕ ﺍﻟﺘﺒﻠﻴﻎ ﻓﻲ ﻋﺎﻡ ‪٢٠٠٩‬؛‬ ‫ﺎ ﻤﺴﺘﻘ ﹰ‬ ‫ﺃﻥ ﻴﺠﺭﻱ ﺘﻘﻴﻴﻤﹰ‬ ‫ﺃﻥ ﻴﻭﺍﺼل ﺍﻟﻨﻅﺭ ﻓﻲ ﻤﺴﺄﻟﺔ ﺍﻟﺘﺒﻠﻴﻎ ﻓﻲ ﻋﺎﻡ ‪.٢٠١٠‬‬ ‫)‪(٩‬‬ ‫)‪(١٠‬‬

‫ﺍﻟﻤﺭﻓﻕ‬ ‫ﺍﻟﻨﻁﺎﻕ‬ ‫ﻴﺒﻴﻥ ﻫﺫﺍ ﺍﻟﻤﺭﻓﻕ ﺍﻟﺨﻁﻭﻁ ﺍﻟﻌﺭﻴﻀﺔ ﻟﻠﻨﻬﺞ ﺍﻟﻤﻘﺘﺭﺡ ﻟﺘﻘﺩﻴﻡ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻘﺎﺭﻴﺭ ﺇﻟﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻋﻥ‬ ‫ﹰ‪،‬‬ ‫ﺍﻟﺘﻘﺩﻡ ﺍﻟﻤﺤﺭﺯ ﻓﻲ ﺘﻨﻔﻴﺫ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪ .‬ﻭﻴﻐﻁﻲ ﻫﺫﺍ ﺍﻟﻨﻬﺞ‪ ،‬ﺘﻘﺭﻴﺒﺎ‬ ‫‪‬ﺘﻭﻗﻊ ﺃﻥ ﻴﺴﺘﻌﺭﻀﻪ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻗﺒل ﻋﺎﻡ ‪.٢٠١٠‬‬ ‫ﺍﻟﺴﻨﻭﺍﺕ ﺍﻟﺨﻤﺱ ﺍﻷﻭﻟﻰ ﻭﻴ‬

‫ﺍﻟﻤﺎﺩﺓ ‪٢١‬‬ ‫ﺍﻟﺘﺒﻠﻴﻎ ﻭﺘﺒﺎﺩل ﺍﻟﻤﻌﻠﻭﻤﺎﺕ‬ ‫ﻴﻘﺩﻡ ﻜل ﻁﺭﻑ ﺇﻟﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﻋﻥ ﻁﺭﻴﻕ ﺍﻷﻤﺎﻨﺔ‪ ،‬ﺘﻘﺎﺭﻴﺭ ﺩﻭﺭﻴﺔ ﻋﻥ ﺘﻨﻔﻴـﺫﻩ ﻟﻬـﺫﻩ ﺍﻻﺘﻔﺎﻗﻴـﺔ‪،‬‬ ‫‪-١‬‬ ‫ﺘﺸﻤل ﻤﺎ ﻴﻠﻲ‪:‬‬ ‫ﻤﻌﻠﻭﻤﺎﺕ ﻋﻥ ﺍﻟﺘﺩﺍﺒﻴﺭ ﺍﻟﺘﺸﺭﻴﻌﻴﺔ ﻭﺍﻟﺘﻨﻔﻴﺫﻴﺔ ﻭﺍﻹﺩﺍﺭﻴﺔ ﺃﻭ ﺍﻟﺘـﺩﺍﺒﻴﺭ ﺍﻷﺨـﺭﻯ ﺍﻟﻤﺘﺨـﺫﺓ ﻟﺘﻨﻔﻴـﺫ‬ ‫)ﺃ(‬ ‫ﺍﻻﺘﻔﺎﻗﻴﺔ؛‬

‫)ﺏ( ﻤﻌﻠﻭﻤﺎﺕ‪ ،‬ﻋﻨﺩ ﺍﻻﻗﺘﻀﺎﺀ‪ ،‬ﻋﻥ ﺃﻱ ﺼﻌﻭﺒﺎﺕ ﺃﻭ ﻋﻘﺒﺎﺕ ﺘﻌﺘﺭﺽ ﺘﻨﻔﻴﺫﻩ ﺍﻻﺘﻔﺎﻗﻴﺔ‪ ،‬ﻭﻋﻥ ﺍﻟﺘﺩﺍﺒﻴﺭ‬ ‫ﺍﻟﻤﺘﺨﺫﺓ ﻟﺘﺫﻟﻴل ﺘﻠﻙ ﺍﻟﻌﻘﺒﺎﺕ؛‬ ‫ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﺍﻟﻤﻨﺎﺴﺒﺔ ﻋﻥ ﺍﻟﻤﺴﺎﻋﺩﺓ ﺍﻟﻤﺎﻟﻴﺔ ﻭﺍﻟﺘﻘﻨﻴﺔ ﺍﻟﻤﻘﺩﻤﺔ ﺃﻭ ﺍﻟﻤﺘﻠﻘﺎﺓ ﻤﻥ ﺃﺠل ﺃﻨﺸﻁﺔ ﻤﻜﺎﻓﺤـﺔ‬ ‫ﻤﻌﻠﻭﻤﺎﺕ ﻋﻥ ﺍﻟﻤﺭﺍﻗﺒﺔ ﻭﺍﻟﺒﺤﻭﺙ ﻋﻠﻰ ﺍﻟﻨﺤﻭ ﺍﻟﻭﺍﺭﺩ ﻓﻲ ﺍﻟﻤﺎﺩﺓ ‪٢٠‬؛‬ ‫ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﺍﻟﻤﺒﻴﻨﺔ ﻓﻲ ﺍﻟﻤﻭﺍﺩ ‪ ٣-٦‬ﻭ‪ ٢-١٣‬ﻭ‪ ٣-١٣‬ﻭ‪)٤-١٣‬ﺩ( ﻭ‪ ٥-١٥‬ﻭ‪.٢-١٩‬‬ ‫)ﺝ(‬ ‫ﺍﻟﺘﺒﻎ؛‬ ‫)ﺩ(‬ ‫)ﻫ(‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪30‬‬

‫ﻴﺤﺩﺩ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺘﻭﺍﺘﺭ ﻭﺃﺸﻜﺎل ﺘﻘﺩﻴﻡ ﺠﻤﻴﻊ ﺍﻷﻁﺭﺍﻑ ﻟﻠﺘﻘﺎﺭﻴﺭ‪ .‬ﻭﻴﻘﺩﻡ ﻜل ﻁﺭﻑ ﺘﻘﺭﻴﺭﻩ ﺍﻷﻭﻟـﻲ‬ ‫‪-٢‬‬ ‫ﻓﻲ ﻏﻀﻭﻥ ﺴﻨﺘﻴﻥ ﻤﻥ ﺒﺩﺀ ﺴﺭﻴﺎﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺒﺎﻟﻨﺴﺒﺔ ﻟﻪ‪.‬‬ ‫ﺀ‬ ‫ﻼ ﺒﺎﻟﻤﺎﺩﺘﻴﻥ ‪ ٢٢‬ﻭ‪ ،٢٦‬ﻴﻨﻅﺭ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﻟﺘﺭﺘﻴﺒﺎﺕ ﺍﻟﺭﺍﻤﻴﺔ ﺇﻟﻰ ﻤﺴﺎﻋﺩﺓ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﺒﻨـﺎ ‪‬‬ ‫ﻋﻤ ﹰ‬ ‫‪-٣‬‬ ‫ﻋﻠﻰ ﻁﻠﺒﻬﺎ‪ ،‬ﻟﻠﻭﻓﺎﺀ ﺒﺎﻟﺘﺯﺍﻤﺎﺘﻬﺎ ﺒﻤﻭﺠﺏ ﻫﺫﻩ ﺍﻟﻤﺎﺩﺓ‪.‬‬ ‫ﻴﺨﻀﻊ ﺘﺒﻠﻴﻎ ﻭﺘﺒﺎﺩل ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﺒﻤﻘﺘﻀﻰ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻟﻠﻘﺎﻨﻭﻥ ﺍﻟﻭﻁﻨﻲ ﺒﺸﺄﻥ ﺍﻟﺨﺼﻭﺼﻴﺔ ﻭﺍﻟﺴﺭﻴﺔ‪ ،‬ﻭﺘﺤﻤﻲ‬ ‫‪-٤‬‬ ‫ﺍﻷﻁﺭﺍﻑ‪ ،‬ﺤﺴﺏ ﺍﻻﺘﻔﺎﻕ ﺍﻟﻤﺘﺒﺎﺩل ﺒﻴﻨﻬﺎ‪ ،‬ﺃﻱ ﻤﻌﻠﻭﻤﺎﺕ ﺴﺭﻴﺔ ﻴﺘﻡ ﺘﺒﺎﺩﻟﻬﺎ‪.‬‬

‫ﺍﻟﻬﺩﻑ‬ ‫ﺍﻟﻬﺩﻑ ﺍﻟﻤﺘﻭﺨﻰ ﻤﻥ ﺍﻟﺘﺒﻠﻴﻎ ﻫﻭ ﺘﻤﻜﻴﻥ ﺍﻷﻁﺭﺍﻑ ﻤﻥ ﻓﻬﻡ ﺘﺠﺎﺭﺏ ﺒﻌﻀﻬﺎ ﺍﻟﺒﻌﺽ ﻓﻲ ﺘﻨﻔﻴﺫ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ‬ ‫ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ﻭﺍﻟﺘﻌﻠﻡ ﻤﻥ ﻫﺫﻩ ﺍﻟﺘﺠﺎﺭﺏ‪ ،‬ﻭﺫﻟﻙ ﺒﺘﻘﺩﻴﻡ ﺘﻔﺎﺼﻴل ﻋﻥ ﺍﻟﺘﻘـﺩﻡ ﺍﻟـﺫﻱ‬ ‫ﺘﺤﺭﺯﻩ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻷﻋﻀﺎﺀ ﻓﻲ ﺍﻟﺘﻨﻔﻴﺫ‪.‬‬ ‫ﻭﺴﺘﺸﻜل ﺘﻘﺎﺭﻴﺭ ﺍﻷﻁﺭﺍﻑ ﺍﻷﺴﺎﺱ ﺍﻟﺫﻱ ﻴﺴﺘﻨﺩ ﺇﻟﻴﻪ ﺍﻟﻨﻅﺭ ﻓﻲ ﺘﻨﻔﻴﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻭﻓﻘﹰ‬ ‫ﺎ ﻟﻠﻤﺎﺩﺓ ‪)(٥)٢٣‬ﺩ(‪.‬‬

‫ﺘﺭﺘﻴﺒﺎﺕ ﺍﻟﺘﺒﻠﻴﻎ ﺍﻟﻤﺘﺩﺭﺠﺔ‬ ‫‪‬ﻘﺘﺭﺡ ﺃﻥ ﺘﻜﻭﻥ ﺘﺭﺘﻴﺒﺎﺕ ﺍﻟﺘﺒﻠﻴﻎ ﻤﺘﺩﺭﺠﺔ‪ ،‬ﺒﺤﻴﺙ ﻴـﺸﻤل ﺍﻟﺘﻘﺭﻴـﺭ ﺍﻷﻭل ﺍﻟﺒﻨـﻭﺩ ﺍﻷﺴﺎﺴـﻴﺔ ﻟﻠﺒﻴﺎﻨـﺎﺕ‬ ‫ﻴ‬ ‫ﹸﺩﺭﺝ ﻤﺴﺎﺌل ﺃﻋﻘﺩ ﺃﻭ ﺘﻔﺎﺼﻴل ﺃﻜﺒـﺭ ﻓـﻲ‬ ‫ﻭﺍﻟﺘﺸﺭﻴﻌﺎﺕ ﻭﺍﻟﻀﺭﺍﺌﺏ ﻭﺍﻟﺘﻤﻭﻴل ﻓﻴﻤﺎ ﻴﺘﻌﻠﻕ ﺒﺄﻨﺸﻁﺔ ﺍﻟﺘﻨﻔﻴﺫ‪ ،‬ﻭﺒﺤﻴﺙ ﺘ‬ ‫ﺍﻟﺘﻘﺎﺭﻴﺭ ﺍﻟﻼﺤﻘﺔ‪ .‬ﻭﻟﺘﻴﺴﻴﺭ ﺫﻟﻙ‪ ،‬ﻴﻤﻜﻥ ﺘﺠﻤﻴﻊ ﺍﻷﺴﺌﻠﺔ ﻓﻲ ﺜﻼﺙ ﻓﺌﺎﺕ‪.‬‬

‫ﺩﻭﺭﻴﺔ ﺍﻟﺘﻘﺎﺭﻴﺭ ﻭﺘﻭﻗﻴﺘﻬﺎ‬ ‫‪‬ﻘﺘﺭﺡ ﺃﻥ ﺘﻘﺩﻡ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﻟﺒﺩﺍﻴﺔ ﺘﻘﺎﺭﻴﺭﻫﺎ ﺒﻌﺩ ﺍﻟﺘﺼﺩﻴﻕ ﻋﻠﻰ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺒﺴﻨﺘﻴﻥ‪ ،‬ﻤﺜﻠﻤﺎ ﺘـﻨﺹ ﻋﻠﻴـﻪ‬ ‫ﻴ‬ ‫ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪ ،‬ﺜﻡ ﻜل ﺜﻼﺙ ﺴﻨﻭﺍﺕ ﻤﺘﺘﺎﻟﻴﺔ‪ ،‬ﻋﻠﻰ ﺍﻟﻨﺤﻭ ﺍﻟﺘﺎﻟﻲ‪:‬‬ ‫ﺘﻘﺩﻡ ﺍﻷﻁﺭﺍﻑ ﺘﻘﺎﺭﻴﺭ ﺒﺸﺄﻥ ﺠﻤﻴﻊ ﺍﻷﺴﺌﻠﺔ ﺍﻟﺭﺌﻴﺴﻴﺔ ﺍﻟﻤﻨﺩﺭﺠﺔ ﻀﻤﻥ ﺍﻟﻔﺌﺔ ‪ ١‬ﻓﻲ ﻏﻀﻭﻥ ﺴﻨﺘﻴﻥ ﻤﻥ‬ ‫ﺘﺎﺭﻴﺦ ﺒﺩﺀ ﻨﻔﺎﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺒﺎﻟﻨﺴﺒﺔ ﻟﻜل ﻤﻨﻬﺎ‪ .‬ﻭﺴﻴﺸﻜل ﺫﻟﻙ ﺘﺭﺘﻴﺒﺎﺕ ﺍﻟﺘﺒﻠﻴﻎ ﺍﻟﺩﻨﻴﺎ‪ .‬ﻭﻴﺠﻭﺯ ﻟﻸﻁـﺭﺍﻑ‬ ‫ﺎ ﺘﻘﺎﺭﻴﺭ ﺒﺸﺄﻥ ﺃﺴﺌﻠﺔ ﺍﺨﺘﻴﺎﺭﻴﺔ ﻤﻨﺘﻘﺎﺓ‪ ،‬ﺇﺫﺍ ﺭﻏﺒﺕ ﻓﻲ ﺫﻟﻙ‪) .‬ﺍﻨﻅﺭ ﺍﺴﺘﻤﺎﺭﺓ ﺍﻟﺘﺒﻠﻴﻎ‪(.‬‬ ‫ﺃﻥ ﺘﻘﺩﻡ ﺃﻴﻀﹰ‬ ‫ﺘﻘﺩﻡ ﺍﻷﻁﺭﺍﻑ ﺘﻘﺎﺭﻴﺭ ﺒﺸﺄﻥ ﺠﻤﻴﻊ ﺍﻷﺴﺌﻠﺔ ﺍﻟﻤﻨﺩﺭﺠﺔ ﻀﻤﻥ ﺍﻟﻔﺌﺔ ‪ ٢‬ﻓﻲ ﻏﻀﻭﻥ ﺨﻤﺱ ﺴﻨﻭﺍﺕ ﻤﻥ‬ ‫ﺘﺎﺭﻴﺦ ﺒﺩﺀ ﻨﻔﺎﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺒﺎﻟﻨﺴﺒﺔ ﻟﻜل ﻤﻨﻬﺎ‪ .‬ﻭﺘﺸﻜل ﻫﺫﻩ ﺍﻟﺘﻘﺎﺭﻴﺭ ﻤﺘﻁﻠﺒﺎﺕ ﺍﻟﺘﺒﻠﻴﻎ ﺍﻟـﺩﻨﻴﺎ‪ .‬ﻭﻴﺠـﻭﺯ‬ ‫ﺎ ﺘﻘﺎﺭﻴﺭ ﺒﺸﺄﻥ ﺃﺴﺌﻠﺔ ﺍﺨﺘﻴﺎﺭﻴﺔ ﻤﻨﺘﻘﺎﺓ‪ ،‬ﺇﺫﺍ ﺭﻏﺒﺕ ﻓﻲ ﺫﻟﻙ‪) .‬ﻟﻡ ﻴﺘﻡ ﺘﺤﺩﻴـﺩﻫﺎ‬ ‫ﻟﻸﻁﺭﺍﻑ ﺃﻥ ﺘﻘﺩﻡ ﺃﻴﻀﹰ‬ ‫ﺒﻌﺩ‪(.‬‬ ‫ﺘﻘﺩﻡ ﺍﻷﻁﺭﺍﻑ ﺘﻘﺎﺭﻴﺭ ﺒﺸﺄﻥ ﺠﻤﻴﻊ ﺍﻷﺴﺌﻠﺔ ﺍﻟﻤﻨﺩﺭﺠﺔ ﻀﻤﻥ ﺍﻟﻔﺌﺔ ‪ ٣‬ﻓﻲ ﻏﻀﻭﻥ ﺜﻤﺎﻨﻲ ﺴﻨﻭﺍﺕ ﻤﻥ‬ ‫ﺘﺎﺭﻴﺦ ﺒﺩﺀ ﻨﻔﺎﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺒﺎﻟﻨﺴﺒﺔ ﻟﻠﺒﻠﺩ‪) .‬ﻟﻡ ﻴﺘﻡ ﺘﺤﺩﻴﺩﻫﺎ ﺒﻌﺩ‪(.‬‬ ‫•‬

‫•‬

‫•‬

‫ﹸﺴﺘﻜﻤل ﻫﺫﻩ ﺍﻟﺘﻘﺎﺭﻴﺭ ﻟﻠﺒﻠﺩ ﺒﺨﻁﻁ ﺍﻷﻁﺭﺍﻑ ﺍﻟﻘﻁﺭﻴﺔ ﺍﻟﺴﻨﻭﻴﺔ ﺍﻟﺨﺎﺼﺔ ﺒﺎﻟﺘﻨﻔﻴﺫ‪.‬‬ ‫ﻭﺴﺘ‬

‫‪31‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﻻ ﻤﻥ ﺃﻥ ﻴﺤﻴﻥ ﻤﻭﻋﺩ ﺘﻘﺩﻴﻡ ﺠﻤﻴﻊ ﺘﻘﺎﺭﻴﺭ‬ ‫ﻭﺴﺘﺘﻴﺢ ﻫﺫﻩ ﺍﻟﻌﻤﻠﻴﺔ ﻟﻸﻤﺎﻨﺔ ﺘﻠﻘﻲ ﺍﻟﺘﻘﺎﺭﻴﺭ ﺒﺼﻭﺭﺓ ﻤﺘﺩﺭﺠﺔ ﺒﺩ ﹰ‬ ‫ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﻟﻭﻗﺕ ﺫﺍﺘﻪ‪.‬‬ ‫ﻭﻴﻨﺒﻐﻲ ﺃﻥ ﺘﻀﻊ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﻋﺘﺒﺎﺭﻫﺎ‪ ،‬ﻟﺩﻯ ﺇﻋﺩﺍﺩ ﺍﻟﺘﻘﺎﺭﻴﺭ‪ ،‬ﻓﺭﺹ ﺍﻟﺘﻌﻠﻡ ﻤﻥ ﺒﻌﻀﻬﺎ ﺍﻟﺒﻌﺽ‪ ،‬ﻜﻤـﺎ‬ ‫ﹸﺩﺭﺝ ﺃﻤﺜﻠﺔ ﺃﻓﻀل ﺍﻟﻤﻤﺎﺭﺴﺎﺕ ﺃﻭ ﺘﻔﺎﺼﻴل ﺍﻻﺘﺼﺎل ﺒﺎﻟﺒﺭﻴﺩ ﺍﻹﻟﻜﺘﺭﻭﻨﻲ ﺒﺎﻟﺸﺨﺹ ﺍﻟﺫﻱ‬ ‫ﻴﻨﺒﻐﻲ‪ ،‬ﻋﻨﺩ ﺍﻻﻗﺘﻀﺎﺀ‪ ،‬ﺃﻥ ﺘ‬ ‫ﻴﻤﻜﻨﻪ ﺇﻋﻁﺎﺀ ﺍﻟﻤﺯﻴﺩ ﻤﻥ ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﻋﻥ ﺠﺎﻨﺏ ﻤﻥ ﺠﻭﺍﻨﺏ ﺍﻟﺘﻨﻔﻴﺫ‪.‬‬

‫ﺍﻟﻤﺴﺎﻋﺩﺓ ﺍﻟﻤﻘﺩﻤﺔ ﺇﻟﻰ ﺍﻟﺒﻠﺩﺍﻥ ﺫﺍﺕ ﺍﻻﻗﺘﺼﺎﺩﺍﺕ ﺍﻟﻨﺎﻤﻴﺔ ﻭﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﺘﻲ ﺘﻤـﺭ ﺍﻗﺘـﺼﺎﺩﺍﺘﻬﺎ‬ ‫ﺒﻤﺭﺤﻠﺔ ﺍﻨﺘﻘﺎﻟﻴﺔ‬ ‫ﻓﻲ ﻫﺫﺍ ﺍﻟﻔﺭﻉ ﻤﻥ ﺍﻟﺘﻘﺭﻴﺭ ﻴﻨﺒﻐﻲ ﺃﻥ ﺘﻘﻭﻡ ﺍﻷﻁﺭﺍﻑ ﺒﺎﻟﺘﺒﻠﻴﻎ ﻋﻤﺎ ﻴﻠﻲ‪:‬‬ ‫ﻗﺩﺭﺘﻬﺎ ﻋﻠﻰ ﺘﻘﺩﻴﻡ ﺍﻟﻤﺴﺎﻋﺩﺓ‪ ،‬ﺍﻟﻤﺎﻟﻴﺔ ﻤﻨﻬﺎ ﻭﺍﻟﺘﻘﻨﻴﺔ‪ ،‬ﻓﻲ ﺤﺎﻟﺔ ﺍﻟﺸﺭﻜﺎﺀ ﺍﻹﻨﻤﺎﺌﻴﻴﻥ ﻭﻜﺫﻟﻙ ﺍﻟﻤـﺴﺎﻋﺩﺓ‬ ‫ﺍﻟﻤﻘﺩﻤﺔ ﺒﺎﻟﻔﻌل؛ ﺃﻭ‬ ‫ﺍﻟﻤﺠﺎﻻﺕ ﺍﻟﺘﻲ ﺘﺭﻯ ﺃﻨﻬﺎ ﺘﺤﺘﺎﺝ ﻓﻴﻬﺎ ﺇﻟﻰ ﻤﺴﺎﻋﺩﺓ ﻭﻤﺩﻯ ﺘﻠﺒﻴﺔ ﻫـﺫﻩ ﺍﻟﺤﺎﺠـﺔ ﺃﻭ ﻋـﺩﻡ ﺘﻠﺒﻴﺘﻬـﺎ‪،‬‬ ‫ﻭﺍﻟﺘﻘﺩﻴﺭﺍﺕ ﺍﻟﺨﺎﺼﺔ ﺒﺎﻟﻤﺴﺎﻋﺩﺓ ﺍﻟﺘﻘﻨﻴﺔ ﻭﺍﻟﻤﺎﻟﻴﺔ ﺍﻟﻼﺯﻤﺔ ﻟﺘﻤﻜﻴﻨﻬﺎ ﻤﻥ ﺍﻻﻨﺘﻘﺎل ﺇﻟﻰ ﻓﺌﺔ ﺍﻟﺘﺒﻠﻴﻎ ﺍﻟﺘﺎﻟﻴﺔ‪،‬‬ ‫ﺎ‬ ‫ﻓﻲ ﺤﺎﻟﺔ ﺍﻻﻗﺘﺼﺎﺩﺍﺕ ﺍﻟﻨﺎﻤﻴﺔ ﻭﺍﻻﻗﺘﺼﺎﺩﺍﺕ ﺍﻟﺘﻲ ﺘﻤﺭ ﺒﻤﺭﺤﻠﺔ ﺍﻨﺘﻘﺎﻟﻴﺔ‪ .‬ﻭﻴﻤﻜﻥ ﺃﻥ ﻴﺸﻤل ﺫﻟﻙ ﺃﻴـﻀﹰ‬ ‫ﺃﻴﺔ ﺼﻌﻭﺒﺎﺕ ﺃﻭ ﻋﻘﺒﺎﺕ ﺘﻌﺘﺭﺽ ﺴﺒﻴل ﺍﻟﺘﻨﻔﻴﺫ‪ ،‬ﻭﻜﺫﻟﻙ ﺍﻟﻤﺴﺎﻋﺩﺓ ﺍﻟﻤﺘﻠﻘﺎﺓ‪ /‬ﺍﻟﻤﻘﺩﻤﺔ ﺒﺎﻟﻔﻌل‪.‬‬ ‫•‬ ‫•‬

‫ﻭﺒﺎﻹﻀﺎﻓﺔ ﺇﻟﻰ ﺫﻟﻙ ﻴﻨﺒﻐﻲ ﺃﻥ ﺘﻨﻅﺭ ﺍﻷﻤﺎﻨﺔ‪ ،‬ﻋﻠﻰ ﻭﺠﻪ ﺍﻟﺨﺼﻭﺹ‪ ،‬ﻓﻲ ﻫﺫﺍ ﺍﻟﻔﺭﻉ ﺍﻟﺨـﺎﺹ ﺒﺘﻘـﺎﺭﻴﺭ‬ ‫ﺍﻷﻁﺭﺍﻑ‪ ،‬ﻭﺃﻥ ﺘﻌﻤل ﻜﻤﺭﻜﺯ ﺘﺒﺎﺩل ﻫﺩﻓﻪ ﺘﻴﺴﻴﺭ ﺘﻨﺴﻴﻕ ﺍﻟﻤﻬﺎﺭﺍﺕ ﻭﺍﻟﻤﻭﺍﺭﺩ ﺍﻟﻤﺘﺎﺤﺔ ﻤﻊ ﺍﻻﺤﺘﻴﺎﺠـﺎﺕ ﺍﻟﻤﺤـﺩﺩﺓ‪.‬‬ ‫ﻭﻓﻲ ﺍﻟﺤﺎﻟﺔ ﺍﻷﻭﻟﻰ ﻴﻨﺒﻐﻲ ﺃﻥ ﺘﻌﻤل ﺍﻷﻤﺎﻨﺔ ﻋﻠﻰ ﺇﺩﺍﺭﺓ ﻫﺫﻩ ﺍﻟﻌﻤﻠﻴﺔ ﺩﺍﺨل ﺍﻷﻗﺎﻟﻴﻡ ﻟﻜﻲ ﺘﺘﺴﻨﻰ ﺯﻴﺎﺩﺓ ﺍﻟﻜﻔـﺎﺀﺓ ﻓـﻲ‬ ‫ﺍﻟﻌﻤل ﻭﺘﻌﺯﻴﺯ ﺍﻟﻔﻬﻡ ﺩﺍﺨل ﺍﻷﻗﺎﻟﻴﻡ‪.‬‬

‫ﺒﻴﺎﻨﺎﺕ ﻭﺒﺤﻭﺙ ﺍﻟﻤﺭﺍﻗﺒﺔ ﻓﻲ ﺍﻟﻭﻗﺕ ﺍﻟﺤﺎﻀﺭ‬ ‫ﻴﻨﺒﻐﻲ ﻟﻸﻤﺎﻨﺔ ﺃﻥ ﺘﺴﺘﺨﺩﻡ ﻤﺠﻤﻭﻉ ﺍﻟﺒﻴﺎﻨﺎﺕ ﺍﻟﻤﺘﻭﺍﻓﺭﺓ ﻟﺩﻴﻬﺎ ﺒﻤﺎ ﻓﻲ ﺫﻟﻙ ﺒﻴﺎﻨﺎﺕ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴـﺔ‬ ‫ﻭﻤﺒﺎﺩﺭﺓ ﺍﻟﺘﺤﺭﺭ ﻤﻥ ﺍﻟﺘﺒﻎ‪ ،‬ﻭﺃﻴﺔ ﺒﻴﺎﻨﺎﺕ ﺃﺨﺭﻯ ﻤﻨﺎﺴﺒﺔ‪ ،‬ﻭﺍﻟﺘﻲ ﺘﻌﺭﻓﻬﺎ ﺤﻕ ﺍﻟﻤﻌﺭﻓﺔ ﻭﺘﺴﺘﺄﻨﺱ ﺒﻬﺎ‪ ،‬ﻭﻤﻨﻬﺎ‪:‬‬ ‫ﺍﻟﻤﺴﺢ ﺍﻟﻌﺎﻟﻤﻲ ﺍﻟﺨﺎﺹ ﺒﺎﻟﺸﺒﺎﺏ ﻭﺍﻟﺘﺒﻎ‪ ،‬ﺍﻟﺫﻱ ﺘﺠﺭﻴﻪ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺒﺎﻻﺸﺘﺭﺍﻙ ﻤﻊ ﻤﺭﺍﻜﺯ‬ ‫ﺍﻟﻭﻻﻴﺎﺕ ﺍﻟﻤﺘﺤﺩﺓ ﻟﻤﻜﺎﻓﺤﺔ ﺍﻷﻤﺭﺍﺽ ﻭﺍﻟﻭﻗﺎﻴﺔ ﻤﻨﻬﺎ‬ ‫ﺍﻟﻤﺴﺢ ﺍﻟﻌﺎﻟﻤﻲ ﺍﻟﺨﺎﺹ ﺒﺎﻟﻌﺎﻤﻠﻴﻥ ﻓﻲ ﺍﻟﻤﺩﺍﺭﺱ‪ ،‬ﺍﻟﺫﻱ ﺘﺠﺭﻴﻪ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺒﺎﻻﺸﺘﺭﺍﻙ ﻤﻊ‬ ‫ﻤﺭﺍﻜﺯ ﺍﻟﻭﻻﻴﺎﺕ ﺍﻟﻤﺘﺤﺩﺓ ﻟﻤﻜﺎﻓﺤﺔ ﺍﻷﻤﺭﺍﺽ ﻭﺍﻟﻭﻗﺎﻴﺔ ﻤﻨﻬﺎ‬ ‫ﺍﻟﻤﺴﺢ ﺍﻟﻌﺎﻟﻤﻲ ﺍﻟﺨﺎﺹ ﺒﻤﻬﻨﻴﻲ ﺍﻟﺼﺤﺔ‪ ،‬ﺍﻟﺫﻱ ﺘﺠﺭﻴﻪ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺒﺎﻻﺸﺘﺭﺍﻙ ﻤﻊ ﻤﺭﺍﻜﺯ‬ ‫ﺍﻟﻭﻻﻴﺎﺕ ﺍﻟﻤﺘﺤﺩﺓ ﻟﻤﻜﺎﻓﺤﺔ ﺍﻷﻤﺭﺍﺽ ﻭﺍﻟﻭﻗﺎﻴﺔ ﻤﻨﻬﺎ‬ ‫ﺍﻟﻤﺴﺢ ﺍﻟﺼﺤﻲ ﺍﻟﻌﺎﻟﻤﻲ‬ ‫ﻗﺎﻋﺩﺓ ﺒﻴﺎﻨﺎﺕ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻟﺨﺎﺼﺔ ﺒﺎﻟﻭﻓﻴﺎﺕ‬ ‫ﻗﺎﻋﺩﺓ ﺍﻟﺒﻴﺎﻨﺎﺕ ﺍﻹﻗﻠﻴﻤﻴﺔ ﺍﻟﺨﺎﺼﺔ ﺒﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬ ‫ﺍﻟﻨﻬﺞ ﺍﻟﺘﺩﺭﻴﺠﻲ ﻟﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ‬ ‫•‬ ‫•‬ ‫•‬ ‫•‬ ‫•‬ ‫•‬ ‫•‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪32‬‬

‫ﺍﻟﺘﺭﺠﻤﺔ‬ ‫ﺘﻘﺩﻡ ﺍﻷﻁﺭﺍﻑ ﺘﻘﺎﺭﻴﺭﻫﺎ ﺒﺈﺤﺩﻯ ﺍﻟﻠﻐﺎﺕ ﺍﻟﺭﺴﻤﻴﺔ ﺍﻟﺴﺕ‪ ،‬ﻭﻻ ﻴﻨﺒﻐﻲ ﺃﻥ ﺘﺘﻭﻗـﻊ ﻤـﻥ ﺍﻷﻤﺎﻨـﺔ ﺃﻥ ﺘﻘـﻭﻡ‬ ‫ﺒﺘﺭﺠﻤﺘﻬﺎ‪ .‬ﻭﺒﺎﻟﺭﻏﻡ ﻤﻥ ﺫﻟﻙ‪ ،‬ﻴﺘﻭﻗﻊ ﺃﻥ ﺘﻘﻭﻡ ﺍﻷﻤﺎﻨﺔ‪ ،‬ﻋﻨﺩ ﺍﻟﻨﻅﺭ ﻓﻲ ﺍﻟﺘﻘﺎﺭﻴﺭ‪ ،‬ﺒﺈﺘﺎﺤـﺔ ﻤﻠﺨـﺼﺎﺕ ﻟﻠﺘﻘـﺎﺭﻴﺭ ﺃﻭ‬ ‫ﺒﺘﺤﻠﻴﻼﺕ ﻟﻠﺘﻘﺎﺭﻴﺭ ﺘﺭﻜﺯ ﻋﻠﻰ ﺍﻹﻨﺠﺎﺯﺍﺕ ﺍﻟﺒﺎﺭﺯﺓ ﺃﻭ ﺍﻟﻤﺠﺎﻻﺕ ﺍﻟﺘﻲ ﻴﻜﻭﻥ ﺘﺒﺎﺩل ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﺤﻭﻟﻬﺎ ﺫﺍ ﻗﻴﻤﺔ‪.‬‬

‫ﺘﺒﻠﻴﻎ ﺍﻟﻤﻌﻠﻭﻤﺎﺕ‬ ‫ﹸﺘـﺎﺡ‬ ‫‪‬ﻘﺘـﺭﺡ ﺃﻥ ﺘ‬ ‫ﻟﺘﻴﺴﻴﺭ ﺍﻟﺤﺼﻭل ﻋﻠﻰ ﺃﻤﺜﻠﺔ ﻷﻓﻀل ﺍﻟﻤﻤﺎﺭﺴﺎﺕ ﻓﻲ ﻤﺠﺎﻻﺕ ﻤﺤﺩﺩﺓ ﻟﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪ ،‬ﻴ‬ ‫ﺘﻘﺎﺭﻴﺭ ﺠﻤﻴﻊ ﺍﻷﻁﺭﺍﻑ ﻋﻠﻰ ﺃﺤﺩ ﻤﻭﺍﻗﻊ ﺍﻹﻨﺘﺭﻨﺕ ﻤﻊ ﺘﺭﺘﻴﺒﻬﺎ ﺘﺤﺕ ﺍﻟﻌﻨﺎﻭﻴﻥ ﺍﻟﺘﺎﻟﻴﺔ‪ :‬ﺘﻘﺎﺭﻴﺭ ﻟﻔﺘﺭﺓ ﺴﻨﺘﻴﻥ‪ ،‬ﻭﺘﻘﺎﺭﻴﺭ‬ ‫ﻟﻔﺘﺭﺓ ﺨﻤﺱ ﺴﻨﻭﺍﺕ‪ ،‬ﻭﺘﻘﺎﺭﻴﺭ ﻟﻔﺘﺭﺓ ﺜﻤﺎﻨﻲ ﺴﻨﻭﺍﺕ؛ ﻟﺘﻤﻜﻴﻥ ﺍﻷﻁﺭﺍﻑ ﻤﻥ ﻓﻬﻡ ﺍﻟﺘﻘﺩﻡ ﺍﻟﻤﺤﺭﺯ ﻋﻠﻰ ﺍﻟﺼﻌﻴﺩ ﺍﻟﺩﻭﻟﻲ‬ ‫‪‬ﺘﺎﺡ ﻟﻠﺒﻠﺩﺍﻥ ﺍﻟﺘﻲ ﻟﻡ ﺘﺼﺩﻕ ﺒﻌﺩ‬ ‫‪‬ﺘﻭﻗﻊ ﺃﻥ ﻴ‬ ‫ﻓﻲ ﺘﻨﻔﻴﺫ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪ .‬ﻭﻴ‬ ‫ﻋﻠﻰ ﺍﻻﺘﻔﺎﻗﻴﺔ‪ ،‬ﻭﺍﻟﺘﻲ ﻗﺩ ﺘﺭﻏﺏ ﻓﻲ ﺍﻟﺤﺼﻭل ﻋﻠﻰ ﻤﻌﻠﻭﻤﺎﺕ ﺘﺘﻴﺢ ﻟﻬﺎ ﺍﺘﺨﺎﺫ ﺨﻁﻭﺍﺕ ﻓﻌﺎﻟﺔ ﻓﻲ ﻤﺠـﺎل ﻤﻜﺎﻓﺤـﺔ‬ ‫ﺍﻟﺘﺒﻎ‪ ،‬ﺍﻟﻨﻔﺎﺫ ﺇﻟﻰ ﻫﺫﺍ ﺍﻟﻤﻭﻗﻊ ﻋﻠﻰ ﺍﻹﻨﺘﺭﻨﺕ‪ .‬ﻭﻴﺘﻔﻕ ﻫﺫﺍ ﻤﻊ ﻫﺩﻑ ﺘﻌﻠﻡ ﺍﻷﻁﺭﺍﻑ ﻤﻥ ﺘﺠﺎﺭﺏ ﺒﻌﻀﻬﺎ ﺍﻟﺒﻌﺽ‪.‬‬ ‫ﻼ‬ ‫‪‬ﺘﻭﻗﻊ ﺃﻥ ﺘﻘﺩﻡ ﺍﻷﻤﺎﻨﺔ ﺘﺤﻠـﻴ ﹰ‬ ‫ﻭﻴﺘﻭﻗﻊ ﺃﻥ ﺘﺒﺩﻱ ﺍﻷﻤﺎﻨﺔ ﺍﻟﺘﻌﻠﻴﻘﺎﺕ ﻟﻜل ﻁﺭﻑ ﻤﻥ ﺍﻷﻁﺭﺍﻑ ﺍﻟﻤﺒﻠﻐﺔ‪ .‬ﻜﻤﺎ ﻴ‬ ‫ﺔ ﻤﻥ‬ ‫‪‬ﻘﺩﻡ ﻫﺫﺍ ﺍﻟﻤﻠﺨﺹ ﻜل ﻋﺎﻡ‪ ،‬ﺒﺩﺍﻴ ﹰ‬ ‫ﻟﻠﺘﻘﺩﻡ ﺍﻟﺫﻱ ﻴﺘﻡ ﺇﺤﺭﺍﺯﻩ ﻋﻠﻰ ﺍﻟﺼﻌﻴﺩ ﺍﻟﺩﻭﻟﻲ ﻓﻲ ﺘﻨﻔﻴﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ‪ .‬ﻭﻴﻨﺒﻐﻲ ﺃﻥ ﻴ‬ ‫ﻋﺎﻡ ‪ .٢٠٠٧‬ﻭﻴﻨﺒﻐﻲ ﺃﻥ ﻴﺴﺘﻬﺩﻑ ﻤﺎ ﻴﻠﻲ‪:‬‬ ‫ﺘﻭﻀﻴﺢ ﺍﻟﺘﻘﺩﻡ ﺍﻟﻤﺤﺭﺯ ﻋﻠﻰ ﺍﻟﺼﻌﻴﺩﻴﻥ ﺍﻟﺩﻭﻟﻲ ﻭﺍﻹﻗﻠﻴﻤﻲ؛‬ ‫ﺘﺴﻠﻴﻁ ﺍﻟﻀﻭﺀ ﻋﻠﻰ ﺃﺒﺭﺯ ﺍﻹﻨﺠﺎﺯﺍﺕ؛‬ ‫ﺍﻟﺩﻻﻟﺔ ﻋﻠﻰ ﺇﺭﺍﺩﺓ ﺍﻟﺘﻌﻠﻡ ﻤﻥ ﺍﻟﻐﻴﺭ‪.‬‬ ‫•‬ ‫•‬ ‫•‬

‫‪‬ﻘﺘﺭﺡ ﺃﻥ ﺘﻭﻓﺭ ﺍﺠﺘﻤﺎﻋﺎﺕ ﺍﻟﻤﺠﻤﻭﻋﺎﺕ ﺍﻹﻗﻠﻴﻤﻴﺔ ﺍﻟﻘﺎﺌﻤﺔ ﺍﻟﺘﺎﺒﻌﺔ ﻟﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴـﺔ ﻓﺭﺼـﺔ‬ ‫ﻜﻤﺎ ﻴ‬ ‫ﻟﺘﺒﺎﺩل ﺍﻟﻤﻌﻠﻭﻤﺎﺕ‪ ،‬ﻭﺍﻟﺤﺼﻭل ﻋﻠﻰ ﺘﻌﻠﻴﻘﺎﺕ ﻤﻥ ﺍﻷﻁﺭﺍﻑ ﺍﻷﺨﺭﻯ ﺒﺨﺼﻭﺹ ﺍﻟﺘﻘﺩﻡ ﺍﻟﻤﺤﺭﺯ ﻓﻲ ﺘﻨﻔﻴـﺫ ﺍﺘﻔﺎﻗﻴـﺔ‬ ‫ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪.‬‬ ‫ﹰ‪ ،‬ﺒﺎﻻﺴﺘﻨﺎﺩ ﺇﻟﻰ ﺍﻟﺘﻘﺎﺭﻴﺭ ﺍﻟﺘﻲ ﺘﺘﻠﻘﺎﻫـﺎ ﺍﻷﻤﺎﻨـﺔ‬ ‫ﺎ ﻭﻋﺎﻟﻤﻴﺎ‬ ‫ﻭﺴﻴﻘﻭﻡ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺒﺘﺤﻠﻴل ﺍﻟﺘﻘﺩﻡ‪ ،‬ﺇﻗﻠﻴﻤﻴﹰ‬ ‫ﻭﺘﺤﻠﻠﻬﺎ‪.‬‬

‫ﻭﺘﺠﺩﺭ ﺍﻹﺸﺎﺭﺓ ﺇﻟﻰ ﺃﻥ ﺍﻟﺒﻨﻭﺩ ﺍﻟﻤﺤﺩﺩﺓ ﻓﻲ ﺍﺴﺘﻤﺎﺭﺓ ﺍﻟﺘﺒﻠﻴﻎ ﻟﻴﺴﺕ ﻭﺍﻓﻴﺔ‪ ،‬ﻭﻟﻜﻨﻬﺎ ﺘﻌﻜـﺱ ﺭﻭﺡ ﺍﻻﺘﻔﺎﻗﻴـﺔ‬ ‫ﻭﻤﻘﺼﺩﻫﺎ‪.‬‬

‫ﺍﻟﺘﻭﺠﻬﺎﺕ ﺍﻟﻤﺴﺘﻘﺒﻠﻴﺔ‬ ‫‪‬ﻘﺘﺭﺡ ﻜﺫﻟﻙ ﺇﺠﺭﺍﺀ ﺘﻘﻴﻴﻡ ﻤﺴﺘﻘل ﻟﺘﺭﺘﻴﺒﺎﺕ ﺍﻟﺘﺒﻠﻴﻎ ﻓﻲ ﻋﺎﻡ ‪ ،٢٠٠٩‬ﻋﻠﻰ ﺃﻥ ﻴﺘﻭﻟﻰ ﻤـﺅﺘﻤﺭ ﺍﻷﻁـﺭﺍﻑ‬ ‫ﻴ‬ ‫ﺍﻟﻨﻅﺭ ﻓﻲ ﺍﻷﻤﺭ ﻤﺭﺓ ﺃﺨﺭﻯ ﻓﻲ ﻋﺎﻡ ‪.٢٠١٠‬‬

‫‪33‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺍﺴﺘﻤﺎﺭﺓ ﺍﻟﺘﺒﻠﻴﻎ‬ ‫ﻤﻨﺸﺄ ﺍﻟﺘﻘﺭﻴﺭ‬ ‫ﺍﺴﻡ ﺍﻟﻁﺭﻑ ﺍﻟﻤﺘﻌﺎﻗﺩ‬ ‫ﺍﺴﻡ ﻤﻭﻅﻑ ﺍﻻﺘﺼﺎل ﻭﻟﻘﺒﻪ‬

‫‪-١‬‬ ‫)ﺃ(‬

‫)ﺏ( ﻤﻌﻠﻭﻤﺎﺕ ﻋﻥ ﻤﺭﻜﺯ ﺍﻻﺘﺼﺎل‪ /‬ﺍﻟﺘﻨﺴﻴﻕ ﺍﻟﻭﻁﻨﻲ‬ ‫ﺍﻟﻌﻨﻭﺍﻥ ﺍﻟﺒﺭﻴﺩﻱ‬ ‫ﺭﻗﻡ ﺍﻟﻔﺎﻜﺱ‬ ‫ﺭﻗﻡ ﺍﻟﻬﺎﺘﻑ‬

‫ﻋﻨﻭﺍﻥ ﺍﻟﺒﺭﻴﺩ ﺍﻹﻟﻜﺘﺭﻭﻨﻲ‬ ‫)ﺝ( ﻤﻌﻠﻭﻤﺎﺕ ﻋﻥ ﻤﻭﻅﻑ ﺍﻻﺘﺼﺎل ﺍﻟـﺫﻱ ﻴﻘـﺩﻡ‬ ‫ﺍﻟﺘﻘﺭﻴﺭ ﺍﻟﻭﻁﻨﻲ ﺇﺫﺍ ﻜﺎﻥ ﻏﻴﺭ ﺍﻟﺸﺨﺹ ﺍﻟﻤﺫﻜﻭﺭ ﺃﻋﻼﻩ‬ ‫ﺍﺴﻡ ﻤﻭﻅﻑ ﺍﻻﺘﺼﺎل ﻭﻟﻘﺒﻪ‬ ‫ﺍﻟﻌﻨﻭﺍﻥ ﺍﻟﺒﺭﻴﺩﻱ‬ ‫ﺭﻗﻡ ﺍﻟﻔﺎﻜﺱ‬ ‫ﺭﻗﻡ ﺍﻟﻬﺎﺘﻑ‬

‫ﻋﻨﻭﺍﻥ ﺍﻟﺒﺭﻴﺩ ﺍﻹﻟﻜﺘﺭﻭﻨﻲ‬ ‫ﺘﻭﻗﻴﻊ ﺍﻟﻤﻭﻅﻑ ﺍﻟﻤﺴﺅﻭل ﻋﻥ ﺘﻘﺩﻴﻡ ﺍﻟﺘﻘﺭﻴﺭ‬ ‫ﺍﻻﺴﻡ ﺍﻟﻜﺎﻤل ﻟﻠﻤﺅﺴﺴﺔ‬ ‫ﺍﺴﻡ ﺍﻟﻤﻭﻅﻑ ﻭﻟﻘﺒﻪ‬ ‫)ﺩ(‬

‫ﺍﻟﻌﻨﻭﺍﻥ ﺍﻟﺒﺭﻴﺩﻱ‬ ‫ﺭﻗﻡ ﺍﻟﻔﺎﻜﺱ‬ ‫ﺭﻗﻡ ﺍﻟﻬﺎﺘﻑ‬

‫ﻋﻨﻭﺍﻥ ﺍﻟﺒﺭﻴﺩ ﺍﻹﻟﻜﺘﺭﻭﻨﻲ‬ ‫ﻋﻨﻭﺍﻥ ﺼﻔﺤﺔ ﺍﻹﻨﺘﺭﻨﺕ‬ ‫)ﻫ( ﺍﻟﻔﺘﺭﺓ ﺍﻟﻤﺒﻠﻎ ﻋﻨﻬﺎ‬ ‫)ﻭ( ﺘﺎﺭﻴﺦ ﺘﻘﺩﻴﻡ ﺍﻟﺘﻘﺭﻴﺭ‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪34‬‬

‫ﺒﻴﺎﻨﺎﺕ ﺩﻴﻤﻐﺭﺍﻓﻴﺔ‬ ‫ﺍﻟﻌﻤﺭ ﻭﺍﻟﺠﻨﺱ‪:‬‬ ‫)ﺃ(‬

‫‪-٢‬‬

‫ﺍﻟﺴﻨﺔ )ﺃﺤﺩﺙ ﺴﻨﺔ(‬

‫ﺍﻟﻨﺴﺒﺔ ﺍﻟﻤﺌﻭﻴﺔ ﻟﻠﺴﻜﺎﻥ ﺍﻟﺫﻜﻭﺭ‬ ‫ﺍﻟﻨﺴﺒﺔ ﺍﻟﻤﺌﻭﻴﺔ ﻟﻠﺴﻜﺎﻥ ﺍﻹﻨﺎﺙ‬ ‫ﺍﻟﻨﺴﺒﺔ ﺍﻟﻤﺌﻭﻴﺔ ﻤﻥ ﻤﺠﻤﻭﻉ ﺍﻟﺴﻜﺎﻥ‬ ‫ﺍﻷﺼل ﺍﻹﺜﻨﻲ )ﺍﺨﺘﻴﺎﺭﻱ(‪:‬‬ ‫)ﺏ(‬

‫ﺍﻟﻔﺌﺎﺕ ﺍﻟﻌﻤﺭﻴﺔ‬

‫ﺍﺴﻡ ﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻹﺜﻨﻴﺔ‬ ‫ﺍﻟﻨﺴﺒﺔ ﺍﻟﻤﺌﻭﻴﺔ ﻤﻥ ﻤﺠﻤﻭﻉ ﺍﻟﺴﻜﺎﻥ‬

‫ﺘﻌﺎﻁﻲ ﺍﻟﺘﺒﻎ‬ ‫ﻤﻌﺩل ﺍﻻﻨﺘﺸﺎﺭ )ﺍﻟﻤﺭﺠﻊ‪ :‬ﺍﻟﻤﺎﺩﺓ ‪)٢-١٩‬ﺃ( ﻭﺍﻟﻤﺎﺩﺓ ‪ ،٢-٢٠‬ﻭﺍﻟﻤﺎﺩﺓ ‪)٣-٢٠‬ﺃ((‬ ‫ﺍﻟﺘﺒﻎ ﺍﻟﻤﺴﺘﻌﻤل ﻓﻲ ﺍﻟﺘﺩﺨﻴﻥ‪:‬‬ ‫ﻤﻌﺩل ﺍﻻﻨﺘﺸﺎﺭ‬ ‫)‪(٪‬‬ ‫ﺴﻨﺔ ﺍﻟﺒﻴﺎﻨﺎﺕ‬ ‫)ﺃﺤﺩﺙ ﺴﻨﺔ(‬ ‫ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﺍﻟﻤﺩﺭﺠﺔ‬ ‫ﺍﻟﻔﺌﺎﺕ ﺍﻟﻌﻤﺭﻴﺔ‪١‬‬

‫‪-٣‬‬

‫)‪(١‬‬ ‫)ﺃ(‬

‫)ﺍﻟﺒﺎﻟﻐﻭﻥ(‬

‫َﺭﻀﻴﻭﻥ‪٢‬‬ ‫ﺍﻟﻤﺩﺨﻨﻭﻥ ﺍﻟﻌ‬ ‫ﺍﻟﻤﺩﺨﻨﺎﺕ ﺍﻟﻴﻭﻤﻴﺎﺕ‪٢‬‬

‫ﺍﻟﻤﺩﺨﻨﻭﻥ ﺍﻟﻴﻭﻤﻴﻭﻥ‪٢‬‬

‫ﺍﻟﺫﻜﻭﺭ‬

‫ﺍﻹﻨﺎﺙ‬

‫ﺍﻟﻤﺠﻤﻭﻉ )ﺫﻜﻭﺭ ﻭﺇﻨﺎﺙ(‬

‫ﺍﻟﻤﺩﺨﻨﺎﺕ ﺍﻟﻌﺭﻀﻴﺎﺕ‪٢‬‬ ‫ﺍﻟﻤﺩﺨﻨﻭﻥ ﺍﻟﻴﻭﻤﻴﻭﻥ‪٢‬‬

‫ﺍﻟﻤﺩﺨﻨﻭﻥ ﺍﻟﻌﺭﻀﻴﻭﻥ‪٢‬‬

‫‪ ١‬ﻴﻔﻀل ﺍﺴﺘﺨﺩﺍﻡ ﻓﺌﺎﺕ ﺍﻟﻌﺸﺭ ﺴﻨﻭﺍﺕ‪ ،‬ﻤﺜل‪ ،٤٤-٣٥ ،٣٤-٢٥ :‬ﺇﻟﺦ‪.‬‬

‫‪ ٢‬ﺘﻀﻊ ﺍﻷﻁﺭﺍﻑ ﺘﻌﺎﺭﻴﻑ ﻟﻬﺫﺍ ﺍﻟﻤﺼﻁﻠﺢ‪.‬‬

‫‪35‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬ ‫ُﺘﻴﺤﺕ ﻫﺫﻩ ﺍﻟﺒﻴﺎﻨﺎﺕ‪:‬‬ ‫ﺎ ﻤﻥ ﻗﺒل ﻜل ﻓﺌﺔ ﺴﻜﺎﻨﻴﺔ ﻤﺩﺨﻨﺔ‪ ،‬ﺇﻥ ﺃ‬ ‫‪‬ﺭﺠﻰ ﺘﻘﺩﻴﻡ ﻤﺘﻭﺴﻁ ﻋﺩﺩ ﺍﻟﺴﺠﺎﺌﺭ ﺍﻟﻤﺩﺨﻨﺔ ﻴﻭﻤﻴﹰ‬ ‫ﻴ‬ ‫ﻤﺘﻭﺴﻁ ﻋﺩﺩ‬ ‫ﺍﻟﺴﺠﺎﺌﺭ ﺍﻟﻤﺩﺨﻨﺔ‬ ‫ﺎ‬ ‫ﻴﻭﻤﻴﹰ‬ ‫ﺴﻨﺔ ﺍﻟﺒﻴﺎﻨﺎﺕ‬ ‫)ﺃﺤﺩﺙ ﺴﻨﺔ(‬ ‫ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ‬ ‫ﺍﻟﻤﺩﺭﺠﺔ‬ ‫ﺍﻟﻔﺌﺎﺕ ﺍﻟﻌﻤﺭﻴﺔ‪١‬‬

‫)ﺍﻟﺒﺎﻟﻐﻭﻥ(‬

‫ﺍﻟﻤﺩﺨﻨﻭﻥ‪٢‬‬ ‫ﻤﺠﻤﻭﻉ ﺍﻟﻤﺩﺨﻨﻴﻥ ﻭﺍﻟﻤﺩﺨﻨﺎﺕ‪٢‬‬ ‫ﺍﻟﻤﺩﺨﻨﺎﺕ‪٢‬‬

‫ﺍﻟﺘﺒﻎ ﺍﻟﻌﺩﻴﻡ ﺍﻟﺩﺨﺎﻥ‪ ،‬ﺒﻤﺎ ﻓﻲ ﺫﻟﻙ ﺍﻟﺴﻌﻭﻁ ﻭﺘﺒﻎ ﺍﻟﻤﻀﻎ )ﺍﺨﺘﻴﺎﺭﻱ(‪:‬‬ ‫ﻤﻌﺩل ﺍﻻﻨﺘﺸﺎﺭ‬ ‫)‪(٪‬‬ ‫ﺴﻨﺔ ﺍﻟﺒﻴﺎﻨﺎﺕ‬ ‫)ﺃﺤﺩﺙ ﺴﻨﺔ(‬ ‫ﺍﻟﻔﺌﺎﺕ ﺍﻟﻌﻤﺭﻴﺔ‪ ١‬ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ‬ ‫ﺍﻟﻤﺩﺭﺠﺔ‬ ‫)ﺍﻟﺒﺎﻟﻐﻭﻥ(‬

‫)ﺏ(‬

‫ﺍﻟﺫﻜﻭﺭ‬ ‫ﺍﻟﻤﺘﻌﺎﻁﻭﻥ ﺍﻟﻴﻭﻤﻴﻭﻥ‬ ‫َﺭﻀﻴﻭﻥ‪٢‬‬ ‫ﺍﻟﻤﺘﻌﺎﻁﻭﻥ ﺍﻟﻌ‬ ‫ﺍﻹﻨﺎﺙ‬ ‫ﺍﻟﻤﺘﻌﺎﻁﻴﺎﺕ ﺍﻟﻌﺭﻀﻴﺎﺕ‪١‬‬ ‫ﺍﻟﻤﺠﻤﻭﻉ‬ ‫ﺍﻟﻤﺘﻌﺎﻁﻭﻥ ﺍﻟﻌﺭﻀﻴﻭﻥ ﻤﻥ ﺍﻟﺠﻨﺴﻴﻥ‪١‬‬ ‫ﺍﻟﻤﺘﻌﺎﻁﻭﻥ ﺍﻟﻴﻭﻤﻴﻭﻥ ﻤﻥ ﺍﻟﺠﻨﺴﻴﻥ‬ ‫ﺍﻟﻤﺘﻌﺎﻁﻴﺎﺕ ﺍﻟﻴﻭﻤﻴﺎﺕ‬

‫)ﺝ( ﺇﺫﺍ ﻜﺎﻨﺕ ﻫﻨﺎﻙ ﺒﻴﺎﻨﺎﺕ ﻤﻨﺎﺴﺒﺔ ﺨﺎﺼﺔ ﺒﺎﻻﻨﺘﺸﺎﺭ ﻤﺘﻭﺍﻓﺭﺓ ﺒـﺸﺄﻥ ﺍﻟﻤﺠﻤﻭﻋـﺎﺕ ﺍﻹﺜﻨﻴـﺔ‪،‬‬ ‫ﻴﺭﺠﻰ ﺘﻘﺩﻴﻤﻬﺎ‪:‬‬ ‫ﻤﻌﺩل ﺍﻻﻨﺘﺸﺎﺭ )‪(٪‬‬ ‫ﺴﻨﺔ ﺍﻟﺒﻴﺎﻨﺎﺕ‬ ‫)ﺃﺤﺩﺙ ﺴﻨﺔ(‬ ‫ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ‬ ‫ﺍﻟﻤﺩﺭﺠﺔ‬ ‫ﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻹﺜﻨﻴﺔ‬ ‫ﺍﻟﻤﺘﻌﺎﻁﻭﻥ ﺍﻟﻴﻭﻤﻴﻭﻥ‬

‫َﺭﻀﻴﻭﻥ‪١‬‬ ‫ﺍﻟﻤﺘﻌﺎﻁﻭﻥ ﺍﻟﻌ‬

‫ﺎ ﻟﻠﻤﺩﺨﻨﻴﻥ ﻤﻥ ﺍﻟﺸﺒﺎﺏ‪ ،‬ﻋﻠﻰ ﺴﺒﻴل ﺍﻟﻤﺜﺎل‪ ،‬ﺴﻴﺠﺎﺭﺓ ﻭﺍﺤﺩﺓ ﻋﻠﻰ ﺍﻷﻗل ﺨﻼل ﺍﻟﺜﻼﺜـﻴﻥ‬ ‫‪ ١‬ﻴﻨﺒﻐﻲ ﺃﻥ ﺘﻀﻊ ﺍﻷﻁﺭﺍﻑ ﺘﻌﺭﻴﻔﹰ‬ ‫ﺎ ﺍﻟﻤﺎﻀﻴﺔ‪.‬‬ ‫ﻴﻭﻤﹰ‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ ‫‪‬ﺭﺠﻰ ﺘﻘﺩﻴﻤﻬﺎ‪:‬‬ ‫ﺇﺫﺍ ﻜﺎﻨﺕ ﻫﻨﺎﻙ ﺒﻴﺎﻨﺎﺕ ﻤﻨﺎﺴﺒﺔ ﺨﺎﺼﺔ ﺒﺎﻻﻨﺘﺸﺎﺭ ﻤﺘﻭﺍﻓﺭﺓ ﺒﺸﺄﻥ ﻓﺌﺎﺕ ﺍﻟﺸﺒﺎﺏ‪ ،‬ﻴ‬ ‫ﺍﻻﻨﺘﺸﺎﺭ )‪١(٪‬‬ ‫ﺴﻨﺔ ﺍﻟﺒﻴﺎﻨﺎﺕ‬ ‫)ﺃﺤﺩﺙ ﺴﻨﺔ(‬ ‫ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ‬ ‫ﺍﻟﻤﺩﺭﺠﺔ‬ ‫ﻓﺌﺎﺕ ﺍﻟﺸﺒﺎﺏ‪٢‬‬

‫‪36‬‬

‫)ﺩ(‬

‫ﺍﻟﺫﻜﻭﺭ‬ ‫ﺍﻹﻨﺎﺙ‬

‫ﺍﻟﺘﻭﺭﻴﺩ‬ ‫ﺎ ﻟﻠﻤﺎﺩﺓ ‪(٥-١٥‬‬ ‫ﺍﻟﺘﻭﺭﻴﺩ ﺍﻟﻤﺸﺭﻭﻉ ﻟﻠﺘﺒﻎ )ﺍﻟﻤﺭﺠﻊ‪ :‬ﺍﻟﻤﺎﺩﺓ ‪)٤-٢٠‬ﺝ(‪ ،‬ﻭﺍﻟﻤﺎﺩﺓ ‪)٤-١٥‬ﺃ(‪ ،‬ﻭﻓﻘﹰ‬ ‫ﺍﻟﻭﺍﺭﺩﺍﺕ‬ ‫ﺍﻟﺼﺎﺩﺭﺍﺕ‬ ‫ﺍﻹﻨﺘﺎﺝ ﺍﻟﻤﺤﻠﻲ‬

‫)‪(٢‬‬ ‫)ﺃ(‬

‫ﺍﻟﺴﻨﺔ )ﺃﺤﺩﺙ ﺴﻨﺔ(‬ ‫ﺍﻟﻜﻤﻴﺔ )ﻴﺭﺠﻰ ﺘﺤﺩﻴﺩ ﺍﻟﻤﻨﺘﺞ ﻭﺍﻟﻭﺤﺩﺓ؛‬ ‫ﻼ(‬ ‫ﺒﻤﻼﻴﻴﻥ ﺍﻟﺴﺠﺎﺌﺭ‪ ،‬ﻤﺜ ﹰ‬ ‫)ﺏ(‬

‫ﻤﻼﺤﻅﺔ‪ :‬ﺍﻟﺘﻭﺭﻴﺩ ﺍﻟﻤﺸﺭﻭﻉ = ﺍﻹﻨﺘﺎﺝ ﺍﻟﻤﺤﻠﻲ ‪) +‬ﺍﻟﻭﺍﺭﺩﺍﺕ ‪ -‬ﺍﻟﺼﺎﺩﺭﺍﺕ(‬ ‫‪‬ﺭﺠﻰ ﺘﻘﺩﻴﻡ ﻤﻌﻠﻭﻤﺎﺕ ﻋﻥ ﺤﺠﻡ ﺍﻟﻤﺒﻴﻌﺎﺕ ﺍﻟﻤﻌﻔﺎﺓ ﻤﻥ ﺍﻟﺭﺴﻭﻡ‪ ،‬ﺇﻥ ﺘﻭﺍﻓﺭﺕ‪.‬‬ ‫ﻴ‬

‫ﺎ ﻟﻠﻤﺎﺩﺓ ‪(٥-١٥‬‬ ‫ﻤﺼﺎﺩﺭﺓ ﺍﻟﺘﺒﻎ ﻏﻴﺭ ﺍﻟﻤﺸﺭﻭﻉ )ﺍﻟﻤﺭﺠﻊ‪ :‬ﺍﻟﻤﺎﺩﺓ ‪)٤-١٥‬ﺃ( ﻭﻓﻘﹰ‬ ‫ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﺍﻷﺨﺭﻯ‬ ‫)ﺍﺨﺘﻴﺎﺭﻱ؛ ﻴﺭﺠﻰ ﺘﺤﺩﻴﺩ ﺍﻟﻤﻨﺘﺞ(‬ ‫ﺍﻟﺴﺠﺎﺌﺭ‬

‫)ﺝ(‬

‫ﺍﻟﺴﻨﺔ )ﺃﺤﺩﺙ ﺴﻨﺔ(‬ ‫ﺍﻟﻜﻤﻴﺔ ﺍﻟﻤﺼﺎﺩﺭﺓ‬ ‫ﻼ(‬ ‫)ﻴﺭﺠﻰ ﺘﺤﺩﻴﺩ ﺍﻟﻭﺤﺩﺓ؛ ﺒﻤﻼﻴﻴﻥ ﺍﻟﻘﻁﻊ ﻤﺜ ﹰ‬ ‫‪‬ﺭﺠﻰ ﺘﻘﺩﻴﻡ ﻤﻌﻠﻭﻤﺎﺕ ﻋﻥ ﻜﻤﻴﺎﺕ ﺍﻟﺘﺒﻎ ﻏﻴﺭ ﺍﻟﻤﺸﺭﻭﻋﺔ ﺃﻭﺍﻟﻤﻬﺭﺒﺔ )ﺍﺨﺘﻴـﺎﺭﻱ(؟ )ﺍﻟﻤﺭﺠـﻊ‪:‬‬ ‫ﻴ‬ ‫ﺎ ﻟﻠﻤﺎﺩﺓ ‪(٥-١٥‬‬ ‫ﺍﻟﻤﺎﺩﺓ ‪)٤-١٥‬ﺃ( ﻭﻓﻘﹰ‬ ‫)ﺩ(‬

‫‪ ١‬ﺘﻀﻊ ﺍﻷﻁﺭﺍﻑ ﺘﻌﺎﺭﻴﻑ ﻟﻬﺫﺍ ﺍﻟﻤﺼﻁﻠﺢ‪.‬‬

‫‪37‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﻓﺭﺽ ﺍﻟﻀﺭﺍﺌﺏ‬ ‫ﻴﺭﺠﻰ ﺒﻴﺎﻥ ﻤﻌﺩﻻﺕ ﺍﻟﻀﺭﺍﺌﺏ ﺍﻟﺘﻲ ﺘﻔﺭﻀﻭﻨﻬﺎ ﻋﻠﻰ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﻋﻠـﻰ ﺠﻤﻴـﻊ ﻤـﺴﺘﻭﻴﺎﺕ‬ ‫ﺍﻟﺤﻜﻭﻤﺔ‪ ،‬ﻭﻴﺭﺠﻰ ﺘﻭﺨﻲ ﺍﻟﺩﻗﺔ ﻗﺩﺭ ﺍﻹﻤﻜﺎﻥ )ﻴﺤﺩﺩ ﻨﻭﻉ ﺍﻟﻀﺭﻴﺒﺔ‪ :‬ﻤﻜﺱ‪ ،‬ﺃﻭ ﻀـﺭﻴﺒﺔ ﺍﻟﻘﻴﻤـﺔ‬ ‫ﺍﻟﻤﻀﺎﻓﺔ ﺃﻭ ﺭﺴﻭﻡ ﻋﻠﻰ ﺍﻟﻤﺒﻴﻌﺎﺕ ﺃﻭ ﺍﻟﻭﺍﺭﺩﺍﺕ(‪) .‬ﺍﻟﻤﺭﺠﻊ‪ :‬ﺍﻟﻤﺎﺩﺓ ‪(٣-٦‬‬ ‫)ﺃ(‬

‫‪-٤‬‬

‫ﻴﺭﺠﻰ ﺇﺭﻓﺎﻕ ﺍﻟﻭﺜﺎﺌﻕ ﺫﺍﺕ ﺍﻟﺼﻠﺔ )ﺍﻟﻤﺭﺠﻊ‪ :‬ﺍﻟﻤﺎﺩﺓ ‪) .(٣-٦‬ﺍﻟﺭﺠﺎﺀ ﺘﻘﺩﻴﻡ ﺍﻟﻭﺜﺎﺌﻕ ﺒﻭﺍﺤﺩﺓ ﻤـﻥ‬ ‫ﺎ(‪.‬‬ ‫ﺍﻟﻠﻐﺎﺕ ﺍﻟﺴﺕ ﺍﻟﺭﺴﻤﻴﺔ‪ ،‬ﺇﺫﺍ ﻜﺎﻥ ﺫﻟﻙ ﻤﺘﺎﺤﹰ‬ ‫ﻴﺭﺠﻰ ﺒﻴﺎﻥ ﺃﺴﻌﺎﺭ ﺍﻟﺒﻴﻊ ﺒﺎﻟﺘﺠﺯﺌﺔ ﻷﺸﻴﻊ ﺜـﻼﺙ ﻋﻼﻤـﺎﺕ ﺘﺠﺎﺭﻴـﺔ ﻤـﻥ ﻤﻨﺘﺠـﺎﺕ ﺍﻟﺘﺒـﻎ‬ ‫ﺍﻟﻤﺤﻠﻴﺔ ﻭﺍﻟﻤﺴﺘﻭﺭﺩﺓ ﺍﻟﻤﻨﺩﺭﺠﺔ ﻀﻤﻥ ﻭﻻﻴﺘﻜﻡ ﺍﻟﻘﻀﺎﺌﻴﺔ‪ ،‬ﻭﺫﻜﺭ ﺍﻟﺴﻨﺔ ﺫﺍﺕ ﺍﻟـﺼﻠﺔ )ﺍﻟﻤﺭﺠـﻊ‪:‬‬ ‫ﺍﻟﻤﺎﺩﺓ ‪)٢-٦‬ﺃ((‬

‫)ﺏ(‬ ‫)ﺝ(‬

‫ﺍﻟﺘﺩﺍﺒﻴﺭ ﺍﻟﺘﺸﺭﻴﻌﻴﺔ ﻭﺍﻟﺘﻨﻔﻴﺫﻴﺔ ﻭﺍﻹﺩﺍﺭﻴﺔ‪ ،‬ﻭﺍﻟﺘﺩﺍﺒﻴﺭ ﺍﻷﺨﺭﻯ‬ ‫ﺍﻷﺴﺌﻠﺔ ﺍﻷﺴﺎﺴﻴﺔ‬ ‫)‪(١‬‬

‫‪-٥‬‬

‫ﹸﻌﺒﺭ ﻋﻥ ﺭﻭﺡ ﻭﻤﻘﺼﺩ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ‪.‬‬ ‫ﻴﻨﺒﻐﻲ ﻤﻼﺤﻅﺔ ﺃﻥ ﺍﻟﺘﺩﺍﺒﻴﺭ ﺍﻟﻤﺤﺩﺩﺓ ﺃﺩﻨﺎﻩ ﻟﻴﺴﺕ ﺸﺎﻤﻠﺔ‪ ،‬ﻭﺇﻨﻤﺎ ﺘ‬ ‫ﻴﺭﺠﻰ ﺍﻹﺠﺎﺒﺔ ﺒﻨﻌﻡ ﺃﻭ ﻻ‪ .‬ﻭﻓﻲ ﺤﺎل ﺍﻹﺠﺎﺒﺔ ﺒﻨﻌﻡ‪ ،‬ﻴﺭﺠﻰ ﺇﺭﻓﺎﻕ ﻤﻠﺨﺹ ﻭﺠﻴﺯ ﻭﺍﻟﻭﺜﺎﺌﻕ ﺍﻟﻤﻌﻨﻴﺔ‪) .‬ﺍﻟﺭﺠﺎﺀ ﺘﻭﻓﻴﺭ‬ ‫ﺎ(‪.‬‬ ‫ﺍﻟﻭﺜﺎﺌﻕ ﺒﻭﺍﺤﺩﺓ ﻤﻥ ﺍﻟﻠﻐﺎﺕ ﺍﻟﺴﺕ ﺍﻟﺭﺴﻤﻴﺔ‪ ،‬ﺇﺫﺍ ﻜﺎﻥ ﺫﻟﻙ ﻤﺘﺎﺤﹰ‬ ‫ـﺎﺀ ﻻ‬ ‫ـﻡ )ﺍﻟﺭﺠـ‬ ‫ﻼ ﺒﺎﻟﻤﺎﺩﺓ ‪)١-٢١‬ﺃ(‪ ،‬ﻫل ﻗﻤﺘﻡ ﺒﺎﻋﺘﻤﺎﺩ ﻭﺘﻨﻔﻴﺫ ﺘﺩﺍﺒﻴﺭ ﺘﺸﺭﻴﻌﻴﺔ ﻭﺘﻨﻔﻴﺫﻴـﺔ ﻨﻌـ‬ ‫ﻋﻤ ﹰ‬ ‫ﺇﺭﻓـﺎﻕ ﻤﻠﺨـﺹ‬ ‫ﻭﺇﺩﺍﺭﻴﺔ ﻭ‪ /‬ﺃﻭ ﺘﺩﺍﺒﻴﺭ ﺃﺨﺭﻯ ﺒﺸﺄﻥ‪:‬‬ ‫ﻭﺠﻴﺯ ﻭﺍﻟﻭﺜـﺎﺌﻕ‬ ‫ﺫﺍﺕ ﺍﻟﺼﻠﺔ(‬ ‫ﺤﻅﺭ ﺃﻭ ﺘﻘﻴﻴﺩ ﻤﺒﻴﻌﺎﺕ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﺍﻟﻤﻌﻔـﺎﺓ ﻤـﻥ ﺍﻟـﻀﺭﺍﺌﺏ ﻭﺍﻟﺭﺴـﻭﻡ‬ ‫َﻠﻬﻡ؟‬ ‫ﻗﺒ‬ ‫ﺍﻟﺠﻤﺭﻜﻴﺔ ﺇﻟﻰ ﺍﻟﻤﺴﺎﻓﺭﻴﻥ ﺍﻟﺩﻭﻟﻴﻴﻥ ﻭ‪ /‬ﺃﻭ ﺘﻭﺭﻴﺩﻫﺎ ﻤﻥ ‪‬‬ ‫ﻜﺎﻤﻠﺔ‪ /‬ﺠﺯﺌﻴﺔ‪ /‬ﻤﻌﺩﻭﻤﺔ‬ ‫ﻓﻲ ﺃﻤﺎﻜﻥ ﺍﻟﻌﻤل ﺍﻟﺩﺍﺨﻠﻴﺔ؟‬ ‫ ﺍﻟﻤﺒﺎﻨﻲ ﺍﻟﺤﻜﻭﻤﻴﺔ‬‫ ﻤﺭﺍﻓﻕ ﺍﻟﺭﻋﺎﻴﺔ ﺍﻟﺼﺤﻴﺔ‬‫ ﺍﻟﻤﺭﺍﻓﻕ ﺍﻟﺘﻌﻠﻴﻤﻴﺔ‬‫ ﺃﻤﺎﻜﻥ ﺍﻟﻌﻤل ﺍﻟﺨﺎﺼﺔ‬‫ ﺃﻤﺎﻜﻥ ﺃﺨﺭﻯ‬‫ﺍﻟﻤﺎﺩﺓ‬

‫ﺍﻟﺘﺩﺍﺒﻴﺭ ﺍﻟﺴﻌﺭﻴﺔ ﻭﺍﻟﻀﺭﻴﺒﻴﺔ ﻟﻠﺤﺩ ﻤﻥ ﺍﻟﻁﻠﺏ ﻋﻠﻰ ﺍﻟﺘﺒﻎ‬ ‫‪)٢-٦‬ﺏ(‬

‫ﺍﻟﺤﻤﺎﻴﺔ ﻤﻥ ﺍﻟﺘﻌﺭﺽ ﻟﺩﺨﺎﻥ ﺍﻟﺘﺒﻎ‬ ‫‪٢-٨‬‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ ‫ﻓﻲ ﻭﺴﺎﺌل ﺍﻟﻨﻘل ﺍﻟﻌﺎﻡ؟‬ ‫ﻓﻲ ﺍﻷﻤﺎﻜﻥ ﺍﻟﻌﻤﻭﻤﻴﺔ ﺍﻟﺩﺍﺨﻠﻴﺔ؟‬ ‫ﺍﻟﻤﺭﺍﻓﻕ ﺍﻟﺜﻘﺎﻓﻴﺔ‬ ‫ﺍﻟﺤﺎﻨﺎﺕ ﻭﺍﻟﻨﻭﺍﺩﻱ ﺍﻟﻠﻴﻠﻴﺔ‬ ‫ﺍﻟﻤﻁﺎﻋﻡ‬ ‫ﺃﻤﺎﻜﻥ ﺃﺨﺭﻯ‬ ‫‬‫‬‫‬‫‪-‬‬

‫‪38‬‬

‫‪‬ﺭﺠﻰ ﺘﻘﺩﻴﻡ ﺘﻔﺎﺼﻴل ﻤﺤﺩﺩﺓ ﻟﻠﺤﻅﺭ ﺍﻟﺠﺯﺌﻲ‪ ،‬ﻓﻲ ﻫﺫﺍ‬ ‫ﺇﺫﺍ ﻜﺎﻨﺕ ﺇﺠﺎﺒﺎﺘﻙ "ﺠﺯﺌﻴﺔ" ﺒﺸﺄﻥ ﺍﻟﺘﺩﺍﺒﻴﺭ ﺍﻟﻭﺍﺭﺩﺓ ﻓﻲ ﺍﻟﻤﺎﺩﺓ ‪ ،٢-٨‬ﻴ‬ ‫ﺍﻹﻁﺎﺭ‪:‬‬ ‫ﺘﻨﻅﻴﻡ ﺍﻟﻜﺸﻑ ﻋﻥ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ‬ ‫ﻤﻁﺎﻟﺒﺔ ﺼﺎﻨﻌﻲ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﻭ‪ /‬ﺃﻭ ﻤﺴﺘﻭﺭﺩﻴﻬﺎ ﺒـﺄﻥ ﻴﻜـﺸﻔﻭﺍ ﻟﻠـﺴﻠﻁﺎﺕ‬ ‫ﺍﻟﺤﻜﻭﻤﻴﺔ ﻋﻥ ﻤﺤﺘﻭﻴﺎﺘﻬﺎ؟‬ ‫‪١٠‬‬

‫ﺍﻻﺘﺠﺎﺭ ﻏﻴﺭ ﺍﻟﻤﺸﺭﻭﻉ ﺒﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ‬ ‫ﺍﺸﺘﺭﺍﻁ ﺃﻥ ﺘﺤﻤل ﺍﻟﻌﺒﻭﺍﺕ ﻋﻼﻤﺔ ﺘﺴﺎﻋﺩ ﻋﻠﻰ ﺘﺤﺩﻴﺩ ﻤﻨﺸﺄ ﺍﻟﻤﻨﺘﺞ؟‬ ‫ﺎ ﺒﺼﻭﺭﺓ ﻗﺎﻨﻭﻨﻴﺔ ﻟﻠﺒﻴـﻊ ﻓـﻲ‬ ‫ﻭﺘﺴﺎﻋﺩ ﻋﻠﻰ ﺘﺤﺩﻴﺩ ﻤﺎ ﺇﺫﺍ ﻜﺎﻥ ﺍﻟﻤﻨﺘﺞ ﻤﻁﺭﻭﺤﹰ‬ ‫ﺍﻟﺴﻭﻕ ﺍﻟﻤﺤﻠﻴﺔ؟‬ ‫ﹸﻌﺭﺽ ﺍﻟﻌﻼﻤﺎﺕ ﺒﺸﻜل ﻭﺍﻀﺢ ﻟﻠﻌﻴﺎﻥ ﻭ‪ /‬ﺃﻭ ﺃﻥ ﺘﺭﺩ ﺒﺎﻟﻠﻐـﺔ ﺃﻭ‬ ‫ﺍﺸﺘﺭﺍﻁ ﺃﻥ ﺘ‬ ‫ﺍﻟﻠﻐﺎﺕ ﺍﻟﺭﺌﻴﺴﻴﺔ؟‬ ‫ﺍﻟﺘﻤﻜﻴﻥ ﻤﻥ ﻤﺼﺎﺩﺭﺓ ﺍﻹﻴﺭﺍﺩﺍﺕ ﺍﻟﻤﺘﺄﺘﻴﺔ ﻤﻥ ﺍﻻﺘﺠﺎﺭ ﻏﻴﺭ ﺍﻟﻤﺸﺭﻭﻉ؟‬ ‫ﻤﻨﺢ ﺍﻟﺘﺭﺍﺨﻴﺹ ﺃﻭ ﺍﺘﺨﺎﺫ ﺘﺩﺍﺒﻴﺭ ﺃﺨﺭﻯ ﻤﻥ ﺃﺠل ﻤﺭﺍﻗﺒﺔ ﺃﻭ ﺘﻨﻅـﻴﻡ ﺍﻹﻨﺘـﺎﺝ‬ ‫ﻭﺍﻟﺘﻭﺯﻴﻊ؟‬ ‫ـﺩ‬ ‫ـﻰ ﺘﺤﺩﻴـ‬ ‫‪‬ﺭﺠـ‬ ‫ﻴ‬ ‫ﺍﻟﺴﻥ ﺍﻟﻘﺎﻨﻭﻨﻴﺔ‪:‬‬ ‫‪‬ﺭ؟‬ ‫ﺤﻅﺭ ﻤﺒﻴﻌﺎﺕ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﺍﻟﺘﻲ ﺘﺴﺘﻬﺩﻑ ﺍﻟﻘﺼ‬ ‫ﺎ‬ ‫ﺤﻅﺭ ﺃﻭ ﺘﻌﺯﻴﺯ ﺤﻅﺭ ﺘﻭﺯﻴﻊ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﺍﻟﻤﺠﺎﻨﻴﺔ ﻋﻠﻰ ﺍﻟﻨﺎﺱ ﻭﺨﺼﻭﺼﹰ‬ ‫‪‬ﺭ؟‬ ‫ﺍﻟﻘﺼ‬ ‫ﺤﻅﺭ ﺒﻴﻊ ﺍﻟﺴﺠﺎﺌﺭ ﺍﻟﻤﻔﺭﺩﺓ ﺃﻭ ﻓﻲ ﻋﻠﺏ ﺼﻐﻴﺭﺓ؟‬ ‫ﻓﺭﺽ ﺠﺯﺍﺀﺍﺕ ﻋﻠﻰ ﺍﻟﺒﺎﻋﺔ ﻭﺍﻟﻤﻭﺯﻋﻴﻥ؟‬ ‫‪‬ﺭ؟‬ ‫ﺤﻅﺭ ﻤﺒﻴﻌﺎﺕ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﺒﻭﺍﺴﻁﺔ ﺍﻟﻘﺼ‬ ‫ﻤﻌﺎﻟﺠﺔ ﻤﺴﺄﻟﺔ ﺍﻟﻤﺴﺅﻭﻟﻴﺔ ﺍﻟﺠﻨﺎﺌﻴﺔ ﻭﺍﻟﻤﺩﻨﻴـﺔ‪ ،‬ﺒﻤـﺎ ﻓﻴﻬـﺎ ﺍﻟﺘﻌـﻭﻴﺽ ﻋﻨـﺩ‬ ‫ﺍﻻﻗﺘﻀﺎﺀ؟‬ ‫‪)٢-١٥‬ﺃ(‬

‫‪٣-١٥‬‬

‫‪)٤-١٥‬ﺏ( ﺴﻥ ﺃﻭ ﺘﻌﺯﻴﺯ ﺘﺸﺭﻴﻊ ﻀﺩ ﺍﻻﺘﺠﺎﺭ ﻏﻴﺭ ﺍﻟﻤﺸﺭﻭﻉ ﺒﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ؟‬ ‫‪)٤-١٥‬ﻫ(‬ ‫‪٧-١٥‬‬

‫‪‬ﺭ‬ ‫‪‬ﺭ ﻭﺍﻟﻤﺒﻴﻌﺎﺕ ﺒﻭﺍﺴﻁﺔ ﺍﻟﻘﺼ‬ ‫ﺍﻟﻤﺒﻴﻌﺎﺕ ﺍﻟﺘﻲ ﺘﺴﺘﻬﺩﻑ ﺍﻟﻘﺼ‬ ‫‪١-١٦‬‬ ‫‪٢-١٦‬‬ ‫‪٣-١٦‬‬ ‫‪٦-١٦‬‬ ‫‪٧-١٦‬‬ ‫ﺍﻟﻤﺴﺅﻭﻟﻴﺔ‬ ‫‪١-١٩‬‬

‫‪39‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬ ‫ﺃﺴﺌﻠﺔ ﺍﺨﺘﻴﺎﺭﻴﺔ‬ ‫)‪(٢‬‬

‫ﺎ ﺒﺄﻨﻪ ﻻ ﺘﺸﺘﺭﻁ ﺍﻹﺠﺎﺒﺔ ﻋﻥ ﻫﺫﻩ ﺍﻷﺴﺌﻠﺔ ﻋﻨﺩ ﺘﻘﺩﻴﻡ ﺍﻟﺘﻘﺎﺭﻴﺭ ﺍﻟﻤﻨﺩﺭﺠﺔ ﻀﻤﻥ ﺍﻟﻔﺌﺔ ‪ ،١‬ﻭﻟﻜـﻥ‬ ‫ﻴﻨﺒﻐﻲ ﺍﻹﺤﺎﻁﺔ ﻋﻠﻤﹰ‬ ‫ﺘﺠﻭﺯ ﺍﻹﺠﺎﺒﺔ ﻋﻨﻬﺎ ﻓﻲ ﺫﻟﻙ ﺍﻟﺤﻴﻥ‪ ،‬ﺇﻥ ﺃﻤﻜﻥ‪.‬‬ ‫ـﺎﺀ ﻻ‬ ‫ـﻡ )ﺍﻟﺭﺠـ‬ ‫ﻫل ﻗﻤﺘﻡ ﺒﺎﻋﺘﻤﺎﺩ ﻭﺘﻨﻔﻴﺫ ﺘﺩﺍﺒﻴﺭ ﺘﺸﺭﻴﻌﻴﺔ ﺃﻭ ﺘﻨﻔﻴﺫﻴﺔ ﺃﻭ ﺇﺩﺍﺭﻴـﺔ ﻭ‪ /‬ﺃﻭ ﻨﻌـ‬ ‫ﺇﺭﻓـﺎﻕ ﻤﻠﺨـﺹ‬ ‫ﺘﺩﺍﺒﻴﺭ ﺃﺨﺭﻯ ﺒﺸﺄﻥ‪:‬‬ ‫ﻭﺠﻴﺯ ﻭﺍﻟﻭﺜـﺎﺌﻕ‬ ‫ﺫﺍﺕ ﺍﻟﺼﻠﺔ(‪١‬‬ ‫ﻓﺤﺹ ﻭﻗﻴﺎﺱ ﻤﺤﺘﻭﻴﺎﺕ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ؟‬ ‫ﻓﺤﺹ ﻭﻗﻴﺎﺱ ﺍﻨﺒﻌﺎﺜﺎﺕ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ‬ ‫ﺘﻨﻅﻴﻡ ﻤﺤﺘﻭﻴﺎﺕ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ؟‬ ‫ﺘﻨﻅﻴﻡ ﺍﻨﺒﻌﺎﺜﺎﺕ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ؟‬ ‫ﺘﻐﻠﻴﻑ ﻭﺘﻭﺴﻴﻡ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ‬ ‫ﺍﺸﺘﺭﺍﻁ ﺃﻻ ﺘﺅﺩﻱ ﻁﺭﻴﻘﺔ ﺘﻐﻠﻴﻑ ﻭﺘﻭﺴﻴﻡ ﻤﻨﺘﺞ ﺍﻟﺘﺒﻎ ﺇﻟﻰ ﺍﻟﺘﺭﻭﻴﺞ ﻟـﻪ‬ ‫ﺎ؟‬ ‫ﺎ ﺨﺎﻁﺌﹰ‬ ‫ﹸﻌﻁﻲ ﺍﻨﻁﺒﺎﻋﹰ‬ ‫ﺒﺄﻱ ﻭﺴﻴﻠﺔ ﻜﺎﺫﺒﺔ ﺃﻭ ﺨﺎﺩﻋﺔ ﺃﻭ ﻤﻀﻠﻠﺔ ﺃﻭ ﻗﺩ ﺘ‬ ‫ﺎ ﺃﻱ ﺸﻜل ﻤﻥ ﺃﺸـﻜﺎل ﺍﻟﺘﻐﻠﻴـﻑ ﻭﺍﻟﺘﻭﺴـﻴﻡ‬ ‫ﺍﺸﺘﺭﺍﻁ ﺃﻥ ﻴﺤﻤل ﺃﻴﻀﹰ‬ ‫ﺘﺤﺫﻴﺭﺍﺕ ﺼﺤﻴﺔ ﺘﺼﻑ ﺁﺜﺎﺭ ﺘﻌﺎﻁﻲ ﺍﻟﺘﺒﻎ ﺍﻟﻀﺎﺭﺓ؟‬ ‫ﻀﻤﺎﻥ ﺃﻥ ﺘﻜﻭﻥ ﺍﻟﺘﺤﺫﻴﺭﺍﺕ ﺍﻟﺼﺤﻴﺔ ﻤﻌﺘﻤﺩﺓ ﻤﻥ ﺍﻟـﺴﻠﻁﺔ ﺍﻟﻭﻁﻨﻴـﺔ‬ ‫ﺍﻟﻤﺨﺘﺼﺔ؟‬ ‫ﻀﻤﺎﻥ ﺃﻥ ﺘﻜﻭﻥ ﺍﻟﺘﺤﺫﻴﺭﺍﺕ ﺍﻟﺼﺤﻴﺔ ﻤﺘﻐﺎﻴﺭﺓ؟‬ ‫ﻀﻤﺎﻥ ﺃﻥ ﺘﻜﻭﻥ ﺍﻟﺘﺤﺫﻴﺭﺍﺕ ﺍﻟﺼﺤﻴﺔ ﻜﺒﻴﺭﺓ ﻭﻭﺍﻀﺤﺔ ﻭﻅﺎﻫﺭﺓ ﻟﻠﻌﻴﺎﻥ‬ ‫ﻭﻤﻘﺭﻭﺀﺓ؟‬ ‫ﻀﻤﺎﻥ ﺃﻥ ﺘﻐﻁﻲ ﺍﻟﺘﺤﺫﻴﺭﺍﺕ ﺍﻟﺼﺤﻴﺔ ﻤﺎ ﻻ ﻴﻘل ﻋﻥ ‪ ٪٣٠‬ﻤﻥ ﻤﺴﺎﺤﺔ‬ ‫ﺍﻟﻌﺭﺽ ﺍﻟﺭﺌﻴﺴﻴﺔ؟‬ ‫ﻀﻤﺎﻥ ﺃﻥ ﺘﻐﻁﻲ ﺍﻟﺘﺤﺫﻴﺭﺍﺕ ﺍﻟﺼﺤﻴﺔ ‪ ٪٥٠‬ﺃﻭ ﺃﻜﺜـﺭ ﻤـﻥ ﻤـﺴﺎﺤﺔ‬ ‫ﺍﻟﻌﺭﺽ ﺍﻟﺭﺌﻴﺴﻴﺔ؟‬ ‫ﻀﻤﺎﻥ ﺃﻥ ﺘﺘﺨﺫ ﺍﻟﺘﺤﺫﻴﺭﺍﺕ ﺍﻟﺼﺤﻴﺔ ﺸﻜل ﺼـﻭﺭ ﺃﻭ ﻨﻘـﻭﺵ ﺃﻭ ﺃﻥ‬ ‫ﹰ؟‬ ‫ﺍ ﻭﻨﻘﻭﺸﺎ‬ ‫ﺘﺸﻤل ﺼﻭﺭﹰ‬ ‫ﺍﺸﺘﺭﺍﻁ ﺃﻥ ﻴﺘﻀﻤﻥ ﺃﻱ ﺸﻜل ﻤﻥ ﺃﺸﻜﺎل ﺍﻟﺘﻐﻠﻴﻑ ﻭﺍﻟﺘﻭﺴﻴﻡ ﻤﻌﻠﻭﻤـﺎﺕ‬ ‫ﻋﻥ ﻤﻜﻭﻨﺎﺕ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﺫﺍﺕ ﺍﻟﺼﻠﺔ ﻭﺍﻨﺒﻌﺎﺜﺎﺘﻬﺎ؟‬ ‫‪)١-١١‬ﺃ(‬ ‫‪)١-١١‬ﺏ(‬ ‫‪)١-١١‬ﺏ()‪(١‬‬ ‫‪)١-١١‬ﺏ()‪(٢‬‬ ‫‪)١-١١‬ﺏ()‪(٣‬‬ ‫ﺍﻟﻤﺎﺩﺓ‬

‫ﺘﻨﻅﻴﻡ ﻤﺤﺘﻭﻴﺎﺕ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ‬ ‫‪٩‬‬

‫‪)١-١١‬ﺏ()‪(٤‬‬ ‫‪)١-١١‬ﺏ()‪(٥‬‬ ‫‪٢-١١‬‬

‫‪‬ﺭﺠﻰ ﺘﻘﺩﻴﻡ ﻫﺫﻩ ﺍﻟﻭﺜﺎﺌﻕ ﺒﻭﺍﺤﺩﺓ ﻤﻥ ﺍﻟﻠﻐﺎﺕ ﺍﻟﺴﺕ ﺍﻟﺭﺴﻤﻴﺔ‪ ،‬ﺇﻥ ﺃﻤﻜﻥ‪ ،‬ﻤﻊ ﺍﻹﺸﺎﺭﺓ ﺒﺎﻟﺘﺤﺩﻴﺩ ﺇﻟﻰ ﻓﺭﻭﻉ ﺘـﺸﺭﻴﻌﻜﻡ ﺫﻱ‬ ‫‪ ١‬ﻴ‬ ‫ﺍﻟﺼﻠﺔ ﻓﻴﻤﺎ ﻴﺘﻌﻠﻕ ﺒﻜل ﺇﺠﺎﺒﺔ "ﺒﻨﻌﻡ"‪.‬‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪40‬‬

‫ﺍﺸﺘﺭﺍﻁ ﺃﻥ ﺘﻅﻬﺭ ﺍﻟﺘﺤﺫﻴﺭﺍﺕ ﻭﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﺍﻟﻜﺘﺎﺒﻴﺔ ﺍﻷﺨﺭﻯ ﻋﻠﻰ ﻜـل‬ ‫ﻋﺒﻭﺓ ﻭﻋﻠﻰ ﺃﻱ ﺸﻜل ﻤﻥ ﺃﺸﻜﺎل ﺍﻟﺘﻐﻠﻴﻑ ﻭﺍﻟﺘﻭﺴﻴﻡ ﺍﻟﺨﺎﺭﺠﻴﻴﻥ ﺒﻠﻐﺔ ﺃﻭ‬ ‫ﻟﻐﺎﺕ ﺒﻠﺩﻜﻡ ﺍﻟﺭﺌﻴﺴﻴﺔ؟‬ ‫ﻓﺭﺽ ﺤﻅﺭ ﺸﺎﻤل ﻋﻠﻰ ﺠﻤﻴﻊ ﺃﺸﻜﺎل ﺍﻹﻋﻼﻥ ﻋﻥ ﺍﻟﺘﺒﻎ ﻭﺍﻟﺘﺭﻭﻴﺞ ﻟﻪ‬ ‫ﻭﺭﻋﺎﻴﺘﻪ؟‬ ‫ﺒﻤﺎ ﻓﻲ ﺫﻟﻙ ﺃﻨﺸﻁﺔ ﺍﻹﻋﻼﻥ ﻭﺍﻟﺘﺭﻭﻴﺞ ﻭﺍﻟﺭﻋﺎﻴـﺔ ﺍﻟﻌـﺎﺒﺭﺓ ﻟﻠﺤـﺩﻭﺩ‬ ‫ﻭﺍﻟﻨﺎﺸﺌﺔ ﻤﻥ ﺩﺍﺨل ﺇﻗﻠﻴﻡ ﺒﻠﺩﻜﻡ؟‬ ‫ﻓﺭﺽ ﻗﻴﻭﺩ ﻋﻠﻰ ﺠﻤﻴﻊ ﺃﻨﺸﻁﺔ ﺍﻹﻋﻼﻥ ﻋﻥ ﺍﻟﺘﺒـﻎ ﻭﺍﻟﺘـﺭﻭﻴﺞ ﻟـﻪ‬ ‫ﻭﺭﻋﺎﻴﺘﻪ‪ ،‬ﺤﺎل ﻋﺩﻡ ﻭﺠﻭﺩ ﺤﻅﺭ ﺸﺎﻤل؟‬ ‫ﻓﺭﺽ ﻗﻴﻭﺩ ﺃﻭ ﻓﺭﺽ ﺤﻅﺭ ﺸﺎﻤل ﻋﻠﻰ ﺃﻨﺸﻁﺔ ﺍﻹﻋـﻼﻥ ﻭﺍﻟﺘـﺭﻭﻴﺞ‬ ‫ﻭﺍﻟﺭﻋﺎﻴﺔ ﺍﻟﻌﺎﺒﺭﺓ ﻟﻠﺤﺩﻭﺩ ﻭﺍﻟﻨﺎﺸﺌﺔ ﻤﻥ ﺩﺍﺨل ﺇﻗﻠﻴﻡ ﺒﻠﺩﻜﻡ؟‬ ‫ﺤﻅﺭ ﺠﻤﻴﻊ ﺃﺸﻜﺎل ﺍﻹﻋﻼﻥ ﻋﻥ ﺍﻟﺘﺒﻎ ﻭﺍﻟﺘﺭﻭﻴﺞ ﻟﻪ ﻭﺭﻋﺎﻴﺘـﻪ ﺍﻟﺘـﻲ‬ ‫‪‬ﺝ ﻟﻤﻨﺘﺞ ﻤﻥ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﺒﺄﻱ ﻭﺴﻴﻠﺔ ﻜﺎﺫﺒﺔ ﺃﻭ ﺨﺎﺩﻋﺔ ﺃﻭ ﻤﻀﻠﻠﺔ‬ ‫ﺘﺭﻭ‬ ‫ﺎ؟‬ ‫ﺎ ﺨﺎﻁﺌﹰ‬ ‫ﹸﻌﻁﻲ ﺍﻨﻁﺒﺎﻋﹰ‬ ‫ﺃﻭ ﻗﺩ ﺘ‬ ‫ﺍﻟﻤﻁﺎﻟﺒﺔ ﺒﺄﻥ ﺘﺼﺤﺏ ﺘﺤﺫﻴﺭﺍﺕ ﺼﺤﻴﺔ ﺃﻭ ﺘﺤﺫﻴﺭﺍﺕ ﺃﻭ ﺭﺴﺎﺌل ﺃﺨﺭﻯ‬ ‫ﻤﻼﺌﻤﺔ ﻜل ﺃﻨﺸﻁﺔ ﺍﻹﻋﻼﻥ ﻋﻥ ﺍﻟﺘﺒﻎ ﻭﺍﻟﺘﺭﻭﻴﺞ ﻟﻪ ﻭﺭﻋﺎﻴﺘﻪ؟‬ ‫ﺘﻘﻴﻴﺩ ﺍﺴﺘﺨﺩﺍﻡ ﺍﻟﺤﻭﺍﻓﺯ ﺍﻟﻤﺒﺎﺸﺭﺓ ﺃﻭ ﻏﻴﺭ ﺍﻟﻤﺒﺎﺸﺭﺓ ﺍﻟﺘﻲ ﺘﺸﺠﻊ ﻋﺎﻤـﺔ‬ ‫ﺍﻟﻨﺎﺱ ﻋﻠﻰ ﺸﺭﺍﺀ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ؟‬ ‫ﻤﻁﺎﻟﺒﺔ ﺩﻭﺍﺌﺭ ﺼﻨﺎﻋﺔ ﺍﻟﺘﺒﻎ ﺒﺎﻟﻜﺸﻑ ﻟﻠﺴﻠﻁﺎﺕ ﺍﻟﺤﻜﻭﻤﻴﺔ ﺍﻟﻤﻌﻨﻴﺔ ﻋﻤـﺎ‬ ‫ﺘﻨﻔﻘﻪ ﻫﺫﻩ ﺍﻟﺩﻭﺍﺌﺭ ﻋﻠﻰ ﺍﻷﻨﺸﻁﺔ ﺍﻟﺘﻲ ﻟﻡ ﺘﺤﻅـﺭ ﺒﻌـﺩ ﻓﻴﻤـﺎ ﻴﺘﻌﻠـﻕ‬ ‫ﺒﺎﻹﻋﻼﻥ ﻭﺍﻟﺘﺭﻭﻴﺞ ﻭﺍﻟﺭﻋﺎﻴﺔ؟‬ ‫ﻓﺭﺽ ﻗﻴﻭﺩ ﻋﻠﻰ ﺍﻹﻋﻼﻥ ﻭﺍﻟﺘﺭﻭﻴﺞ ﻭﺍﻟﺭﻋﺎﻴﺔ ﻓﻲ ﺍﻹﺫﺍﻋﺔ ﻭﺍﻟﺘﻠﻔﺯﻴﻭﻥ‬ ‫ﻭﻭﺴﺎﺌل ﺍﻹﻋﻼﻡ ﺍﻟﻤﻁﺒﻭﻋﺔ ﻭﻭﺴﺎﺌل ﺍﻹﻋﻼﻡ ﺍﻷﺨﺭﻯ ﻤﺜل ﺍﻹﻨﺘﺭﻨﺕ؟‬ ‫ﻓﺭﺽ ﺤﻅﺭ ﺃﻭ ﻗﻴﻭﺩ ﻋﻠﻰ ﺭﻋﺎﻴﺔ ﺸﺭﻜﺎﺕ ﺍﻟﺘﺒﻎ ﻟﻸﺤﺩﺍﺙ ﻭﺍﻷﻨـﺸﻁﺔ‬ ‫ﺍﻟﺩﻭﻟﻴﺔ ﻭ‪ /‬ﺃﻭ ﻟﻠﻤﺸﺘﺭﻜﻴﻥ ﻓﻴﻬﺎ؟‬

‫‪٣-١١‬‬

‫ﺍﻹﻋﻼﻥ ﻋﻥ ﺍﻟﺘﺒﻎ ﻭﺍﻟﺘﺭﻭﻴﺞ ﻟﻪ ﻭﺭﻋﺎﻴﺘﻪ‬ ‫‪٢-١٣‬‬

‫‪٣-١٣‬‬

‫‪)٤-١٣‬ﺃ(‬

‫‪)٤-١٣‬ﺏ(‬ ‫‪)٤-١٣‬ﺝ(‬ ‫‪)٤-١٣‬ﺩ(‬

‫‪)٤-١٣‬ﻫ(‬ ‫‪)٤-١٣‬ﻭ(‬

‫ﺇﺫﺍ ﻜﺎﻨﺕ ﻟﺩﻴﻜﻡ ﺃﻴﺔ ﺘﺸﺭﻴﻌﺎﺕ ﺃﻭ ﺘﺩﺍﺒﻴﺭ ﺃﺨﺭﻯ ﻻ ﻴﺸﻤﻠﻬﺎ ﺍﻟﺴﺅﺍل ﺍﻟﺨﺎﻤﺱ‪ ،‬ﻓﺒﺈﻤﻜﺎﻨﻜﻡ ﺇﻴﺭﺍﺩ ﺘﻔﺎﺼﻴل ﺃﺨﺭﻯ ﻫﻨﺎ‪:‬‬

‫‪41‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺍﻟﺒﺭﺍﻤﺞ ﻭﺍﻟﺨﻁﻁ‬ ‫ﺍﻷﺴﺌﻠﺔ ﺍﻷﺴﺎﺴﻴﺔ‬ ‫)‪(١‬‬

‫‪-٦‬‬

‫ﻴﻨﺒﻐﻲ ﻤﻼﺤﻅﺔ ﺃﻥ ﺍﻟﺘﺩﺍﺒﻴﺭ ﺍﻟﻤﺤﺩﺩﺓ ﺃﺩﻨﺎﻩ ﻟﻴﺴﺕ ﺸﺎﻤﻠﺔ ﻭﺇﻨﻤﺎ ﺘﻌﺒﺭ ﻋﻥ ﺭﻭﺡ ﻭﻤﻘﺼﺩ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ‪.‬‬ ‫ﻻ‬ ‫ﻨﻌﻡ )ﺍﻟﺭﺠﺎﺀ‬ ‫ﺇﺭﻓﺎﻕ ﺍﻟﻭﺜﺎﺌﻕ‬ ‫ﺫﺍﺕ ﺍﻟﺼﻠﺔ(‪١‬‬ ‫ﻫل ﻗﻤﺘﻡ ﺒﺈﻋﺩﺍﺩ ﻭﺘﻨﻔﻴﺫ ﺍﺴﺘﺭﺍﺘﻴﺠﻴﺎﺕ ﻭﺨﻁﻁ ﻭﺒﺭﺍﻤﺞ ﻭﻁﻨﻴﺔ ﺸﺎﻤﻠﺔ ﻤﺘﻌﺩﺩﺓ ﺍﻟﻘﻁﺎﻋﺎﺕ‬ ‫ﻟﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ؟ )ﺍﻟﻤﺎﺩﺓ ‪(١-٥‬‬ ‫ﺇﺫﺍ ﻜﺎﻨﺕ ﺍﻹﺠﺎﺒﺔ ﻻ‪ ،‬ﻓﻬل ﺘﻡ ﺇﻋﺩﺍﺩ ﻭﺘﻨﻔﻴﺫ ﺍﺴﺘﺭﺍﺘﻴﺠﻴﺎﺕ ﻭﺨﻁﻁ ﻭﺒـﺭﺍﻤﺞ ﺠﺯﺌﻴـﺔ؟‬ ‫)ﺍﻟﻤﺎﺩﺓ ‪(١-٥‬‬ ‫ﻱ ﻤﻥ ﺍﻟﺴﺅﺍﻟﻴﻥ ﺍﻷﻭﻟﻴﻥ ﺒﺎﻹﻴﺠﺎﺏ‪ ،‬ﻓﻤﺎ ﻫﻲ ﺍﻟﻤﺴﺎﺌل ﻤﻥ ﻀﻤﻥ ﺍﻟﺒﻨﻭﺩ ﺍﻟﺘﺎﻟﻴﺔ ﺍﻟﺘـﻲ ﺘـﺘﻡ‬ ‫ﺇﺫﺍ ﻜﺎﻨﺕ ﺇﺠﺎﺒﺘﻜﻡ ﻋﻠﻰ ﺃ ﱟ‬ ‫‪‬ﺭﺠـﻰ ﺘﻘـﺩﻴﻡ‬ ‫‪‬ﺭﺠﻰ ﻭﻀﻊ ﺍﻟﻌﻼﻤﺎﺕ‪ ،‬ﻭﻤﻠﺨﺹ ﻭﺠﻴﺯ‪) .‬ﻴ‬ ‫ﺘﻐﻁﻴﺘﻬﺎ ﻓﻲ ﻫﺫﻩ ﺍﻻﺴﺘﺭﺍﺘﻴﺠﻴﺎﺕ ﻭﺍﻟﺨﻁﻁ ﻭﺍﻟﺒﺭﺍﻤﺞ؟ ﻴ‬ ‫ﺍﻟﻤﻠﺨﺹ ﺒﺈﺤﺩﻯ ﺍﻟﻠﻐﺎﺕ ﺍﻟﺭﺴﻤﻴﺔ ﺍﻟﺴﺕ(‪.‬‬ ‫ﺍﻻﻟﺘﺯﺍﻤﺎﺕ ﺍﻟﻌﺎﻤﺔ‬ ‫ﺇﻗﺎﻤﺔ ﺁﻟﻴﺔ ﺘﻨﺴﻴﻕ ﻭﻁﻨﻴﺔ ﺃﻭ ﻤﺭﻜﺯ )ﻤﺭﺍﻜﺯ( ﺍﺘﺼﺎل ﻟﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ؟‬ ‫ﺤﻤﺎﻴﺔ ﺍﻟﺴﻴﺎﺴﺎﺕ ﻤﻥ ﺍﻟﻤﺼﺎﻟﺢ ﺍﻟﺘﺠﺎﺭﻴﺔ ﻭﺃﻴﺔ ﻤﺼﺎﻟﺢ ﺭﺍﺴﺨﺔ ﺃﺨﺭﻯ ﻟﺩﻭﺍﺌﺭ ﺼﻨﺎﻋﺔ ﺍﻟﺘﺒﻎ؟‬ ‫ﺘﻭﺴﻴﻊ ﻨﻁﺎﻕ ﺍﻻﺴﺘﻔﺎﺩﺓ ﻤﻥ ﺒﺭﺍﻤﺞ ﻓﻌﺎﻟﺔ ﻭﺸﺎﻤﻠﺔ ﻟﻠﺘﺜﻘﻴﻑ ﻭﻟﺘﻭﻋﻴﺔ ﺍﻟﺠﻤﻬـﻭﺭ ﺒـﺸﺄﻥ ﺍﻟﻤﺨـﺎﻁﺭ‬ ‫ﺍﻟﺼﺤﻴﺔ؟‬ ‫‪ ...‬ﺘﺴﺘﻬﺩﻑ ﺍﻟﻜﺒﺎﺭ ﻭ‪ /‬ﺃﻭ ﻋﺎﻤﺔ ﺍﻟﺠﻤﻬﻭﺭ؟‬ ‫‪ ...‬ﺘﺴﺘﻬﺩﻑ ﺍﻷﻁﻔﺎل ﻭﺍﻟﺸﺒﺎﺏ؟‬ ‫ﺘﻭﻋﻴﺔ ﺍﻟﺠﻤﻬﻭﺭ ﺒﺸﺄﻥ ﺍﻟﻤﺨﺎﻁﺭ ﺍﻟﺼﺤﻴﺔ ﺍﻟﻤﺤﺘﻤﻠﺔ ﺍﻟﻤﺘﺭﺘﺒﺔ ﻋﻠﻰ ﺍﺴـﺘﻬﻼﻙ ﺍﻟﺘﺒـﻎ ﻭﺍﻟﺘﻌـﺭﺽ‬ ‫ﻟﺩﺨﺎﻨﻪ‪ ،‬ﻭﺒﺸﺄﻥ ﻓﻭﺍﺌﺩ ﺍﻹﻗﻼﻉ ﻋﻥ ﺘﻌﺎﻁﻲ ﺍﻟﺘﺒﻎ ﻭﺃﻨﻤﺎﻁ ﺍﻟﺤﻴﺎﺓ ﺍﻟﻤﺘﺤﺭﺭﺓ ﻤﻥ ﺍﻟﺘﺒﻎ؟‬ ‫ﺤﺼﻭل ﻋﺎﻤﺔ ﺍﻟﻨﺎﺱ ﻋﻠﻰ ﻤﺠﻤﻭﻋﺔ ﻭﺍﺴﻌﺔ ﻤﻥ ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﻋﻥ ﺩﻭﺍﺌﺭ ﺼﻨﺎﻋﺔ ﺍﻟﺘﺒﻎ؟‬ ‫ﺘﻭﻋﻴﺔ ﻭﻤﺸﺎﺭﻜﺔ ﺍﻟﻬﻴﺌﺎﺕ ﺍﻟﻌﺎﻤﺔ ﻭﺍﻟﺨﺎﺼﺔ ﻭﺍﻟﻤﻨﻅﻤﺎﺕ ﻏﻴﺭ ﺍﻟﺤﻜﻭﻤﻴﺔ ﻏﻴـﺭ ﺍﻟﻤﻨﺘـﺴﺒﺔ ﻟـﺩﻭﺍﺌﺭ‬ ‫ﺼﻨﺎﻋﺔ ﺍﻟﺘﺒﻎ ﻓﻲ ﻭﻀﻊ ﻭﺘﻨﻔﻴﺫ ﺒﺭﺍﻤﺞ ﻭﺍﺴﺘﺭﺍﺘﻴﺠﻴﺎﺕ ﻤﺸﺘﺭﻜﺔ ﺒﻴﻥ ﺍﻟﻘﻁﺎﻋﺎﺕ ﻤﻥ ﺃﺠل ﻤﻜﺎﻓﺤـﺔ‬ ‫ﺍﻟﺘﺒﻎ؟‬ ‫‪)١٢‬ﺏ(‬ ‫‪)١٢‬ﺝ(‬ ‫‪)١٢‬ﻫ(‬ ‫‪)٢-٥‬ﺃ(‬ ‫‪٣-٥‬‬ ‫‪)١٢‬ﺃ(‬

‫ﺍﻟﺘﺜﻘﻴﻑ ﻭﺍﻻﺘﺼﺎل ﻭﺍﻟﺘﺩﺭﻴﺏ ﻭﺘﻭﻋﻴﺔ ﺍﻟﺠﻤﻬﻭﺭ‬

‫‪‬ﺭﺠﻰ ﺘﻘﺩﻴﻡ ﻫﺫﻩ ﺍﻟﻭﺜﺎﺌﻕ ﺒﺈﺤﺩﻯ ﺍﻟﻠﻐﺎﺕ ﺍﻟﺴﺕ ﺍﻟﺭﺴﻤﻴﺔ‪ ،‬ﺇﻥ ﺃﻤﻜﻥ‪.‬‬ ‫‪ ١‬ﻴ‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪42‬‬

‫ﺍﻟﺘﺩﺍﺒﻴﺭ ﺍﻟﺭﺍﻤﻴﺔ ﺇﻟﻰ ﺍﻟﺤﺩ ﻤﻥ ﺍﻟﻁﻠﺏ ﻓﻴﻤﺎ ﻴﺘﻌﻠﻕ ﺒﺎﻻﻋﺘﻤﺎﺩ ﻋﻠﻰ ﺍﻟﺘﺒﻎ ﻭﺍﻹﻗﻼﻉ ﻋﻨﻪ‬ ‫ﻤﺒﺎﺩﺉ ﺘﻭﺠﻴﻬﻴﺔ ﺸﺎﻤﻠﺔ ﻭﻤﺘﻜﺎﻤﻠﺔ‪ ،‬ﻗﺎﺌﻤﺔ ﻋﻠﻰ ﺍﻟﻘﺭﺍﺌﻥ ﺍﻟﻌﻠﻤﻴﺔ ﻭﺃﻓﻀل ﺍﻟﻤﻤﺎﺭﺴﺎﺕ‪ ،‬ﻟﺘﻌﺯﻴﺯ ﺍﻹﻗﻼﻉ‬ ‫ﻋﻥ ﺘﻌﺎﻁﻲ ﺍﻟﺘﺒﻎ ﻭﺍﻟﻌﻼﺝ ﺍﻟﻤﻼﺌﻡ ﻟﻼﻋﺘﻤﺎﺩ ﻋﻠﻰ ﺍﻟﺘﺒﻎ؟‬ ‫ﺘﻴﺴﻴﺭ ﺍﻟﺤﺼﻭل ﺒﺘﻜﻠﻔﺔ ﻤﻴﺴﻭﺭﺓ ﻋﻠﻰ ﺍﻟﻌﻼﺝ ﻤﻥ ﺍﻻﻋﺘﻤﺎﺩ ﻋﻠﻰ ﺍﻟﺘﺒﻎ‪ ،‬ﺒﻤﺎ ﻓﻲ ﺫﻟﻙ ﺍﻟﻤﺴﺘﺤﻀﺭﺍﺕ‬ ‫ﺍﻟﺼﻴﺩﻻﻨﻴﺔ؟‬ ‫ﺘﻌﺯﻴﺯ ﺍﻟﺒﺩﺍﺌل ﺫﺍﺕ ﺍﻟﺠﺩﻭﻯ ﺍﻻﻗﺘﺼﺎﺩﻴﺔ ﻟﻠﻌﺎﻤﻠﻴﻥ ﻓﻲ ﺼﻨﺎﻋﺔ ﺍﻟﺘﺒﻎ ﻭﺯﺍﺭﻋﻴﻪ ﻭﺁﺤﺎﺩ ﺒﺎﺌﻌﻴﻪ‪ ،‬ﺤﺴﺏ‬ ‫ﺍﻟﺤﺎﻟﺔ؟‬ ‫ﺇﺠﺭﺍﺀ ﺍﻟﺒﺤﻭﺙ ﺍﻟﺘﻲ ﺘﺘﻨﺎﻭل ﺍﻟﻌﻭﺍﻤل ﺍﻟﺤﺎﺴﻤﺔ ﻓﻲ ﺍﺴﺘﻬﻼﻙ ﺍﻟﺘﺒﻎ ﻭﺍﻟﺘﻌﺭﺽ ﻟﺩﺨﺎﻨﻪ ﻭﻋﻭﺍﻗﺒﻬﻤـﺎ‪،‬‬ ‫ﻭﺍﻟﺒﺤﻭﺙ ﺍﻟﺘﻲ ﺘﺴﺘﻬﺩﻑ ﺘﺤﺩﻴﺩ ﺍﻟﻤﺤﺎﺼﻴل ﺍﻟﺒﺩﻴﻠﺔ ﻟﻠﺘﺒﻎ؟‬ ‫ﱠﺜﺔ ﻤﺴﺘﻘﺎﺓ ﻤﻥ ﺒﺭﺍﻤﺞ ﺍﻟﻤﺭﺍﻗﺒﺔ ﺍﻟﻭﻁﻨﻴﺔ؟‬ ‫ﻗﺎﻋﺩﺓ ﺒﻴﺎﻨﺎﺕ ﻤﺤﺩ‬ ‫‪١-١٤‬‬ ‫‪)٢-١٤‬ﺩ(‬

‫ﺘﻘﺩﻴﻡ ﺍﻟﺩﻋﻡ ﻟﻸﻨﺸﻁﺔ ﺍﻟﺒﺩﻴﻠﺔ ﺫﺍﺕ ﺍﻟﺠﺩﻭﻯ ﺍﻻﻗﺘﺼﺎﺩﻴﺔ‬ ‫‪١٧‬‬

‫ﺍﻟﺒﺤﻭﺙ ﻭﺍﻟﻤﺭﺍﻗﺒﺔ ﻭﺘﺒﺎﺩل ﺍﻟﻤﻌﻠﻭﻤﺎﺕ‬ ‫‪)١-٢٠‬ﺃ(‬ ‫‪)٤-٢٠‬ﺏ(‬

‫ﺃﺴﺌﻠﺔ ﺍﺨﺘﻴﺎﺭﻴﺔ‬

‫)‪(٢‬‬

‫ﺍﻟﺘﺜﻘﻴﻑ ﻭﺍﻻﺘﺼﺎل ﻭﺍﻟﺘﺩﺭﻴﺏ ﻭﺘﻭﻋﻴﺔ ﺍﻟﺠﻤﻬﻭﺭ‬ ‫ﻭﻀﻊ ﺒﺭﺍﻤﺞ ﻤﻼﺌﻤﺔ ﻟﻠﺘﺩﺭﻴﺏ ﺃﻭ ﺍﻟﺘﺜﻘﻴﻑ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪ ،‬ﺘﻜﻭﻥ ﻤﻭﺠﻬـﺔ ﻷﺸـﺨﺎﺹ ﻤﺜـل‬ ‫ﺍﻟﻌﺎﻤﻠﻴﻥ ﺍﻟﺼﺤﻴﻴﻥ‪ ،‬ﻭﺍﻟﻌﺎﻤﻠﻴﻥ ﻓﻲ ﺍﻟﻤﺠﺘﻤﻌﺎﺕ ﺍﻟﻤﺤﻠﻴﺔ‪ ،‬ﻭﺍﻟﻤﺭﺸﺩﻴﻥ ﺍﻻﺠﺘﻤﺎﻋﻴﻴﻥ‪ ،‬ﻭﺍﻟﻌﺎﻤﻠﻴﻥ ﻓـﻲ‬ ‫ﺍﻟﻤﺠﺎل ﺍﻹﻋﻼﻤﻲ‪ ،‬ﻭﺍﻟﻤﺭﺒﻴﻥ‪ ،‬ﻭﺼﻨﺎﻉ ﺍﻟﻘﺭﺍﺭ‪ ،‬ﻭﺍﻹﺩﺍﺭﻴﻴﻥ‪ ،‬ﻭﺴﺎﺌﺭ ﺍﻷﺸﺨﺎﺹ ﺍﻟﻤﻌﻨﻴﻴﻥ؟‬ ‫ﺘﻭﻋﻴﺔ ﻋﺎﻤﺔ ﺍﻟﻨﺎﺱ ﻭﺤﺼﻭﻟﻬﻡ ﻋﻠﻰ ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﺎﻟﻌﻭﺍﻗﺏ ﺍﻟﺼﺤﻴﺔ ﻭﺍﻻﻗﺘﺼﺎﺩﻴﺔ ﻭﺍﻟﺒﻴﺌﻴﺔ‬ ‫ﺍﻟﻀﺎﺭﺓ ﺍﻟﻤﺘﺭﺘﺒﺔ ﻋﻠﻰ ﺇﻨﺘﺎﺝ ﺍﻟﺘﺒﻎ ﻭﺍﺴﺘﻬﻼﻜﻪ؟‬ ‫ﺘﺼﻤﻴﻡ ﻭﺘﻨﻔﻴﺫ ﺒﺭﺍﻤﺞ ﺒﻬﺩﻑ ﺍﻟﺘﺸﺠﻴﻊ ﻋﻠﻰ ﺍﻹﻗﻼﻉ ﻋﻥ ﺘﻌﺎﻁﻲ ﺍﻟﺘﺒﻎ‪ ،‬ﻓﻲ ﺃﻤﺎﻜﻥ ﻤﺜل ﺍﻟﻤﺅﺴﺴﺎﺕ‬ ‫ﺍﻟﺘﻌﻠﻴﻤﻴﺔ ﻭﻤﺭﺍﻓﻕ ﺍﻟﺭﻋﺎﻴﺔ ﺍﻟﺼﺤﻴﺔ ﻭﺃﻤﺎﻜﻥ ﺍﻟﻌﻤل ﻭﺃﻭﺴﺎﻁ ﻤﻤﺎﺭﺴﺔ ﺍﻟﺭﻴﺎﻀﺔ؟‬ ‫ﺩﻤﺞ ﺘﺸﺨﻴﺹ ﻭﻋﻼﺝ ﺍﻻﻋﺘﻤﺎﺩ ﻋﻠﻰ ﺍﻟﺘﺒﻎ ﻭﺨﺩﻤﺎﺕ ﺇﺴﺩﺍﺀ ﺍﻟﻤﺸﻭﺭﺓ ﺒﺸﺄﻥ ﺍﻹﻗﻼﻉ ﻋﻥ ﺍﻟﺘﺒﻎ ﻓـﻲ‬ ‫ﺍﻟﺒﺭﺍﻤﺞ ﺍﻟﻭﻁﻨﻴﺔ ﺍﻟﺼﺤﻴﺔ ﻭﺍﻟﺘﻌﻠﻴﻤﻴﺔ‪ ،‬ﻭﺍﻟﺨﻁﻁ ﻭﺍﻻﺴﺘﺭﺍﺘﻴﺠﻴﺎﺕ ﺍﻟﻭﻁﻨﻴـﺔ‪ ،‬ﺒﻤـﺸﺎﺭﻜﺔ ﺍﻟﻌـﺎﻤﻠﻴﻥ‬ ‫ﺍﻟﺼﺤﻴﻴﻥ ﻭﺍﻟﻌﺎﻤﻠﻴﻥ ﻓﻲ ﺍﻟﻤﺠﺘﻤﻌﺎﺕ ﺍﻟﻤﺤﻠﻴﺔ ﻭﺍﻟﻤﺭﺸﺩﻴﻥ ﺍﻻﺠﺘﻤﺎﻋﻴﻴﻥ‬ ‫ﺇﻗﺎﻤﺔ ﺒﺭﺍﻤﺞ‪ ،‬ﻀﻤﻥ ﻤﺭﺍﻓﻕ ﺍﻟﺭﻋﺎﻴﺔ ﺍﻟﺼﺤﻴﺔ ﻭﻤﺭﺍﻜﺯ ﺍﻟﺘﺄﻫﻴل ﺍﻟـﺼﺤﻲ‪ ،‬ﻟﻠﺘـﺸﺨﻴﺹ ﻭﺇﺴـﺩﺍﺀ‬ ‫ﺍﻟﻤﺸﻭﺭﺓ ﻭﺍﻟﻭﻗﺎﻴﺔ ﻤﻥ ﺍﻻﻋﺘﻤﺎﺩ ﻋﻠﻰ ﺍﻟﺘﺒﻎ ﻭﻋﻼﺠﻪ‬ ‫ﺍﻻﻫﺘﻤﺎﻡ ﺍﻟﻭﺍﺠﺏ ﺒﺤﻤﺎﻴﺔ ﺍﻟﺒﻴﺌﺔ ﻭﺼﺤﺔ ﺍﻷﻓﺭﺍﺩ‪ ،‬ﻓﻴﻤﺎ ﻴﺨﺹ ﺍﻟﺒﻴﺌﺔ ﺒﺸﺄﻥ ﺯﺭﺍﻋﺔ ﺍﻟﺘﺒـﻎ ﻭﺼـﻨﻌﻪ‬ ‫ﺩﺍﺨل ﺃﺭﺍﻀﻲ ﺒﻠﺩﻜﻡ؟‬ ‫‪)١٢‬ﺩ(‬

‫‪)١٢‬ﻭ(‬

‫ﺍﻟﺘﺩﺍﺒﻴﺭ ﺍﻟﺭﺍﻤﻴﺔ ﺇﻟﻰ ﺍﻟﺤﺩ ﻤﻥ ﺍﻟﻁﻠﺏ ﻓﻴﻤﺎ ﻴﺘﻌﻠﻕ ﺒﺎﻻﻋﺘﻤﺎﺩ ﻋﻠﻰ ﺍﻟﺘﺒﻎ ﻭﺍﻹﻗﻼﻉ ﻋﻨﻪ‬ ‫‪)٢-١٤‬ﺃ(‬ ‫‪)٢-١٤‬ﺏ(‬

‫‪)٢-١٤‬ﺝ(‬

‫ﺤﻤﺎﻴﺔ ﺍﻟﺒﻴﺌﺔ ﻭﺼﺤﺔ ﺍﻷﻓﺭﺍﺩ‬ ‫‪١٨‬‬

‫‪43‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺍﻟﺒﺤﻭﺙ ﻭﺍﻟﻤﺭﺍﻗﺒﺔ ﻭﺘﺒﺎﺩل ﺍﻟﻤﻌﻠﻭﻤﺎﺕ‬ ‫ﺘﻭﻓﻴﺭ ﺍﻟﺘﺩﺭﻴﺏ ﻭﺍﻟﺩﻋﻡ ﺍﻟﻤﻭﺠﻪ ﻟﺠﻤﻴﻊ ﺍﻟﻌﺎﻤﻠﻴﻥ ﻓﻲ ﺃﻨﺸﻁﺔ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪ ،‬ﺒﻤﺎ ﻓﻲ ﺫﻟﻙ ﺍﻟﺒﺤـﺙ‬ ‫ﻭﺍﻟﺘﻁﺒﻴﻕ ﻭﺍﻟﺘﻘﻴﻴﻡ؟‬ ‫ﺒﺭﺍﻤﺞ ﻤﻥ ﺃﺠل ﻤﺭﺍﻗﺒﺔ ﻤﺩﻯ ﺍﺴﺘﻬﻼﻙ ﺍﻟﺘﺒﻎ ﻭﺍﻟﺘﻌﺭﺽ ﻟﺩﺨﺎﻨﻪ ﻭﺃﻨﻤﺎﻁﻪ ﻭﺍﻟﻌﻭﺍﻤل ﺍﻟﺤﺎﺴﻤﺔ ﻓﻴﻪ‬ ‫ﻭﻋﻭﺍﻗﺒﻪ‪ ،‬ﻋﻠﻰ ﺍﻟﻤﺴﺘﻭﻴﺎﺕ ﺍﻟﻭﻁﻨﻴﺔ ﻭﺍﻹﻗﻠﻴﻤﻴﺔ ﻭﺍﻟﻌﺎﻟﻤﻴﺔ؟‬ ‫ﺇﻗﺎﻤﺔ ﻨﻅﺎﻡ ﻭﻁﻨﻲ ﺨﺎﺹ ﺒﺎﻟﻤﺭﺍﻗﺒﺔ ﺍﻟﻭﺒﺎﺌﻴﺔ ﻻﺴﺘﻬﻼﻙ ﺍﻟﺘﺒﻎ ﻭﺍﻟﻤﺅﺸﺭﺍﺕ ﺍﻻﺠﺘﻤﺎﻋﻴﺔ ﻭﺍﻻﻗﺘﺼﺎﺩﻴﺔ‬ ‫ﻭﺍﻟﺼﺤﻴﺔ ﺫﺍﺕ ﺍﻟﺼﻠﺔ؟‬ ‫ﹰ‪،‬‬ ‫ﺘﺒﺎﺩل ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﺍﻟﻌﻠﻤﻴﺔ ﻭﺍﻟﺘﻘﻨﻴﺔ ﻭﺍﻻﺠﺘﻤﺎﻋﻴﺔ ﻭﺍﻻﻗﺘﺼﺎﺩﻴﺔ ﻭﺍﻟﺘﺠﺎﺭﻴﺔ ﻭﺍﻟﻘﺎﻨﻭﻨﻴﺔ ﺍﻟﻤﺘﺎﺤﺔ ﻋﻤﻭﻤﺎ‬ ‫ﻋﻼﻭﺓ ﻋﻠﻰ ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﺍﻟﻤﺘﺼﻠﺔ ﺒﻤﻤﺎﺭﺴﺎﺕ ﺼﻨﺎﻋﺔ ﺍﻟﺘﺒﻎ ﻭﺯﺭﺍﻋﺘﻪ؟‬ ‫ﱠﺜﺔ ﺘﻀﻡ ﺍﻟﻘﻭﺍﻨﻴﻥ ﻭﺍﻟﻠﻭﺍﺌﺢ ﺍﻟﺨﺎﺼﺔ ﺒﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪ ،‬ﻭﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﺍﻟﺨﺎﺼﺔ‬ ‫ﺇﻋﺩﺍﺩ ﻗﺎﻋﺩﺓ ﺒﻴﺎﻨﺎﺕ ﻤﺤﺩ‬ ‫ﺒﺈﻨﻔﺎﺫﻫﺎ‪ ،‬ﺒﺎﻹﻀﺎﻓﺔ ﺇﻟﻰ ﺍﻟﻭﻻﻴﺔ ﺍﻟﻘﻀﺎﺌﻴﺔ ﺍﻟﻭﺜﻴﻘﺔ ﺍﻟﺼﻠﺔ ﺒﺎﻟﻤﻭﻀﻭﻉ؟‬ ‫‪)١-٢٠‬ﺏ(‬ ‫‪٢-٢٠‬‬ ‫‪)٣-٢٠‬ﺃ(‬ ‫‪٤-٢٠‬‬ ‫‪)٤-٢٠‬ﺃ(‬

‫ﺍﻟﻤﺴﺎﻋﺩﺓ ﺍﻟﺘﻘﻨﻴﺔ ﻭﺍﻟﻤﺎﻟﻴﺔ‬

‫‪-٧‬‬

‫ﺍﻟﻬﺩﻑ ﻤﻥ ﻫﺫﺍ ﺍﻟﻔﺭﻉ ﻫﻭ ﻤﺴﺎﻋﺩﺓ ﺍﻷﻤﺎﻨﺔ ﻋﻠﻰ ﺘﻴﺴﻴﺭ ﻋﻤﻠﻴﺔ ﺍﻟﺘﻨﺴﻴﻕ ﺒﻴﻥ ﺍﻟﻤﻬﺎﺭﺍﺕ ﻭﺍﻟﻤﻭﺍﺭﺩ ﺍﻟﻤﺘﺎﺤـﺔ‪ ،‬ﻭﺒـﻴﻥ‬ ‫ﺍﻻﺤﺘﻴﺎﺠﺎﺕ ﺍﻟﻤﺤﺩﺩﺓ‪.‬‬ ‫ﻼ ﺒﺎﻟﻤﺎﺩﺓ ‪)١-٢١‬ﺝ(‪ ،‬ﻫل ﻗﺩﻤﺘﻡ ﺃﻭ ﺘﻠﻘﻴﺘﻡ ﻤﺴﺎﻋﺩﺓ ﻤﺎﻟﻴﺔ ﺃﻭ ﺘﻘﻨﻴﺔ )ﻤﻥ ﺨﻼل ﻗﻨﻭﺍﺕ ﺃﺤﺎﺩﻴـﺔ‪ ،‬ﺃﻭ ﺜﻨﺎﺌﻴـﺔ‪ ،‬ﺃﻭ‬ ‫ﻋﻤ ﹰ‬ ‫ﺇﻗﻠﻴﻤﻴﺔ‪ ،‬ﺃﻭ ﺩﻭﻥ ﺇﻗﻠﻴﻤﻴﺔ‪ ،‬ﺃﻭ ﻗﻨﻭﺍﺕ ﺃﺨﺭﻯ ﻤﺘﻌﺩﺩﺓ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﺒﻤﺎ ﻓﻲ ﺫﻟﻙ ﺍﻟﻤﻨﻅﻤﺎﺕ ﺍﻟﺤﻜﻭﻤﻴﺔ ﺍﻟﺩﻭﻟﻴﺔ ﺍﻹﻗﻠﻴﻤﻴـﺔ‬ ‫ﻭﺍﻟﺩﻭﻟﻴﺔ ﻭﺍﻟﻤﺅﺴﺴﺎﺕ ﺍﻟﻤﺎﻟﻴﺔ ﻭﺍﻹﻨﻤﺎﺌﻴﺔ ﺫﺍﺕ ﺍﻟﺼﻠﺔ( ﻹﻋﺩﺍﺩ ﻭﺘﻌﺯﻴﺯ ﺒﺭﺍﻤﺞ ﺸﺎﻤﻠﺔ ﻤﺘﻌﺩﺩﺓ ﺍﻟﻘﻁﺎﻋـﺎﺕ ﻟﻤﻜﺎﻓﺤـﺔ‬ ‫ﺍﻟﺘﺒﻎ ﻓﻲ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻨﺎﻤﻴﺔ ﺍﻷﻁﺭﺍﻑ ﻭﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻤﺭ ﺍﻗﺘﺼﺎﺩﺍﺘﻬﺎ ﺒﻤﺭﺤﻠﺔ ﺍﻨﺘﻘﺎﻟﻴﺔ‪ ،‬ﻭﺫﻟﻙ ﻓﻲ ﺃﻱ ﻤﻥ ﺍﻟﻤﺠـﺎﻻﺕ‬ ‫ﺍﻟﺘﺎﻟﻴﺔ‪:‬‬ ‫ﺘﻡ ﺘﻘﺩﻴﻡ ﻤﺴﺎﻋﺩﺓ ﺘﻡ ﺘﻠﻘﻲ ﻤﺴﺎﻋﺩﺓ‬ ‫ـﺭﺍﺩ‬ ‫ـﻰ ﺇﻴـ‬ ‫ـﺭﺍﺩ )ﻴﺭﺠـ‬ ‫ـﻰ ﺇﻴـ‬ ‫)ﻴﺭﺠـ‬ ‫ﺍﻟﺘﻔﺎﺼﻴل ﺃﺩﻨﺎﻩ( ﺍﻟﺘﻔﺎﺼﻴل ﺃﺩﻨﺎﻩ(‬ ‫□ ﻨﻌﻡ ‪ □ /‬ﻻ‬ ‫□ ﻨﻌﻡ ‪ □ /‬ﻻ‬ ‫□ ﻨﻌﻡ ‪ □ /‬ﻻ‬ ‫□ ﻨﻌﻡ ‪ □ /‬ﻻ‬ ‫ﺘﻁﻭﻴﺭ ﻭﻨﻘل ﻭﺍﻜﺘﺴﺎﺏ ﺍﻟﺘﻜﻨﻭﻟﻭﺠﻴﺎ ﻭﺍﻟﻤﻌﺎﺭﻑ ﻭﺍﻟﻤﻬﺎﺭﺍﺕ ﻭﺍﻟﻘـﺩﺭﺍﺕ ﻭﺍﻟﺨﺒـﺭﺍﺕ‬ ‫ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ؟ )ﺍﻟﻤﺎﺩﺓ ‪)١-٢٢‬ﺃ((‬ ‫ﺘﻭﻓﻴﺭ ﺍﻟﺨﺒﺭﺍﺕ ﺍﻟﺘﻘﻨﻴﺔ ﻭﺍﻟﻌﻠﻤﻴﺔ ﻭﺍﻟﻘﺎﻨﻭﻨﻴﺔ ﻭﻤﺎ ﺇﻟﻰ ﺫﻟـﻙ ﻤـﻥ ﺍﻟﺨﺒـﺭﺍﺕ ﻤـﻥ‬ ‫ﺃﺠل ﻭﻀﻊ ﻭﺘﻌﺯﻴﺯ ﺍﻻﺴﺘﺭﺍﺘﻴﺠﻴﺎﺕ ﻭﺍﻟﺨﻁﻁ ﻭﺍﻟﺒﺭﺍﻤﺞ ﺍﻟﻭﻁﻨﻴﺔ ﻟﻤﻜﺎﻓﺤـﺔ ﺍﻟﺘﺒـﻎ؟‬ ‫)ﺍﻟﻤﺎﺩﺓ ‪)١-٢٢‬ﺏ((‬ ‫ﺎ ﻟﻠﻤـﺎﺩﺓ ‪١٢‬؟‬ ‫ﺒﺭﺍﻤﺞ ﺍﻟﺘﺩﺭﻴﺏ ﺃﻭ ﺍﻟﺘﻭﻋﻴﺔ ﺍﻟﻤﻨﺎﺴـﺒﺔ ﻟﻠﻌـﺎﻤﻠﻴﻥ ﺍﻟﻤﻌﻨﻴـﻴﻥ ﻁﺒﻘـﹰ‬ ‫)ﺍﻟﻤﺎﺩﺓ ‪)١-٢٢‬ﺝ((‬ ‫ﻼ ﻋـﻥ ﺍﻟـﺩﻋﻡ‬ ‫ﺘﻭﻓﻴﺭ ﺍﻟﻤﻭﺍﺩ ﻭﺍﻟﻤﻌﺩﺍﺕ ﻭﺍﻹﻤﺩﺍﺩﺍﺕ ﺍﻟﻼﺯﻤﺔ ﻋﻨﺩ ﺍﻻﻗﺘﻀﺎﺀ‪ ،‬ﻓـﻀ ﹰ‬ ‫ﺍﻟﻠﻭﺠﺴﺘﻲ‪ ،‬ﻻﺴﺘﺭﺍﺘﻴﺠﻴﺎﺕ ﻭﺨﻁﻁ ﻭﺒﺭﺍﻤﺞ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ؟ )ﺍﻟﻤﺎﺩﺓ ‪)١-٢٢‬ﺩ((‬

‫□ ﻨﻌﻡ ‪ □ /‬ﻻ‬ ‫□ ﻨﻌﻡ ‪ □ /‬ﻻ‬ ‫□ ﻨﻌﻡ ‪ □ /‬ﻻ‬

‫□ ﻨﻌﻡ ‪ □ /‬ﻻ‬ ‫□ ﻨﻌﻡ ‪ □ /‬ﻻ‬ ‫□ ﻨﻌﻡ ‪ □ /‬ﻻ‬

‫ﺘﺤﺩﻴﺩ ﺃﺴﺎﻟﻴﺏ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪ ،‬ﺒﻤﺎ ﻓﻴﻬﺎ ﺍﻟﻌﻼﺝ ﺍﻟﺸﺎﻤل ﻹﺩﻤﺎﻥ ﺍﻟﻨﻴﻜﻭﺘﻴﻥ؟ )ﺍﻟﻤـﺎﺩﺓ‬

‫‪)١-٢٢‬ﻫ((‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪44‬‬

‫□ ﻨﻌﻡ ‪ □ /‬ﻻ‬

‫□ ﻨﻌﻡ ‪ □ /‬ﻻ‬

‫ﺍﻟﻨﻬﻭﺽ ﺒﺎﻟﺒﺤﻭﺙ ﻟﺯﻴﺎﺩﺓ ﺍﻟﻘﺩﺭﺓ ﻋﻠﻰ ﺘﺤﻤل ﺘﻜـﺎﻟﻴﻑ ﺍﻟﻌـﻼﺝ ﺍﻟـﺸﺎﻤل ﻹﺩﻤـﺎﻥ‬ ‫ﺍﻟﻨﻴﻜﻭﺘﻴﻥ؟ )ﺍﻟﻤﺎﺩﺓ ‪)١-٢٢‬ﻭ((‬ ‫ﻤﺴﺎﻋﺩﺓ ﺃﺨﺭﻯ )ﻴﺭﺠﻰ ﺫﻜﺭﻫﺎ(‪:‬‬ ‫ﺘﻔﺎﺼﻴل ﺇﻀﺎﻓﻴﺔ‪:‬‬

‫ﺇﺫﺍ ﻜﺎﻨﺕ ﺇﺠﺎﺒﺘﻜﻡ "ﻻ" ﻋﻥ ﺃﻱ ﻤﻥ ﺍﻟﺒﻨﻭﺩ ﺃﻋﻼﻩ‪ ،‬ﻴﺭﺠﻰ ﺒﻴﺎﻥ ﻤﺎ ﺇﺫﺍ ﻜﺎﻨﺕ ﻫﻨﺎﻙ ﺃﻴﺔ ﻤﺴﺎﻋﺩﺓ ﻤﺎﻟﻴﺔ ﺃﻭ ﺘﻘﻨﻴﺔ ﻗﺩ ﺘﻜﻭﻥ ﻗﻴـﺩ‬ ‫ﺍﻟﻨﻅﺭ‪.‬‬ ‫ﺇﺫﺍ ﻜﺎﻨﺕ ﺇﺠﺎﺒﺘﻜﻡ "ﻨﻌﻡ" ﻋﻥ ﺃﻱ ﻤﻥ ﺍﻟﺒﻨﻭﺩ ﺃﻋﻼﻩ‪ ،‬ﻴﺭﺠﻰ ﺒﻴﺎﻥ ﺍﻟﺒﻠﺩ ﺍﻟﺫﻱ ﺘﻠﻘﻴﺘﻡ ﻤﻨﻪ ﺍﻟﻤﺴﺎﻋﺩﺓ ﺃﻭ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﺘﻲ ﺘﻠﻘﻴﺘﻡ ﻤﻨﻬـﺎ‬ ‫ﺍﻟﻤﺴﺎﻋﺩﺓ ﺃﻭ ﺍﻟﺒﻠﺩ ﺍﻟﺫﻱ ﻗﺩﻤﺘﻡ ﺇﻟﻴﻪ ﺍﻟﻤﺴﺎﻋﺩﺓ ﺃﻭ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﺘﻲ ﻗﺩﻤﺘﻡ ﺇﻟﻴﻬﺎ ﻤﺴﺎﻋﺩﺓ‪.‬‬

‫ﻼ ﺒﺎﻟﻤﺎﺩﺓ ‪ ،٣-٢١‬ﻫل ﻗﺩﻤﺘﻡ ﺃﻭ ﺘﻠﻘﻴﺘﻡ ﻤﺴﺎﻋﺩﺓ ﻤﺎﻟﻴﺔ ﺃﻭ ﺘﻘﻨﻴﺔ ﻟﺩﻋﻡ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻨﺎﻤﻴﺔ ﺍﻷﻁﺭﺍﻑ ﻭﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ‬ ‫ﻋﻤ ﹰ‬ ‫ﺘﻤﺭ ﺍﻗﺘﺼﺎﺩﺍﺘﻬﺎ ﺒﻤﺭﺤﻠﺔ ﺍﻨﺘﻘﺎﻟﻴﺔ‪ ،‬ﻤﻥ ﺃﺠل ﺍﻟﻭﻓﺎﺀ ﺒﺎﻟﺘﺯﺍﻤﺎﺘﻬﺎ ﺍﻟﺨﺎﺼﺔ ﺒﺎﻟﺘﺒﻠﻴﻎ؟‬ ‫□ ﻨﻌﻡ ‪ □ /‬ﻻ )ﻴﺭﺠﻰ ﺇﻴـﺭﺍﺩ‬ ‫ﺍﻟﺘﻔﺎﺼﻴل ﺃﺩﻨﺎﻩ(‬ ‫□ ﻨﻌﻡ ‪ □ /‬ﻻ )ﻴﺭﺠﻰ ﺇﻴﺭﺍﺩ ﺘﻡ ﺘﻠﻘﻲ ﻤﺴﺎﻋﺩﺓ‬ ‫ﺍﻟﺘﻔﺎﺼﻴل ﺃﺩﻨﺎﻩ(‬ ‫ﺘﻡ ﺘﻘﺩﻴﻡ ﻤﺴﺎﻋﺩﺓ‬ ‫ﺘﻔﺎﺼﻴل ﺇﻀﺎﻓﻴﺔ‪:‬‬

‫ﺇﺫﺍ ﻜﺎﻨﺕ ﺇﺠﺎﺒﺘﻜﻡ "ﻻ" ﻋﻥ ﺃﻱ ﻤﻥ ﺍﻟﺒﻨﻭﺩ ﺃﻋﻼﻩ‪ ،‬ﻴﺭﺠﻰ ﺒﻴﺎﻥ ﻤﺎ ﺇﺫﺍ ﻜﺎﻨﺕ ﻫﻨﺎﻙ ﺃﻴﺔ ﻤﺴﺎﻋﺩﺓ ﻤﺎﻟﻴﺔ ﺃﻭ ﺘﻘﻨﻴﺔ ﻗﺩ ﺘﻜﻭﻥ ﻗﻴـﺩ‬ ‫ﺍﻟﻨﻅﺭ‪.‬‬ ‫ﺇﺫﺍ ﻜﺎﻨﺕ ﺇﺠﺎﺒﺘﻜﻡ "ﻨﻌﻡ" ﻋﻥ ﺃﻱ ﻤﻥ ﺍﻟﺒﻨﻭﺩ ﺃﻋﻼﻩ‪ ،‬ﻴﺭﺠﻰ ﺒﻴﺎﻥ ﺍﻟﺒﻠﺩ ﺍﻟﺫﻱ ﺘﻠﻘﻴﺘﻡ ﻤﻨﻪ ﺍﻟﻤﺴﺎﻋﺩﺓ ﺃﻭ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﺘﻲ ﺘﻠﻘﻴﺘﻡ ﻤﻨﻬـﺎ‬ ‫ﺍﻟﻤﺴﺎﻋﺩﺓ ﺃﻭ ﺍﻟﺒﻠﺩ ﺍﻟﺫﻱ ﻗﺩﻤﺘﻡ ﺇﻟﻴﻪ ﺍﻟﻤﺴﺎﻋﺩﺓ ﺃﻭ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﺘﻲ ﻗﺩﻤﺘﻡ ﺇﻟﻴﻬﺎ ﻤﺴﺎﻋﺩﺓ‪.‬‬

‫ﻫل ﺤﺩﺩﺘﻡ ﺃﻱ ﻓﺠﻭﺍﺕ ﻤﻌﻴﻨﺔ ﺒﻴﻥ ﺍﻟﻤﻭﺍﺭﺩ ﺍﻟﻤﺘﺎﺤﺔ ﻭﺍﻻﺤﺘﻴﺎﺠﺎﺕ ﺍﻟﻤﻘﺩﺭﺓ‪ ،‬ﻭﺫﻟﻙ ﻟﻠﻤﺴﺎﻋﺩﺓ ﺍﻟﻤﺎﻟﻴﺔ ﻭﺍﻟﺘﻘﻨﻴﺔ ﺍﻟﻤﻘﺩﻤﺔ‬ ‫ﺃﻭ ﺍﻟﻤﺘﻠﻘﺎﺓ؟‬ ‫ﻻ‬

‫□‬

‫□ ﻨﻌﻡ )ﻴﺭﺠﻰ ﺇﻴﺭﺍﺩ ﺍﻟﺘﻔﺎﺼﻴل ﺃﺩﻨﺎﻩ(‬ ‫ﺘﻔﺎﺼﻴل ﺇﻀﺎﻓﻴﺔ‪:‬‬

‫ﺃﻭﻟﻭﻴﺎﺕ ﺘﻨﻔﻴﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬

‫‪-٨‬‬

‫ﻤﺎ ﻫﻲ ﻤﺠﺎﻻﺕ ﺍﻷﻭﻟﻭﻴﺔ ﻓﻲ ﺘﻨﻔﻴﺫ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ﻓﻲ ﺩﺍﺌﺭﺓ ﺇﻁـﺎﺭ‬ ‫ﻭﻻﻴﺘﻜﻡ ﺍﻟﻘﻀﺎﺌﻴﺔ؟ )ﺍﻟﻤﺎﺩﺓ ‪)١-٢١‬ﺏ((‬

‫ﻤﺎ ﻫﻲ ﺍﻟﻘﻴﻭﺩ ﺃﻭ ﺍﻟﻌﻘﺒﺎﺕ ﺍﻟﺘﻲ ﻭﺍﺠﻬﺘﻤﻭﻫﺎ ﻓﻲ ﺘﻨﻔﻴﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ؟ )ﺍﻟﻤﺎﺩﺓ ‪)١-٢١‬ﺏ((‪.‬‬

‫‪45‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬ ‫ﺘﻌﻠﻴﻘﺎﺕ ﺇﻀﺎﻓﻴﺔ‬ ‫‪-٩‬‬

‫‪‬ﺭﺠﻰ ﺘﻘﺩﻴﻡ ﺃﻱ ﻤﻌﻠﻭﻤﺎﺕ ﺫﺍﺕ ﺼﻠﺔ ﺘﺭﻭﻨﻬﺎ ﻤﻬﻤﺔ ﻭﻟﻡ ﺘﺘﻡ ﺘﻐﻁﻴﺘﻬﺎ ﻓﻲ ﻤﻭﺍﻀﻊ ﺃﺨﺭﻯ‪.‬‬ ‫ﻴ‬

‫ﺘﻌﻠﻴﻘﺎﺕ ﻋﻠﻰ ﺍﻻﺴﺘﺒﻴﺎﻥ‬ ‫‪‬ﺭﺠﻰ ﺇﺒﺩﺍﺀ ﺘﻌﻠﻴﻘﺎﺘﻜﻡ ﻤﻥ ﺃﺠل ﺇﺩﺨﺎل ﺘﺤﺴﻴﻨﺎﺕ ﻋﻠﻰ ﺍﻻﺴﺘﺒﻴﺎﻥ ﺍﻟﺨﺎﺹ ﺒﺎﻟﻔﺌﺔ ‪.١‬‬ ‫ﻴ‬ ‫)ﺃ(‬

‫‪-١٠‬‬

‫ﻼ ﺒﺈﻋﺩﺍﺩ ﺍﻻﺴﺘﺒﻴﺎﻥ ﺍﻟﺨﺎﺹ ﺒﺎﻟﻔﺌﺔ ‪.٢‬‬ ‫‪‬ﺭﺠﻰ ﺇﺒﺩﺍﺀ ﻤﻼﺤﻅﺎﺘﻜﻡ ﻤﻥ ﺃﺠل ﺍﻟﻘﻴﺎﻡ ﻤﺴﺘﻘﺒ ﹰ‬ ‫ﻴ‬

‫)ﺏ(‬

‫)ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻟﺨﺎﻤﺴﺔ‪ ١٧ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪-٢٠٠٦‬‬ ‫ﺍﻟﻠﺠﻨﺔ "ﺃ"‪ ،‬ﺍﻟﺘﻘﺭﻴﺭ ﺍﻟﺭﺍﺒﻊ(‬

‫ﻭﻀﻊ ﻤﺒﺎﺩﺉ ﺘﻭﺠﻴﻬﻴﺔ ﻟﺘﻨﻔﻴﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ‬

‫)‪FCTC/COP1(15‬‬

‫ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪،‬‬ ‫ﺒﻌﺩ ﺍﻟﻨﻅﺭ ﻓﻲ ﺍﻟﻤﺎﺩﺘﻴﻥ ‪ ٧‬ﻭ‪ ٩‬ﻤﻥ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪ ،‬ﺍﻟﻠﺘـﻴﻥ‬ ‫ﺘﻁﻠﺒﺎﻥ ﻤﻥ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺍﻗﺘﺭﺍﺡ ﻤﺒﺎﺩﺉ ﺘﻭﺠﻴﻬﻴﺔ ﺒﺸﺄﻥ ﺘﻨﻔﻴﺫ ﺃﺤﻜﺎﻡ ﺍﻟﻤﻭﺍﺩ ﻤﻥ ‪ ٨‬ﺇﻟﻰ ‪ ١٣‬ﻋﻠـﻰ ﺍﻟﻤـﺴﺘﻭﻯ‬ ‫ﺍﻟﻭﻁﻨﻲ؛‬ ‫ﻭﺇﺫ ﻴﺩﺭﻙ ﻤﺎ ﻴﻤﻜﻥ ﻟﻬﺫﻩ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﺃﻥ ﺘﻘﺩﻤﻪ ﻤﻥ ﻤﺴﺎﻋﺩﺓ ﻟﻸﻁﺭﺍﻑ ﻋﻠﻰ ﺇﻋﺩﺍﺩ ﻭﺘﻨﻔﻴﺫ ﺴﻴﺎﺴﺎﺕ‬ ‫ﻭﺒﺭﺍﻤﺞ ﺘﺘﻌﻠﻕ ﺒﺎﻟﺘﺩﺍﺒﻴﺭ ﻏﻴﺭ ﺍﻟﺴﻌﺭﻴﺔ ﺍﻟﺭﺍﻤﻴﺔ ﺇﻟﻰ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪ ،‬ﻭﺍﻟﻭﺍﺭﺩﺓ ﻓﻲ ﺍﻟﻤﻭﺍﺩ ﻤﻥ ‪ ٨‬ﺇﻟﻰ ‪١٣‬؛‬ ‫ﺎ ﺒﺎﻟﺤﺎﺠﺔ ﺇﻟﻰ ﻤﻌﺎﻟﺠﺔ ﺍﻟﻘﻀﺎﻴﺎ ﺫﺍﺕ ﺍﻟﺼﻠﺔ ﺒﺎﻟﻤﺎﺩﺘﻴﻥ ‪ ٣-٥‬ﻭ‪١٤‬؛‬ ‫ﻭﺇﺫ ﻴﻘﺭ ﺃﻴﻀﹰ‬ ‫ﻭﺇﺫ ﻴﺭﻏﺏ ﻓﻲ ﺘﻌﺯﻴﺯ ﺇﺘﺎﺤﺔ ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﺄﻓﻀل ﻤﻤﺎﺭﺴﺎﺕ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ ﻟﺠﻤﻴﻊ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﻟﻜﻲ‬ ‫ﺎ ﻟﻠﻅﺭﻭﻑ ﺍﻟﻭﻁﻨﻴﺔ؛‬ ‫ﺘﺴﺘﺨﺩﻤﻬﺎ‪ ،‬ﺤﺴﺒﻤﺎ ﻴﻘﺘﻀﻲ ﺍﻷﻤﺭ‪ ،‬ﻓﻲ ﺴﻴﺎﻕ ﻭﻀﻊ ﻭﺘﻨﻔﻴﺫ ﻗﻭﺍﻨﻴﻨﻬﺎ ﺍﻟﻭﻁﻨﻴﺔ ﻭﻭﻓﻘﹰ‬ ‫ﻭﺇﺫ ﻴﺭﻏﺏ ﻓﻲ ﺘﺤﻘﻴﻕ ﺃﻗﺼﻰ ﻗﺩﺭ ﻤﻤﻜﻥ ﻤﻥ ﺍﻟﻔﻌﺎﻟﻴﺔ ﻭﺍﻟﻜﻔﺎﺀﺓ ﻓﻲ ﻭﻀﻊ ﻭﺇﻋﺩﺍﺩ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ‪ ،‬ﻭﺇﺫ‬ ‫ﺍ‬ ‫ﻴﺩﺭﻙ ﺍﻟﺩﻭﺭ ﺍﻟﺫﻱ ﻴﻤﻜﻥ ﻟﻠﻤﻨﻅﻤﺎﺕ ﺍﻟﺤﻜﻭﻤﻴﺔ ﺍﻟﺩﻭﻟﻴﺔ ﻭﺍﻟﻤﻨﻅﻤﺎﺕ ﻏﻴﺭ ﺍﻟﺤﻜﻭﻤﻴﺔ ﺍﻟﻘﻴﺎﻡ ﺒﻪ ﻓﻲ ﻫﺫﻩ ﺍﻟﻤﻬﻤﺔ‪ ،‬ﻨﻅـﺭﹰ‬ ‫ﻻﺘﺴﺎﻉ ﻤﺠﺎﻻﺕ ﺨﺒﺭﺘﻬﺎ ﻓﻲ ﻫﺫﻩ ﺍﻟﻘﻀﺎﻴﺎ؛‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪46‬‬

‫ﻗﺭﺭ ﻤﺎ ﻴﻠﻲ‪:‬‬ ‫ﺍﻋﺘﻤﺎﺩ ﺍﻟﻘﻭﺍﻟﺏ ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﺒﺨﺼﻭﺹ ﺍﻟﻤﺎﺩﺘﻴﻥ ‪ ٨‬ﻭ‪ ،٩‬ﻭﻋﻠـﻰ ﺍﻟﻨﺤـﻭ‬ ‫)‪(١‬‬ ‫ﺍﻟﻭﺍﺭﺩ ﻓﻲ ﺍﻟﻤﺭﻓﻘﻴﻥ ‪ ١‬ﻭ‪ ٢‬ﺍﻟﻤﻠﺤﻘﻴﻥ ﺒﻬﺫﺍ ﺍﻟﻘﺭﺍﺭ؛‬ ‫ﺎ ﺒﺎﻟﻘﻭﺍﻟﺏ ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﺒﺨﺼﻭﺹ ﺍﻟﻤـﺭﺤﻠﺘﻴﻥ ‪ ٢‬ﻭ‪ ٣‬ﻤـﻥ‬ ‫ﺍﻹﺤﺎﻁﺔ ﻋﻠﻤﹰ‬ ‫)‪(٢‬‬ ‫ﺍﻟﻤﺎﺩﺓ ‪ ،٩‬ﻭﺍﻟﻤﻭﺍﺩ ﻤﻥ ‪ ١٠‬ﺇﻟﻰ ‪ ،١٣‬ﻜﺄﻤﺜﻠﺔ ﻟﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﻟﻬﺫﻩ ﺍﻟﻤﻭﺍﺩ ﻜﻤﺎ ﺘﺭﺩ ﻓﻲ ﺍﻟﻤﺭﻓﻘﺎﺕ‬ ‫ﻤﻥ ‪ ٣‬ﺇﻟﻰ ‪ ٥‬ﺍﻟﻤﻠﺤﻘﺔ ﺒﻬﺫﺍ ﺍﻟﻘﺭﺍﺭ؛‬ ‫ﻤﻨﺢ ﺍﻷﻭﻟﻭﻴﺔ ﺍﻟﻘﺼﻭﻯ ﻟﻠﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﺍﻟﺨﺎﺼﺔ ﺒﺎﻟﻤﺎﺩﺓ ‪ ٨‬ﻭﺍﻟﻤﺭﺤﻠﺔ ﺍﻷﻭﻟـﻰ ﻤـﻥ ﺍﻟﻤـﺎﺩﺓ‬ ‫)‪(٣‬‬ ‫‪ ،٩‬ﻭﺃﻥ ﻴﻁﻠﺏ ﺇﻟﻰ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺍﻟﺸﺭﻭﻉ ﻓﻲ ﺍﻟﻌﻤل ﺒﺸﺄﻥ ﻫﺫﻩ ﺍﻟﻤﺒـﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴـﺔ‪ ،‬ﻋﻠـﻰ ﺃﺴـﺎﺱ‬ ‫ﻭﺩﺓ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﺇﻟﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺜﺎﻨﻲ‪ ،‬ﺇﻥ ﺃﻤﻜـﻥ‪ ،‬ﺃﻭ ﺘﻘـﺩﻴﻡ ﺘﻘـﺎﺭﻴﺭ‬ ‫ﺍﻟﻘﻭﺍﻟﺏ‪ ،‬ﻭﺘﻘﺩﻴﻡ ﻤﺴ ‪‬‬ ‫ﻤﺭﺤﻠﻴﺔ؛‬ ‫ﺍﻋﺘﻤﺎﺩ ﺍﻟﻤﻌﺎﻴﻴﺭ ﺍﻟﺘﺎﻟﻴﺔ ﺒﺸﺄﻥ ﺘﺤﺩﻴﺩ ﺃﻭﻟﻭﻴﺎﺕ ﺍﻟﻌﻤل ﺍﻟﻤﺘﻌﻠﻕ ﺒﺎﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﻓﻴﻤـﺎ ﻴﺘـﺼل‬ ‫)‪(٤‬‬ ‫ﹰ‪ ،‬ﻭﺍﻟﻤﺎﺩﺘﻴﻥ ‪ ٣-٥‬ﻭ‪ ١٤‬ﻭﺍﻟﺘﻲ ﻁﻠﺒﺘﻬـﺎ‬ ‫ﺒﺎﻟﻤﻭﺍﺩ ﻤﻥ ‪ ٩‬ﺇﻟﻰ ‪ ،١٣‬ﺒﻤﻭﺠﺏ ﺃﺤﻜﺎﻡ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﺘﺤﺩﻴﺩﺍ‬ ‫ﻋﺩﺓ ﺃﻁﺭﺍﻑ‪:‬‬ ‫‪-١‬‬ ‫ﺍﻟﻁﻠﺒﺎﺕ ﺍﻟﺘﻲ ﺘﻘﺩﻤﻬﺎ ﺍﻷﻁﺭﺍﻑ‪ :‬ﻴﻨﺒﻐﻲ ﻟﻠﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﺃﻥ ﺘﺴﺎﻋﺩ ﺍﻷﻁﺭﺍﻑ ﻋﻠـﻰ‬ ‫ﺘﻨﻔﻴﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ‪.‬‬ ‫ﺍﻟﻌﻤل ﺍﻟﺤﺎﻟﻲ ﺍﻟﺫﻱ ﻴﻤﻜﻥ ﺍﻻﺴﺘﻨﺎﺩ ﺇﻟﻴﻪ‪ :‬ﻫﻨﺎﻙ ﺃﻋﻤﺎل ﺫﺍﺕ ﺼﻠﺔ ﺒﺎﻟﻤﻭﻀﻭﻉ ‪ ،‬ﻤﺜـل‬ ‫‪-٢‬‬ ‫ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﻟﻤﺒﺎﺩﺭﺓ ﺍﻟﺘﺤﺭﺭ ﻤﻥ ﺍﻟﺘﺒﻎ‪ ،‬ﻭﻤﻥ ﺜﻡ ﻴﻤﻜﻥ ﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴـﺔ ﺒـﺸﻜل‬ ‫ﺃﺴﺭﻉ ﻭﺒﻜﻔﺎﺀﺓ‪.‬‬ ‫‪-٣‬‬ ‫ﺍ‬ ‫ﺍﻟﻘﻴﻤﺔ ﺍﻟﻤﻀﺎﻓﺔ ﻋﻠﻰ ﺍﻟﻤﺴﺘﻭﻯ ﺍﻟﺩﻭﻟﻲ‪ :‬ﻗﺩ ﺘﺅﺩﻱ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴـﺔ ﺍﻟﺩﻭﻟﻴـﺔ ﺩﻭﺭﹰ‬ ‫ﺎ ﻓﻲ ﻤﺴﺎﻋﺩﺓ ﺍﻷﻁﺭﺍﻑ ﻋﻠﻰ ﺍﻟﻭﻓﺎﺀ ﺒﺒﻌﺽ ﺍﻟﺘﺯﺍﻤﺎﺘﻬﺎ‪ ،‬ﻓﻲ ﺤﻴﻥ ﺃﻥ ﻤﺸﺎﺭﻜﺔ ﻋـﺩﺩ ﻤـﻥ‬ ‫ﺨﺎﺼﹰ‬ ‫ﺍﻷﻁﺭﺍﻑ ﺘﺘﻴﺢ ﺘﺒﺎﺩل ﺍﻟﺨﺒﺭﺍﺕ ﻭﺘﻘﺎﺴﻡ ﺍﻟﺘﻜﺎﻟﻴﻑ‪.‬‬ ‫ﺍﻷﺜﺭ ﺍﻟﻤﺤﺘﻤل ﻟﻠﺘﺩﺒﻴﺭ ﺍﻟﻤﺤﺩﺩ ﻓﻲ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ‪ :‬ﺍﻟﻤﻌﺭﻭﻑ ﺃﻥ ﺍﻟﺘﺩﺍﺒﻴﺭ ﻓﻌﺎﻟﺔ ﻓﻲ‬ ‫‪-٤‬‬ ‫ﺍﻟﺤﺩ ﻤﻥ ﺃﺜﺭ ﺍﻟﺘﺒﻎ‪.‬‬ ‫ﺴﻬﻭﻟﺔ ﺍﻟﺘﻨﻔﻴﺫ‪ :‬ﻭﻴﺸﻤل ﺫﻟﻙ ﺘﻜﺎﻟﻴﻑ ﺍﻟﺘﻨﻔﻴﺫ‪.‬‬ ‫‪-٥‬‬

‫ﺍﺴﺘﻌﺩﺍﺩ ﺍﻷﻁﺭﺍﻑ ﻟﺘﺤﻤل ﺃﻋﺒﺎﺀ ﺍﻟﻘﻴﺎﺩﺓ‪ :‬ﺘﻁﻭﻋﺕ ﺍﻷﻁﺭﺍﻑ ﺒﺘﺴﻴﻴﺭ ﺍﻟﻤﻨﺎﻗﺸﺎﺕ ﺒـﺸﻜل‬ ‫‪-٦‬‬ ‫ﺭﺌﻴﺴﻲ‪ ،‬ﺃﻭ ﺒﺩﻭﺭ ﺍﻟﺸﺭﻜﺎﺀ‪ ،‬ﺃﻭ ﺒﺩﻭﺭ ﺍﻟﻤﺭﺍﺠﻌﺔ‪.‬‬ ‫ﻗﺎﺒﻠﻴﺔ ﺍﻟﻨﺘﺎﺌﺞ ﻟﻠﻘﻴﺎﺱ‪ :‬ﻴﺘﻌﻠﻕ ﻫﺫﺍ ﺒﺎﻟﺘﺒﻠﻴﻎ )ﺍﻟﻤﺎﺩﺓ ‪ (٢١‬ﻭﺒﺈﻤﻜﺎﻨﻴـﺔ ﻗﻴـﺎﺱ ﺍﻟﺒﻴﺎﻨـﺎﺕ‬ ‫‪-٧‬‬ ‫ﻭﺘﺤﻠﻴﻠﻬﺎ‪.‬‬

‫‪47‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺍﻟﻤﺴﺎﻫﻤﺔ ﻓﻲ ﺍﻟﺤﻔﺎﻅ ﻋﻠﻰ ﺍﻟﻘﻭﺓ ﺍﻟﺩﺍﻓﻌﺔ ﻓﻲ ﺘﻨﻔﻴﺫ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ‪ :‬ﻭﻟﻬﺫﺍ ﺃﻫﻤﻴـﺔ‬ ‫‪-٨‬‬ ‫ﺨﺎﺼﺔ ﻓﻲ ﺍﻟﻤﺭﺍﺤل ﺍﻟﻤﺒﻜﺭﺓ ﻟﻠﺘﻨﻔﻴﺫ‪.‬‬ ‫ﺘﻜﺎﻟﻴﻑ ﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ‪ :‬ﻴﻨﺒﻐﻲ ﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﺒﻜﻔﺎﺀﺓ‪.‬‬ ‫‪-٩‬‬

‫‪ -١٠‬ﺍﻟﺘﻌﺎﻭﻥ ﺍﻟﺩﻭﻟﻲ ﻭﺘﻘﺎﺴﻡ ﺍﻟﺘﻜﺎﻟﻴﻑ ﺃﻤﺭﺍﻥ ﺃﺴﺎﺴﻴﺎﻥ ﻟﺘﻨﻔﻴﺫ ﻋﻨﺎﺼﺭ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴـﺔ‬ ‫ﻋﻠﻰ ﺍﻟﻨﺤﻭ ﺍﻟﻔﻌﺎل‪.‬‬ ‫)‪(٥‬‬ ‫ﻤﻁﺎﻟﺒﺔ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺒﺎﻻﺴﺘﻔﺎﺩﺓ ﻤﻥ ﻫﺫﻩ ﺍﻟﻤﻌﺎﻴﻴﺭ ﻓﻲ ﺇﻋﺩﺍﺩ ﺨﻁـﺔ ﻋﻤـل ﻟﻭﻀـﻊ ﺍﻟﻤﺒـﺎﺩﺉ‬ ‫ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﺎﻟﻤﻭﺍﺩ ﺫﺍﺕ ﺍﻟﺼﻠﺔ‪ ،‬ﻜﻲ ﻴﻨﻅﺭ ﻓﻴﻬﺎ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﺠﺘﻤﺎﻋﻪ ﺍﻟﺜﺎﻨﻲ؛‬ ‫ﺩﻋﻭﺓ ﺍﻟﻤﻨﻅﻤﺎﺕ ﺍﻟﺤﻜﻭﻤﻴﺔ ﺍﻟﺩﻭﻟﻴﺔ ﻭﺍﻟﻤﻨﻅﻤﺎﺕ ﻏﻴﺭ ﺍﻟﺤﻜﻭﻤﻴﺔ ﺫﺍﺕ ﺍﻟﺨﺒﺭﺓ ﺍﻟﺨﺎﺼﺔ ﻓﻲ ﺍﻷﻤﻭﺭ‬ ‫)‪(٦‬‬ ‫ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﺎﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ‪ ،‬ﺇﻟﻰ ﺍﻟﻤﺸﺎﺭﻜﺔ ﻭﺍﻟﻤﺴﺎﻫﻤﺔ ﺒﻨﺸﺎﻁ ﻓﻲ ﻤﻭﺍﺼﻠﺔ ﻭﻀـﻊ ﻭﺇﻋـﺩﺍﺩ ﺍﻟﻤﺒـﺎﺩﺉ‬ ‫ﺀ ﻋﻠﻰ ﻁﻠﺏ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ‪.‬‬ ‫ﺍﻟﺘﻭﺠﻴﻬﻴﺔ‪ ،‬ﺒﻨﺎ ‪‬‬

‫ﺍﻟﻤﺭﻓﻕ ‪ :١‬ﺍﻟﻤﺎﺩﺓ ‪ :٨‬ﺍﻟﺤﻤﺎﻴﺔ ﻤﻥ ﺍﻟﺘﻌﺭﺽ ﻟﺩﺨﺎﻥ ﺍﻟﺘﺒﻎ‬ ‫ﺍﻟﻤﺎﺩﺓ ‪:٨‬‬ ‫ﺍﻟﺤﻤﺎﻴﺔ ﻤﻥ ﺍﻟﺘﻌﺭﺽ ﻟﺩﺨﺎﻥ ﺍﻟﺘﺒﻎ‬ ‫ﺍﻟﻤﻭﻀﻭﻉ‬

‫ﺍﻟﻤﺤﺘﻭﻴﺎﺕ‪:‬‬ ‫ﺍﻷﺴﺎﺱ ﺍﻟﻤﻨﻁﻘﻲ‪ :‬ﺘﻌﺘﺭﻑ ﺍﻷﻁﺭﺍﻑ ﺒﺄﻥ ﺍﻷﺩﻟﺔ ﺍﻟﻌﻠﻤﻴﺔ ﻗﺩ ﺒﺭﻫﻨـﺕ‬ ‫ﺎ ﻟﻠﺸﻙ ﻋﻠﻰ ﺃﻥ ﺍﻟﺘﻌﺭﺽ ﻟﺩﺨﺎﻥ ﺍﻟﺘﺒﻎ ﻴـﺅﺩﻱ ﺇﻟـﻰ‬ ‫ﺒﻤﺎ ﻻ ﻴﺩﻉ ﻤﻜﺎﻨﹰ‬ ‫ﺍﻟﻤﻭﺕ ﻭﺍﻟﻤﺭﺽ ﻭﺍﻟﻌﺠﺯ‪ .‬ﻭﻟﺫﻟﻙ ﻴﻨﺒﻐﻲ ﺘﻭﻓﻴﺭ ﺍﻟﺤﻤﺎﻴﺔ ﻤﻥ ﺍﻟﺘﻌﺭﺽ‬ ‫ﻟﺩﺨﺎﻥ ﺍﻟﺘﺒﻎ ﻓﻲ ﺃﻤﺎﻜﻥ ﺍﻟﻌﻤل ﺍﻟﺩﺍﺨﻠﻴﺔ ﻭﻭﺴﺎﺌل ﺍﻟﻨﻘل ﺍﻟﻌﺎﻡ‪ ،‬ﻭﺍﻷﻤﺎﻜﻥ‬ ‫ﺍﻟﻌﺎﻤﺔ ﺍﻟﺩﺍﺨﻠﻴﺔ ﻭﺍﻷﻤﺎﻜﻥ ﺍﻟﻌﺎﻤﺔ ﺍﻷﺨﺭﻯ‪ .‬ﻭﻤﻥ ﻭﺠﻬﺔ ﻨﻅﺭ ﺍﻟﺼﺤﺔ‬ ‫ﺍﻟﻌﻤﻭﻤﻴﺔ ﻟﻴﺱ ﻫﻨﺎﻙ ﺃﻱ ﻤﺴﺘﻭﻯ "ﻤﺄﻤﻭﻥ" ﻤﻥ ﻤـﺴﺘﻭﻴﺎﺕ ﺍﻟﺘـﺩﺨﻴﻥ‬ ‫‪‬ﻨﺎﺕ ﻗﺎﻁﻌﺔ ﺘﺩل ﻋﻠﻰ ﺃﻥ ﺍﻷﺴـﺎﻟﻴﺏ ﺍﻟﻬﻨﺩﺴـﻴﺔ‬ ‫ﺍﻟﻼﺇﺭﺍﺩﻱ‪ .‬ﻭﻫﻨﺎﻙ ﺒﻴ‬ ‫ﻻ ﺘﻭﻓﺭ ﺍﻟﺤﻤﺎﻴﺔ ﻤﻥ ﺍﻟﺘﻌﺭﺽ ﻟﺩﺨﺎﻥ ﺍﻟﺘﺒﻎ‪.‬‬ ‫ﺍﻟﻐﺭﺽ‪ :‬ﺇﻋﺩﺍﺩ ﻤﺒﺎﺩﺉ ﺘﻭﺠﻴﻬﻴﺔ ﻟﻠﺤﻤﺎﻴﺔ ﻤﻥ ﺍﻟﺘﻌﺭﺽ ﻟﺩﺨﺎﻥ ﺍﻟﺘﺒﻎ‪.‬‬ ‫ﺍﻟﺘﻌﺭﻴﻑ ﺍﻟﻭﺍﻀﺢ ﻟﻠﻌﻨﺎﺼﺭ ﺍﻟﻭﺍﺭﺩﺓ ﻓﻲ ‪ -١‬ﺇﻴﻀﺎﺡ ﻭﺘﺤﺩﻴﺩ ﺍﻟﻤﺼﻁﻠﺤﺎﺕ ﺍﻟﻤﺴﺘﺨﺩﻤﺔ ﺍﻟﺘﺎﻟﻴـﺔ‪" :‬ﺍﻟﺘﻌـﺭﺽ‬ ‫ﻟﺩﺨﺎﻥ ﺍﻟﺘﺒﻎ"‪" ،‬ﺃﻤﺎﻜﻥ ﺍﻟﻌﻤل ﺍﻟﺩﺍﺨﻠﻴﺔ"؛ "ﻭﺴﺎﺌل ﺍﻟﻨﻘل ﺍﻟﻌﺎﻡ" "ﺍﻷﻤﺎﻜﻥ‬ ‫ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ‬ ‫ﺍﻟﻌﻤﻭﻤﻴﺔ ﺍﻟﺩﺍﺨﻠﻴﺔ"؛ "ﺍﻷﻤﺎﻜﻥ ﺍﻟﻌﻤﻭﻤﻴﺔ ﺍﻷﺨﺭﻯ"‬ ‫‪ -٢‬ﻨﻁﺎﻕ ﻭﻤﺩﻯ ﺘﻐﻁﻴﺔ ﺍﻟﺴﻴﺎﺴﺎﺕ ﺍﻟﺭﺍﻤﻴـﺔ ﺇﻟـﻰ ﺍﻟﺤﻤﺎﻴـﺔ ﻤـﻥ‬ ‫ﺍﻟﺘﻌﺭﺽ ﻟﺩﺨﺎﻥ ﺍﻟﺘﺒﻎ‬ ‫‪ -٣‬ﺍﻟﺘﻭﺼﻴﺎﺕ ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﺘﻨﻔﻴﺫ ﻭﺇﻋﻤﺎل ﺍﻟﺘﺩﺍﺒﻴﺭ ﺍﻟﺘﺸﺭﻴﻌﻴﺔ ﻭﺍﻹﺩﺍﺭﻴﺔ‬ ‫‪ -٤‬ﺍﻟﺘﻭﺼﻴﺎﺕ ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﺭﺼﺩ ﻭﺘﻘﻴﻴﻡ ﺍﻟﺘﺩﺍﺒﻴﺭ ﺍﻟﺘﺸﺭﻴﻌﻴﺔ ﻭﺍﻹﺩﺍﺭﻴﺔ‬ ‫‪ -٥‬ﺘﺼﻨﻴﻑ ﺍﻟﺘﺩﺨﻴﻥ ﺍﻟﻼﺇﺭﺍﺩﻱ ﻋﻠﻰ ﺃﻨﻪ ﻴﺴﺒﺏ ﺍﻹﺼﺎﺒﺔ ﺒﺎﻟﺴﺭﻁﺎﻥ‬ ‫ﺍﻷﻏﺭﺍﺽ ﻭﺍﻷﺴﺎﺱ ﺍﻟﻤﻨﻁﻘﻲ‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪48‬‬

‫‪ -١‬ﺘﻭﺤﻴﺩ ﺘﺩﺍﺒﻴﺭ ﻭﺃﻨﺸﻁﺔ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‬ ‫‪ -٢‬ﺍﻟﺘﻌﺎﻭﻥ ﺍﻟﺩﻭﻟﻲ ﻭﺘﺒﺎﺩل ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﻋﻥ ﺃﻓـﻀل ﺍﻟﻤﻤﺎﺭﺴـﺎﺕ‬ ‫ﻭﺍﻟﺩﺭﻭﺱ ﺍﻟﻤﺴﺘﻔﺎﺩﺓ‬ ‫‪ -٣‬ﻤﻥ ﺸﺄﻥ ﺘﻭﻓﻴﺭ ﻤﺒﺎﺩﺉ ﺘﻭﺠﻴﻬﻴﺔ ﻤﻥ ﻗﺒل ﻤﺅﺘﻤﺭ ﺍﻷﻁـﺭﺍﻑ ﺃﻥ‬ ‫ﻴﺴﻬل ﺍﻟﺘﻁﺒﻴﻕ‪ /‬ﺍﻟﺘﻨﻔﻴﺫ‬ ‫‪ -١‬ﻗﺎﻡ ﻜل ﻤﻥ ﻤﺒﺎﺩﺭﺓ ﺍﻟﻤﻨﻅﻤﺔ ﻟﻠﺘﺤـﺭﺭ ﻤـﻥ ﺍﻟﺘﺒـﻎ ﻭﺍﻟﻤﺭﻜـﺯ‬ ‫ﺍﻟﻤﺘﻌﺎﻭﻥ ﻤﻊ ﺍﻟﻤﻨﻅﻤﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ )ﺠﺎﻤﻌﺔ ﺠﻭﻥ ﻫﻭﺒﻜﻨﺯ ﻓﻲ‬ ‫ﺒﻠﺘﻴﻤﻭﺭ‪ ،‬ﻤﺎﺭﻴﻼﻨﺩ‪ ،‬ﺍﻟﻭﻻﻴﺎﺕ ﺍﻟﻤﺘﺤﺩﺓ ﺍﻷﻤﺭﻴﻜﻴﺔ( ﺒﺘﻨﻅـﻴﻡ ﻤـﺸﺎﻭﺭﺓ‬ ‫ﹸﻨﺸﺭ‬ ‫ﺨﺒﺭﺍﺀ ﻓﻲ ﻫﺫﺍ ﺍﻟﻤﺠﺎل ﻓﻲ ﺘﺸﺭﻴﻥ ﺍﻟﺜﺎﻨﻲ‪ /‬ﻨﻭﻓﻤﺒﺭ ‪ .٢٠٠٥‬ﻭﺴﺘ‬ ‫ﺘﻭﺼﻴﺎﺕ ﺴﻴﺎﺴﺔ ﺍﻟﻤﻨﻅﻤﺔ ﺍﻟﻌﺎﻤﺔ ﺒﺨﺼﻭﺹ ﺍﻟﺘـﺩﺨﻴﻥ ﺍﻟـﻼﺇﺭﺍﺩﻱ‬ ‫ﻭﺍﻟﺒﻴﺌﺎﺕ ﺍﻟﺨﺎﻟﻴﺔ ﻤﻥ ﺍﻟﺩﺨﺎﻥ ﻋﻠﻰ ﺃﺴﺎﺱ ﻫﺫﻩ ﺍﻟﻤﺸﺎﻭﺭﺓ‪.‬‬ ‫‪ -٢‬ﻭﻟﻤﺒﺎﺩﺭﺓ ﺍﻟﺘﺤﺭﺭ ﻤﻥ ﺍﻟﺘﺒـﻎ ﻓـﻲ ﻤﻜﺘـﺏ ﻤﻨﻅﻤـﺔ ﺍﻟـﺼﺤﺔ‬ ‫ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻗﻠﻴﻤﻲ ﻟﻸﻤﺭﻴﻜﺘﻴﻥ‪ /‬ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﻟﻠﺒﻠـﺩﺍﻥ ﺍﻷﻤﺭﻴﻜﻴـﺔ‬ ‫ﻤﺸﺭﻭﻉ ﺒﻌﻨﻭﺍﻥ "ﻤﺒﺎﺩﺭﺓ ﺍﻟﺘﺤﺭﺭ ﻤﻥ ﺩﺨﺎﻥ ﺍﻟﺘﺒﻎ ﻓـﻲ ﺍﻷﻤـﺭﻴﻜﺘﻴﻥ"‬ ‫ﻤﺨﺼﺹ ﻟﻠﺘﻭﻋﻴﺔ ﺒﺎﻟﻀﺭﺭ ﺍﻟﻨﺎﺠﻡ ﻋﻥ ﺍﻟﺘﺩﺨﻴﻥ ﺍﻟﻼﺇﺭﺍﺩﻱ‪ ،‬ﻭﺩﻋـﻡ‬ ‫ﺍﻟﺠﻬﻭﺩ ﺍﻟﻤﺒﺫﻭﻟﺔ ﻤﻥ ﺃﺠل ﺘﻌﺯﻴﺯ ﺍﻟﺘﺤﺭﺭ ﻤـﻥ ﺩﺨـﺎﻥ ﺍﻟﺘﺒـﻎ ﻓـﻲ‬ ‫ﺍﻷﻤﺭﻴﻜﺘﻴﻥ‪.‬‬ ‫‪ -٣‬ﻭﻨﺸﺭﺕ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺃﻓﻀل ﺍﻟﻤﻤﺎﺭﺴﺎﺕ ﻓﻲ ﻤﺠﺎل‬ ‫ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺩﺨﻴﻥ ﺍﻟﻼﺇﺭﺍﺩﻱ ﻀﻤﻥ ﺍﻟﺴﻠﺴﻠﺔ ﺍﻟﺘﻲ ﺘـﺼﺩﺭﻫﺎ ﺒﻌﻨـﻭﺍﻥ‬ ‫"ﻗﺼﺹ ﺍﻟﻨﺠﺎﺡ ﻭﺍﻟﺩﺭﻭﺱ ﺍﻟﻤﺴﺘﻔﺎﺩﺓ"‪.‬‬ ‫ﻨﻤﺎﺫﺝ ﻟﻠﺘﺸﺭﻴﻌﺎﺕ ﻓﻲ ﺒﻌﺽ ﺍﻟﺒﻠﺩﺍﻥ‬ ‫‪ -١‬ﺃﻴﺭﻟﻨﺩﺍ‪ :‬ﻟﻭﺍﺌﺢ )ﺤﻅﺭ( ﺘﺩﺨﻴﻥ ﺍﻟﺘﺒﻎ ‪٢٠٠٣‬‬ ‫‪ -٢‬ﻨﻴﻭﺯﻴﻠﻨﺩﺍ‪ :‬ﻗﺎﻨﻭﻥ ﺍﻟﺒﻴﺌﺎﺕ ﺍﻟﺨﺎﻟﻴﺔ ﻤﻥ ﺍﻟﺩﺨﺎﻥ‪١٩٩٠ ،‬‬ ‫‪ -٣‬ﺍﻟﻨﺭﻭﻴﺞ‪ :‬ﻗﺎﻨﻭﻥ ﺍﻟﺘﺒﻎ‪) ١٩٧٣ ،‬ﺍﻟﻤﻨﻘﺢ ﻓﻲ ‪(٢٠٠٣‬‬ ‫‪ -٤‬ﺍﻟﺴﻭﻴﺩ‪ :‬ﺍﻟﻘﺎﻨﻭﻥ ‪ ٦٥:٠٤/٢٠٠٣‬ﺒـﺸﺄﻥ ﻤﺅﺴـﺴﺎﺕ ﺍﻷﻜـل‬ ‫ﻭﺍﻟﺸﺭﺏ ﺍﻟﺨﺎﻟﻴﺔ ﻤﻥ ﺍﻟﺩﺨﺎﻥ‪٢٠٠٤ ،‬‬ ‫‪ -٥‬ﺃﻭﺭﻭﻏﻭﺍﻱ‪ :‬ﺍﻟﻤﺭﺴﻭﻡ ﺭﻗﻡ ‪ ٠٥/٢٦٨‬ﺒﺸﺄﻥ ﻤﻨﻊ ﺍﻟﺘﺩﺨﻴﻥ ﻓـﻲ‬ ‫ﺠﻤﻴﻊ ﺍﻷﻤﺎﻜﻥ ﺍﻟﻌﺎﻤﺔ‬ ‫‪‬ﺩﻟﺕ ﻤﻭﺍﺩﻩ ﻓـﻲ‬ ‫‪ -٦‬ﺍﻟﻬﻨﺩ‪ :‬ﺍﻟﺘﺸﺭﻴﻊ ﺍﻟﺼﺎﺩﺭ ﻓﻲ ﻋﺎﻡ ‪٢٠٠٣‬؛ ﻭﻋ‬ ‫ﻋﺎﻡ ‪٢٠٠٤‬‬ ‫ﺍﻟﻨﺸﺭ ﺒﻤﻌﺭﻓﺔ ﻤﺒﺎﺩﺭﺓ ﺍﻟﺘﺤﺭﺭ ﻤﻥ ﺍﻟﺘﺒﻎ‪:‬‬

‫ﺍﻻﺤﺘﻴﺎﺠﺎﺕ‪ /‬ﺍﻟﻘﻴﻤﺔ ﺍﻟﻤﻀﺎﻓﺔ‬

‫ﺍﻟﻌﻤل ﺍﻟﺤﺎﻟﻲ ﺍﻟﺫﻱ ﻴﻤﻜﻥ ﺍﻻﺴﺘﻨﺎﺩ ﺇﻟﻴﻪ‬

‫ﺍﻟﺠﻬﺔ ﺍﻟﻘﺎﺌﻤﺔ ﺒﺎﻟﺘﻨﻔﻴﺫ )ﺒﺘﻔـﻭﻴﺽ ﻤـﻥ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ‪ ،‬ﺒﺎﻟﺘﺸﺎﻭﺭ ﻤﻊ ﻤﺒﺎﺩﺭﺓ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻟﺨﺎﺼﺔ‬ ‫ﺒﺎﻟﺘﺤﺭﺭ ﻤﻥ ﺍﻟﺘﺒﻎ‪ ،‬ﻭﺒﻤﺴﺎﻋﺩﺓ ﻤﻥ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺭﺍﻏﺒﺔ ﻓﻲ ﺍﻟﻤـﺸﺎﺭﻜﺔ‬ ‫ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ(‬ ‫ﻟﻀﻤﺎﻥ ﺍﻟﺘﻤﺜﻴل ﺍﻹﻗﻠﻴﻤﻲ‪.‬‬

‫ﺍﻟﻌﻤﻠﻴﺔ‪:‬‬

‫‪49‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬ ‫ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻌﺭﺽ ﺍﻟﻘﻴـﺎﻡ ﺒـﺩﻭﺭ ﻓﻨﻠﻨﺩﺍ ﻭﺃﻴﺭﻟﻨﺩﺍ ﻭﻨﻴﻭﺯﻴﻠﻨﺩﺍ‬ ‫ﺍﻟﻤﻴﺴﺭﻴﻥ ﺍﻟﺭﺌﻴﺴﻴﻴﻥ‬ ‫)ﻋﻥ ﻁﺭﻴﻕ ﺤﺸﺩ ﺍﻟﻤﻭﺍﺭﺩ ﺃﻭ ﺒﻭﺍﺴـﻁﺔ‬ ‫ﺍﻷﻋﻤﺎل ﺍﻟﺘﻘﻨﻴﺔ(‬

‫ـﺭﺽ ﺍﻟﺒﺭﺍﺯﻴل ﻭﺍﻟﻜﺎﻤﻴﺭﻭﻥ ﻭﺍﻟﺼﻴﻥ ﻭﺠﻴﺒﻭﺘﻲ ﻭﻓﻴﺠﻲ ﻭﻓﺭﻨﺴﺎ ﻭﺃﻟﻤﺎﻨﻴـﺎ‬ ‫ـﻲ ﺘﻌـ‬ ‫ـﺭﻯ ﺍﻟﺘـ‬ ‫ـﺭﺍﻑ ﺍﻷﺨـ‬ ‫ﺍﻷﻁـ‬ ‫ﺍﻟﻤﺸﺎﺭﻜﺔ ﻓﻲ ﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﻭﻫﻨﻐﺎﺭﻴﺎ ﻭﺠﺎﻤﺎﻴﻜﺎ ﻭﻤﺩﻏﺸﻘﺭ ﻭﻤﺎﻟﻲ ﻭﺍﻟﻤﻜـﺴﻴﻙ ﻭﺒﻨﻤـﺎ ﻭﺒﻴـﺭﻭ‬ ‫ﻭﺍﻟﺴﻭﻴﺩ ﻭﺘﺎﻴﻠﻨﺩ ﻭﺍﻟﻤﻤﻠﻜﺔ ﺍﻟﻤﺘﺤﺩﺓ ﻟﺒﺭﻴﻁﺎﻨﻴـﺎ ﺍﻟﻌﻅﻤـﻰ ﻭﺃﻴﺭﻟﻨـﺩﺍ‬ ‫ﺍﻟﺸﻤﺎﻟﻴﺔ ﻭﺃﻭﺭﻭﻏﻭﺍﻱ ﻭﻓﺎﻨﻭﺍﺘﻭ‬ ‫ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻌﺭﺽ ﺍﻟﻘﻴـﺎﻡ ﺒـﺩﻭﺭ ﺍﻟﺭﺃﺱ ﺍﻷﺨﻀﺭ ﻭﺠﺯﺭ ﻤﺎﺭﺸﺎل ﻭﺍﻟﻨﺭﻭﻴﺞ ﻭﺒﺎﻻﻭ‬ ‫ﺍﻟﻤﺭﺍﺠﻌﻴﻥ )ﺒﺎﻹﻀﺎﻓﺔ ﺇﻟـﻰ ﻤﺠﻤﻭﻋـﺔ‬ ‫ﺍﻟﺨﺒﺭﺍﺀ ﺍﻟﻌﺎﺩﻴﻴﻥ(‬ ‫ﺇﺫﺍ ﺘﻭﻟﺕ ﺍﻟﺘﻨﻔﻴﺫ ﻤﺒﺎﺩﺭﺓ ﺍﻟﺘﺤﺭﺭ ﻤﻥ ﺍﻟﺘﺒﻎ ﻓـﺴﺘﺤﺘﺎﺝ ﻋﻨﺩﺌـﺫ ﺇﻟـﻰ‬ ‫ﻤﻴﺯﺍﻨﻴﺔ ﺇﻀﺎﻓﻴﺔ‪.‬‬ ‫ﺇﺫﺍ ﺘﻭﻟﺕ ﺍﻟﺘﻨﻔﻴﺫ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻓﺴﻴﻠﺯﻡ ﻋﻨﺩﺌﺫ ﺃﻥ ﻴﻌﻁـﻲ ﻤـﺅﺘﻤﺭ‬ ‫ﺍﻷﻁﺭﺍﻑ ﺍﻟﻤﻭﺍﺭﺩ ﺍﻟﻼﺯﻤﺔ ﻷﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ‪.‬‬ ‫ﻭﻓﻲ ﻜﻠﺘﺎ ﺍﻟﺤﺎﻟﺘﻴﻥ ﺴﺘﻠﺯﻡ ﻤﻴﺯﺍﻨﻴﺔ ﺇﻀﺎﻓﻴﺔ ﻟﻀﻤﺎﻥ ﺘﻤﻜـﻥ ﻤﻨـﺩﻭﺒﻲ‬ ‫ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻨﺎﻤﻴﺔ ﻤﻥ ﺍﻟﻤﺸﺎﺭﻜﺔ‪.‬‬ ‫ﺍﻹﻁﺎﺭ ﺍﻟﺯﻤﻨﻲ‪:‬‬ ‫‪‬ﺩﺓ‬ ‫ﻭﺒﺎﻟﻨﺴﺒﺔ ﻟﻠﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﻴﻨﺒﻐﻲ ﺃﻥ ﺘﻘـﺩﻡ ﻤـﺴﻭ‬ ‫ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﺃﻭ ﻴﻘﺩﻡ ﺘﻘﺭﻴﺭ ﻤﺭﺤﻠﻲ‪ ،‬ﺤﺴﺏ ﺍﻻﻗﺘﻀﺎﺀ‪ ،‬ﺤـﻭل‬ ‫ﻤﺎ ﺘﻡ ﻤﻥ ﺃﻋﻤﺎل ﺤﺘﻰ ﺫﻟﻙ ﺍﻟﺤﻴﻥ‪.‬‬ ‫‪ ١‬ﺃﻴﻠﻭل‪ /‬ﺴﺒﺘﻤﺒﺭ ‪٢٠٠٦‬‬ ‫ﺎ‬ ‫ﻗﺒل ﺍﻟﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺒﺴﺘﻴﻥ ﻴﻭﻤﹰ‬ ‫ﺎ‬ ‫ﻗﺒل ﺍﻟﻴﻭﻡ ﺍﻷﻭل ﻟﻠﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺒﺜﻼﺜﻴﻥ ﻴﻭﻤﹰ‬ ‫ﻤﻥ ﺍﻟﻀﺭﻭﺭﻱ ﻋﻘﺩ ﺍﺠﺘﻤﺎﻉ ﺃﻭ ﺍﺠﺘﻤﺎﻋﻴﻥ‬ ‫ﺍﻵﺜﺎﺭ ﻤﻥ ﺤﻴﺙ ﺍﻟﻤﻭﺍﺭﺩ‬

‫ﻟﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ‬

‫ﻟﻠﻤﺭﺍﺠﻌﺔ‬ ‫ﻟﻌﺭﻀﻬﺎ ﻋﻠﻰ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ‬ ‫ﻟﺘﻌﻤﻴﻤﻬﺎ ﻋﻠﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪50‬‬

‫ﺍﻟﻤﺭﻓﻕ ‪ :٢‬ﺍﻟﻤﺎﺩﺓ ‪ :٩‬ﺘﻨﻅﻴﻡ ﺍﻟﻤﻨﺘﺠﺎﺕ‬ ‫ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﻟﺘﻨﻔﻴﺫ ﺍﻟﻤﺎﺩﺘﻴﻥ ‪ ٩‬ﻭ‪ ١٠‬ﺒﺸﺄﻥ ﺘﻨﻅﻴﻡ ﻤﺤﺘﻭﻴﺎﺕ‬ ‫ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﻭﺘﻨﻅﻴﻡ ﺍﻟﻜﺸﻑ ﻋﻥ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ‬ ‫ﺍﻟﻤﻭﻀﻭﻉ‬ ‫ﻤﻘﺩﻤﺔ‬

‫ﻴﺘﻀﻤﻥ ﻭﻀﻊ ﻫﺫﻩ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﺜـﻼﺙ ﻤﺭﺍﺤـل‪ :‬ﺍﻟﻤﺭﺤﻠـﺔ‬ ‫ﺍﻷﻭﻟﻰ ‪ -‬ﻭﻀﻊ ﻤﺒﺩﺃ ﺘﻭﺠﻴﻬﻲ ﻟﻔﺤﺹ ﻭﻗﻴﺎﺱ ﻤﺤﺘﻭﻴﺎﺕ ﻭﺍﻨﺒﻌﺎﺜـﺎﺕ‬ ‫ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ؛ ﺍﻟﻤﺭﺤﻠﺘﺎﻥ ﺍﻟﺜﺎﻨﻴﺔ ﻭﺍﻟﺜﺎﻟﺜﺔ – ﻤﻌﺎﻟﺠﺔ ﺍﻟﻠﻭﺍﺌﺢ ﺍﻟﺘﻨﻅﻴﻤﻴﺔ‬ ‫ﻭ‪ /‬ﺃﻭ ﺍﻟﻜﺸﻑ )ﺍﻟﻤﺎﺩﺓ ‪ .(١٠‬ﻭﻴﻨﻅﺭ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓـﻲ ﺘﺭﺘﻴـﺏ‬ ‫ﺘﻨﺎﻭل ﺍﻟﻤﺭﺤﻠﺘﻴﻥ ﺍﻟﺜﺎﻨﻴﺔ ﻭﺍﻟﺜﺎﻟﺜﺔ ﻓﻲ ﺩﻭﺭﺘﻪ ﺍﻟﺜﺎﻨﻴﺔ‪.‬‬ ‫ﺎ‬ ‫ﺍﺘﺨﺎﺫ ﻓﺤﺹ ﻭﻗﻴﺎﺱ ﻤﺤﺘﻭﻴﺎﺕ ﻭﺍﻨﺒﻌﺎﺜﺎﺕ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﺃﺴﺎﺴﹰ‬ ‫ﻟﻠﺘﻨﻅﻴﻡ‬ ‫ﺇﻋﻁﺎﺀ ﻤﺒﺎﺩﺉ ﺘﻭﺠﻴﻬﻴﺔ ﻟﻔﺤﺹ ﻭﻗﻴﺎﺱ ﻤﺤﺘﻭﻴـﺎﺕ ﻭﺍﻨﺒﻌﺎﺜـﺎﺕ‬ ‫ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ‬ ‫ﺘﻨﺎﻭل ﻓﺤﺹ ﻭﻗﻴﺎﺱ ﻤﺤﺘﻭﻴﺎﺕ ﺍﻟﺘﺒﻎ ﻭﺍﻨﺒﻌﺎﺜﺎﺕ ﺍﻟـﺩﺨﺎﻥ ﻤـﻥ‬ ‫ﻤﻨﻅﻭﺭ ﺍﻟﺼﺤﺔ ﺍﻟﻌﻤﻭﻤﻴﺔ‬ ‫ﻻ(‬ ‫ﺍﻟﺒﺩﺀ ﺒﺎﻟﺴﺠﺎﺌﺭ )ﻷﻨﻬﺎ ﺃﺸﻴﻊ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﺍﺴﺘﻌﻤﺎ ﹰ‬ ‫ﺍﻟﺘﺭﻜﻴﺯ ﻋﻠﻰ ﻤﺠﻤﻭﻋﺔ ﻤﻌﻴﻨﺔ ﻤﻥ ﺍﻟﻤﻭﺍﺩ ﺃﻭ ﺍﻨﺒﻌﺎﺜﺎﺕ ﺍﻟـﺩﺨﺎﻥ‬ ‫ﺍﻟﻀﺎﺭﺓ ﺒﻭﺠﻪ ﺨﺎﺹ‬ ‫ﺇﺩﺨﺎل ﻤﻌﺎﻴﻴﺭ ﻟﺘﻘﺩﻴﺭ ﻤﺩﻯ ﺴﻤﻴﺔ ﺘﻠﻙ ﺍﻟﻤﻭﺍﺩ ﻭ‪ /‬ﺃﻭ ﺍﻟﻤﻨﺘﺠـﺎﺕ‬ ‫ﻭﺘﺴﺒﺒﻬﺎ ﻓﻲ ﺍﻹﺩﻤﺎﻥ ﻭﺍﺠﺘﺫﺍﺒﻬﺎ ﻟﻤﺘﻌﺎﻁﻴﻬﺎ‬ ‫ﺩﺭﺍﺴﺔ ﺍﻟﺴﻤﺎﺕ ﺍﻟﺘﻲ ﺘﺼﻤﻡ ﺒﻬﺎ ﺘﻠﻙ ﺍﻟﻤﻨﺘﺠﺎﺕ‬ ‫ﺇﻋﺩﺍﺩ ﺘﻭﺼﻴﺔ ﺒﻤﻭﺍﺼﻠﺔ ﺍﻟﻌﻤل ﻹﻋـﻼﻡ ﺍﻷﻁـﺭﺍﻑ ﺍﻟﻤﺘﻌﺎﻗـﺩﺓ‬ ‫ﺒﻜﻴﻔﻴﺔ ﺍﻟﻘﻴﺎﻡ‪ ،‬ﻋﻠﻰ ﺃﻓﻀل ﻭﺠﻪ‪ ،‬ﺒﺎﻋﺘﻤﺎﺩ ﺍﺴﺘﺭﺍﺘﻴﺠﻴﺎﺕ ﺠﺩﻴـﺩﺓ‬ ‫‪‬ﻨﺎﺕ ﻋﻠﻤﻴﺔ ﺠﺩﻴـﺩﺓ‬ ‫ﻟﺘﻨﻅﻴﻡ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ‪ ،‬ﻤﻊ ﺍﻟﺤﺼﻭل ﻋﻠﻰ ﺒﻴ‬ ‫ﻭﻤﻊ ﺇﺩﺨﺎل ﻤﻨﺘﺠﺎﺕ ﺠﺩﻴﺩﺓ ﺃﻭ ﻤﻌﺩﻟﺔ ﺇﻟﻰ ﺍﻷﺴﻭﺍﻕ‬ ‫ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﺘﺴﺎﻋﺩ ﺍﻟﺴﻠﻁﺎﺕ ﺍﻟﻭﻁﻨﻴﺔ ﻓـﻲ ﺘﻨﻔﻴـﺫ ﻫـﺫﻩ‬ ‫ﺍﻟﻤﺎﺩﺓ‪ ،‬ﻭﻤﻥ ﺜﻡ ﺘﻴﺴﺭ ﻓﺭﺽ ﺍﻟﻀﻭﺍﺒﻁ ﺍﻟﺘﻨﻅﻴﻤﻴﺔ ﻋﻠﻰ ﺍﻟﺘﺒﻎ‬ ‫ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﺘﻔﻀﻲ ﺇﻟﻰ ﺇﻋﺩﺍﺩ ﻤﺠﻤﻭﻋﺔ ﺒﻴﺎﻨﺎﺕ ﻤـﺴﺘﻘﻠﺔ‬ ‫ﻭﻁﺭﻕ ﻟﻠﻔﺤﺹ ﻭﺍﻟﻘﻴﺎﺱ ﻓﻴﻤﺎ ﻴﺘﻌﻠﻕ ﺒﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﻭﺍﻨﺒﻌﺎﺜﺎﺘﻬﺎ‬ ‫ﻤﻥ ﻤﻨﻅﻭﺭ ﺍﻟﺼﺤﺔ ﺍﻟﻌﻤﻭﻤﻴﺔ ﻓﻲ ﺍﻷﻤﺩﻴﻥ ﺍﻟﻤﺘﻭﺴﻁ ﻭﺍﻟﻁﻭﻴل‬ ‫ﺍﻟﺘﻌﺎﻭﻥ ﺍﻟﺩﻭﻟﻲ ﻓﻲ ﻫﺫﺍ ﺍﻟﻤﺠﺎل ﻴﺅﺩﻱ ﺇﻟـﻰ ﺘﻘﺎﺴـﻡ ﺍﻟﺘﻜـﺎﻟﻴﻑ‬ ‫ﻭﺍﻟﺨﺒﺭﺍﺕ )ﺍﻟﻘﻴﻤﺔ ﺍﻟﻤﻀﺎﻓﺔ ﻟﻠﺘﻌﺎﻭﻥ ﺍﻟﺩﻭﻟﻲ(‬

‫ﻴﺘﻤﺜل ﺍﻟﻐﺭﺽ ﺍﻟﻌﺎﻡ ﻟﻠﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﻟﺘﻨﻔﻴﺫ ﺃﺤﻜـﺎﻡ ﺍﻟﻤـﺎﺩﺘﻴﻥ ‪٩‬‬ ‫ﻭ‪ ١٠‬ﻓﻲ ﻤﺴﺎﻋﺩﺓ ﺍﻷﻁﺭﺍﻑ ﻋﻠﻰ ﺘﻌﺯﻴﺯ ﺘﻨﻅﻴﻡ ﻤﺤﺘﻭﻴﺎﺕ ﻤﻨﺘﺠـﺎﺕ‬ ‫ﺍﻟﺘﺒﻎ‪.‬‬

‫•‬ ‫•‬

‫ﺍﻟﻤﺤﺘﻭﻴﺎﺕ‪:‬‬ ‫ﺍﻷﺴﺎﺱ ﺍﻟﻤﻨﻁﻘﻲ‬ ‫ﺍﻟﻐﺭﺽ‬

‫ﺍﻟﺘﻌﺭﻴﻑ ﺍﻟﻭﺍﻀﺢ ﻟﻠﻌﻨﺎﺼﺭ ﺍﻟﻭﺍﺭﺩﺓ ﻓﻲ •‬ ‫ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ‬ ‫•‬ ‫•‬ ‫•‬ ‫•‬ ‫•‬

‫•‬ ‫•‬ ‫•‬

‫ﺍﻻﺤﺘﻴﺎﺠﺎﺕ‪ /‬ﺍﻟﻘﻴﻤﺔ ﺍﻟﻤﻀﺎﻓﺔ‬

‫‪51‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬ ‫ﺍﻟﻌﻤل ﺍﻟﺤﺎﻟﻲ ﺍﻟﺫﻱ ﻴﻤﻜﻥ ﺍﻻﺴﺘﻨﺎﺩ ﺇﻟﻴﻪ‬

‫ﺎ‬ ‫ﺇﻋﺩﺍﺩ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﺒﺎﻻﺴﺘﻨﺎﺩ ﺇﻟﻰ ﺍﻟﻌﻤل ﺍﻟﺫﻱ ﺘﻀﻁﻠﻊ ﺒﻬﺎ ﺤﺎﻟﻴﹰ‬ ‫ﻤﺠﻤﻭﻋﺔ ﺍﻟﺩﺭﺍﺴﺔ ﺍﻟﻤﻌﻨﻴﺔ ﺒﺘﻨﻅﻴﻡ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﻭﻤﺒـﺎﺩﺭﺓ ﻤﻨﻅﻤـﺔ‬ ‫ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻟﺨﺎﺼﺔ ﺒﺎﻟﺘﺤﺭﺭ ﻤﻥ ﺍﻟﺘﺒﻎ )ﻋﻠﻰ ﻤﻨﻅﻤﺔ ﺍﻟـﺼﺤﺔ‬ ‫ﺍﻟﻌﺎﻟﻤﻴﺔ‪ /‬ﻤﺒﺎﺩﺭﺓ ﺍﻟﺘﺤﺭﺭ ﻤﻥ ﺍﻟﺘﺒﻎ ﺃﻥ ﺘﺤﺩﺩ ﻓﻲ ﻭﺜﻴﻘﺔ ﻤﺎ ﺍﻟﺫﻱ ﻴﻤﻜﻥ‬ ‫ﺃﻥ ﺘﻨﺠﺯﻩ ﺒﺎﻟﻔﻌل ﻭﺃﻥ ﺘﻭﺍﺼل ﺍﻟﻌﻤل ﺒﺸﺄﻥ ﻫﺫﺍ ﺍﻟﻤﻭﻀﻭﻉ(‪.‬‬

‫ﺍﻟﺠﻬﺔ ﺍﻟﻘﺎﺌﻤﺔ ﺒﺎﻟﺘﻨﻔﻴﺫ )ﺒﺘﻔـﻭﻴﺽ ﻤـﻥ ﺘﺴﺘﻬل ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻋﻤﻠﻬﺎ ﻤﻊ ﻤﺒﺎﺩﺭﺓ ﻤﻨﻅﻤﺔ ﺍﻟـﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴـﺔ‬ ‫ﺍﻟﺨﺎﺼﺔ ﺒﺎﻟﺘﺤﺭﺭ ﻤﻥ ﺍﻟﺘﺒﻎ ﻭﻤﺠﻤﻭﻋﺔ ﺍﻟﺩﺭﺍﺴـﺔ ﺍﻟﻤﻌﻨﻴـﺔ ﺒﺘﻨﻅـﻴﻡ‬ ‫ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ(‬ ‫ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﺒﺎﻟﺘﺸﺎﻭﺭ ﻤﻊ ﺍﻟﻬﻴﺌﺎﺕ ﺍﻟﺩﻭﻟﻴﺔ ﺍﻟﻤﺨﺘﺼﺔ ﻋﻨﺩ ﺍﻟﻀﺭﻭﺭﺓ‬ ‫‪‬ﺭﻴﻥ ﺭﺌﻴـﺴﻴﻴﻥ‪،‬‬ ‫– ﺒﺈﺭﺸﺎﺩﺍﺕ ﻤﻥ ﺍﻷﻁﺭﺍﻑ ﺍﻟﻤﺘﻌﺎﻗﺩﺓ ﺍﻟﻤﺤﺩﺩﺓ ﻜﻤﻴﺴ‬ ‫ﻭﺒﻤﺴﺎﻋﺩﺓ ﻤﻥ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺭﺍﻏﺒﺔ ﻓﻲ ﺍﻟﻌﻤل ﻋﻠﻰ ﻀـﻤﺎﻥ ﺍﻟﺘﻤﺜﻴـل‬ ‫ﺍﻹﻗﻠﻴﻤﻲ‪.‬‬ ‫ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻌﺭﺽ ﺍﻟﻘﻴـﺎﻡ ﺒـﺩﻭﺭ ﻜﻨﺩﺍ ﻭﺍﻟﺠﻤﺎﻋﺔ ﺍﻷﻭﺭﻭﺒﻴﺔ ﻭﺍﻟﻨﺭﻭﻴﺞ‬ ‫ﺍﻟﻤﻴﺴﺭﻴﻥ ﺍﻟﺭﺌﻴﺴﻴﻴﻥ‬ ‫ـﺭﺽ ﺍﻟﺒﺭﺍﺯﻴل ﻭﺍﻟﺼﻴﻥ ﻭﺍﻟﺩﺍﻨﻤﺭﻙ ﻭﻓﻨﻠﻨﺩﺍ ﻭﻫﻨﻐﺎﺭﻴـﺎ ﻭﺍﻷﺭﺩﻥ ﻭﻜﻴﻨﻴـﺎ‬ ‫ـﻲ ﺘﻌـ‬ ‫ـﺭﻯ ﺍﻟﺘـ‬ ‫ـﺭﺍﻑ ﺍﻷﺨـ‬ ‫ﺍﻷﻁـ‬ ‫ﺍﻟﻤﺸﺎﺭﻜﺔ ﻓﻲ ﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﻭﺍﻟﻤﻜﺴﻴﻙ ﻭﻫﻭﻟﻨﺩﺍ ﻭﺘﺎﻴﻠﻨﺩ ﻭﺍﻟﻤﻤﻠﻜﺔ ﺍﻟﻤﺘﺤﺩﺓ ﻟﺒﺭﻴﻁﺎﻨﻴـﺎ ﺍﻟﻌﻅﻤـﻰ‬ ‫ﻭﺃﻴﺭﻟﻨﺩﺍ ﺍﻟﺸﻤﺎﻟﻴﺔ‬ ‫ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻌﺭﺽ ﺍﻟﻘﻴـﺎﻡ ﺒـﺩﻭﺭ ﺃﺴﺘﺭﺍﻟﻴﺎ ﻭﻓﺭﻨﺴﺎ ﻭﺠﺎﻤﺎﻴﻜﺎ‬ ‫ﺍﻟﻤﺭﺍﺠﻌﻴﻥ )ﺒﺎﻹﻀﺎﻓﺔ ﺇﻟـﻰ ﻤﺠﻤﻭﻋـﺔ‬ ‫ﺍﻟﺨﺒﺭﺍﺀ ﺍﻟﻌﺎﺩﻴﻴﻥ(‬ ‫ﺘﻨﻅﺭ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ‪ ،‬ﺒﺎﻟﺘﺸﺎﻭﺭ ﻤﻊ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﻓﻲ ﺨﻁﺔ‬ ‫ﺍﻟﻌﻤل ﻭﺍﻵﺜﺎﺭ ﺍﻟﻤﻴﺯﻨﻴﺔ‪.‬‬ ‫‪‬ﺩﺓ‬ ‫ﻴﻌﺭﺽ ﻋﻠﻰ ﺍﻟﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁـﺭﺍﻑ ﻤـﺴﻭ‬ ‫ﻴﻨﺒﻐﻲ ﺃﻥ ‪‬‬ ‫ﻟﻠﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﺃﻭ ﺘﻘﺭﻴﺭ ﻤﺭﺤﻠﻲ ﻋﻥ ﺍﻟﻌﻤل ﺍﻟﺫﻱ ﺘﻡ ﺍﻟﻘﻴﺎﻡ ﺒـﻪ‬ ‫ﺤﺘﻰ ﺫﻟﻙ ﺍﻟﺤﻴﻥ‪.‬‬ ‫ﺎ ﻋﻠﻰ ﺍﻷﻗل‬ ‫ﻗﺒل ﻋﺭﻀﻬﺎ ﻋﻠﻰ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ ﺒﺴﺘﻴﻥ ﻴﻭﻤﹰ‬ ‫ﺎ ﻋﻠﻰ‬ ‫ﻗﺒل ﺍﻟﻴﻭﻡ ﺍﻷﻭل ﻟﻠﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺒﺘﺴﻌﻴﻥ ﻴﻭﻤﹰ‬ ‫ﺍﻷﻗل‬ ‫ﺎ ﻋﻠﻰ‬ ‫ﻗﺒل ﺍﻟﻴﻭﻡ ﺍﻷﻭل ﻟﻠﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺒﺜﻼﺜﻴﻥ ﻴﻭﻤﹰ‬ ‫ﺍﻷﻗل‬ ‫ﺍﻵﺜﺎﺭ ﻤﻥ ﺤﻴﺙ ﺍﻟﻤﻭﺍﺭﺩ‬ ‫ﺍﻹﻁﺎﺭ ﺍﻟﺯﻤﻨﻲ‪:‬‬

‫ﺍﻟﻌﻤﻠﻴﺔ‪:‬‬

‫ﻟﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ‬ ‫ﻟﻠﻤﺭﺍﺠﻌﺔ‬ ‫ﻟﻌﺭﻀﻬﺎ ﻋﻠﻰ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ‬ ‫ﻟﺘﻌﻤﻴﻤﻬﺎ ﻋﻠﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪52‬‬

‫ﹸﻨﺎﻗﺵ ﺒﻌﺩ( ﻟﻭﻀﻊ ﻤﺒﺎﺩﺉ ﺘﻭﺠﻴﻬﻴﺔ ﻓﻴﻤﺎ ﻴﺘﻌﻠﻕ ﺒﺘﻐﻠﻴﻑ‬ ‫ﺍﻟﻤﺭﻓﻕ ‪ :٣‬ﻨﻤﻭﺫﺝ ﺨﻁﺔ ﻋﻤل )ﻟﻡ ﺘ‬ ‫ﻭﺘﻭﺴﻴﻡ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ‬ ‫ﺍﻟﻤﺎﺩﺓ ‪:١١‬‬ ‫ﺘﻐﻠﻴﻑ ﻭﺘﻭﺴﻴﻡ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ‬ ‫ﺇﻥ ﺩﻭﺍﺌﺭ ﺼﻨﺎﻋﺔ ﺍﻟﺘﺒﻎ ﺘﺯﺩﻫﺭ ﻋﻥ ﻁﺭﻴﻕ ﺒﺙ ﻤﻌﻠﻭﻤـﺎﺕ ﻤـﻀﻠﻠﺔ‬ ‫ﺤﻭل ﻤﺩﻯ ﺘﻘﺒل ﺍﻟﻤﺠﺘﻤﻊ ﻟﻤﻨﺘﺠﺎﺘﻬﺎ ﻭﺁﺜﺎﺭﻫﺎ ﺍﻟﺼﺤﻴﺔ‪ .‬ﻭﻟﻜﺒﺢ ﺠﻤﺎﺡ‬ ‫ﻭﺒﺎﺀ ﺘﻌﺎﻁﻲ ﺍﻟﺘﺒﻎ‪ ،‬ﻴﻨﺒﻐﻲ ﺘﻭﻋﻴﺔ ﻤﺴﺘﻬﻠﻜﻲ ﻫﺫﻩ ﺍﻟﻤﻨﺘﺠﺎﺕ ﺒﻌﻭﺍﻗـﺏ‬ ‫ﺘﻌﺎﻁﻴﻬﺎ‪.‬‬ ‫ﺍﻟﻤﻭﻀﻭﻉ‬ ‫ﺍﻷﻏﺭﺍﺽ ﻭﺍﻷﺴﺎﺱ ﺍﻟﻤﻨﻁﻘﻲ‬

‫ﺍﻟﻤﺤﺘﻭﻴﺎﺕ‪:‬‬

‫ﺘﺯﻭﻴﺩ ﺍﻟﻤﺴﺘﻬﻠﻜﻴﻥ ﺒﻤﻌﻠﻭﻤﺎﺕ ﺃﻓﻀل ﻗﺎﺌﻤﺔ ﻋﻠﻰ ﺍﺨﺘﺒﺎﺭ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ‬ ‫ﻓﻲ ﺍﻟﺒﺸﺭ‪ ،‬ﻭﺘﺠﻨﺏ ﻨﻘل ﺍﻻﻨﻁﺒﺎﻉ ﺒﺄﻥ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﻟﻬﺎ ﻤﻨﺎﻓﻊ ﺼﺤﻴﺔ‬ ‫ﻨﺴﺒﻴﺔ‪.‬‬

‫ﺍﻟﺘﻌﺭﻴﻑ ﺍﻟﻭﺍﻀﺢ ﻟﻠﻌﻨﺎﺼﺭ ﺍﻟﻭﺍﺭﺩﺓ ﻓﻲ ﻴﺠﺏ ﺃﻥ ﺘﺤﻤل ﻋﺒﻭﺓ ﻤﻨﺘﺞ ﺍﻟﺘﺒﻎ ﻭﺒﻁﺎﻗﺎﺕ ﺍﻟﺘﻭﺴﻴﻡ ﻤﻌﻠﻭﻤﺎﺕ ﻋﻥ‪:‬‬ ‫ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ‬ ‫• ﺍﻟﺘﺤﺫﻴﺭﺍﺕ ﺍﻟﺼﺤﻴﺔ‬ ‫ﺎ ﺤﻭل ﺍﻟﻤﻜﻭﻨﺎﺕ ﺃﻭ ﺍﻻﻨﺒﻌﺎﺜﺎﺕ ﺍﻟﺴﺎﻤﺔ‬ ‫ﺒﻴﺎﻨﹰ‬ ‫ﺍﻟﻠﻐﺔ )ﺍﻟﻠﻐﺎﺕ( ﺍﻟﺭﺴﻤﻴﺔ ﻟﻠﺒﻠﺩ‬ ‫ﺭﺴﺎﺌل ﻭﺍﻓﻴﺔ ﻋﻥ ﺍﻹﻗﻼﻉ ﻋﻥ ﺍﻟﺘﺩﺨﻴﻥ‬ ‫•‬ ‫•‬

‫ﻤﻌﻠﻭﻤﺎﺕ ﻋﻥ ﺍﻟﺘﺄﺜﻴﺭﺍﺕ ﺍﻻﻗﺘﺼﺎﺩﻴﺔ ﺍﻟﻀﺎﺭﺓ‬ ‫ﺤﺠﻡ ﺍﻟﺒﻁﺎﻗﺔ ﺍﻟﻤﻭﻀﻭﻋﺔ ﻋﻠﻰ ﺍﻟﻌﺒﻭﺓ‬ ‫ﺍﺴﺘﺨﺩﺍﻡ ﺍﻟﺘﺤﺫﻴﺭﺍﺕ ﺍﻟﻤﺼﻭﺭﺓ‬

‫•‬

‫•‬

‫ﺘﺒﺎﺩل ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﻋﻥ ﺃﻓﻀل ﺍﻟﻤﻤﺎﺭﺴﺎﺕ ﺍﻟﺩﻭﻟﻴﺔ‬

‫•‬

‫•‬ ‫ﺍﻻﺤﺘﻴﺎﺠﺎﺕ‪ /‬ﺍﻟﻘﻴﻤﺔ ﺍﻟﻤﻀﺎﻓﺔ‬ ‫ﺍﻟﻌﻤل ﺍﻟﺤﺎﻟﻲ ﺍﻟﺫﻱ ﻴﻤﻜﻥ ﺍﻻﺴﺘﻨﺎﺩ ﺇﻟﻴﻪ‬

‫ﺘﻌﺯﻴﺯ ﺍﻟﺘﺩﺍﺒﻴﺭ ﻭﺍﻟﺘﺸﺭﻴﻌﺎﺕ‬

‫•‬

‫ﻤﻨﺸﻭﺭﺍﺕ ﺍﻟﺤﻜﻭﻤـﺎﺕ‪ ،‬ﻭﺍﻟﻤﻨﻅﻤـﺎﺕ ﺍﻟﺤﻜﻭﻤﻴـﺔ ﺍﻟﺩﻭﻟﻴـﺔ‪،‬‬ ‫ﻭﺍﻟﻤﻨﻅﻤﺎﺕ ﻏﻴﺭ ﺍﻟﺤﻜﻭﻤﻴﺔ‪ ،‬ﻭﻏﻴﺭ ﺫﻟﻙ ﻤﻥ ﺍﻟﻤﻨﺸﻭﺭﺍﺕ‪ ،‬ﺒﻤـﺎ‬ ‫ﻓﻴﻬﺎ ﺍﻟﺩﺭﺍﺴﺎﺕ ﺍﻟﺭﺴﻤﻴﺔ ﻭﻏﻴﺭ ﺍﻟﺭﺴﻤﻴﺔ ﺍﻟﺘﻲ ﺘﻨﺸﺭﻫﺎ ﻤﻨﻅﻤـﺔ‬ ‫ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ‬

‫ﺍﻟﺩﺭﺍﺴﺎﺕ ﺍﻟﺭﺴﻤﻴﺔ ﻭﻏﻴﺭ ﺍﻟﺭﺴﻤﻴﺔ ﺍﻟﺘﻲ ﺘﻜﻠﻑ ﺍﻟﻤﻨﻅﻤﺔ ﺠﻬﺎﺕ‬ ‫ﻤﻌﻴﻨﺔ ﺒﺈﺠﺭﺍﺌﻬﺎ‬

‫ﺍﻟﻤﻭﺍﺭﺩ ﺍﻟﻤﺘﺎﺤﺔ ﺘﺸﻤل‪:‬‬

‫•‬

‫•‬

‫•‬

‫ﺍﻟﺠﻬﺔ ﺍﻟﻘﺎﺌﻤﺔ ﺒﺎﻟﺘﻨﻔﻴﺫ )ﺒﺘﻔـﻭﻴﺽ ﻤـﻥ ﺍﻟﺨﻴﺎﺭ ‪ -١‬ﺘﻌﻤل ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺍﻟﺘﻲ ﺴﺘﻔﻭﺽ‪ ،‬ﺒﺎﻟﻘﻴﺎﻡ ﺒﻬﺫﺍ ﺍﻟـﺩﻭﺭ‪،‬‬ ‫ﻤﻊ ﻤﺒﺎﺩﺭﺓ ﺍﻟﺘﺤﺭﺭ ﻤﻥ ﺍﻟﺘﺒﻎ‪.‬‬ ‫ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ(‬ ‫ﺍﻟﺨﻴﺎﺭ ‪ -٢‬ﻟﻤﺒﺎﺩﺭﺓ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻟﺨﺎﺼﺔ ﺒﺎﻟﺘﺤﺭﺭ ﻤـﻥ‬ ‫ﺍﻟﺘﺒﻎ ﻤﻥ ﺃﺠل ﺍﺴﺘﻤﺭﺍﺭ ﺍﻟﺘﻌﺎﻭﻥ ﻤﻊ ﻤﺠﻤﻭﻋـﺔ ﺍﻟﺩﺭﺍﺴـﺔ ﺍﻟﻤﻌﻨﻴـﺔ‬ ‫ﺒﺘﻨﻅﻴﻡ ﺍﻟﺘﺒﻎ ﻭﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﺒﻐﺭﺽ ﻤﺭﺍﺠﻌﺘﻬﺎ ﻭﺇﻗﺭﺍﺭﻫﺎ‬ ‫ﻭﺍﻋﺘﻤﺎﺩﻫﺎ ﻤﻥ ﻗﺒل ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪.‬‬

‫ﺍﻟﻌﻤﻠﻴﺔ‪:‬‬

‫‪53‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺍﻟﺨﻴﺎﺭ ‪ -٣‬ﺇﻨﺸﺎﺀ ﻓﺭﻴﻕ ﻏﻴﺭ ﺭﺴﻤﻲ ﻤﻥ ﺍﻟﺨﺒﺭﺍﺀ ﻓﻲ ﻤﺠﺎل ﺍﻟﻔﺤﺹ‬ ‫ﻭﺍﻟﺒﺤﻭﺙ ﺒﺸﺄﻥ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ‪ ،‬ﻭﺘﺼﻤﻴﻤﻬﺎ‪ ،‬ﻭﺇﺩﻤﺎﻨﻬﺎ‪ ،‬ﻭﺍﻟﺤـﺩ ﻤـﻥ‬ ‫ﺃﻀﺭﺍﺭﻫﺎ‪ ،‬ﻭﺍﻟﻠﻭﺍﺌﺢ ﺍﻟﻤﻨﻅﻤﺔ ﻟﻬﺎ‪.‬‬ ‫ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻌﺭﺽ ﺍﻟﻘﻴـﺎﻡ ﺒـﺩﻭﺭ ﺍﻟﺒﺭﺍﺯﻴل ﻭﻜﻨﺩﺍ‬ ‫ﺍﻟﻤﻴﺴﺭﻴﻥ ﺍﻟﺭﺌﻴﺴﻴﻴﻥ )ﻋﻥ ﻁﺭﻴﻕ ﺤﺸﺩ‬ ‫ﺍﻟﻤﻭﺍﺭﺩ ﺃﻭ ﺒﻭﺍﺴﻁﺔ ﺍﻷﻋﻤﺎل ﺍﻟﺘﻘﻨﻴﺔ(‬ ‫ـﺭﺽ ﺃﺴﺘﺭﺍﻟﻴﺎ ﻭﺍﻟﺼﻴﻥ ﻭﺠﻴﺒﻭﺘﻲ ﻭﺍﻟﺠﻤﺎﻋﺔ ﺍﻷﻭﺭﻭﺒﻴﺔ ﻭﻫﻨﻐﺎﺭﻴﺎ ﻭﻤـﺎﻟﻲ‬ ‫ـﻲ ﺘﻌـ‬ ‫ـﺭﻯ ﺍﻟﺘـ‬ ‫ـﺭﺍﻑ ﺍﻷﺨـ‬ ‫ﺍﻷﻁـ‬ ‫ﺍﻟﻤﺸﺎﺭﻜﺔ ﻓﻲ ﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﻭﺍﻟﻤﻜﺴﻴﻙ ﻭﺒﻨﻤﺎ ﻭﺒﻴﺭﻭ ﻭﺴـﻨﻐﺎﻓﻭﺭﺓ ﻭﺠﻨـﻭﺏ ﺃﻓﺭﻴﻘﻴـﺎ ﻭﺘﺎﻴﻠﻨـﺩ‬ ‫ﻭﺃﻭﺭﻭﻏﻭﺍﻱ‬ ‫ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻌﺭﺽ ﺍﻟﻘﻴـﺎﻡ ﺒـﺩﻭﺭ ﻨﻴﻭﺯﻴﻠﻨﺩﺍ‬ ‫ﺍﻟﻤﺭﺍﺠﻌﻴﻥ )ﺒﺎﻹﻀﺎﻓﺔ ﺇﻟـﻰ ﻤﺠﻤﻭﻋـﺔ‬ ‫ﺍﻟﺨﺒﺭﺍﺀ ﺍﻟﻌﺎﺩﻴﻴﻥ(‬ ‫ﺍﻟﺨﻴﺎﺭ ‪ -١‬ﺘﻜﻭﻥ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻤﻴﺯﺍﻨﻴﺔ ﻟﺫﻟﻙ ﺃﻭ ﻴﻘـﻭﻡ ﺒﺤـﺸﺩ‬ ‫ﺍﻟﻤﻭﺍﺭﺩ ﻋﻥ ﻁﺭﻴﻕ ﻁﺭﻑ ﺃﻭ ﺃﻜﺜﺭ ﻤﻥ ﺍﻟﻤﻴـﺴﺭﻴﻥ )ﻤـﻥ ﺍﻟﻘﺎﺌﻤـﺔ‬ ‫ﺍﻟﻭﺍﺭﺩﺓ ﺃﻋﻼﻩ(‪.‬‬ ‫ﺍﻟﺨﻴﺎﺭ ‪ -٢‬ﻴﻤﻜﻥ ﺘﻬﻴﺌﺔ ﻤﺒﺎﺩﺭﺓ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴـﺔ ﺍﻟﺨﺎﺼـﺔ‬ ‫ﺒﺎﻟﺘﺤﺭﺭ ﻤﻥ ﺍﻟﺘﺒﻎ ﻟﻜﻲ ﺘﺴﺎﻋﺩ ﺍﻟﺒﻠﺩﺍﻥ ﻋﻠﻰ ﺯﻴﺎﺩﺓ ﻗـﺩﺭﺍﺘﻬﺎ‪ ،‬ﻭﻟﻜـﻥ‬ ‫ﺍﻟﻤﺒﺎﺩﺭﺓ ﺴﻭﻑ ﺘﺤﺘﺎﺝ ﺇﻟﻰ ﻤﺯﻴﺩ ﻤﻥ ﺍﻟﺘﻤﻭﻴل ﻤﻥ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻤﺎﻨﺤﺔ ﺇﺫﺍ‬ ‫ﺘﻘﺭﺭ ﻋﻘﺩ ﺃﻜﺜﺭ ﻤﻥ ﺍﺠﺘﻤﺎﻉ ﻭﺍﺤﺩ‪.‬‬ ‫ﺍﻟﺨﻴﺎﺭ ‪ -٣‬ﺘﻜﻭﻥ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻤﻴﺯﺍﻨﻴﺔ ﻟﺫﻟﻙ ﺃﻭ ﻴﻘـﻭﻡ ﺒﺤـﺸﺩ‬ ‫ﺍﻟﻤﻭﺍﺭﺩ ﺒﻁﺭﻴﻘﺔ ﺃﺨﺭﻯ‪.‬‬ ‫‪‬ﺤﺘﺎﺝ ﺇﻟﻰ ﻤﻴﺯﺍﻨﻴﺔ ﺇﻀـﺎﻓﻴﺔ ﻟـﻀﻤﺎﻥ‬ ‫ﻓﻲ ﺍﻟﺤﺎﻻﺕ ﺍﻟﺜﻼﺙ‪ ،‬ﺴﻭﻑ ﻴ‬ ‫ﺘﻤﻜﻥ ﻤﻨﺩﻭﺒﻲ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻨﺎﻤﻴﺔ ﻤﻥ ﺍﻟﻤﺸﺎﺭﻜﺔ‪.‬‬ ‫ﺍﻹﻁﺎﺭ ﺍﻟﺯﻤﻨﻲ‪:‬‬ ‫ﺴﻴﻠﺯﻡ ﻋﻘﺩ ﺍﺠﺘﻤﺎﻉ ﺃﻭ ﺍﺠﺘﻤﺎﻋﻴﻥ‬ ‫‪ ١‬ﺃﻴﻠﻭل‪ /‬ﺴﺒﺘﻤﺒﺭ ‪٢٠٠٦‬‬ ‫ﺎ‬ ‫ﻗﺒل ﺍﻟﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺒﺴﺘﻴﻥ ﻴﻭﻤﹰ‬ ‫ﺎ‬ ‫ﻗﺒل ﺍﻟﻴﻭﻡ ﺍﻷﻭل ﻟﻠﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺒﺜﻼﺜﻴﻥ ﻴﻭﻤﹰ‬ ‫ﺍﻵﺜﺎﺭ ﻤﻥ ﺤﻴﺙ ﺍﻟﻤﻭﺍﺭﺩ‬

‫ﻟﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ‬ ‫ﻟﻠﻤﺭﺍﺠﻌﺔ‬ ‫ﻟﻌﺭﻀﻬﺎ ﻋﻠﻰ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ‬ ‫ﻟﺘﻌﻤﻴﻤﻬﺎ ﻋﻠﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪54‬‬

‫ﹸﻨﺎﻗﺵ ﺒﻌﺩ( ﻟﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﻟﺘﻨﻅﻴﻡ ﺍﻹﻋﻼﻥ‬ ‫ﺍﻟﻤﺭﻓﻕ ‪ :٤‬ﻨﻤﻭﺫﺝ ﻟﺨﻁﺔ ﻋﻤل )ﻟﻡ ﺘ‬ ‫ﺍﻟﻌﺎﺒﺭ ﻟﻠﺤﺩﻭﺩ‬ ‫ﺍﻟﻤﺎﺩﺓ ‪:١٣‬‬ ‫ﺘﻨﻅﻴﻡ ﺍﻹﻋﻼﻥ ﺍﻟﻌﺎﺒﺭ ﻟﻠﺤﺩﻭﺩ‬ ‫ﺍﻟﻤﻭﻀﻭﻉ‬

‫ﺍﻷﻏﺭﺍﺽ‪:‬‬ ‫ﺍﻷﻏﺭﺍﺽ ﻭﺍﻷﺴﺎﺱ ﺍﻟﻤﻨﻁﻘﻲ‬ ‫• ﻤﺴﺎﻋﺩﺓ ﺍﻷﻁﺭﺍﻑ ﻋﻠﻰ ﻀﺒﻁ‪ /‬ﺘﻨﻅﻴﻡ ﺍﻹﻋﻼﻥ ﺍﻟﻌﺎﺒﺭ ﻟﻠﺤﺩﻭﺩ‪.‬‬ ‫ﺍﻷﺴﺎﺱ ﺍﻟﻤﻨﻁﻘﻲ‪:‬‬ ‫• ﻤﻥ ﺍﻟﺜﺎﺒﺕ ﺃﻥ ﺍﻹﻋﻼﻥ ﻋﻥ ﺍﻟﺘﺒﻎ‪ ،‬ﺒﻤﺎ ﻓﻲ ﺫﻟﻙ ﺍﻹﻋﻼﻥ ﺍﻟﻌﺎﺒﺭ‬ ‫ﻟﻠﺤﺩﻭﺩ‪ ،‬ﻴﺸﺠﻊ ﻏﻴﺭ ﺍﻟﻤﺩﺨﻨﻴﻥ ﻋﻠﻰ ﺍﻟﺘﺩﺨﻴﻥ‪ ،‬ﻭﻴﺜـﺒﻁ ﻋﺯﻴﻤـﺔ‬ ‫ﺍﻟﻤﺩﺨﻨﻴﻥ ﻋﻠﻰ ﺍﻹﻗﻼﻉ‪.‬‬ ‫‪ o‬ﻓﻲ ﻫﺫﺍ ﺍﻟﻘﺎﻟﺏ‪ ،‬ﻴﺸﻴﺭ ﻤﺼﻁﻠﺢ "ﺍﻹﻋﻼﻥ ﺍﻟﻌﺎﺒﺭ ﻟﻠﺤـﺩﻭﺩ"‬ ‫ﺇﻟﻰ ﺍﻹﻋﻼﻥ ﻋﻥ ﺍﻟﻤﻨﺘﺠﺎﺕ ﻭﺍﻟﺘـﺭﻭﻴﺞ ﻟﻬـﺎ ﻭﺭﻋﺎﻴﺘﻬـﺎ‬ ‫ﺒﺎﻟﻁﺭﻕ ﺍﻟﻌﺎﺒﺭﺓ ﻟﻠﺤﺩﻭﺩ‪.‬‬ ‫• ﻟﺫﻟﻙ‪ ،‬ﻤﻥ ﺸﺄﻥ ﺃﻱ ﺤﻅﺭ ﻋﻠﻰ ﺍﻹﻋﻼﻥ ﺍﻟﻌﺎﺒﺭ ﻟﻠﺤﺩﻭﺩ ﺃﻥ ﻴﺅﺜﺭ‬ ‫ﺎ ﻋﻠﻰ ﺍﻟﺤﺩ ﻤﻥ ﺍﺴﺘﻬﻼﻙ ﺍﻟﺘﺒﻎ‪ ،‬ﻭﻤﻥ ﺜﻡ ﺍﻟﺤﺩ ﻤﻥ‬ ‫ﺍ ﻤﻠﻤﻭﺴﹰ‬ ‫ﺘﺄﺜﻴﺭﹰ‬ ‫ﻤﻌﺩل ﺍﻟﻭﻓﻴﺎﺕ ﻭﺍﻟﻤﺭﺍﻀﺔ ﺍﻟﻨﺎﺠﻤﺔ ﻋﻨﻪ‪ ،‬ﻭﺍﻻﺭﺘﻘـﺎﺀ ﺒﻨﻭﻋﻴـﺔ‬ ‫ﺍﻟﺤﻴﺎﺓ‪.‬‬ ‫ﺍ ﺃﻥ ﺘـﺅﺩﻱ ﺁﺜـﺎﺭ ﺍﻹﻋـﻼﻥ‬ ‫• ﺇﻀﺎﻓﺔ ﺇﻟﻰ ﺫﻟﻙ‪ ،‬ﻤﻥ ﺍﻟﻤﻤﻜﻥ ﺠﺩﹰ‬ ‫ﺍﻟﻌﺎﺒﺭ ﻟﻠﺤﺩﻭﺩ ﺇﻟﻰ ﺍﻹﻀﺭﺍﺭ ﺒﺤﻅﺭ ﺍﻹﻋﻼﻥ ﺍﻟﺩﺍﺨﻠﻲ ﻭﻤﻥ ﺜـﻡ‬ ‫ﻓﺈﻥ ﺍﻟﺘﺨﻠﺹ ﻤﻥ ﺍﻹﻋﻼﻥ ﺍﻟﻌﺎﺒﺭ ﻟﻠﺤﺩﻭﺩ ﻗﺩ ﻴﻘـﻭﻱ ﺍﻟﺘـﺩﺍﺒﻴﺭ‬ ‫ﺍﻟﻤﺤﻠﻴﺔ ﺍﻟﻤﻀﺎﺩﺓ ﻟﻺﻋﻼﻨﺎﺕ‪.‬‬ ‫• ﻋﻠﻰ ﺍﻟﺩﻭل ﺍﻟﻨﻅﺭ ﻓﻲ ﻭﻀﻊ ﺒﺭﻭﺘﻭﻜﻭل ﺨﺎﺹ ﺒﺎﻹﻋﻼﻥ ﺍﻟﻌﺎﺒﺭ‬ ‫ﻟﻠﺤﺩﻭﺩ‪ ،‬ﻋﻠﻰ ﺍﻟﻨﺤﻭ ﺍﻟﻤﺤﺩﺩ ﻓﻲ ﺍﻟﻤﺎﺩﺓ ‪ (٨)١٣‬ﻤـﻥ ﺍﻻﺘﻔﺎﻗﻴـﺔ‬ ‫ﺍﻹﻁﺎﺭﻴﺔ‪.‬‬ ‫ﺍﻟﺘﻌﺭﻴﻑ ﺍﻟﻭﺍﻀﺢ ﻟﻠﻌﻨﺎﺼﺭ ﺍﻟﻭﺍﺭﺩﺓ ﻓﻲ • ﻭﻀﻊ ﺘﻌﺭﻴﻑ ﻭﺍﻀﺢ ﻭﻤﺘﻔﻕ ﻋﻠﻴﻪ ﻟﻺﻋﻼﻥ ﺍﻟﻌـﺎﺒﺭ ﻟﻠﺤـﺩﻭﺩ‪،‬‬ ‫ﺍ ﺇﻟﻰ ﺃﻓﻀل ﺍﻟﻤﻤﺎﺭﺴﺎﺕ ﺍﻟﻘﺎﺌﻤﺔ‪.‬‬ ‫ﻭﻟﻴﻜﻥ ﺫﻟﻙ ﺍﺴﺘﻨﺎﺩﹰ‬ ‫ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ‬ ‫‪ o‬ﻴﻨﺒﻐﻲ ﺃﻻ ﻴﻘﺘﺼﺭ ﺍﻟﺘﻌﺭﻴﻑ ﻋﻠﻰ ﺍﻷﺸﻜﺎل ﺍﻟﺘﻘﻠﻴﺩﻴﺔ ﻟﻭﺴﺎﺌل‬ ‫ﺍﻹﻋﻼﻡ )ﺍﻟﺘﻠﻴﻔﺯﻴﻭﻥ‪ ،‬ﻭﺍﻹﺫﺍﻋـﺔ‪ ،‬ﻭﺍﻟـﺼﺤﺎﻓﺔ‪ ،‬ﻭﺭﻋﺎﻴـﺔ‬ ‫ﺎ ﺍﻟﻭﺴـﺎﺌل‬ ‫ﺍﻷﻨﺸﻁﺔ ﺍﻟﺭﻴﺎﻀﻴﺔ( ﺒل ﻻﺒﺩ ﺃﻥ ﻴﺸﻤل ﺃﻴـﻀﹰ‬ ‫ﺍﻟﻤﺴﺘﺠﺩﺓ )ﻤﺜل ﻭﺴﺎﺌل ﺍﻹﻋﻼﻡ ﺍﻟﻘﺎﺌﻤﺔ ﻋﻠﻰ ﺍﻟﺒﺙ ﺒﺎﻟﺘﻭﺍﺒﻊ‬ ‫ﺍﻻﺼﻁﻨﺎﻋﻴﺔ‪ ،‬ﻭﺍﻷﻓﻼﻡ‪ ،‬ﻭﺍﻹﻨﺘﺭﻨﺕ(‪ .‬ﻜﻤﺎ ﻴﻨﺒﻐﻲ ﺍﻻﻨﺘﺒـﺎﻩ‬ ‫ﻟﻠﺴﻠﻊ ﺍﻻﺴﺘﻬﻼﻜﻴﺔ ﺍﻟﺘﻲ ﺘﺤﻤل ﻋﻼﻤﺎﺕ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ‪ ،‬ﻤﺜل‬ ‫ﺍﻟﻠﻌﺏ ﻭﺍﻟﻤﻼﺒﺱ‪.‬‬ ‫ﺍﻟﺘﻌﺎﻭﻥ ﺒﻌﺩﺓ ﺼﻔﺎﺕ ﻭﻋﻠﻰ ﻋﺩﺓ ﻤﺴﺘﻭﻴﺎﺕ‪ ،‬ﻤﺜل‪:‬‬ ‫‪ o‬ﺍﻟﺘﻌﺎﻭﻥ ﺍﻟﺩﻭﻟﻲ ﻟﻠﺒﺤﺙ ﻓﻲ ﺃﺴﺎﻟﻴﺏ ﻭﺁﺜﺎﺭ ﺍﻹﻋﻼﻥ ﺍﻟﻌـﺎﺒﺭ‬ ‫ﻟﻠﺤﺩﻭﺩ‪ .‬ﻜﻤﺎ ﻴﻨﺒﻐﻲ ﺍﻟﺒﺤﺙ ﻓﻲ ﺍﻟﺘﺩﺍﺒﻴﺭ ﺍﻟﺘﻨﻅﻴﻤﻴﺔ ﺍﻟﻤﺤﺘﻤﻠﺔ‪،‬‬ ‫ﻋﻤ ﹰ‬ ‫ﻼ ﺒﺎﻟﻤﺎﺩﺓ ‪.(٦)١٣‬‬ ‫•‬

‫ﺍﻟﻤﺤﺘﻭﻴﺎﺕ‪:‬‬

‫‪55‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬ ‫•‬

‫ﺍﻟﺘﻌﺎﻭﻥ ﻋﻠﻰ ﺒﺙ ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﺍﻟﻭﺍﺭﺩﺓ ﺃﻋـﻼﻩ ﺒـﺸﻜل‬ ‫ﻓﻌﺎل‪.‬‬

‫ﻤﻁﺎﻟﺒﺔ ﺍﻷﻁﺭﺍﻑ ﺒﺎﺘﺨﺎﺫ ﺇﺠﺭﺍﺀﺍﺕ ﻓﻲ ﺍﻟﺸﻜﺎﻭﻯ ﺍﻟﻤﻘﺩﻤﺔ ﻤـﻥ‬ ‫ﺍ‬ ‫ﺨﺎﺭﺝ ﺤﺩﻭﺩ ﻭﻻﻴﺘﻬﺎ ﺍﻟﻘﻀﺎﺌﻴﺔ ﻀﺩ ﺃﻨﺸﻁﺔ ﺍﻹﻋﻼﻥ‪ ،‬ﺍﺴـﺘﻨﺎﺩﹰ‬ ‫ﺇﻟﻰ ﻭﻻﻴﺘﻬﺎ ﺍﻟﻘﻀﺎﺌﻴﺔ‪.‬‬ ‫ﺘﺤﺩﻴﺩ ﺍﻟﻜﻴﺎﻨﺎﺕ ﺍﻟﻤﺤﻠﻴﺔ ﺍﻟﺘﻲ ﻴﻤﻜﻥ ﺃﻥ ﺘﻜﻭﻥ ﻜﻴﺎﻨﺎﺕ ﻴﺤﺘﻤل ﺃﻥ‬ ‫ﻴﻔﺭﺽ ﻋﻠﻴﻬﺎ ﺤﻅﺭ ﺍﻹﻋﻼﻥ ﺍﻟﻌﺎﺒﺭ ﻟﻠﺤﺩﻭﺩ‪.‬‬

‫‪ o‬ﺍﻟﺘﻌﺎﻭﻥ ﻤﻊ ﺍﻟﻤﻨﻅﻤﺎﺕ ﺍﻟﻌﺎﻟﻤﻴﺔ ﻭﺍﻹﻗﻠﻴﻤﻴﺔ ﻭﺍﻟﻤﺤﻠﻴﺔ ﺍﻟﻤﻌﻨﻴﺔ‬ ‫ﺒﺎﻟﺘﺠﺎﺭﺓ‪ ،‬ﻭﺍﻹﻋﻼﻡ‪ ،‬ﻭﺍﻹﻋﻼﻥ‪ ،‬ﻭﺍﻟﺘﺴﻭﻴﻕ‪.‬‬ ‫‪ o‬ﺍﻟﺘﻌﺎﻭﻥ ﻋﻠﻰ ﺘﻁﻭﻴﺭ ﺘﻜﻨﻭﻟﻭﺠﻴﺎ ﻟﺘﺭﺸﻴﺢ ﻭﺘﻨﻅﻴﻡ ﺍﻹﻋـﻼﻥ‬ ‫ﻓﻲ ﻭﺴﺎﺌل ﺍﻹﻋﻼﻡ‪ ،‬ﺒﻤﺎ ﻓﻲ ﺫﻟﻙ ﺍﻹﻨﺘﺭﻨﺕ‪.‬‬ ‫ﻭﺼﻑ ﺍﻟﻌﻨﺎﺼﺭ ﺍﻟﺘﻲ ﺘﺤﻅﺭ ﺒـﺸﻜل ﺸـﺎﻤل ﺠﻤﻴـﻊ ﺃﺸـﻜﺎل‬ ‫ﺍﻹﻋﻼﻥ ﺍﻟﻌﺎﺒﺭ ﻟﻠﺤﺩﻭﺩ‪ ،‬ﻟﻜﻲ ﻴﺘﻡ ﺇﺩﺭﺍﺠﻬـﺎ ﻓـﻲ ﺒﺭﻭﺘﻭﻜـﻭل‬ ‫ﻤﺤﺘﻤل‪.‬‬

‫•‬ ‫•‬ ‫•‬ ‫ﺍﻻﺤﺘﻴﺎﺠﺎﺕ‪ /‬ﺍﻟﻘﻴﻤﺔ ﺍﻟﻤﻀﺎﻓﺔ‬

‫ﺍﻻﺤﺘﻴﺎﺠﺎﺕ‪:‬‬ ‫• ﺍﻻﻀﻁﻼﻉ ﺒﺒﺤﻭﺙ ﺃﺨﺭﻯ ﻋﻥ ﺃﺴﺎﻟﻴﺏ ﺍﻹﻋﻼﻥ ﺍﻟﻌﺎﺒﺭ ﻟﻠﺤﺩﻭﺩ‬ ‫ﻭﺁﺜﺎﺭﻩ‪ ،‬ﻭﻋﻥ ﺍﻟﺘﺩﺍﺒﻴﺭ ﺍﻟﺘﻨﻅﻴﻤﻴﺔ ﺍﻟﻤﺤﺘﻤﻠﺔ‪.‬‬ ‫• ﺍﻟﺘﻌﺎﻭﻥ ﺒﺸﺄﻥ ﺍﻟﺒﺤﻭﺙ ﺍﻟﻤﺫﻜﻭﺭﺓ ﺃﻋﻼﻩ ﻭﺘﺒﺎﺩل ﺍﻟﻤﻌﻠﻭﻤﺎﺕ‪.‬‬ ‫• ﺍﻟﻨﻅﺭ ﻓﻲ ﻭﻀﻊ ﺒﺭﻭﺘﻭﻜﻭل ﻴﺤﺩﺩ ﺍﻟﺘﺩﺍﺒﻴﺭ ﺍﻟﻤﻨﺎﺴﺒﺔ ﺍﻟﺘﻲ ﺘﺤﺘﺎﺝ‬ ‫ﺇﻟﻰ ﺘﻌﺎﻭﻥ ﺩﻭﻟﻲ ﻤﻥ ﺃﺠل ﻓﺭﺽ ﺤﻅﺭ ﺸﺎﻤل ﻋﻠﻰ ﺍﻹﻋـﻼﻥ‬ ‫ﺍﻟﻌﺎﺒﺭ ﻟﻠﺤﺩﻭﺩ‪ ،‬ﺒﻤﻭﺠﺏ ﺍﻟﻤﺎﺩﺓ ‪.(٨)١٣‬‬ ‫ﺍﻟﻘﻴﻤﺔ ﺍﻟﻤﻀﺎﻓﺔ‪:‬‬ ‫ﻤﻥ ﺸﺄﻥ ﺤﻅﺭ ﺍﻹﻋﻼﻥ ﺍﻟﻌﺎﺒﺭ ﻟﻠﺤﺩﻭﺩ ﺃﻥ ﻴﺤﺩ ﻤﻥ ﺍﺴـﺘﻬﻼﻙ‬ ‫ﺍﻟﺘﺒﻎ‪ ،‬ﻭﻤﻥ ﺜﻡ ﺍﻟﺤﺩ ﻤﻥ ﺍﻟﻤﺭﺍﻀﺔ ﻭﻤﻌﺩل ﺍﻟﻭﻓﻴﺎﺕ‪ ،‬ﻭﺍﻻﺭﺘﻘـﺎﺀ‬ ‫ﺒﻨﻭﻋﻴﺔ ﺍﻟﺤﻴﺎﺓ‪.‬‬ ‫ﻤﻥ ﺸﺄﻥ ﺤﻅﺭ ﺍﻹﻋﻼﻥ ﺍﻟﻌﺎﺒﺭ ﻟﻠﺤـﺩﻭﺩ ﺃﻥ ﻴﻌـﺯﺯ ﺍﻟﺘـﺩﺍﺒﻴﺭ‬ ‫ﺍﻟﻤﺤﻠﻴﺔ ﺍﻟﻤﻀﺎﺩﺓ ﻟﻺﻋﻼﻥ‪.‬‬ ‫ﻤﻥ ﺸﺄﻥ ﺍﻟﻁﺒﻴﻌﺔ ﻋﺒﺭ ﺍﻟﻭﻁﻨﻴﺔ ﻟﻠﻤﺸﻜﻠﺔ ﺃﻥ ﺘﺸﺠﻊ ﻋﻠﻰ ﺯﻴـﺎﺩﺓ‬ ‫ﺍﻟﺘﻌﺎﻭﻥ ﺒﻴﻥ ﺍﻟﺩﻭل ﻭﺍﻟﻤﻨﻅﻤﺎﺕ ﺍﻟﻤﻌﻨﻴﺔ‪.‬‬ ‫ﺍﻟﻤﻭﺍﺭﺩ ﺍﻟﻘﺎﺌﻤﺔ ﺘﺸﻤل‪:‬‬ ‫‪ o‬ﺍﻟﺩﺭﺍﺴﺎﺕ ﺍﻟﺭﺴﻤﻴﺔ ﻭﻏﻴﺭ ﺍﻟﺭﺴﻤﻴﺔ ﺍﻟﺘﻲ ﺘﻜﻠﻑ ﺍﻟﻤﻨﻅﻤـﺔ‬ ‫ﺠﻬﺎﺕ ﻤﻌﻴﻨﺔ ﻟﻠﻘﻴﺎﻡ ﺒﻬﺎ‪.‬‬ ‫‪o‬‬ ‫•‬ ‫•‬ ‫•‬ ‫•‬

‫ﺍﻟﻌﻤل ﺍﻟﺤﺎﻟﻲ ﺍﻟﺫﻱ ﻴﻤﻜﻥ ﺍﻻﺴﺘﻨﺎﺩ ﺇﻟﻴﻪ‬

‫ﺍﻟﻤﻨﺸﻭﺭﺍﺕ ﺍﻟﺤﻜﻭﻤﻴﺔ‪ ،‬ﻭﻤﻨﺸﻭﺭﺍﺕ ﺍﻟﻤﻨﻅﻤﺎﺕ ﺍﻟﺤﻜﻭﻤﻴـﺔ‬ ‫ﺍﻟﺩﻭﻟﻴﺔ‪ ،‬ﻭﻏﻴﺭ ﺍﻟﺤﻜﻭﻤﻴﺔ‪ ،‬ﺒﻤﺎ ﻓﻲ ﺫﻟﻙ ﺍﻟﺩﺭﺍﺴﺎﺕ ﺍﻟﺭﺴﻤﻴﺔ‬ ‫ﻭﻏﻴﺭ ﺍﻟﺭﺴﻤﻴﺔ ﻟﻠﻤﻨﻅﻤﺔ‪.‬‬

‫ﺩﻟﻴل ﺍﻟﺠﻤﺎﻋﺔ ﺍﻷﻭﺭﻭﺒﻴﺔ ﻟﻺﻋﻼﻥ ﻋﻥ ﺍﻟﺘﺒﻎ‪١.٢٠٠٣ ،‬‬

‫‪o‬‬

‫‪ ١‬ﻤﻭﻀﻭﻉ ﻫﺫﺍ ﺍﻟﺩﻟﻴل ﻭﻨﻁﺎﻗﻪ ﻴﺸﻤﻼﻥ "ﺍﻹﻋﻼﻥ ﻋﻥ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﻭﺍﻟﺘﺭﻭﻴﺞ ﻟﻬﺎ‪:‬‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ ‫ﺍﻟﺘﺩﺍﺒﻴﺭ ﺃﻭ ﺍﻟﻤﻤﺎﺭﺴﺎﺕ ﺍﻟﻘﺎﺌﻤﺔ ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒـﺎﻟﺘﻨﻅﻴﻡ ﺍﻟﻌـﺎﺒﺭ‬ ‫ﻟﻠﺤﺩﻭﺩ ﻷﻨﺸﻁﺔ ﺃﺨﺭﻯ‪ ،‬ﻤﺜل ﺍﻟﻤﻨﺸﻭﺭﺍﺕ ﺍﻹﺒﺎﺤﻴﺔ ﻋﻠـﻰ‬ ‫ﺸﺒﻜﺔ ﺍﻹﻨﺘﺭﻨﺕ ﻭﻓﻲ ﺍﻷﻓﻼﻡ‪.‬‬ ‫ﻨﺘﺎﺌﺞ ﺍﻟﻤﺅﺘﻤﺭ ﺍﻟﻤﻌﻨﻲ ﺒﻭﻀﻊ ﻗﺎﻨﻭﻥ ﻋﺎﻟﻤﻲ ﻟﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪،‬‬ ‫ﻨﻴﻭﺩﻟﻬﻲ‪ ٩-٧ ،‬ﻜﺎﻨﻭﻥ ﺍﻟﺜﺎﻨﻲ‪ /‬ﻴﻨﺎﻴﺭ ‪ ،٢٠٠٠‬ﺒﻤﺎ ﻓﻲ ﺫﻟﻙ‬ ‫ﺍﻟﻤﻨﺸﻭﺭﺓ ﺍﻟﻤﻌﻨﻭﻨﺔ "ﺍﻹﻋﻼﻥ ﻋﻥ ﺍﻟﺘﺒﻎ ﻭﺘﺭﻭﻴﺠﻪ‪ :‬ﺍﻟﺤﺎﺠﺔ‬ ‫ﺇﻟﻰ ﺍﺴﺘﺠﺎﺒﺔ ﻋﺎﻟﻤﻴﺔ ﻤﻨﺴﻘﺔ‪١ ".‬‬ ‫‪o‬‬ ‫‪o‬‬

‫‪56‬‬

‫ﺍﻟﻌﻤﻠﻴﺔ‪:‬‬ ‫ﺍﻟﺠﻬﺔ ﺍﻟﻘﺎﺌﻤﺔ ﺒﺎﻟﺘﻨﻔﻴﺫ )ﺒﺘﻔـﻭﻴﺽ ﻤـﻥ ﺍﻟﺨﻴﺎﺭ ‪ -١‬ﺘﻔﻭﻴﺽ ﻤﻬﻤﺔ ﺍﻟﻘﻴﺎﻡ ﺒﻬﺫﺍ ﺍﻟﺩﻭﺭ ﻷﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ‪.‬‬ ‫ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ(‬ ‫ﺍﻟﺨﻴﺎﺭ ‪ -٢‬ﻗﻴﺎﻡ ﻤﺒﺎﺩﺭﺓ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻟﺨﺎﺼﺔ ﺒـﺎﻟﺘﺤﺭﺭ‬ ‫ﹰ‪ ،‬ﺒﺘﻭﺴـﻴﻊ ﻫـﺫﺍ ﺍﻟـﺩﻭﺭ‬ ‫ﺍ ﺘﻘﻨﻴـﺎ‬ ‫ﻤﻥ ﺍﻟﺘﺒﻎ‪ ،‬ﺍﻟﻌﺎﻤﻠﺔ ﺒﺼﻔﺘﻬﺎ ﻤﺴﺘﺸﺎﺭﹰ‬ ‫ﻭﺒﺘﻨﺎﻭل ﺍﻹﻋﻼﻥ ﻋﺒﺭ ﺍﻟﺤﺩﻭﺩ‪.‬‬ ‫ﺍﻟﺨﻴﺎﺭ ‪ -٣‬ﺇﻨﺸﺎﺀ ﻓﺭﻴﻕ ﺨﺒﺭﺍﺀ ﻏﻴﺭ ﺭﺴﻤﻲ ﻴﻌﻨﻰ ﺒـﺎﻹﻋﻼﻥ ﻋﺒـﺭ‬ ‫ﺍﻟﺤﺩﻭﺩ‪.‬‬ ‫ﺍ ﺇﻟـﻰ ﺘﻭﺠﻴـﻪ ﻋـﺎﻡ ‪ ٢٠٠٣‬ﺍﻟﺨـﺎﺹ‬ ‫ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻌﺭﺽ ﺍﻟﻘﻴـﺎﻡ ﺒـﺩﻭﺭ ﺍﻟﺠﻤﺎﻋﺔ ﺍﻷﻭﺭﻭﺒﻴﺔ )ﺍﺴﺘﻨﺎﺩﹰ‬ ‫ﺒﺎﻹﻋﻼﻥ ﻋﻥ ﺍﻟﺘﺒﻎ(‪ ،‬ﻭﺍﻟﻬﻨﺩ )ﻓﻴﻤﺎ ﻴﺘﻌﻠﻕ ﺒﺘﻨﻅﻴﻡ ﺍﻟﺘﺩﺨﻴﻥ ﻓـﻲ ﺩﻭﺭ‬ ‫ﺍﻟﻤﻴﺴﺭﻴﻥ ﺍﻟﺭﺌﻴﺴﻴﻴﻥ‬ ‫ﺍ ﺇﻟﻰ ﻜﺴﺒﻬﺎ ﻗﻀﻴﺔ‬ ‫)ﻋﻥ ﻁﺭﻴﻕ ﺤﺸﺩ ﺍﻟﻤﻭﺍﺭﺩ ﺃﻭ ﺒﻭﺍﺴـﻁﺔ ﺍﻟﺴﻴﻨﻤﺎ(‪ ،‬ﻭﺍﻟﺴﻭﻴﺩ )ﻴﻤﻜﻥ ﺃﻥ ﺘﻘﺩﻡ ﺍﻟﻤﺴﺎﻋﺩﺓ ﺍﺴﺘﻨﺎﺩﹰ‬ ‫" ﻜﻭﻨﺴﻭﻤﻨﺘﻭﻤﺒﻭﺩﺴﻤﺎﻨﻴﻥ ﻀﺩ ﺍﻟﻤﻨﺘﺠﺎﺕ ﺍﻟﺩﻭﻟﻴﺔ ﺍﻟﺭﻓﻴﻌﺔ "‪ ،‬ﻤﺤﻜﻤـﺔ‬ ‫ﺍﻟﻌﻤل ﺍﻟﺘﻘﻨﻲ(‬ ‫ﺍﻟﻌﺩل ﺍﻷﻭﺭﻭﺒﻴﺔ‪ ،٢٠٠١ ،‬ﺇﺫ ﺘﻘﻭل ﺇﻥ ﺤﻅﺭ ﺍﻹﻋﻼﻥ ﻋﺒﺭ ﺍﻟﺤـﺩﻭﺩ‬ ‫ﻟﻪ ﻤﺎ ﻴﺒﺭﺭﻩ ﻷﺴﺒﺎﺏ ﺘﺘﻌﻠﻕ ﺒﺎﻟﺼﺤﺔ ﺍﻟﻌﻤﻭﻤﻴﺔ(‪.‬‬ ‫ـﺭﺽ ﺍﻟﺼﻴﻥ ﻭﻫﻨﻐﺎﺭﻴﺎ ﻭﻤﺩﻏﺸﻘﺭ ﻭﻤﺎﻟﻴﺯﻴﺎ ﻭﺍﻟﻤﻜﺴﻴﻙ ﻭﻨﺎﻤﻴﺒﻴﺎ ﻭﺘﺎﻴﻠﻨﺩ‬ ‫ـﻲ ﺘﻌـ‬ ‫ـﺭﻯ ﺍﻟﺘـ‬ ‫ـﺭﺍﻑ ﺍﻷﺨـ‬ ‫ﺍﻷﻁـ‬ ‫ﺍﻟﻤﺸﺎﺭﻜﺔ ﻓﻲ ﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ‬ ‫ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻌﺭﺽ ﺍﻟﻘﻴـﺎﻡ ﺒـﺩﻭﺭ ﺍﻟﺠﻤﺎﻋﺔ ﺍﻷﻭﺭﻭﺒﻴﺔ‬ ‫ﺍﻟﻤﺭﺍﺠﻌﻴﻥ )ﺒﺎﻹﻀﺎﻓﺔ ﺇﻟـﻰ ﻤﺠﻤﻭﻋـﺔ‬ ‫ﺍﻟﺨﺒﺭﺍﺀ ﺍﻟﻌﺎﺩﻴﻴﻥ(‬ ‫ﻴﺤﺘﻤل ﺃﻥ ﻴﺤﺘﺎﺝ ﺍﻷﺨﺫ ﺒﻬﺫﻩ ﺍﻟﻤﺒـﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴـﺔ ﺇﻟـﻰ ﻤـﻭﺍﺭﺩ‬ ‫ﻜﺜﻴﻔﺔ )ﻤﻥ ﺤﻴﺙ ﺍﻷﻤﻭﺍل ﻭﺍﻟﺨﺒﺭﺓ ﻭﺍﻟﺭﺩ ﻋﻠﻰ ﺍﻟﺘﺤـﺩﻴﺎﺕ ﺍﻟﻨﺎﺸـﺌﺔ‬ ‫ﻋﻥ ﺩﻭﺍﺌﺭ ﺍﻟﺼﻨﺎﻋﺔ( ﻋﻠﻰ ﻨﻁﺎﻕ ﺸـﺒﻴﻪ ﺒﺎﻟﻨﻁـﺎﻕ ﺍﻟـﺫﻱ ﺘﺘﻁﻠﺒـﻪ‬ ‫ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﺎﻟﻤﻭﺍﺩ ‪ ٨‬ﺇﻟﻰ ‪ .١٢‬ﻭﺴﻴﺤﺘﺎﺝ ﺍﻷﻤﺭ ﺇﻟﻰ‬ ‫ﻤﻴﺯﺍﻨﻴﺔ ﺇﻀﺎﻓﻴﺔ ﻟﻀﻤﺎﻥ ﺘﻤﻜـﻴﻥ ﻤﻨـﺩﻭﺒﻲ ﺍﻟﺒﻠـﺩﺍﻥ ﺍﻟﻨﺎﻤﻴـﺔ ﻤـﻥ‬ ‫ﺍﻟﻤﺸﺎﺭﻜﺔ‪.‬‬ ‫ﺍﻵﺜﺎﺭ ﻤﻥ ﺤﻴﺙ ﺍﻟﻤﻭﺍﺭﺩ‬

‫ﻓﻲ ﺍﻟﺼﺤﺎﻓﺔ ﻭﻏﻴﺭﻫﺎ ﻤﻥ ﺍﻟﻤﻁﺒﻭﻋﺎﺕ؛‬ ‫ﻓﻲ ﺨﺩﻤﺎﺕ ﻤﺠﺘﻤﻊ ﺍﻟﻤﻌﻠﻭﻤﺎﺕ؛‬ ‫ﻓﻲ ﺍﻹﺫﺍﻋﺔ؛‬

‫)ﺏ(‬ ‫)ﺝ(‬ ‫)ﺩ(‬

‫)ﺃ(‬

‫ﺎ‪".‬‬ ‫ﻋﻥ ﻁﺭﻴﻕ ﺭﻋﺎﻴﺔ ﺸﺭﻜﺎﺕ ﺍﻟﺘﺒﻎ ﻷﻨﺸﻁﺔ ﺃﺨﺭﻯ‪ ،‬ﺒﻤﺎ ﻓﻲ ﺫﻟﻙ ﺘﻭﺯﻴﻊ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﻤﺠﺎﻨﹰ‬

‫‪http://www.who.int/tobacco/media/en/ROSS2000X.pdf‬‬

‫‪١‬‬

‫‪57‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺍﻹﻁﺎﺭ ﺍﻟﺯﻤﻨﻲ‪:‬‬ ‫ﻋﻠﻰ ﺍﻟﺭﻏﻡ ﻤﻥ ﺃﻥ ﻋﻤل ﻤﺒﺎﺩﺭﺓ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻟﺨﺎﺼـﺔ‬ ‫ﺒﺎﻟﺘﺤﺭﺭ ﻤﻥ ﺍﻟﺘﺒﻎ ﻭﻋﻤل ﻤﺠﻤﻭﻋﺔ ﺍﻟﺩﺭﺍﺴﺔ ﺍﻟﻤﻌﻨﻴﺔ ﺒﺘﻨﻅﻴﻡ ﻤﻨﺘﺠﺎﺕ‬ ‫ﺍﻟﺘﺒﻎ ﻴﻤﻜﻥ ﺃﻥ ﻴﺼﻠﺤﺎ ﻜﺄﺴﺎﺱ ﻟﻭﻀﻊ ﺍﻟﻤﺒـﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴـﺔ‪ ،‬ﻓﺈﻨـﻪ‬ ‫‪‬ﺽ ﺇﻟﻴﻬﺎ ﺃﻤـﺭ ﻭﻀـﻊ ﺍﻟﻤﺒـﺎﺩﺉ‬ ‫‪‬ﺘﻭﻗﻊ ﺃﻥ ﺃﻴﺔ ﻤﺠﻤﻭﻋﺔ ﻴﻔﻭ‬ ‫ﻤﺎﺯﺍل ﻴ‬ ‫ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﺴﺘﺤﺘﺎﺝ ﺇﻟﻰ ﺍﻻﺠﺘﻤﺎﻉ ﻤﺭﺘﻴﻥ ﺇﻟﻰ ﺜـﻼﺙ ﻤـﺭﺍﺕ ﻗﺒـل‬ ‫ﺍﻟﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪.‬‬ ‫ﺎ ﻋﻠﻰ ﺍﻷﻗل ﻤﻥ ﻋﺭﻀﻬﺎ ﻋﻠﻰ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ‬ ‫ﻗﺒل ﺴﺘﻴﻥ ﻴﻭﻤﹰ‬ ‫ﺎ ﻋﻠﻰ ﺍﻷﻗل ﻤﻥ ﺍﻟﻴﻭﻡ ﺍﻷﻭل ﻟﻠﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴﺔ ﻟﻤـﺅﺘﻤﺭ‬ ‫ﻗﺒل ﺘﺴﻌﻴﻥ ﻴﻭﻤﹰ‬ ‫ﺍﻷﻁﺭﺍﻑ‬ ‫ﺎ ﻋﻠﻰ ﺃﺩﻨﻰ ﺘﻘﺩﻴﺭ ﻤﻥ ﺍﻟﻴﻭﻡ ﺍﻷﻭل ﻟﻠـﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴـﺔ‬ ‫ﻗﺒل ﺜﻼﺜﻴﻥ ﻴﻭﻤﹰ‬ ‫ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫ﻟﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ‬

‫ﻟﻠﻤﺭﺍﺠﻌﺔ‬ ‫ﻟﻌﺭﻀﻬﺎ ﻋﻠﻰ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ‬ ‫ﻟﺘﻌﻤﻴﻤﻬﺎ ﻋﻠﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫ﹸﻨﺎﻗﺵ ﺒﻌﺩ( ﻟﻭﻀـﻊ ﺍﻟﻤﺒـﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴـﺔ‪ :‬ﺍﻟﺘﺜﻘﻴـﻑ‬ ‫ﺍﻟﻤﺭﻓﻕ ‪ :٥‬ﻨﻤﻭﺫﺝ ﺨﻁﺔ ﻋﻤل )ﻟﻡ ﺘ‬ ‫ﻭﺍﻻﺘﺼﺎل ﻭﺍﻟﺘﺩﺭﻴﺏ ﻭﺘﻭﻋﻴﺔ ﺍﻟﺠﻤﻬﻭﺭ‬ ‫ﺍﻟﻤﺎﺩﺓ ‪:١٢‬‬ ‫ﺍﻟﺘﺜﻘﻴﻑ ﻭﺍﻻﺘﺼﺎل ﻭﺍﻟﺘﺩﺭﻴﺏ ﻭﺘﻭﻋﻴﺔ ﺍﻟﺠﻤﻬﻭﺭ‬ ‫ﺍﻷﺴﺎﺱ ﺍﻟﻤﻨﻁﻘﻲ‪ :‬ﺘﺴﻠﻡ ﺍﻷﻁﺭﺍﻑ ﺒﺎﻟﺤﺎﺠﺔ ﺇﻟﻰ ﺘﻌﺯﻴﺯ ﻭﺘﻘﻭﻴﺔ ﺘﻭﻋﻴﺔ‬ ‫ﺍﻟﺠﻤﻬﻭﺭ ﺒﻘﻀﺎﻴﺎ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪ ،‬ﻭﺫﻟـﻙ ﺒﺎﺴـﺘﺨﺩﺍﻡ ﺠﻤﻴـﻊ ﺃﺩﻭﺍﺕ‬ ‫ﺍﻻﺘﺼﺎل ﺍﻟﻤﺘﻭﺍﻓﺭﺓ‪ ،‬ﺤﺴﺏ ﺍﻻﻗﺘﻀﺎﺀ‪.‬‬ ‫ﺍﻟﻐﺭﺽ‪ :‬ﺇﻥ ﺍﻟﻨﺠﺎﺡ ﻓﻲ ﺘﻨﻔﻴـﺫ ﺘـﺩﺍﺒﻴﺭ ﻤﻜﺎﻓﺤـﺔ ﺍﻟﺘﺒـﻎ ﻴﺘﻁﻠـﺏ‬ ‫ﺘﻭﻋﻴﺔ‪ /‬ﺘﺜﻘﻴﻑ ﺍﻟﺠﻤﻬﻭﺭ ﺒﺸﺄﻥ ﻗﻀﺎﻴﺎ ﻤﻜﺎﻓﺤـﺔ ﺍﻟﺘﺒـﻎ‪ .‬ﻭﺒﺎﻟﺘـﺎﻟﻲ‪،‬‬ ‫ﻋﻠﻰ ﺍﻷﻁﺭﺍﻑ ﺃﻥ ﺘﻌﻤل ﻋﻠﻰ ﺇﺘﺎﺤﺔ ﻓـﺭﺹ ﻭﺍﺴـﻌﺔ ﻟﻠﺘﻭﺼـل‬ ‫ﺇﻟـﻰ ﺒﺭﺍﻤﺞ ﻓﻌﺎﻟﺔ ﻭﺸﺎﻤﻠﺔ ﺒـﺸﺄﻥ ﺘﻭﻋﻴـﺔ ﺍﻟﺠﻤﻬـﻭﺭ ﺒﺎﻟﻤﺨـﺎﻁﺭ‬ ‫ﺍﻟﺼﺤﻴﺔ ﻟﺘﻌﺎﻁﻲ ﺍﻟﺘﺒﻎ ﻭﺍﻟﺘﻌﺭﺽ ﻟﺩﺨﺎﻥ ﺍﻟﺘﺒﻎ؛ ﻭﺒﺸﺄﻥ ﻓﻭﺍﺌﺩ ﺍﻹﻗﻼﻉ‬ ‫ﻋﻥ ﺘﻌﺎﻁﻲ ﺍﻟﺘﺒﻎ‪ ،‬ﻭﺍﻟﻌﻭﺍﻗﺏ ﺍﻟﻀﺎﺭﺓ ﻹﻨﺘـﺎﺝ ﻭﺍﺴـﺘﻬﻼﻙ ﺍﻟﺘﺒـﻎ‪،‬‬ ‫ﻭﺃﻫﻤﻴﺔ ﺍﺘﺨﺎﺫ ﺘﺩﺍﺒﻴﺭ ﺘﺸﺭﻴﻌﻴﺔ ﻭﻏﻴﺭ ﺫﻟﻙ ﻤﻥ ﺍﻟﺘﺩﺍﺒﻴﺭ ﺍﻟﺭﺍﻤﻴﺔ ﺇﻟـﻰ‬ ‫ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪ .‬ﻭﺒﺎﻟﻤﺜل‪ ،‬ﻓﺈﻥ ﺍﻟﻤﻬﻨﻴﻴﻥ ﻭﺍﻟﻤﺘﻁـﻭﻋﻴﻥ ﻭﺍﻷﺸـﺨﺎﺹ‬ ‫ﺍﻟﺫﻴﻥ ﻴﺘﻭﻟﻭﻥ ﻤﻨﺎﺼﺏ ﻭﻴﻌﻤﻠﻭﻥ ﻓﻲ ﻤﺠﺎﻻﺕ ﻭﺜﻴﻘﺔ ﺍﻟﺼﻠﺔ ﺒﻤﻜﺎﻓﺤﺔ‬ ‫ﺍﻟﺘﺒﻎ‪ ،‬ﻤﺜل ﻤﺨﻁﻁﻲ ﺸﺅﻭﻥ ﺍﻟﺼﺤﺔ ﻭﻤﻬﻨﻴﻲ ﺍﻟﺼﺤﺔ‪ ،‬ﻭﺍﻟﻌﺎﻤﻠﻴﻥ ﻓﻲ‬ ‫‪‬ﻋﻴﻥ‪،‬‬ ‫ﺍﻟﻤﺠﺘﻤﻌﺎﺕ ﺍﻟﻤﺤﻠﻴﺔ‪ ،‬ﻭﻤﻬﻨﻴـﻲ ﻭﺴـﺎﺌل ﺍﻹﻋـﻼﻡ‪ ،‬ﻭﺍﻟﻤـﺸﺭ‬ ‫ﻭﻤﺴﺅﻭﻟﻲ ﺍﻟﺠﻤﺎﺭﻙ ﻭﺍﻟﺸﺭﻁﺔ‪ ،‬ﻴﺤﺘﺎﺠﻭﻥ ﺇﻟﻰ ﺘﺩﺭﻴﺏ ﻤﻨﺎﺴﺏ ﺒﺸﺄﻥ‬ ‫ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪.‬‬ ‫ﺍﻟﻤﻭﻀﻭﻉ‬

‫ﺍﻷﻏﺭﺍﺽ ﻭﺍﻷﺴﺎﺱ ﺍﻟﻤﻨﻁﻘﻲ‬

‫ﺍﻟﻤﺤﺘﻭﻴﺎﺕ‪:‬‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪58‬‬

‫ﺍﻟﺘﻌﺭﻴﻑ ﺍﻟﻭﺍﻀﺢ ﻟﻠﻌﻨﺎﺼﺭ ﺍﻟﻭﺍﺭﺩﺓ ﻓﻲ ‪ -١‬ﺘﺤﺩﻴﺩ ﺍﻟﻤﻜﻭﻨﺎﺕ ﻭﺍﻻﺴﺘﺭﺍﺘﻴﺠﻴﺎﺕ ﺍﻷﺴﺎﺴﻴﺔ ﺍﻟﻼﺯﻤـﺔ ﻟﻭﻀـﻊ‬ ‫ﹸﻌﻨﻰ ﺒﻤﺎ ﻴﻠﻲ‪:‬‬ ‫ﺒﺭﺍﻤﺞ ﻓﻌﺎﻟﺔ ﻭﺸﺎﻤﻠﺔ ﺒﺸﺄﻥ ﺘﻭﻋﻴﺔ ﺍﻟﺠﻤﻬﻭﺭ ﺘ‬ ‫ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ‬ ‫ﺍﻟﻤﺨﺎﻁﺭ ﺍﻟﺼﺤﻴﺔ ﻟﺘﻌﺎﻁﻲ ﺍﻟﺘﺒﻎ ﻭﺍﻟﺘﻌﺭﺽ ﻟﺩﺨﺎﻥ ﺍﻟﺘﺒﻎ‬ ‫ﻓﻭﺍﺌﺩ ﺍﻹﻗﻼﻉ ﻋﻥ ﺘﻌﺎﻁﻲ ﺍﻟﺘﺒﻎ‬ ‫ﺍﻟﻌﻭﺍﻗﺏ ﺍﻟﻀﺎﺭﺓ ﻹﻨﺘﺎﺝ ﻭﺍﺴﺘﻬﻼﻙ ﺍﻟﺘﺒﻎ‬ ‫ﺃﻫﻤﻴﺔ ﺃﺤﻜﺎﻡ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺍﻹﻁﺎﺭﻴﺔ ﻟﺩﻋﻡ ﺍﻟﺘﻨﻔﻴﺫ‬ ‫)ﺃ(‬ ‫)ﺏ(‬ ‫)ﺝ(‬ ‫)ﺩ(‬

‫‪ -٢‬ﺘﻘﺩﻴﻡ ﺘﻭﺼﻴﺎﺕ ﺒﺨﺼﻭﺹ ﺒﺭﺍﻤﺞ ﺍﻟﺘﺩﺭﻴﺏ ﻭ‪ /‬ﺃﻭ ﺍﻟﺘﺤـﺴﻴﺱ‬ ‫ﻭﺍﻟﺘﻭﻋﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪ ،‬ﻤﻭﺠﻬﺔ ﺇﻟـﻰ ﻤﺨﺘﻠـﻑ ﺍﻟﻔﺌـﺎﺕ‬ ‫ﺍﻟﻤﻬﻨﻴﺔ ﺍﻟﻤﺫﻜﻭﺭﺓ ﻓﻲ ﺍﻟﻤﺎﺩﺓ ‪)١٢‬ﺩ(‪.‬‬ ‫‪ -٣‬ﺘﻘﺩﻴﻡ ﺘﻭﺼﻴﺎﺕ ﺒﺸﺄﻥ ﺘﺨﺼﻴﺹ ﺍﻟﻤﻭﺍﺭﺩ ﺍﻟﺒـﺸﺭﻴﺔ ﻭﺘﺨﻁـﻴﻁ‬ ‫ﺍﻟﻨﻅﻡ ﺍﻟﺼﺤﻴﺔ ﻟﺘﻤﻜﻴﻥ ﺍﻟﻤﻬﻨﻴﻴﻥ ﺍﻟﺼﺤﻴﻴﻥ ﻭﻏﻴﺭﻫﻡ ﻤﻥ ﺍﻟﻔﺌـﺎﺕ‬ ‫ﻤﻥ ﺘﻌﺯﻴﺯ ﺍﻟﺘﺜﻘﻴﻑ ﻭﺍﻻﺘﺼﺎل ﻭﺘﻭﻋﻴﺔ ﺍﻟﺠﻤﻬﻭﺭ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ‬ ‫ﺍﻟﺘﺒﻎ‪.‬‬ ‫‪ -٤‬ﺘﺤﺩﻴﺩ ﺍﺴﺘﺭﺍﺘﻴﺠﻴﺎﺕ ﻹﺘﺎﺤﺔ ﺍﻟﻔﺭﺼﺔ ﻟﻠﺠﻤﻬﻭﺭ ﻟﻠﺤﺼﻭل ﻋﻠـﻰ‬ ‫ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﺄﻨﺸﻁﺔ ﺩﻭﺍﺌﺭ ﺼﻨﺎﻋﺔ ﺍﻟﺘﺒﻎ ﻓﻲ ﺍﻟﺒﻠﺩ‪.‬‬ ‫‪ -١‬ﺘﻭﻓﻴﺭ ﺍﻟﺘﻤﺎﺜل ﻓﻲ ﺘﺩﺍﺒﻴﺭ ﻭﺃﻨﺸﻁﺔ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪.‬‬ ‫‪ -٢‬ﺍﻟﺘﻌﺎﻭﻥ ﺍﻟﺩﻭﻟﻲ ﻭﺘﺒﺎﺩل ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﺤﻭل ﺃﻓﻀل ﺍﻟﻤﻤﺎﺭﺴـﺎﺕ‬ ‫ﻭﺤﻭل ﺍﻟﺩﺭﻭﺱ ﺍﻟﻤﺴﺘﻔﺎﺩﺓ‪.‬‬ ‫ﻤﺒﺎﺩﺭﺓ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﻟﻠﺘﺤﺭﺭ ﻤﻥ ﺍﻟﺘﺒﻎ‪:‬‬ ‫‪1. Building blocks for tobacco Control: a handbook. Geneva,‬‬ ‫‪WHO, 2004.‬‬ ‫‪2. Policy recommendations on smoking cessation and treatment of‬‬ ‫‪tobacco dependence: advancing tobacco control in the XXIst‬‬ ‫‪century. Geneva, WHO, 2003.‬‬ ‫‪3. Glossary on WHO Collaborating Centres on Tobacco Control.‬‬ ‫‪WHO, 2005 (publications of WHO collaborating centres can be‬‬ ‫‪accessed through this glossary available online at http://www.‬‬ ‫‪who.int/tobacco/global_interaction/collab_centers/glossary who‬‬ ‫‪_cc_tobacco_control/en/index.html.‬‬ ‫‪4. Tobacco industry and corporate responsibility: an inherent‬‬ ‫‪contradiction. Geneva, WHO, 2004.‬‬ ‫‪5. Tobacco industry documents: What they are, what they tell us‬‬ ‫‪and how to search them. A practical manual (second edition).‬‬ ‫‪Geneva, WHO, 2004.‬‬ ‫‪6. The development of Philip Morris’ position on environmental‬‬ ‫‪tobacco smoke for its web site. Geneva, WHO, 2004.‬‬

‫ﺍﻻﺤﺘﻴﺎﺠﺎﺕ‪ /‬ﺍﻟﻘﻴﻤﺔ ﺍﻟﻤﻀﺎﻓﺔ‬

‫ﺍﻟﻌﻤل ﺍﻟﺤﺎﻟﻲ ﺍﻟﺫﻱ ﻴﻤﻜﻥ ﺍﻻﺴﺘﻨﺎﺩ ﺇﻟﻴﻪ‬

‫‪59‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺍﻟﻌﻤﻠﻴﺔ‪:‬‬ ‫ﺍﻟﺠﻬﺔ ﺍﻟﻘﺎﺌﻤﺔ ﺒﺎﻟﺘﻨﻔﻴﺫ )ﺒﺘﻔـﻭﻴﺽ ﻤـﻥ ﺍﻟﺨﻴﺎﺭ ‪ -١‬ﺘﻔﻭﻴﺽ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺒﺎﻟﻘﻴﺎﻡ ﺒﻬﺫﺍ ﺍﻟﺩﻭﺭ‪.‬‬ ‫ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ(‬ ‫ﺍﻟﺨﻴﺎﺭ ‪ -٢‬ﻗﻴﺎﻡ ﻤﺒﺎﺩﺭﺓ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻟﺨﺎﺼﺔ ﺒـﺎﻟﺘﺤﺭﺭ‬ ‫ﺎ ﺒﺎﻟﺘﺄﺴﻴﺱ ﻋﻠﻰ ﻫﺫﺍ ﺍﻟﺩﻭﺭ‪.‬‬ ‫ﺍ ﺘﻘﻨﻴﹰ‬ ‫ﻤﻥ ﺍﻟﺘﺒﻎ‪ ،‬ﺍﻟﻌﺎﻤﻠﺔ ﺒﺼﻔﺘﻬﺎ ﻤﺴﺘﺸﺎﺭﹰ‬ ‫ﺍﻟﺨﻴﺎﺭ ‪ -٣‬ﻗﻴﺎﻡ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻭﻤﺒﺎﺩﺭﺓ ﺍﻟﺘﺤﺭﺭ ﻤﻥ ﺍﻟﺘﺒـﻎ ﺒﺈﻨـﺸﺎﺀ‬ ‫ﻓﺭﻴﻕ ﺨﺒﺭﺍﺀ ﻏﻴﺭ ﺭﺴﻤﻲ ﻟﺘﻘﺩﻴﻡ ﺍﻟﻤﺸﻭﺭﺓ ﻟﻸﻁﺭﺍﻑ‪.‬‬

‫ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻌﺭﺽ ﺍﻟﻘﻴـﺎﻡ ﺒـﺩﻭﺭ ﺃﻴﺭﻟﻨﺩﺍ‬ ‫ﺍﻟﻤﻴﺴﺭﻴﻥ ﺍﻟﺭﺌﻴﺴﻴﻴﻥ‬ ‫)ﻋﻥ ﻁﺭﻴﻕ ﺤﺸﺩ ﺍﻟﻤﻭﺍﺭﺩ ﺃﻭ ﺒﻭﺍﺴـﻁﺔ‬ ‫ﺍﻟﻌﻤل ﺍﻟﺘﻘﻨﻲ(‬

‫ـﺭﺽ ﺃﺭﻤﻴﻨﻴﺎ ﻭﺍﻟﺭﺃﺱ ﺍﻷﺨﻀﺭ ﻭﺸـﻴﻠﻲ ﻭﺍﻟـﺼﻴﻥ ﻭﺠﻴﺒـﻭﺘﻲ ﻭﻤـﺼﺭ‬ ‫ـﻲ ﺘﻌـ‬ ‫ـﺭﻯ ﺍﻟﺘـ‬ ‫ـﺭﺍﻑ ﺍﻷﺨـ‬ ‫ﺍﻷﻁـ‬ ‫ﺍﻟﻤﺸﺎﺭﻜﺔ ﻓﻲ ﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ ﻭﺇﺴﺘﻭﻨﻴﺎ ﻭﻫﻨﻐﺎﺭﻴﺎ ﻭﺍﻟﻬﻨﺩ ﻭﻤﺎﻟﻲ ﻭﺍﻟﻤﻜﺴﻴﻙ ﻭﺒﻨﻤﺎ ﻭﺒﻴﺭﻭ ﻭﺠﻨـﻭﺏ‬ ‫ﺃﻓﺭﻴﻘﻴﺎ ﻭﺘﺎﻴﻠﻨﺩ‬ ‫ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻌﺭﺽ ﺍﻟﻘﻴـﺎﻡ ﺒـﺩﻭﺭ ﺃﺴﺘﺭﺍﻟﻴﺎ‬ ‫ﺍﻟﻤﺭﺍﺠﻌﻴﻥ )ﺒﺎﻹﻀﺎﻓﺔ ﺇﻟـﻰ ﻤﺠﻤﻭﻋـﺔ‬ ‫ﺍﻟﺨﺒﺭﺍﺀ ﺍﻟﻌﺎﺩﻴﻴﻥ(‬

‫ﺇﺫﺍ ﻜﺎﻨﺕ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﻫﻲ ﺍﻟﺠﻬﺔ ﺍﻟﻘﺎﺌﻤﺔ ﺒﺎﻟﺘﻨﻔﻴـﺫ‪ ،‬ﻓﺈﻨـﻪ ﻴﻨﺒﻐـﻲ‬ ‫ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻋﻨﺩﺌﺫ ﺃﻥ ﻴﻘﺩﻡ ﺇﻟﻰ ﺍﻷﻤﺎﻨﺔ ﺍﻟﻤﻭﺍﺭﺩ ﺍﻟﻼﺯﻤﺔ‬

‫ﺍﻵﺜﺎﺭ ﻤﻥ ﺤﻴﺙ ﺍﻟﻤﻭﺍﺭﺩ‬

‫ﺇﺫﺍ ﻜﺎﻨﺕ ﺍﻟﺠﻬﺔ ﺍﻟﻘﺎﺌﻤﺔ ﺒﺎﻟﺘﻨﻔﻴﺫ ﻫﻲ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴـﺔ‪ ،‬ﻓـﺈﻥ‬ ‫ﻤﺒﺎﺩﺭﺓ ﺍﻟﺘﺤﺭﺭ ﻤﻥ ﺍﻟﺘﺒﻎ ﺍﻟﺘﺎﺒﻌﺔ ﻟﻬﺎ ﺴﺘﺤﺘﺎﺝ ﻋﻨﺩﺌﺫ ﺇﻟـﻰ ﻤﻴﺯﺍﻨﻴـﺔ‬ ‫ﺇﻀﺎﻓﻴﺔ‬ ‫ﺍﻹﻁﺎﺭ ﺍﻟﺯﻤﻨﻲ‪:‬‬ ‫ﻴﺤﺘﺎﺝ ﺍﻷﻤﺭ ﺇﻟﻰ ﺍﺠﺘﻤﺎﻉ ﻭﺍﺤﺩ‬ ‫ﺎ ﻋﻠﻰ ﺍﻷﻗل ﻤﻥ ﻋﺭﻀﻬﺎ ﻋﻠﻰ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ‬ ‫ﻗﺒل ﺴﺘﻴﻥ ﻴﻭﻤﹰ‬

‫ﻟﻭﻀﻊ ﺍﻟﻤﺒﺎﺩﺉ ﺍﻟﺘﻭﺠﻴﻬﻴﺔ‬ ‫ﻟﻠﻤﺭﺍﺠﻌﺔ‬ ‫ﻟﻌﺭﻀﻬﺎ ﻋﻠﻰ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ‬ ‫ﻟﺘﻌﻤﻴﻤﻬﺎ ﻋﻠﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫ﺎ ﻋﻠﻰ ﺍﻷﻗل ﻤﻥ ﺍﻟﻴﻭﻡ ﺍﻷﻭل ﻟﻠﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴﺔ ﻟﻤـﺅﺘﻤﺭ‬ ‫ﻗﺒل ﺘﺴﻌﻴﻥ ﻴﻭﻤﹰ‬ ‫ﺍﻷﻁﺭﺍﻑ‬ ‫ﺎ ﻋﻠﻰ ﺃﺩﻨﻰ ﺘﻘﺩﻴﺭ ﻤﻥ ﺍﻟﻴﻭﻡ ﺍﻷﻭل ﻟﻠـﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴـﺔ‬ ‫ﻗﺒل ﺜﻼﺜﻴﻥ ﻴﻭﻤﹰ‬ ‫ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ ‫)ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻟﺨﺎﻤﺴﺔ‪ ١٧ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪-٢٠٠٦‬‬ ‫ﺍﻟﻠﺠﻨﺔ "ﺃ"‪ ،‬ﺍﻟﺘﻘﺭﻴﺭ ﺍﻟﺜﺎﻟﺙ ﻭﺍﻟﺘﺼﻭﻴﺏ‪ ١٨ ،‬ﺁﺏ‪ /‬ﺃﻏﺴﻁﺱ ‪(٢٠٠٦‬‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬

‫‪60‬‬

‫ﻭﻀﻊ ﺍﻟﺒﺭﻭﺘﻭﻜﻭﻻﺕ‬

‫)‪FCTC/COP1(16‬‬

‫ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪،‬‬ ‫ﺇﺫ ﻴﺄﺨﺫ ﻓﻲ ﺍﻋﺘﺒﺎﺭﻩ ﺃﺤﻜﺎﻡ ﺍﻟﻤﺎﺩﺘﻴﻥ ‪ ٨-١٣‬ﻭ‪ ٣٣‬ﻤﻥ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﺍﻹﻁﺎﺭﻴـﺔ ﺒـﺸﺄﻥ‬ ‫ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ؛‬ ‫ﺎ ﺍﻟﺤﺎﺠﺔ ﺇﻟﻰ ﺍﻹﺴﻬﺎﺏ ﻓﻲ ﺘﻔﺼﻴل ﺍﻻﻟﺘﺯﺍﻤﺎﺕ ﺍﻟﻭﺍﺭﺩﺓ ﻓﻲ ﺍﻟﻤﺎﺩﺓ ‪ ١٥‬ﻓﻲ ﺇﻁﺎﺭ‬ ‫ﻭﺇﺫ ﻴﺄﺨﺫ ﻓﻲ ﺍﻋﺘﺒﺎﺭﻩ ﺃﻴﻀﹰ‬ ‫ﹰ؛‬ ‫ﺼﻙ ﻗﺎﻨﻭﻨﻲ ﻤﻠﺯﻡ ﺩﻭﻟﻴﺎ‬ ‫ﻭﺇﺫ ﻴﻌﺘﺭﻑ ﺒﺄﻥ ﺍﻟﺘﻌﺎﻭﻥ ﺍﻟﺩﻭﻟﻲ ﻤﻥ ﺃﺠل ﻓﺭﺽ ﺤﻅﺭ ﺸﺎﻤل ﻋﻠﻰ ﺍﻹﻋﻼﻥ ﻭﺍﻟﺘﺭﻭﻴﺞ ﻭﺍﻟﺭﻋﺎﻴـﺔ ﻋﺒـﺭ‬ ‫ﺍﻟﺤﺩﻭﺩ ﻤﺠﺎل ﻫﺎﻡ ﻤﻥ ﻤﺠﺎﻻﺕ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ؛‬ ‫ﺎ ﻤـﻥ‬ ‫ﻻ ﻫﺎﻤـﹰ‬ ‫ﺎ ﺒﺄﻥ ﺍﻟﺘﻌﺎﻭﻥ ﺍﻟﺩﻭﻟﻲ ﻤﻥ ﺃﺠل ﻤﺭﺍﻗﺒﺔ ﺍﻻﺘﺠﺎﺭ ﻏﻴﺭ ﺍﻟﻤﺸﺭﻭﻉ ﻴﻌﺩ ﻤﺠـﺎ ﹰ‬ ‫ﻭﺇﺫ ﻴﻌﺘﺭﻑ ﺃﻴﻀﹰ‬ ‫ﻤﺠﺎﻻﺕ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ؛‬

‫ﻗﺭﺭ ﻤﺎ ﻴﻠﻲ‪:‬‬ ‫ﻤﻁﺎﻟﺒﺔ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺍﻟﻘﻴﺎﻡ ﺒﻤﺎ ﻴﻠﻲ‪ ،‬ﺒﺘﻭﺠﻴﻪ ﻤﻥ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ‪:‬‬ ‫ﺩﻋﻭﺓ ﻜل ﺇﻗﻠﻴﻡ ﻤﻥ ﺃﻗﺎﻟﻴﻡ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ‪ ،‬ﺒﺎﻟﺘﺸﺎﻭﺭ ﻤﻊ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻨﺘﻤﻲ‬ ‫)ﺃ(‬ ‫ﺇﻟﻴﻪ‪ ،‬ﺇﻟﻰ ﺘﺴﻤﻴﺔ ﻋﺩﺩ ﻤﻥ ﺍﻟﺨﺒﺭﺍﺀ ﻻ ﻴﺘﺠﺎﻭﺯ ﺍﻷﺭﺒﻌﺔ ﻟﻜل ﺇﻗﻠـﻴﻡ‪ ،‬ﻤـﻥ ﺃﺠـل ﺇﻋـﺩﺍﺩ ﻗﺎﻟـﺏ‬ ‫ﺍ ﺇﻟﻰ ﺃﺤﻜﺎﻡ ﺍﻟﻤﺎﺩﺓ ‪ ١٥‬ﻤـﻥ ﺍﻻﺘﻔﺎﻗﻴـﺔ‪ ،‬ﻤـﻊ‬ ‫ﻟﺒﺭﻭﺘﻭﻜﻭل ﺒﺸﺄﻥ ﺍﻻﺘﺠﺎﺭ ﻏﻴﺭ ﺍﻟﻤﺸﺭﻭﻉ‪ ،‬ﺍﺴﺘﻨﺎﺩﹰ‬ ‫ﻤﺭﺍﻋﺎﺓ ﺍﻷﻋﻤﺎل ﺍﻟﺘﻲ ﺘﻀﻁﻠﻊ ﺒﻬﺎ ﺍﻟﻜﻴﺎﻨﺎﺕ ﺍﻟﻤﺨﺘﺼﺔ ﻓﻲ ﻫﺫﺍ ﺍﻟﻤﻀﻤﺎﺭ؛‬ ‫)ﺏ( ﺩﻋﻭﺓ ﻜل ﺇﻗﻠﻴﻡ ﻤﻥ ﺃﻗﺎﻟﻴﻡ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ‪ ،‬ﺒﺎﻟﺘﺸﺎﻭﺭ ﻤﻊ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺘﻲ ﺘﻨﺘﻤﻲ‬ ‫ﺇﻟﻴﻪ‪ ،‬ﺇﻟﻰ ﺘﺴﻤﻴﺔ ﻋﺩﺩ ﻤﻥ ﺍﻟﺨﺒﺭﺍﺀ ﻻ ﻴﺘﺠﺎﻭﺯ ﺍﻷﺭﺒﻌﺔ ﻟﻜل ﺇﻗﻠﻴﻡ ﻤﻥ ﺃﺠل ﺇﻋﺩﺍﺩ ﻗﺎﻟﺏ ﻟﺒﺭﻭﺘﻭﻜﻭل‬ ‫ﺍ ﺇﻟﻰ ﺃﺤﻜﺎﻡ ﺍﻟﻤـﺎﺩﺓ ‪٨-١٣‬‬ ‫ﺒﺸﺄﻥ ﺍﻹﻋﻼﻥ ﻋﻥ ﺍﻟﺘﺒﻎ ﻭﺍﻟﺘﺭﻭﻴﺞ ﻟﻪ ﻭﺭﻋﺎﻴﺘﻪ ﻋﺒﺭ ﺍﻟﺤﺩﻭﺩ‪ ،‬ﺍﺴﺘﻨﺎﺩﹰ‬ ‫ﻤﻥ ﺍﻻﺘﻔﺎﻗﻴﺔ‪ ،‬ﻤﻊ ﻤﺭﺍﻋﺎﺓ ﺍﻷﻋﻤﺎل ﺍﻟﺘﻲ ﺘﻀﻁﻠﻊ ﺒﻬﺎ ﺍﻟﻜﻴﺎﻨﺎﺕ ﺍﻟﻤﺨﺘﺼﺔ ﻓﻲ ﻫﺫﺍ ﺍﻟﻤﻀﻤﺎﺭ؛‬ ‫ﺇﺫﺍ ﻟﻡ ﻴﺘﻤﻜﻥ ﻓﺭﻴﻘﺎ ﺍﻟﺨﺒﺭﺍﺀ ﺒﻌﺩ ﻤﻥ ﺍﻗﺘﺭﺍﺡ ﻗﻭﺍﻟﺏ ﻤﻜﺘﻤﻠﺔ ﺤﺘﻰ ﻴﻨﻅﺭ ﻓﻴﻬـﺎ ﻤـﺅﺘﻤﺭ‬ ‫)ﺝ(‬ ‫ﺎ ﻴﺒﻴﻥ ﻨﻁﺎﻕ ﺍﻟﺒﺭﻭﺘﻭﻜـﻭﻻﺕ‬ ‫ﺍﻷﻁﺭﺍﻑ ﺍﻟﺜﺎﻨﻲ‪ ،‬ﻓﻴﻨﺒﻐﻲ ﻟﻬﻤﺎ ﺃﻥ ﻴﻌﺩ‬ ‫ﺍ ﻤﺭﺤﻠﻴﹰ‬ ‫‪‬ﺍ‪ ،‬ﻋﻠﻰ ﺍﻷﻗل‪ ،‬ﺘﻘﺭﻴﺭﹰ‬ ‫ﺍﻟﻤﺴﺘﻘﺒﻠﻴﺔ ﻭﻋﻨﺎﺼﺭﻫﺎ ﺍﻟﺭﺌﻴﺴﻴﺔ ﻭﻫﻴﻜﻠﻬﺎ؛‬ ‫ﺇﺫﺍ ﺭﺃﺕ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ ﺃﻥ ﺃﺤﺩ ﺍﻟﻘﺎﻟﺒﻴﻥ‪ ،‬ﺃﻭ ﻜﻠﻴﻬﻤﺎ‪ ،‬ﻗﺩ ﺒﻠﻎ ﻤﺭﺤﻠﺔ ﻤﺘﻘﺩﻤﺔ ﺒﻤﺎ ﻴﻜﻔـﻲ‪،‬‬ ‫)ﺩ(‬ ‫ﻓﺈﻨﻬﺎ ﺘﻌﺭﺽ ﺃﺤﺩﻫﻤﺎ ﺃﻭ ﻜﻠﻴﻬﻤﺎ ﻋﻠﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺩﻭﺭﺘﻪ ﺍﻟﺜﺎﻨﻴﺔ‪ .‬ﻭﺇﻥ ﻟﻡ ﻴﻜﻥ ﺍﻷﻤـﺭ‬ ‫ﻜﺫﻟﻙ ﻓﺈﻥ ﻫﻴﺌﺔ ﺍﻟﻤﻜﺘﺏ ﺘﻘﺩﻡ ﺘﻘﺭﻴﺭﹰ‬ ‫ﺎ ﺃﻭ ﺘﻘﺭﻴﺭﻴﻥ ﻤﺭﺤﻠﻴﻴﻥ ﻤﻥ ﻭﻀﻊ ﻓﺭﻴﻘﻲ ﺍﻟﺨﺒﺭﺍﺀ؛‬ ‫ﺍ ﻤﺭﺤﻠﻴﹰ‬ ‫ﻤﻁﺎﻟﺒﺔ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺒﺎﺘﺨﺎﺫ ﺍﻟﺘﺭﺘﻴﺒﺎﺕ ﺍﻟﻀﺭﻭﺭﻴﺔ‪ ،‬ﺒﻤﺎ ﻓﻴﻬﺎ ﺍﻟﺘﺭﺘﻴﺒﺎﺕ ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﺎﻟﻤﻴﺯﺍﻨﻴﺔ‪ ،‬ﺤﺘﻰ‬ ‫)‪(٢‬‬ ‫ﻴﺘﺴﻨﻰ ﻟﻔﺭﻴﻘﻲ ﺍﻟﺨﺒﺭﺍﺀ ﺍﻻﺠﺘﻤﺎﻉ ﻓﻲ ﺃﻗﺭﺏ ﻭﻗﺕ ﻤﻤﻜﻥ‪.‬‬ ‫)ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻟﺨﺎﻤﺴﺔ‪ ١٧ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪-٢٠٠٦‬‬ ‫ﺍﻟﻠﺠﻨﺔ "ﺃ"‪ ،‬ﺍﻟﺘﻘﺭﻴﺭ ﺍﻟﺜﺎﻨﻲ(‬ ‫)‪(١‬‬

‫‪61‬‬

‫ﺍﻟﻘﺭﺍﺭﺍﺕ‬

‫ﺇﻨﺸﺎﺀ ﻤﺠﻤﻭﻋﺔ ﺩﺭﺍﺴﺔ ﻤﻌﻨﻴﺔ ﺒﺎﻟﻤﺤﺎﺼﻴل ﺍﻟﺒﺩﻴﻠﺔ‬

‫)‪FCTC/COP1(17‬‬

‫ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪،‬‬ ‫ﺇﺫ ﻴﻀﻊ ﻓﻲ ﺍﻋﺘﺒﺎﺭﻩ ﺍﻟﻤﻭﺍﺩ ‪ ١٧‬ﻭ‪)١-٢٠‬ﺃ( ﻭ‪)١-٢٢‬ﺏ( ﻭ‪ ٣-٢٦‬ﻤﻥ ﺍﺘﻔﺎﻗﻴﺔ ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴـﺔ‬ ‫ﺍﻹﻁﺎﺭﻴﺔ ﺒﺸﺄﻥ ﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ؛‬ ‫ﻭﺇﺫ ﻴﻌﺘﺭﻑ ﺒﺎﻟﺤﺎﺠﺔ ﺇﻟﻰ ﺘﻌﺯﻴﺯ ﺍﻟﺒﺩﺍﺌل ﺫﺍﺕ ﺍﻟﺠﺩﻭﻯ ﺍﻻﻗﺘﺼﺎﺩﻴﺔ ﻟﻠﻌﺎﻤﻠﻴﻥ ﻓﻲ ﺼﻨﺎﻋﺔ ﺍﻟﺘﺒﻎ ﻭﺯﺍﺭﻋﻴـﻪ‬ ‫ﻭﺁﺤﺎﺩ ﺍﻟﺒﺎﻋﺔ‪ ،‬ﺤﺴﺏ ﺍﻟﺤﺎﻟﺔ؛‬ ‫‪‬ﺽ‬ ‫‪‬ﺩﺍﺕ ﻭﻋﻭﺍﻗﺏ ﺍﺴﺘﻬﻼﻙ ﺍﻟﺘﺒـﻎ ﻭﺍﻟﺘﻌـﺭ‬ ‫ﹼﺭ ﺒﺄﻫﻤﻴﺔ ﺍﻟﺘﻘﻴﻴﻤﺎﺕ ﺍﻟﺒﺤﺜﻴﺔ ﻭﺍﻟﻌﻠﻤﻴﺔ ﺍﻟﺘﻲ ﺘﺘﻨﺎﻭل ﻤﺤﺩ‬ ‫ﻭﺇﺫ ﻴﺫﻜ‬ ‫ﻟﺩﺨﺎﻥ ﺍﻟﺘﺒﻎ‪ ،‬ﻭﻜﺫﻟﻙ ﺍﻟﺒﺤﻭﺙ ﺍﻟﺭﺍﻤﻴﺔ ﺇﻟﻰ ﺘﺤﺩﻴﺩ ﺍﻟﺒﺩﺍﺌل ﺫﺍﺕ ﺍﻟﺠﺩﻭﻯ ﺍﻻﻗﺘﺼﺎﺩﻴﺔ؛‬ ‫ﻭﺇﺫ ﻴﺭﻯ ﺃﻥ ﻤﺌﺎﺕ ﺍﻵﻻﻑ ﻤﻥ ﺍﻷﺴﺭ‪ ،‬ﻭﻻﺴﻴﻤﺎ ﻓﻲ ﺍﻟﺒﻠﺩﺍﻥ ﺍﻟﻨﺎﻤﻴﺔ‪ ،‬ﺘﺸﺎﺭﻙ ﻓﻲ ﺯﺭﺍﻋﺔ ﺍﻟﺘﺒﻎ‪ ،‬ﻭﺃﻥ ﻤـﻥ‬ ‫ﺍﻟﻤﺭﺠﺢ ﺃﻥ ﻴﻨﺨﻔﺽ ﺍﻟﻁﻠﺏ ﻋﻠﻰ ﻤﻨﺘﺠﺎﺕ ﺍﻟﺘﺒﻎ ﺒﻴﻥ ﺍﻷﻤﺩ ﺍﻟﻤﺘﻭﺴﻁ ﻭﺍﻷﻤﺩ ﺍﻟﻁﻭﻴل؛‬ ‫‪‬ﺩ ﻋﻠﻰ ﺍﻟﺤﺎﺠﺔ ﺇﻟﻰ ﺘﻌﺯﻴﺯ ﺍﻟﺘﻌﺎﻭﻥ‪ ،‬ﺤﺴﺏ ﺍﻻﻗﺘﻀﺎﺀ‪ ،‬ﻓﻲ ﺍﻟﻤﻴﺎﺩﻴﻥ ﺍﻟﻌﻠﻤﻴﺔ ﻭﺍﻟﺘﻘﻨﻴـﺔ ﻭﺍﻟﻘﺎﻨﻭﻨﻴـﺔ‬ ‫ﻭﺇﺫ ﻴﺸﺩ‬ ‫ﺒﻬﺩﻑ ﻭﻀﻊ ﺴﻴﺎﺴﺎﺕ ﻟﺘﻭﻓﻴﺭ ﺃﺴﺒﺎﺏ ﺍﻟﺭﺯﻕ ﺍﻟﺒﺩﻴﻠﺔ ﺍﻟﻤﻨﺎﺴﺒﺔ ﺫﺍﺕ ﺍﻟﺠﺩﻭﻯ ﺍﻻﻗﺘﺼﺎﺩﻴﺔ ﻭﺍﻟﻘﺎﻨﻭﻨﻴﺔ ﻟﻠﻌـﺎﻤﻠﻴﻥ ﻓـﻲ‬ ‫ﺼﻨﺎﻋﺔ ﺍﻟﺘﺒﻎ ﻭﺯﺍﺭﻋﻴﻪ؛‬ ‫ﺎ ﺒﺎﻟﻌﻤل ﺍﻟﻬﺎﻡ ﺍﻟﺫﻱ ﻴﺠﺭﻱ ﺘﺤﺕ ﻤﻅﻠﺔ ﻓﺭﻗﺔ ﺍﻟﻌﻤل ﺍﻟﻤﺨﺼﺼﺔ ﺍﻟﺘﺎﺒﻌﺔ ﻟﻸﻤـﻡ ﺍﻟﻤﺘﺤـﺩﺓ‬ ‫ﻭﺇﺫ ﻴﺤﻴﻁ ﻋﻠﻤﹰ‬ ‫ﻭﺍﻟﻤﺸﺘﺭﻜﺔ ﺒﻴﻥ ﺍﻟﻭﻜﺎﻻﺕ ﺍﻟﻤﻌﻨﻴﺔ ﺒﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ‪ ،‬ﻭﻻﺴﻴﻤﺎ ﺍﻟﻁﺎﺌﻔﺔ ﺍﻟﻭﺍﺴﻌﺔ ﻤﻥ ﺍﻟﻭﻜﺎﻻﺕ ﺍﻟﺘـﻲ ﺘﻤﺘﻠـﻙ ﺍﻟﺨﺒـﺭﺓ‬ ‫ﺍﻟﻤﻌﺘﺭﻑ ﺒﻬﺎ ﻓﻲ ﻫﺫﺍ ﺍﻟﻤﺠﺎل‪ ،‬ﺒﻤﺎ ﻓﻴﻬﺎ ﻤﻨﻅﻤﺔ ﺍﻷﻤﻡ ﺍﻟﻤﺘﺤﺩﺓ ﻟﻸﻏﺫﻴﺔ ﻭﺍﻟﺯﺭﺍﻋﺔ ﻭﺒﺭﻨﺎﻤﺞ ﺍﻷﻤﻡ ﺍﻟﻤﺘﺤﺩﺓ ﺍﻹﻨﻤﺎﺌﻲ‬ ‫ﻭﺒﺭﻨﺎﻤﺞ ﺍﻷﻤﻡ ﺍﻟﻤﺘﺤﺩﺓ ﻟﻠﺒﻴﺌﺔ ﻭﺍﻟﺒﻨﻙ ﺍﻟﺩﻭﻟﻲ‪ ،‬ﻭﻏﻴﺭﻫﺎ ﻤﻥ ﺍﻟﻭﻜﺎﻻﺕ؛‬

‫ﻗﺭﺭ ﻤﺎ ﻴﻠﻲ‪:‬‬ ‫ﺇﻨﺸﺎﺀ ﻤﺠﻤﻭﻋﺔ ﺩﺭﺍﺴﺔ ﻤﺨﺼﺼﺔ ﻤﻔﺘﻭﺤﺔ ﺍﻟﻌﻀﻭﻴﺔ ﺃﻤﺎﻡ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺍﻟﻤﻬﺘﻤﺔ ﺒﻐﺭﺽ‬ ‫)‪(١‬‬ ‫ﺘﺤﻘﻴﻕ ﻤﺎ ﻴﻠﻲ‪:‬‬ ‫ﺘﻠﺨﻴﺹ ﻤﺩﻯ ﺍﻻﺴﺘﻌﻴﺎﺏ ﺍﻟﺭﺍﻫﻥ ﻟﻠﺒﺩﺍﺌل ﺍﻟﻘﺎﺌﻤﺔ ﺫﺍﺕ ﺍﻟﺠﺩﻭﻯ ﺍﻻﻗﺘﺼﺎﺩﻴﺔ‪ ،‬ﻟﻠﻌﺎﻤﻠﻴﻥ ﻓﻲ‬ ‫)ﺃ(‬ ‫ﺼﻨﺎﻋﺔ ﺍﻟﺘﺒﻎ ﻭﺯﺍﺭﻋﻴﻪ ﻭﺁﺤﺎﺩ ﺍﻟﺒﺎﻋﺔ‪ ،‬ﺤﺴﺏ ﺍﻟﺤﺎﻟﺔ؛‬ ‫ﺘﻭﺼﻴﺔ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﺒﺂﻟﻴﺎﺕ ﻟﺘﻘﻴﻴﻡ ﺁﺜﺎﺭ ﻤﻤﺎﺭﺴﺎﺕ ﺸﺭﻜﺎﺕ ﺍﻟﺘﺒﻎ ﻋﺒﺭ ﺍﻟﺯﻤﻥ؛‬ ‫ﺎ ﻟﻠﻤﺎﺩﺓ ‪١٧‬؛‬ ‫ﺎ ﻋﻠﻰ ﺍﻟﻤﺴﺘﻭﻯ ﺍﻟﻭﻁﻨﻲ ﻭﻓﻘﹰ‬ ‫ﺘﻘﺩﻴﻡ ﺘﻘﺎﺭﻴﺭ ﻋﻥ ﺍﻟﻤﺒﺎﺩﺭﺍﺕ ﺍﻟﻤﻨﻔﺫﺓ ﺤﺎﻟﻴﹰ‬ ‫ﺍﻟﺘﻭﺼﻴﺔ ﺒﺎﺘﺨﺎﺫ ﻤﺒﺎﺩﺭﺍﺕ ﺫﺍﺕ ﻤﺭﺩﻭﺩﻴﺔ ﻓﻲ ﻤﻴﺩﺍﻥ ﺍﻟﺘﻨﻭﻴﻊ؛‬ ‫)ﺏ(‬ ‫)ﺝ(‬ ‫)ﺩ(‬

‫ﺘﻜﻠﻴﻑ ﻤﺠﻤﻭﻋﺔ ﺍﻟﺩﺭﺍﺴﺔ ﺒﺎﻟﻌﻤل ﺍﻟﻭﺜﻴﻕ ﻤﻊ ﺍﻟﻤﻨﻅﻤﺎﺕ ﺍﻟﺩﻭﻟﻴﺔ ﺍﻟﻤﺨﺘﺼﺔ‪ ،‬ﻭﻻﺴﻴﻤﺎ ﻤﻨﻅﻤﺔ ﺍﻷﻤﻡ‬ ‫)‪(٢‬‬ ‫ﺍﻟﻤﺘﺤﺩﺓ ﻟﻸﻏﺫﻴﺔ ﻭﺍﻟﺯﺭﺍﻋﺔ ﻭﺍﻟﺒﻨﻙ ﺍﻟﺩﻭﻟﻲ‪ ،‬ﻭﺒﺎﻟﺘﻌﺎﻭﻥ ﻓﻲ ﻋﻤﻠﻬﺎ ﻤﻊ ﻓﺭﻗﺔ ﺍﻟﻌﻤل ﺍﻟﻤﺨﺼـﺼﺔ ﺍﻟﺘﺎﺒﻌـﺔ‬ ‫ﻟﻸﻤﻡ ﺍﻟﻤﺘﺤﺩﺓ ﻭﺍﻟﻤﺸﺘﺭﻜﺔ ﺒﻴﻥ ﺍﻟﻭﻜﺎﻻﺕ ﺍﻟﻤﻌﻨﻴﺔ ﺒﻤﻜﺎﻓﺤﺔ ﺍﻟﺘﺒﻎ؛‬

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ ‫‪‬ل‬ ‫ﻤﻁﺎﻟﺒﺔ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ ﺒﺎﻟﺘﺸﺎﻭﺭ ﻤﻊ ﺍﻷﻁﺭﺍﻑ ﺍﻟﻤﻬﺘﻤﺔ ﺒﻬﺩﻑ ﺍﻟﺒﺤﺙ ﻋﻥ ﺠﻬﺔ ﺘﺴﺘﻀﻴﻑ ﻭﺘﻤﻭ‬ ‫)‪(٣‬‬ ‫ﱠﺭ‬ ‫ﺍﻻﺠﺘﻤﺎﻉ ﺍﻷﻭل ﻟﻤﺠﻤﻭﻋﺔ ﺍﻟﺩﺭﺍﺴﺔ‪ ،‬ﻗﺒل ﻨﻬﺎﻴﺔ ﻋﺎﻡ ‪ ،٢٠٠٦‬ﻭﺫﻟﻙ ﺒﺎﻟﺘﻌﺎﻭﻥ ﻤﻊ ﺃﻤﺎﻨﺔ ﺍﻻﺘﻔﺎﻗﻴﺔ‪ ،‬ﻭﺇﺫﺍ ﺘﻌﺫ‬ ‫ﺫﻟﻙ‪ ،‬ﺘﺘﻡ ﺍﻟﻤﻁﺎﻟﺒﺔ ﺒﻌﻘﺩ ﺍﻻﺠﺘﻤﺎﻉ ﺒﺎﻻﻗﺘﺭﺍﻥ ﻤﻊ ﺍﻟﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ؛‬ ‫)‪(٤‬‬ ‫ﺘﻜﻠﻴﻑ ﻤﺠﻤﻭﻋﺔ ﺍﻟﺩﺭﺍﺴﺔ ﺒﺘﻘﺩﻴﻡ ﺘﻘﺭﻴﺭ ﺇﻟﻰ ﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺩﻭﺭﺘﻪ ﺍﻟﺜﺎﻨﻴـﺔ ﻋـﻥ ﻨﺘـﺎﺌﺞ‬ ‫ﻤﻨﺎﻗﺸﺎﺕ ﺍﺠﺘﻤﺎﻋﻬﺎ ﺍﻷﻭل‪.‬‬ ‫)ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻟﺨﺎﻤﺴﺔ‪ ١٧ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪-٢٠٠٦‬‬ ‫ﺍﻟﻠﺠﻨﺔ "ﺃ"‪ ،‬ﺍﻟﺘﻘﺭﻴﺭ ﺍﻟﺨﺎﻤﺱ(‬

‫‪62‬‬

‫ﻤﻭﻋﺩ ﻭﻤﻜﺎﻥ ﺍﻨﻌﻘﺎﺩ ﺍﻟﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴﺔ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓ ﻲ اﺗﻔﺎﻗﻴ ﺔ ﻣﻨﻈﻤ ﺔ اﻟ ﺼﺤﺔ‬ ‫اﻟﻌﺎﻟﻤﻴﺔ اﻹﻃﺎرﻳﺔ ﺑﺸﺄن ﻣﻜﺎﻓﺤﺔ اﻟﺘﺒﻎ‬

‫)‪FCTC/COP1(18‬‬

‫ﺎ ﻟﻠﻤﺎﺩﺘﻴﻥ ‪ ٣‬ﻭ‪ ٤‬ﻤﻥ ﻨﻅﺎﻤﻬﺎ ﺍﻟﺩﺍﺨﻠﻲ‪ ،‬ﻋﻘﺩ ﺍﻟﺩﻭﺭﺓ ﺍﻟﺜﺎﻨﻴﺔ‬ ‫ﻗﺭﺭﺕ ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‪ ،‬ﻭﻓﻘﹰ‬ ‫ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ ﻓﻲ ﺘﺎﺭﻴﺦ ﻭﻤﻜﺎﻥ ﺴﻴﺘﻡ ﺘﺤﺩﻴﺩﻫﻤﺎ ﻓﻲ ﺍﻟﺸﻬﻭﺭ ﺍﻟﺴﺘﺔ ﺍﻷﻭﻟﻰ ﻤﻥ ﻋﺎﻡ ‪.٢٠٠٧‬‬ ‫)ﺍﻟﺠﻠﺴﺔ ﺍﻟﻌﺎﻤﺔ ﺍﻟﺨﺎﻤﺴﺔ‪ ١٧ ،‬ﺸﺒﺎﻁ‪ /‬ﻓﺒﺭﺍﻴﺭ ‪(٢٠٠٦‬‬

‫ـــــــــــــ‬

LIST OF PARTICIPANTS LISTE DES PARTICIPANTS REPRESENTATIVES OF PARTIES REPRESENTANTS DES PARTIES

ARMENIA – ARMENIE Chief delegate - Chef de délégation Mr T. Hakobyan Deputy Minister of Health Deputy chief delegate - Chef adjoint de la délégation Mr Z. Mnatsakanian Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Mr A. Bazarchyan Coordinator of the Anti-Tobacco Programme, Ministry of Health Alternate(s) - Suppléant(s) Mr A. Apitonian Counsellor, Permanent Mission, Geneva AUSTRALIA – AUSTRALIE Chief delegate - Chef de délégation Ms J. Hefford Assistant Secretary, Drug Strategy Branch, Department of Health and Ageing Delegate(s) – Délégué(s) Ms P. Marshall Director, Tobacco, Drug Prevention and Youth Policy Section, Drugs Strategy Branch, Department of Health and Ageing Ms C. Patterson Minister-Counsellor (Health), Permanent Mission, Geneva - 63 -

Alternate(s) - Suppléant(s) Mr M. Sawers First Secretary, Permanent Mission, Geneva Adviser(s) - Conseiller(s) Ms C. Holliday Administrative Assistant, Permanent Mission, Geneva Mr G. Adlide Counsellor (AusAID), Permanent Mission, Geneva Ms L. Oates-Mercier Programme Officer (AusAID), Permanent Mission, Geneva AUSTRIA – AUTRICHE Chief delegate - Chef de délégation Mrs M. Rauch-Kallat Federal Minister of Health and Women Deputy chief delegate - Chef adjoint de la Délégation Dr W. Petritsch Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Dr C. Lassmann Deputy Head, Health and Social Affairs Division, Federal Ministry for Foreign Affairs Alternate(s) - Suppléant(s) Mrs C. Kokkinakis Deputy Permanent Representative, Geneva

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ Dr H. Friza Attaché (Health Affairs), Permanent Mission, Geneva Mrs A. Haas Health Attaché, Permanent Representation of Austria, Brussels Mr F. Pressl Cabinet, Federal Ministry of Health and Women Dr V. Gregorich-Schega Director, International Health Relations, Federal Ministry of Health and Women Dr B. Magistris Director, European Union Coordination for Health, Liaison Services, Federal Ministry of Health and Women Dr J. Schopper Director, Psychoactive Substances Division, Federal Ministry of Health and Women Mrs C. Sedlmeier Deputy Director, European Union Coordination for Health, Liaison Services, Federal Ministry of Health and Women Dr C. Franta Psychoactive Substances Division, Federal Ministry of Health and Women Mrs A. Punzet International Health Relations, Federal Ministry of Health and Women Dr D. Zimper International Health Relations, Federal Ministry of Health and Women Dr H. Heller Director, Federal Ministry of Finance Mr J. Pfeiffer Federal Ministry of Finance Mr J. Gasser Federal Ministry of Justice Mr G. Fretska Head, Federal Ministry of the Interior Mr J. Sykora Head of Unit, Directorate-General I, General Secretariat of the Council of the European Union, Brussels Mr E. Esteller Directorate-General I, General Secretariat of the Council of the European Union, Brussels

64

Mr G. Houttuin Deputy Head of the Liaison Office, Council of the European Union, Geneva Mr J. Lilliehook Counsellor, Council of the European Union, Geneva Mrs M.-N. Adler Permanent Mission, Geneva Mrs B. Krippl Permanent Mission, Geneva Mr C. Hörhan Spokesman of the Federal Minister for Health and Women AZERBAIJAN – AZERBAIDJAN Delegate(s) – Délégué(s) Mr R. Novruzov Attaché, Permanent Mission, Geneva BANGLADESH – BANGLADESH Chief delegate - Chef de délégation Dr T. Ali Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Mr M.S. Islam Joint Secretary, Ministry of Health and Family Welfare Mr M.-U. Zaman Minister, Permanent Mission, Geneva Alternate(s) - Suppléant(s) Mr N.U. Ahmed Second Secretary, Permanent Mission, Geneva

65

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ Mme M.T. Timmermans Délégué Wallonie-Bruxelles, Mission permanente, Genève Mme M. Wauters Administration des Soins de Santé, Ministère de la Communauté flamande Mme A. Deltour Attaché Santé, Représentation permanente auprès de l’Union européenne, Bruxelles M. D. Angelet Service Nations Unies, Service public fédéral Affaires étrangères Mme O. Schoonbroodt Délégation Wallonie-Bruxelles, Genève BENIN – BENIN Chief delegate - Chef de délégation Professor D.A. Kinde-Gazard Ministre de la Santé publique Delegate(s) - Délégué(s) M. L. Bio Bigou Député à l’Assemblée Nationale M. S. Amehou Ambassadeur, Représentant permanent, Genève Alternate(s) - Suppléant(s) Dr B.H. Faïhun Secrétaire général, Ministère de la Santé publique Dr L. Assogba Directeur national de la Protection sanitaire, Ministère de la Santé publique M. Y. Amoussou Premier Conseiller, Mission permanente, Genève BHUTAN – BHOUTAN Chief delegate - Chef de délégation Dr G. Tshering Secretary, Ministry of Health

BARBADOS – BARBADE Delegate(s) - Délégué(s) Mr S. Deane Chief Health Planner, Ministry of Health BELARUS – BELARUS Chief delegate - Chef de délégation Mr M. Rimzha Deputy Minister for Health Delegate(s) - Délégué(s) Mr S. Aleinik Permanent Representative, Geneva Mr A. Molchan Counsellor, Permanent Mission, Geneva Alternate(s) - Suppléant(s) Mr A. Panferov Second Secretary, General Legal Department, Ministry of Foreign Affairs BELGIUM – Belgique Chief delegate - Chef de délégation M. F. Roux Ambassadeur, Représentant permanent, Genève Delegate(s) - Délégué(s) Mme P. Bernaert Cabinet du Ministre de la Santé publique et des Affaires sociales Mme F. Gustin Ministre conseiller, Représentant permanent adjoint, Genève Alternate(s) - Suppléant(s) Mme L. Meulenbergs Service des Relations internationales, Service public fédéral Santé publique, Sécurité de la Chaîne alimentaire et Environnement

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ Delegate(s) - Délégué(s) Mr S.T. Rabgye Ambassador, Permanent Representative, Geneva Ms D. Tshering Counsellor, Permanent Mission, Geneva Alternate(s) - Suppléant(s) Mr S. Phuntsho Joint Director, Information and Communication Bureau, Ministry of Health BOLIVIA – BOLIVIE Chief delegate - Chef de délégation Dr. F. Antezana Araníbar Asesor Principal, Despacho del Ministro de Salud y Deportes Delegate(s) - Délégué(s) Sr. G. Poggi Borda Ministro Consejero, Misión Permanente, Ginebra BOTSWANA – BOTSWANA Chief delegate - Chef de délégation Mr B. Mokgothu Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Mr T.M. Lekuni Deputy Permanent Representative, Minister Counsellor, Geneva Mr S.S. Mokgweetsinyana Chief Health Officer, Ministry of Health Alternate(s) - Suppléant(s) Mrs M.S. Matlho Counsellor, Permanent Mission, Geneva Mr T. Mogotsi First Secretary, Permanent Mission, Geneva Mr F. Rubinstein Director, National Agency for Health Surveillance, Ministry of Health Mr A. Sanches Peraci Director, Department of Production, Financing and Protection, Secretariat of Family Agriculture, Ministry of Agrarian Development Mr L.F. de Seixas Corrêa Brazilian Ambassador to Germany, Berlin Mr C.A. da Rocha Paranhos Ambassador, Alternate Permanent Representative, Geneva Mr A.C. do Nascimento Pedro Minister Counsellor, Permanent Mission, Geneva Alternate(s) - Suppléant(s) Mr S. Alcázar Counsellor and Head, Department of International Affairs, Ministry of Health Dr V.L. da Costa e Silva Special Adviser, Ministry of Health BRAZIL – BRESIL Chief delegate - Chef de délégation Mr C. Hugueney Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s)

66

Ms T.M. Cavalcante Head, Division of Tobacco Control and Other Risk Factors, National Institute of Cancer Mr M. Fisch Berredo Menezes General Coordinator of Inspection, Ministry of Finance Mr P.M. de Castro Saldanha Second Secretary, Permanent Mission, Geneva

67

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ Delegate(s) - Délégué(s) Dr V. Tzekov Deputy Minister of Health Dr M. Gavrailova Head of Department, Public Health Protection, Public Health Protection and Control Directorate, Ministry of Health Alternate(s) - Suppléant(s) Mrs J. Andonova Director, European Integration International Cooperation, Trade and Markets Directorate, Tobacco Fund, Ministry of Agriculture and Forestry Mrs D. Parusheva Second Secretary, Permanent Mission, Geneva CAMBODIA – CAMBODGE

Ms M. Ribeiro Nogueira Guebel Third Secretary, Ministry of Foreign Relations Mr C.A. Toselli Adviser, Department of Foreigners, Ministry of Justice Mr C.A. Ribeiro Xavier Adviser, Ministry of Education Mr J.O. Miranda Pacheco Adviser, Ministry of Agriculture, Livestock and Food Supply Mr G. Simon Adviser, Ministry of Agriculture, Livestock and Food Supply Mr C.H. Spezia Adviser, Secretariat for Work and Education Management in Health, Ministry of Health BRUNEI DARUSSALAM – BRUNEI DARUSSALAM Chief delegate - Chef de délégation Dr Hajah Intan Haji Salleh Director-General of Health Services, Ministry of Health Delegate(s) - Délégué(s) Mrs Hajah Zahrah Dato Paduka Haji Hashim Acting Assistant Director of Research and Development, Ministry of Health Ms Dk Suzylawati Pg Indera Wijaya Pg Dato Dr Hj Ismail Legal Adviser, Ministry of Health Alternate(s) - Suppléant(s) Ms Farida Hairani Hisham Second Secretary, Permanent Mission, Geneva BULGARIA – BULGARIE Chief delegate - Chef de délégation Mr P. Draganov Ambassador, Permanent Representative, Geneva

Chief delegate - Chef de délégation Mrs Ouk Monna Secretary of State, Ministry of Health Delegate(s) - Délégué(s) Mr Phan Peuv Second Secretary, Permanent Mission, Geneva CANADA – CANADA Chief delegate - Chef de délégation Ms C. Gilders Director-General, International Affairs Directorate, Health Canada Delegate(s) - Délégué(s) Mr T. Cormier Deputy Permanent Representative, Geneva Ms N. St Lawrence Senior Adviser, International Affairs Directorate, Health Canada Alternate(s) - Suppléant(s) Mr D. Choiniere Director, Regulations and Compliance, Tobacco Control

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ Programme, Health Canada Ms V. Brouchet Legal Counsel, Health Canada Mr B. Rogers Senior Policy Analyst, Office of Policy, Tobacco Control Programme, Health Canada Mr P. Oldham Counsellor, Permanent Mission, Geneva Mr A. Hazlewood Provincial Adviser, Province of British Columbia Mr N. Collishaw Research Director, Physicians for a Smokefree Canada CAPE VERDE – CAP-VERT Delegate(s) - Délégué(s) Dr I. Figueiredo Soares Directrice des Services de Maladies non transmissibles, Ministère de la Santé CENTRAL AFRICAN REPUBLIC – REPUBLIQUE CENTRAFRICAINE Delegate(s) - Délégué(s) Dr J. Ngaba Expert en législation pharmaceutique, Cabinet du Ministre de la Santé Publique et de la Population CHILE – CHILI Chief delegate - Chef de délégation Sr. J. Martabit Embajador, Representante Permanente, Ginebra Delegate(s) - Délégué(s) Sr. J.E. Eguiguren Ministro Consejero, Misión Permanente, Ginebra Dr. F. Muñoz Jefe, División de Prevención y Control de Enfermedades, Subsecretaría de Salud Pública, Ministerio de Salud Alternate(s) - Suppléant(s) Sr. P. Utreras Consejero, Misión Permanente, Ginebra Sr. B. del Picó Segundo Secretario, Misión Permanente, Ginebra Sr. J.M. Concha Segundo Secretario, Dirección de Política Multilateral, Ministerio de Relaciones Exteriores Sr. S. Pavlovic Jefe, Departamento de Asesoría Jurídica, Ministerio de Salud CHINA – CHINE Chief delegate - Chef de délégation

68

Mrs Ou Xinqian Vice Chairperson, National Development and Reform Commission Delegate(s) - Délégué(s) Mr Sha Zukang Ambassador, Permanent Representative, Geneva Dr Zhang Bin Deputy Director-General, Department of Maternal and Community Health, Ministry of Health Alternate(s) - Suppléant(s) Mr Li Yangzhe Deputy Director-General, Bureau of Economic Operation, National Development and Reform Commission Mr Li Bin Deputy Director-General, Department of International Affairs, National Development and Reform Commission Dr Qi Qingdong Deputy Director-General, Department of International Cooperation, Ministry of Health

69

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ Ms Xing Zhaohong Programme Officer, Department of Economic Construction, Ministry of Finance Mr Zhang Ze Attaché, Permanent Mission, Geneva COOK ISLANDS – ILES COOK

Mr Yang Yong’an Deputy Director-General, Department of Foreign Affairs, State Tobacco Monopoly Administration Mr Fu Cong Counsellor, Permanent Mission, Geneva Ms Liang Yan Secretary, National Development and Reform Commission Mr Lu Zhikun Division Director, Bureau of Economic Operation, National Development and Reform Commission Ms Hu Meiqi Division Director, Department of International Cooperation, Ministry of Health Dr Tao Jin Division Director, Department of Maternal and Community Health, Ministry of Health Mr Yang Hongfeng Division Director, Department of Advertisement Administration, State Administration for Industry and Commerce Mr Zhao Baidong Division Director, Department of Foreign Affairs, State Tobacco Monopoly Administration Mr Gou Haibo Deputy Division Director, Department of International Treaty and Law, Ministry of Foreign Affairs Mr Yang Xiaokun First Secretary, Permanent Mission, Geneva Ms Su Zhongbi Assistant Researcher, Yunnan Academy of Tobacco Science Ms Wan Qian Programme Officer, National Development and Reform Commission

Delegate(s) - Délégué(s) Ms N.N. Short Director of Public Health, Ministry of Health CYPRUS – CHYPRE Chief delegate - Chef de délégation Mr J.C. Droushiotis Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Mr N. Nicolaou Counsellor, Deputy Permanent Representative, Geneva Mr H. Herodotou Health Inspector, Medical and Public Health Services, Ministry of Health Alternate(s) - Suppléant(s) Ms M. Soloyianni Permanent Mission, Geneva DEMOCRATIC PEOPLE’S REPUBLIC OF KOREA – REPUBLIQUE POPULAIRE DEMOCRATIQUE DE COREE Chief delegate - Chef de délégation Mr Kye Chun Yong Deputy Permanent Representative, Geneva Delegate(s) - Délégué(s) Mr Jang Chun Sik Expert, Ministry of Foreign Affairs Mr Song In Bom Expert, Ministry of Public Health

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ Lutte anti-tabac, Ministère de la Santé EGYPT – EGYPTE Chief delegate - Chef de délégation Mr S. Shoukry Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Mr A. Meleka Minister, Deputy Permanent Representative, Geneva Dr M. Mahmoud Ministy of Health and Population Alternate(s) - Suppléant(s) Dr M. Mehrez Ministry of Health and Population Mr T. Khalaf Third Secretary, Permanent Mission, Geneva ESTONIA – ESTONIE Chief delegate - Chef de délégation Mr T. Nirk Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s)

70

Alternate(s) - Suppléant(s) Mr Jang Il Hun Counsellor, Permanent Mission, Geneva DEMOCRATIC REPUBLIC OF THE CONGO – REPUBLIQUE DEMOCRATIQUE DU CONGO

Chief delegate - Chef de délégation M. A. Mindua Kesia-Mbe Ambassadeur, Représentant permanent, Genève Delegate(s) - Délégué(s) M. Y.R. Mbuyu Muteba Directeur, Programme National de Lutte contre les Toxicomanies et les Substances Toxiques, Point Focal national de la Lutte antitabac M. X.H. Tati Premier Conseiller d’Ambassade, Direction des Organisations internationales, Ministère des Affaires Etrangères et de la Coopération Internationale Alternate(s) - Suppléant(s) M. S. Mutomb Mujing Conseiller, Mission permanente, Genève DENMARK – DANEMARK Chief delegate - Chef de délégation Mr K. Geil Senior Adviser, Ministry of the Interior and Health Delegate(s) - Délégué(s) Ms H. Findsen Health Counsellor, Permanent Representation of Denmark, Brussels DJIBOUTI – DJIBOUTI Delegate(s) - Délégué(s) Mme S. Ali Higo Coordinatrice nationale, Programme de la

Mr A. Lipand Chief Specialist, Health Policy Unit, Ministry of Social Affairs Mrs K. Sibul Third Secretary, Permanent Mission, Geneva EUROPEAN COMMUNITY – COMMUNAUTE EUROPEENNE Chief delegate - Chef de délégation Mr C. Trojan Ambassador, Permanent Delegation of the European Commission, Geneva Delegate(s) - Délégué(s) Ms M.-J. Jonczy-Montastruc Principal Legal Adviser, Legal Service of the European Commission

71

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ FINLAND – FINLANDE

Mr T. Bechet Minister Counsellor, Head of the United Nations Section, Permanent Delegation of the European Commission, Geneva Alternate(s) - Suppléant(s) Dr M. Rajala Minister Counsellor, United Nations Section, Permanent Delegation of the European Commission, Geneva Ms T. Emmerling Deputy Head of Unit, Directorate-General, Health and Consumer Protection Mr A. Maunu Administrator, Directorate-General, Health and Consumer Protection Mr I. Walton-George Head of Unit, European Anti-Fraud Office Mr A. Rowan Principal Administrator, European Anti-Fraud Office Mr F. van Driessche Policy Officer, Directorate-General, Taxation and Customs Union Ms L. Pignataro-Nolin Legal Service of the European Commission Mr A. Adamou Member of the European Parliament Ms S. Magnano Environment Committee Secretariat, European Parliament Mr C. Schlyter Member of the European Parliament FIJI – FIDJI Delegate(s) - Délégué(s) Dr L. Waqatakirewa Chief Executive Officer, Ministry of Health

Chief delegate - Chef de délégation Mr O. Simonen Senior Adviser, Ministry of Social Affairs and Health Delegate(s) - Délégué(s) Ms S. Koskenkorva Senior Adviser, Ministry of Social Affairs and Health Mr A. Koho Special Adviser, Finnish Mission to the European Union, Brussels Alternate(s) - Suppléant(s) Ms A. Ehrnrooth Special Adviser, Finnish Mission to the European Union, Brussels Ms S. Sammalkivi Second Secretary, Permanent Mission, Geneva FRANCE – France Chief delegate - Chef de délégation M. J.-M. Ripert Ambassadeur, Représentant permanent, Genève Delegate(s) - Délégué(s) Dr D. Jayle Président, Mission Interministérielle de Lutte contre la Drogue et la Toxicomanie Dr P. Melihan-Cheinin Chef, Bureau des Pratiques addictives, Direction générale de la Santé, Ministère de la Santé et des Solidarités Alternate(s) - Suppléant(s) Dr S. Ratte Institut national du Cancer

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ Mme N. Larochette Bureau des Pratiques addictives, Direction générale de la Santé, Ministère de la Santé et des Solidarités M. D. Martin Bureau des Pratiques addictives, Direction Générale de la Santé, Ministère de la Santé et des Solidarités M. M. Giacomini Représentant permanent adjoint, Genève M. G. Delvallée Sous-Direction des Affaires économiques, Ministère des Affaires étrangères Mme J. Tor-de Tarlé Premier Secrétaire, Mission permanente, Genève Mme P. Renoul Conseiller, Mission permanente, Genève M. J.-F. Trogrlic Conseiller (Affaires sociales), Mission permanente, Genève M. A. Atger Mission interministérielle de Lutte contre la Drogue et la Toxicomanie Mlle V. Basso Mission permanente, Genève GERMANY – Allemagne Chief delegate - Chef de délégation Mr M. Steiner Ambassador, Permanent Representative, Geneva Deputy chief delegate - Chef adjoint de la Délégation Mrs B. Siefker-Eberle Deputy Permanent Representative, Geneva Alternate(s) - Suppléant(s) Dr F. Niggemeier Permanent Representation to the European Union, Brussels Dr I. von Voss Counsellor, Permanent Mission, Geneva Dr W. Traub Bundesrat, Ministry for Social Affairs, Baden-Wuerttemberg

72

Mr T. Hofmann Deputy Head, Multilateral Cooperation in the Field of Health Division, Federal Ministry of Health, Bonn Mrs K. Frels Deputy Head, Multilateral Cooperation in the Field of Health Division, Federal Ministry of Health, Bonn Mr P. Neuerburg Attaché, Permanent Mission, Geneva GHANA – GHANA Chief delegate - Chef de délégation Dr K. Bawuah-Edusei Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Professor A.B. Akosa Director-General, Ghana Health Service Dr J. Amankwa Regional Director, Upper East Bolgatanga Alternate(s) - Suppléant(s) Ms M.A. Alomatu First Secretary, Permanent Mission, Geneva Ms A. Amartey Head, Tobacco and Substances of Abuse Department, Food and Drugs Board Mrs E.K. Wellington Senior Health Research Officer, Ghana Health Service GUATEMALA – GUATEMALA Chief delegate - Chef de délégation Sr. C.R. Martínez Embajador, Representante Permanente, Ginebra

73

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ Mr B. Lenhardt Counsellor, Ministry of Economics and Transport Mr A. Bukai Counsellor, Ministry of Agriculture and Rural Development Mr B. Rátkai Third Secretary, Permanent Mission, Geneva ICELAND – ISLANDE Delegate(s) - Délégué(s) Ms S. Gudmundsdottir Chief Counsellor, Department of Legal Affairs, Ministry of Health and Social Security INDIA – INDE Chief delegate - Chef de délégation Mr S. Singh Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Mrs B. Thyagrajan Joint Secretary, Ministry of Health and Family Welfare Mr M.S. Grover Deputy Permanent Representative, Geneva Alternate(s) - Suppléant(s) Dr K. Srinath Reddy Professor of Cardiology, All India Institute of Medical Sciences Mr V.K. Trivedi First Secretary, Permanent Mission, Geneva IRAN (ISLAMIC REPUBLIC OF) – IRAN (REPUBLIQUE ISLAMIQUE D’) Chief delegate - Chef de délégation Dr S.M. Alavian Deputy Minister of Health and Medical Education

Delegate(s) - Délégué(s) Sra. S. Hochstetter Consejero, Misión Permanente, Ginebra Sra. M.S. Urruela Segundo Secretario, Misión Permanente, Ginebra Alternate(s) - Suppléant(s) Dra. M.A. Flores González Asesora Específica, Ministerio de Salud Pública y Asistencia Social HONDURAS – HONDURAS Chief delegate - Chef de délégation Sr. J.B. Zapata Embajador, Representante Permanente, Ginebra Delegate(s) - Délégué(s) Dr. R. Batres Director-General, Instituto Hondureño para la Prevención del Alcoholismo, Drogadicción y Farmacodependencia Sr. M. Pérez Zepeda Segundo Secretario, Misión Permanente, Ginebra HUNGARY – HONGRIE Chief delegate - Chef de délégation Mr G. Szelei Kiss Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Dr J. Vizi Expert, National Centre for Epidemiology Mr T. Demjén Expert, National Centre for Health Promotion Alternate(s) - Suppléant(s) Mr B. Raffay Expert, Ministry of Health

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ Delegate(s) - Délégué(s) Dr S.M.K. Sajjadpour Ambassador, Permanent Representative, Geneva Mr R. Bayat Mokhtari Counsellor, Permanent Mission, Geneva Alternate(s) - Suppléant(s) Dr N. Baliq Adviser to the Deputy Minister of Health IRELAND – IRLANDE Chief delegate - Chef de délégation Delegate(s) - Délégué(s) Mrs M. Whelan Ambassador, Permanent Representative, Geneva Deputy chief delegate - Chef adjoint de la Délégation Mr E. Corcoran Principal Officer, Tobacco Control Unit, Department of Health and Children Delegate(s) - Délégué(s) Mr D. Smyth Deputy Permanent Representative, Permanent Mission, Geneva Alternate(s) - Suppléant(s) Mr G. O’Dufaigh Assistant Principal Officer, Tobacco Control Unit, Department of Health and Children Mr K. Devine Higher Executive Officer, Tobacco Control Unit, Department of Health and Children Ms S. McEvoy Acting Chief Environmental Health Officer, Department of Health and Children Mr P. Synnott Assistant Principal Officer, International Unit, Department of Health and Children Ms E. Efrat-Smilg Director, Treaties Department, Ministry of Foreign Affairs Ms I. Mayshar Senior Deputy Legal Adviser, Ministry of Health Alternate(s) - Suppléant(s) Ms N. Fourman Counsellor, Permanent Mission, Geneva Ms E. Gouldman Zarka Adviser, Permanent Mission, Geneva JAMAICA – JAMAIQUE Chief delegate - Chef de délégation Dr E. Lewis-Fuller Director, Cooperation in Health Policy Analysis, Ministry of Health Delegate(s) - Délégué(s) Ms A. Morris Counsellor, Permanent Mission, Geneva Mrs A. Dubidad-Dixon First Secretary, Permanent Mission, Geneva Mr J. O’Toole Health Counsellor, Irish Permanent Representation to the European Union, Brussels

74

Ms O. Keane Second Secretary, Permanent Mission, Geneva ISRAEL – ISRAEL Chief delegate - Chef de délégation Mr I. Levanon Ambassador, Permanent Representative, Geneva

75

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ Dr R. Akizuki Section Chief, International Affairs Division, Minister’s Secretariat, Ministry of Health, Labour and Welfare Ms Y. Fujino Official, Specialized Agencies Division, Global Issues Department, Ministry of Foreign Affairs JORDAN – JORDANIE Chief delegate - Chef de délégation Dr M. Burayzat Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Dr M.B.A. Qasem Director of Health Safety, Ministry of Health Mr H. Al Husseini First Secretary, Permanent Mission, Geneva KENYA – KENYA Chief delegate - Chef de délégation Ms A.C. Mohamed Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Dr A.E.O. Ogwell Head, Division of Noncommunicable Diseases, Ministry of Health Ms L. Nyambu First Secretary, Permanent Mission, Geneva KIRIBATI – KIRIBATI Chief delegate - Chef de délégation Mr N. Kirata Minister of Health and Medical Services Delegate(s) - Délégué(s) Mr R. Maninraka Secretary of Health and Medical Services

JAPAN – JAPON Chief delegate - Chef de délégation Mr I. Fujisaki Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Mr M. Tsuji Deputy Director-General, Global Issues Department, Ministry of Foreign Affairs Mr H. Minami Minister, Permanent Mission, Geneva Alternate(s) - Suppléant(s) Dr E. Kashiwagi Director, Public Health Affairs, Environmental Health Division, Health Services Bureau, Ministry of Health, Labour and Welfare Mr Y. Kawai Director, Tobacco and Salt Industries Office, Financial Bureau, Ministry of Finance Mr M. Tachikawa Deputy Director, Tobacco and Salt Industries Office, Financial Bureau, Ministry of Finance Dr T. Takei Deputy Director, Policy Planning Division, Department of Health and Welfare for Persons with Disabilities, Social Welfare and War Victim’s Relief Bureau, Ministry of Health, Labour and Welfare Ms T. Tsujisaka First Secretary, Permanent Mission, Geneva Dr N. Murashige Tobacco Free Initiative Officer, Health Service Bureau, Ministry of Health, Labour and Welfare Mr A. Takahashi Unit Chief, Tobacco and Salt Industries Office, Financial Bureau, Ministry of Finance

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ Dr T. Kienene Public Health Consultant LATVIA – LETTONIE Chief delegate - Chef de délégation Ms I. Šmate Deputy Director, Department of Public Health, Ministry of Health Delegate(s) - Délégué(s) Ms G. Vītola Third Secretary, Permanent Mission, Geneva LESOTHO – LESOTHO Alternate(s) - Suppléant(s) Chief delegate - Chef de délégation Mrs M. Rasethuntsa Deputy Principal Secretary, Ministry of Health and Social Welfare Delegate(s) - Délégué(s) Mr N. Leboela Ministry of Health and Social Welfare Mrs N. Mosala Ministry of Health and Social Welfare Alternate(s) - Suppléant(s) Mrs M. Pheko Minister Counsellor, Permanent Mission, Geneva LIBYAN ARAB JAMAHIRIYA – JAMAHIRIYA ARABE LIBYENNE Chief delegate - Chef de délégation Mr A. Benomran Minister, Permanent Mission, Geneva Delegate(s) - Délégué(s) Dr H. Gashut Counsellor, Permanent Mission, Geneva Mr F. Abusaa Third Secretary, Permanent Mission, Geneva LITHUANIA – LITUANIE Chief delegate - Chef de délégation Mr E. Borisovas Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Ms G. Krivelienė Chief Specialist, Division of Public Health, Ministry of Health Ms R. Kazragienė Counsellor, Permanent Mission, Geneva

76

Ms R. Liaudanskienė Health Attaché, Permanent Representation to the European Union, Brussels LUXEMBOURG – LUXEMBOURG Chief delegate - Chef de délégation M. J. Feyder Ambassadeur, Représentant permanent, Genève Delegate(s) - Délégué(s) Dr D. Hansen-Koenig Directeur de la Santé Mme C. Goy Représentant permanent adjoint, Genève Alternate(s) - Suppléant(s) Mme A. Calteux Attaché, Mission du Luxembourg auprès de l’Union européenne, Bruxelles MADAGASCAR – MADAGASCAR Chief delegate - Chef de délégation M. A. Rambeloson Ambassadeur, Représentant permanent, Genève

77

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ MALI – MALI Chief delegate - Chef de délégation M. S. Kasse Chargé d’Affaires, Mission permanente, Genève Delegate(s) - Délégué(s) Dr M. Sidibe Conseiller technique, Ministère de la Santé MALTA – MALTE Chief delegate - Chef de délégation Mr S.F. Borg Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Mr R. Sarsero Counsellor, Permanent Mission, Geneva Mr J. Busuttil First Secretary, Permanent Mission, Geneva Alternate(s) - Suppléant(s) Mr T. Bonnici First Secretary, Permanent Mission, Geneva Dr S. Misfud Legal Officer, Ministry of Health, the Elderly and Community Care MARSHALL ISLANDS – ILES MARSHALL Chief delegate - Chef de délégation Mr R. Edwards Assistant Secretary of Health, Ministry of Health Delegate(s) - Délégué(s) Mr J. Jorbon Assistant Attorney General, Office of the Attorney General

Delegate(s) - Délégué(s) M. J.M. Rasolonjatovo Premier Conseiller, Mission permanente, Genève Dr N.R. Ramanandraibe Directeur, Office national de Lutte anti-tabac, Ministère de la Santé et du Planning familial MALAYSIA – MALAISIE Chief delegate - Chef de délégation Dr Lee Kah Choon Parliamentary Secretary, Ministry of Health Delegate(s) - Délégué(s) Mrs Hsu King Bee Ambassador, Permanent Representative, Geneva Mrs Lee Lay Choo Legal Advisor, Ministry of Health Alternate(s) - Suppléant(s) Dr Zainal Ariffin B. Omar Deputy Director, Noncommunicable Disease Section, Disease Control Division, Ministry of Health Dr Zarihah Bt. Mohd Zain Principal Assistant Director, Environmental and Occupational Health Unit, Disease Control Division, Ministry of Health Mr Mohamed Zin Amran Deputy Permanent Representative, Geneva Mr Wan Aznainizam Yusri Wan Abdul Rashid Second Secretary, Permanent Mission, Geneva MALDIVES – MALDIVES Delegate(s) - Délégué(s) Mr A. Afaal Director, Ministry of Health

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ MAURITANIA – MAURITANIE Chief delegate - Chef de délégation M. M.S. Ould Mohamed Lemine Ambassadeur, Représentant permanent, Genève Delegate(s) - Délégué(s) M. M.F. Ould Mohamedou Conseiller juridique du Ministre de la Santé et des Affaires sociales M. M. Ould Magha Premier Conseiller, Mission permanente, Genève MAURITIUS – MAURICE Chief delegate - Chef de délégation Mr S.B.C. Servansing Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Mr M.I. Latona Minister Counsellor, Permanent Mission, Geneva Mr V. Mungur First Secretary, Permanent Mission, Geneva Alternate(s) - Suppléant(s) Mr U.K. Sookmanee Second Secretary, Permanent Mission, Geneva Miss R. Wilfrid-René Second Secretary, Permanent Mission, Geneva MEXICO – MEXIQUE MONGOLIA – MONGOLIE Chief delegate - Chef de délégation Chief delegate - Chef de délégation Sr. L.A. de Alba Embajador, Representante Permanente, Ginebra Mr D. Boldbaatar Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Sr. P. Macedo Embajador, Representante Permanente Alterno, Ginebra Sr. C. Ruíz Gaytán López Secretario Técnico, Consejo Nacional contra las Adicciones Alternate(s) - Suppléant(s) Sra. D.M. Valle Consejero, Misión Permanente, Ginebra Sra. A. Pérez de León Consultora de Asuntos Internacionales, Consejo Nacional contra las Adicciones, Secretaría de Salud

78

Sr. L.A. Caso González Comisionado de Fomento Sanitario, Representante de la Comisión Federal para la Protección contra Riesgos Sanitarios Dr. V.M. Guisa Cruz Director General de los Centros de Integración Juvenil, Secretaría de Salud Sr. J.M. Sánchez Tercer Secretario, Misión Permanente, Ginebra Srta. G.I. Pérez Juárez Asesora, Misión Permanente, Ginebra MICRONESIA (FEDERATED STATES OF) MICRONESIE (ETATS FEDERES DE) Delegate(s) - Délégué(s) Mr M. Samo Assistant Secretary for Health, Department of Health, Education and Social Affairs

79

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ Mrs S. van Dinter Senior Policy Adviser, Ministry of Foreign Affairs Alternate(s) - Suppléant(s) Mr P. de Coninck Senior Policy Adviser, Ministry of Health, Welfare and Sport Mr R. Kuiten Senior Policy Adviser, Ministry of Health, Welfare and Sport Mr V. Everhardt Senior Policy Adviser, Ministry of Health, Welfare and Sport Mrs G. Vrielink First Secretary, Permanent Mission, Geneva NEW ZEALAND – NOUVELLE-ZELANDE Chief delegate - Chef de délégation

Delegate(s) - Délégué(s) Ms G. Tsetsegdari Senior Officer, Health Policy Coordination Division, Ministry of Health Ms D. Gerelmaa Third Secretary, Permanent Mission, Geneva MYANMAR – MYANMAR Delegate(s) - Délégué(s) Dr Khin Win Thet Assistant Director (Medical Care), Department of Health, Ministry of Health NAMIBIA – NAMIBIE Chief delegate - Chef de délégation Mr R. Nchabi Kamwi Minister of Health and Social Services Delegate(s) - Délégué(s) Dr N. Foster Under-Secretary for Health and Social Welfare Policy, Ministry of Health and Social Services Mr B. Maloboka Chief, Health Programme, Ministry of Health and Social Services NAURU – NAURU Delegate(s) - Délégué(s)

Mr D. O’Connor Associate Minister of Health Delegate(s) - Délégué(s) Mr T. Caughley Ambassador, Permanent Representative, Geneva Mr N. Kiddle Deputy Permanent Representative, Geneva Alternate(s) - Suppléant(s)

Mrs C. Scotty Secretary for Health and Medical Services NETHERLANDS – PAYS-BAS Chief delegate - Chef de délégation Mr J. Draijer Permanent Representation of the Netherlands to the European Union, Brussels Delegate(s) - Délégué(s) Mr I.M. de Jong Ambassador, Permanent Representative, Geneva

Dr A. Bloomfield Chief Adviser, Public Health, Ministry of Health Dr R. Beaglehole Senior Adviser to the Minister NIGER – NIGER Chief delegate - Chef de délégation Dr D. Magagi Conseiller Technique, Ministère de la Santé Publique et de la Lutte Contre les Endémies

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ Delegate(s) - Délégué(s) M. T. Manou Chef, Division juridique bilatérale, Ministère des Affaires érangères, de la Coopération et de l’Intégration africaine Dr I.I. Baaré Point Focal de lutte anti-tabac NIGERIA – NIGERIA Chief delegate - Chef de délégation Chief delegate - Chef de délégation Mr J.U. Ayalogu Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Dr M.E. Anibueze Director, Noncommunicable Disease and Tobacco Control Programme, Ministry of Health Dr S. Baba Senior Counsellor, Permanent Mission, Geneva NIUE – NIOUE Delegate(s) - Délégué(s) Delegate(s) - Délégué(s) Mr M. Nosa Senior Public Health Officer NORWAY – NORVEGE Chief delegate - Chef de délégation Mr W.C. Strømmen Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) PALAU – PALAOS Mr T. Hetland Senior Adviser, Ministry of Health and Care Services Ms T. Kongsvik Counsellor, Permanent Mission, Geneva Delegate(s) - Délégué(s) Mr R.S. Sheikh First Secretary, Permanent Mission, Geneva Ms Ibtissam bint Abdulwahhab Al-Balushi Expert, Health Affairs Mr Yousuf bin Issa bin Ali Al-Zadjali First Secretary, Permanent Mission, Geneva PAKISTAN – PAKISTAN Chief delegate - Chef de délégation Ms T. Janjua Acting Permanent Representative, Geneva Dr Jawad bin Ahmed bin Jawad Al-Lawati Director, Department of Noncommunicable Diseases, Ministry of Health Delegate(s) - Délégué(s) Alternate(s) - Suppléant(s) Ms R.L. Lindbak Adviser, Directorate for Health and Social Issues Mr B. Rosted Adviser, Norwegian Cancer Association OMAN – OMAN

80

Mr M.N. Sheikh Health Education Adviser, Ministry of Health Alternate(s) - Suppléant(s) Mr F. Shah Permanent Mission, Geneva

Dr C.T.O. Otto Chairman, Committee on Health, The Senate, Palau National Congress

81

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ Dr E. Vera Medical Officer VII, Degenerative Diseases Office, National Center for Disease Prevention and Control, Department of Health PORTUGAL – PORTUGAL Chief delegate - Chef de délégation

PANAMA – PANAMA Chief delegate - Chef de délégation Sra. U. Alfú de Reyes Embajadora, Representante Permanente Adjunta, Ginebra Delegate(s) - Délégué(s) Dra. R. Roa Dirección Nacional de Políticas de Salud, Ministerio de Salud PERU – PEROU Chief delegate - Chef de délégation Sr. M. Rodríguez Cuadros Embajador, Representante Permanente, Ginebra Delegate(s) - Délégué(s) Sr. C. Chocano Ministro Consejero, Misión Permanente, Ginebra Dr. R. Torres Lao Dirección General de Promoción de la Salud, Ministerio de Salud Alternate(s) - Suppléant(s)

M. J.C. da Costa Pereira Ambassadeur, Représentant permanent, Genève Delegate(s) - Délégué(s) M. J.A. Sousa Fialho Conseiller, Mission permanente, Genève M. J.S. de Calheiros da Gama Conseiller, Mission permanente, Genève Alternate(s) - Suppléant(s) Mme M.G. Martins Direction générale de la Santé Mme E. Nunes Direction générale de la Santé M. J. Meneses Conseiller, Représentation permanente auprès de l’Union européenne, Bruxelles QATAR – QATAR

Dr. C. Farias Presidente, Comisión Nacional de Lucha Antitabáquica Srta. E. Beraun Primera Secretaria, Misión Permanente, Ginebra PHILIPPINES – PHILIPPINES Chief delegate - Chef de délégation Mr E.A. Manalo Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Mr R.L. Tejada Second Secretary, Permanent Mission, Geneva

Chief delegate - Chef de délégation Mr N.R. Al-Nuaimi Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Mr H.M. Al-Hitmi Director, Foreign Health Relations, National Health Authority Dr I.A. Al-Shaar Director, Preventive Health Department, National Health Authority

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ REPUBLIC OF KOREA – REPUBLIQUE DE COREE Chief delegate - Chef de délégation Mr J.-K. Lee Director-General, Bureau of Health Policy, Ministry of Health and Welfare Delegate(s) - Délégué(s) Mr H.-H. Ahn Counsellor, Permanent Mission, Geneva Mr W.-H. Lee Deputy Director, Government Finance Information and Management Division, Ministry of Finance and Economy Alternate(s) - Suppléant(s) Dr K.-S. Cho Deputy Director, Health Promotion Division, Ministry of Health and Welfare Adviser(s) - Conseiller(s) Ms Y.-J. Shin Chief Researcher, Korean Institute for Health and Social Affairs RWANDA – RWANDA Delegate(s) - Délégué(s) Dr B. Nzeyimana Ministère de la Santé SAINT LUCIA – SAINTE-LUCIE Chief delegate - Chef de délégation Dr D. Bristol President, Saint Lucia Cancer Society Delegate(s) - Délégué(s) Ms E. Serieux-Wilson Officer-in-charge, Substance Abuse Secretariat, Ministry of Health, Human Services, Family Affairs and Gender Relations Delegate(s) – Délégué(s) Dr A. Al-Bidah General Supervisor, Tobacco Control Programme, Ministry of Health SENEGAL – SENEGAL Chief delegate - Chef de délégation M. O. Camara Ambassadeur, Représentant permanent, Genève Delegate(s) - Délégué(s) SAMOA – SAMOA Delegate(s) - Délégué(s) Dr M.M. Tuala Ministry of Health SAUDI ARABIA – ARABIE SAOUDITE Delegate(s) - Délégué(s)

82

M. M. Mbaye Secrétaire général du Ministère de la Santé et de la Prévention médicale Dr P.C. Faye Directeur de la Prévention médicale Alternate(s) - Suppléant(s) M. D.M. Sène Ministre Conseiller, Mission permanente, Genève M. M. Seck Premier Secrétaire, Mission permanente, Genève M. O. Ndao Direction de la Prévention médicale SEYCHELLES - SEYCHELLES

Dr P. Bovet Head of Unit, Prevention and Control of Cardiovascular Diseases, Department of Health, Ministry of Health and Social Services

83

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ Under-Secretary, Ministry of Health Alternate(s) - Suppléant(s) Mr I. Jukič First Secretary, Permanent Mission, Geneva Mrs M. Mahkota Under-Secretary, Ministry of Health SOLOMON ISLANDS – ILES SALOMON Delegate(s) - Délégué(s) Mr J. Koli Minister of Health and Medical Services SOUTH AFRICA – AFRIQUE DU SUD

SINGAPORE – SINGAPOUR Chief delegate - Chef de délégation Mr B. Gafoor Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Ms T. Yoong Director, Adult Health Promotion, Health Promotion Board, Ministry of Health Mr J. Ratnam Deputy Permanent Representative, Geneva Alternate(s) - Suppléant(s)

Chief delegate - Chef de délégation Ms Choo Lin Manager, National Smoking Control Programme, Health Promotion Board, Ministry of Health Ms F. Gan Second Secretary, Permanent Mission, Geneva SLOVAKIA – SLOVAQUIE Chief delegate - Chef de délégation Delegate(s) - Délégué(s) Ms E. Kavcová National Coordinator for Tobacco Control, Ministry of Health Delegate(s) - Délégué(s) Alternate(s) - Suppléant(s) Mrs N. Šeptakova First Secretary, Permanent Mission, Geneva Mr R. Ochaba Ministry of Health SLOVENIA – SLOVENIE Chief delegate - Chef de délégation Mr A. Logar Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Mrs V.-K. Petrič Ms Z.R.S. Mthembu Director, Health Promotion, Department of Health Ms P. Lambert Legal Adviser SPAIN – ESPAGNE Chief delegate - Chef de délégation Sr. J.A. March Pujol Embajador, Representante Permanente, Ginebra Dr G.J. Mtshali Ambassador, Permanent Representative, Geneva Dr M.E. Tshabalala-Msimang Minister of Health Deputy chief delegate - Chef adjoint de la Délégation Ms D. Mafubelu Counsellor (Health), Permanent Mission, Geneva

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ Delegate(s) - Délégué(s) Sr. G. López Mac-Lellan Consejero, Misión Permanente, Ginebra Sra. I. de la Mata Barranco Consejera de Sanidad, Representación Permanente de España ante la Unión Europea, Bruselas Alternate(s) - Suppléant(s) Sr. M. Goizueta Sánchez Consejero (Finanzas), Misión Permanente, Ginebra Sr. A. Carpintero Sáiz Consejero (Agricultura), Misión Permanente, Ginebra Sra. I. Sáiz Martínez-Acitores Jefa de Servicio, Dirección General de Salud Pública, Ministerio de Sanidad y Consumo Sr. A. Calvete Oliva Jefe de Servicio, Dirección General de Salud Pública, Ministerio de Sanidad y Consumo Sra. I. Espiga López Jefe de Sección, Dirección General de Salud Pública, Ministerio de Sanidad y Consumo Sr. P. Tomás Hernández Vicepresidente, Comisionado para el Mercado de Tabacos, Ministerio de Economía y Hacienda Sra. C. Maraver López del Valle Jefe de Área de Estudios Técnicos, Ministerio de Economía y Hacienda SRI LANKA – SRI LANKA Chief delegate - Chef de délégation Mrs S. Fernando Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Dr T.L.C. Somatunge Director (Noncommunicable Diseases), Ministry of Healthcare and Nutrition

84

Mr S. Dissanayake Second Secretary, Permanent Mission, Geneva SUDAN – SOUDAN Chief delegate - Chef de délégation Dr E.F.M. Saeed State Minister, Ministry of Health Delegate(s) - Délégué(s) Mr O.D.F. Mohamed Minister, Chargé d’Affaires, Permanent Mission, Geneva Dr I.S. Elsubai Director of Health Promotion, Ministry of Health Alternate(s) - Suppléant(s) Mrs I.M. Elamin Third Secretary, Permanent Mission, Geneva Dr I.S. Mahgoub, Ministry of Health SWEDEN – SUEDE Chief delegate - Chef de délégation Ms U. Lindblom Desk Officer, Ministry of Health and Social Affairs Delegate(s) - Délégué(s) Ms E. Borsiin Bonnier Ambassador, Permanent Representative, Geneva Ms D. Alopaeus-Ståhl Director, Ministry for Foreign Affairs Alternate(s) - Suppléant(s) Ms H. Pedersen First Secretary, Permanent Mission, Geneva Ms A.-E. Ampèlas Health Counsellor, Permanent Mission, Brussels Mr B. Larenius Customs Attaché, Permanent Mission, Brussels

85

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ Ms Prangtip Kanchanahattakij First Secretary, Permanent Mission, Geneva TOGO –TOGO Delegate(s) - Délégué(s) Dr P. Tchamdja Directeur général de la Santé TONGA – TONGA Delegate(s) - Délégué(s) Dr M. Ake Chief Medical Officer (Public Health), Ministry of Health TURKEY – TURQUIE Chief delegate - Chef de délégation Mr T. Kurttekin Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s)

Mr P. Scharmer Legal Adviser, Ministry of Finance Ms C. Lönnheim Desk Officer, Ministry of Health and Social Affairs Ms M. Haglund Director, National Institute for Public Health SYRIAN ARAB REPUBLIC – REPUBLIQUE ARABE SYRIENNE Delegate(s) - Délégué(s) Dr B.A. El-Zahab Director, Tobacco Control Programme, Ministry of Health THAILAND – THAILANDE Chief delegate - Chef de délégation Dr Hatai Chitanondh President, Thailand Health Promotion Institute, National Health Foundation, Ministry of Public Health Delegate(s) - Délégué(s) Dr Chaisri Supornsilaphachai Acting Director, Bureau of Noncommunicable Diseases, Department of Disease Control, Ministry of Public Health Dr Samarn Futrakul Head, Tobacco and Alcohol Consumption Control Group, Bureau of Noncommunicable Diseases, Department of Disease Control, Ministry of Health Alternate(s) - Suppléant(s) Dr Wikul Visalseth Dental Health Division, Department of Health, Ministry of Public Health Dr Suchada Tungthangthum Associate Professor, Sukhothai Thammathirat Open University Ms Pantinee Tansrisuwan Public Health Officer, Bureau of Noncommunicable Diseases, Department of Disease Control, Ministry of Health

Mrs A. Ugdul Deputy Permanent Representative, Geneva Dr F. Aydinli Deputy Director General, Ministry of Health Alternate(s) - Suppléant(s) Mr H. Kivanc First Counsellor, Permanent Mission, Geneva Mr A. Erden Counsellor, Permanent Mission, Geneva Mr E. Etensel Counsellor, Permanent Mission, Geneva Mrs T. Etensel Counsellor, Permanent Mission, Geneva Miss S. Ozkaya Counsellor, Permanent Mission, Geneva

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ TUVALU –TUVALU Chief delegate - Chef de délégation Mr T. Tanukale Acting Minister for Health Delegate(s) - Délégué(s) Mrs M. Alaloto Assistant Secretary, Ministry of Health UNITED ARAB EMIRATES – EMIRATS ARABES UNIS Delegate(s) - Délégué(s) Dr A. Al-Mutawaa Director, Health Education Department, Ministry of Health UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND ROYAUME-UNI DE GRANDEBRETAGNE ET D’IRLANDE DU NORD Chief delegate - Chef de délégation Mr N. Adkin Head, Tobacco Policy Programme, Department of Health Delegate(s) - Délégué(s) Mr T. Kingham Policy Development Manager, Department of Health Mr T. Roberts Policy Development Manager, Tobacco Regulation, Department of Health Alternate(s) - Suppléant(s) Ms A. Grosskurth Team Leader, Tobacco Regulation, Department of Health Mr N. Thorne Ambassador, Permanent Representative, Geneva Mr J. Metcalfe Deputy Permanent Representative, Geneva Dr C. Presern Counsellor, Permanent Mission, Geneva Ms C. Kitsell First Secretary, Permanent Mission, Geneva Miss H. Thomas Attaché, Permanent Mission, Geneva Miss S. Chubbs Attaché, Permanent Mission, Geneva URUGUAY – URUGUAY Chief delegate - Chef de délégation Sr. G. Valles Embajador, Representante Permanente, Ginebra Delegate(s) - Délégué(s) Dr. M. Asqueta Presidente, Comisión de Salud de la Cámara de Representantes Dr. E. Bianco Comisión Asesora, Ministerio de Salud Pública Alternate(s) - Suppléant(s) Sra. A. De Bellis Primer Secretario, Misión Permanente, Ginebra VANUATU – VANUATU Chief delegate - Chef de délégation Dr M.S. Iatika Minister of Health Services Delegate(s) - Délégué(s) Ms M. Abel Director-General, Ministry of Health VIET NAM – VIET NAM Chief delegate - Chef de délégation Mr Pham Quoc Tru Minister Counsellor, Deputy Permanent

86

87

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ ARGENTINA – ARGENTINE Chief delegate - Chef de délégation

Representative, Geneva Delegate(s) - Délégué(s) Mr Pham Hong Nga Counsellor, Permanent Mission, Geneva Mr Dang Quoc Hung First Secretary, Permanent Mission, Geneva Alternate(s) - Suppléant(s) Dr Phan Thi Hai Department for Treatment, Ministry of Health OBSERVERS OBSERVATURES REPRESENTATIVES OF STATES NON-PARTIES REPRESENTANTS DES ETATS NON PARTIES ALGERIA – ALGERIE Chief delegate - Chef de délégation M. I. Jazairy Ambassadeur, Représentant permanent, Genève Delegate(s) - Délégué(s) Mlle D. Soltani Secrétaire diplomatique, Mission permanente, Genève ANGOLA – ANGOLA Chief delegate - Chef de délégation Dr A. do Nascimento Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Dr E. Neto Sangueve Counsellor, Permanent Mission, Geneva Dr S. Neto de Miranda Assistant for Health, Permanent Mission, Geneva

Sr. A.J. Dumont Embajador, Representante Permanente, Ginebra Delegate(s) - Délégué(s) Srta. A. de Hoz Ministro, Misión Permanente, Ginebra Dra. M. Molinari Asesora, Subsecretaría de Programas de Prevención y Promoción de la Salud, Ministerio de Salud y Ambiente BELIZE – BELIZE Chief delegate - Chef de délégation Ms A. Hunt Chargé d’Affaires, Permanent Mission, Geneva Delegate(s) - Délégué(s) Mr M. Tamasko Permanent Mission, Geneva Adviser(s) - Conseiller(s) Ms E.L.Y. Pan Permanent Mission, Geneva BOSNIA AND HERZEGOVINA – BOSNIE-HERZEGOVINE Chief delegate - Chef de délégation Mrs J. Kalmeta Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Mrs D. Andelić Counsellor, Permanent Mission, Geneva

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ BURKINA FASO – BURKINA FASO Chief delegate - Chef de délégation M. M.B. Nebié Chargé d’Affaires, Mission permanente, Genève Delegate(s) - Délégué(s) Dr T. Kangoye Inspecteur Général des Services de Santé Mme E. Balima Attaché d’Ambassade, Mission permanente, Genève BURUNDI – BURUNDI Chief delegate - Chef de délégation Dr B. Mbonimpa Ministre de la Santé publique Delegate(s) - Délégué(s) M. B. Bukuru Point focal pour la lutte anti-tabac, Ministère de la Santé publique M. N. Nkundwanabake Premier Conseiller, Mission permanente, Genève CAMEROON – CAMEROUN Chief delegate - Chef de délégation Dr M. Baye Lukong Conseiller Technique No. 2, Ministère de la Santé publique (Chief delegate from 6 to 10 February 2006) (Chef de délégation du 6 au 10 février 2006) M. D. Sibetcheu Directeur de la Promotion de la Santé, Ministère de la Santé publique (Chief delegate from 11 to 17 February 2006) (Chef de délégation du 11 au 17 février 2006) Delegate(s) - Délégué(s) Professeur W. Muna Président, Groupe d’experts sur le tabagisme, Ministère de la Santé publique M. B. Togmian Premier Conseiller, Mission permanente, Genève M. H. Akouya Premier Secrétaire, Mission permanente, Genève COLOMBIA – COLOMBIE Delegate(s) - Délégué(s) Dra. L.S. Arango Ministro Consejero, Misión Permanente, Ginebra CONGO – CONGO Chief delegate - Chef de délégation M. J.I. Tendelet Directeur, Cabinet du Ministre de la Santé et de la Population Delegate(s) - Délégué(s) CHAD – TCHAD Chief delegate - Chef de délégation Dr M.E. Mbaïong Ministère de la Santé publique Delegate(s) - Délégué(s)

88

Dr M. Kaba-Mboko Conseiller à la Santé, Ministère de la Santé et de la Population Mme D. Bikouta Premier Conseiller, Mission permanente, Genève Alternate(s) - Suppléant(s) M. M. Badila Chef, Service Traités et Conventions, Ministère des Affaires étrangères et de la Francophonie

89

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ Delegate(s) - Délégué(s) Ms M. Adamić First Secretary, Permanent Mission, Geneva CUBA – CUBA Chief delegate - Chef de délégation

COSTA RICA – COSTA RICA Chief delegate - Chef de délégation Sr. L. Varela Quirós Embajador, Representante Permanente, Ginebra Delegate(s) - Délégué(s) Sr. A. Solano Ortíz Ministro Consejero, Encargado de Negocios a.i., Misión permanente, Ginebra Sr. C. Garbanzo Ministro Consejero, Misión Permanente, Ginebra COTE D’IVOIRE – COTE D’IVOIRE Chief delegate - Chef de délégation M. C.-C. Béké Dassys Ambassadeur, Représentant permanent, Genève Deputy chief delegate - Chef adjoint de la Délégation Dr N’G. Kouame Directeur Coordinateur, Programme national de Lutte contre le Tabagisme Delegate(s) - Délégué(s) M. P. Gleglaud Premier Conseiller, Mission permanente, Genève Alternate(s) - Suppléant(s) Professeur P. Bogui Point focal du tabac, Président de la Commission Scientifique du Programme national de Lutte contre le Tabagisme CROATIA – CROATIE Chief delegate - Chef de délégation Mr G. Markotić Ambassdor, Permanent Representative, Geneva

Sr. J.A. Fernández Palacios Embajador, Representante Permanente, Ginebra Delegate(s) - Délégué(s) Sr. O. León González Segundo Secretario, Misión Permanente, Ginebra CZECH REPUBLIC – REPUBLIQUE TCHEQUE Chief delegate - Chef de délégation Mr P. Hrnčíř Deputy Permanent Representative, Geneva Delegate(s) - Délégué(s) Ms J. Vedralová Department of Health Care, Ministry of Health Mr J. Blažek Second Secretary, Permanent Mission, Geneva DOMINICAN REPUBLIC – REPUBLIQUE DOMINICAINE Chief delegate - Chef de délégation Sr. H.L. Hernández Sánchez Embajador, Representante Permanente, Ginebra Delegate(s) - Délégué(s) Dra. M. Bello de Kemper Consejera, Misión Permanente, Ginebra Dra. I.M. Natera Delmonte Asistente Técnica, Secretaría de Estado de Salud y Asistencia Social

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ Alternate(s) - Suppléant(s) Sr. A. Rosa Director Ejecutivo, Instituto del Tabaco Sr. O. Benítez Vicepresidente Ejecutivo, Junta Agroempresarial Dominicana ECUADOR – EQUATEUR Chief delegate - Chef de délégation Chief delegate - Chef de délégation Sr. J.C. Faidutti Estrada Embajador, Representante Permanente, Ginebra Delegate(s) - Délégué(s) Sr. C. Santos Repetto Primer Secretario, Misión Permanente, Ginebra EL SALVADOR – EL SALVADOR Chief delegate - Chef de délégation Dr. B.F. Larios López Embajador, Representante Permanente, Ginebra Delegate(s) - Délégué(s) Sr. R. Recinos Trejo Ministro Consejero, Misión Permanente, Ginebra ETHIOPIA – ETHIOPIE Delegate(s) - Délégué(s) Ms S. Amin Oumer Third Secretary, Permanent Mission, Geneva GABON – GABON Delegate(s) - Délégué(s) Mme Angone Abena Conseiller, Mission permanente, Genève M. J.-A. Jasmin Ministère de la Santé publique et de la Population Delegate(s) - Délégué(s) M. J.B. Alexandre Ministre Conseiller, Mission permanente, Genève Professor P. Behrakis Medical School, University of Athens Mr A. Cambitsis Minister Counsellor, Permanent Mission, Geneva Alternate(s) - Suppléant(s) Dr A. Pantazopoulou-Fotinea Ministry of Health and Social Solidarity Dr T. Stavrou Ministry of Health and Social Solidarity Ms E. Damigou Counsellor for Health Affairs, Permanent Mission, Geneva Ms D. Anastassopoulou Counsellor for Health Affairs, Permanent Mission to the European Union, Brussels HAITI – HAITI Chief delegate - Chef de délégation Mr T. Kriekoukis Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) GEORGIA – GEORGIE Delegate(s) - Délégué(s) Mr K. Gedevanishvili Chargé d’Affaires a.i., Permanent Mission, Geneva GREECE – GRECE

90

91

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ IRAQ – IRAQ Delegate(s) - Délégué(s) Dr M.S. Abdul-Ghafoor Director, Department of Public Health and Primary Health Care, Ministry of Health ITALY – ITALIE Chief delegate - Chef de délégation Dr C. Guarino Direction Générale des Relations Internationales, Ministère de la Santé Delegate(s) - Délégué(s) Mme L. Fiori Premier Conseiller, Mission permanente, Genève Dr M. Castellina Attaché pour la Santé, Mission permanente de l’Italie, Bruxelles Alternate(s) - Suppléant(s) Mme V. Russo Expert, Coopération technique, Mission permanente, Genève KAZAKHSTAN – KAZAKHSTAN

HOLY SEE – SAINT-SIEGE Chief delegate - Chef de délégation Mgr S.M. Tomasi Nonce Apostolique, Observateur permanent, Genève Delegate(s) - Délégué(s) Mgr F. Nwachukwu Conseiller, Mission permanente d’observation, Genève M. E. Scirpoli Mission permanente d’observation, Genève Mlle F. Polito Mission permanente d’observation, Genève Alternate(s) - Suppléant(s) Mme F. Merico Mission permanente d’observation, Genève INDONESIA – INDONESIE Chief delegate - Chef de délégation Dr M. Wibisono Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Mr S.M. Soemarno Minister Counsellor, Permanent Mission, Geneva Mr L. Simbolon Counsellor, Permanent Mission, Geneva Alternate(s) - Suppléant(s) Dr G. Pandu Setiawan Director of Mental Health, Department of Health Mr A.C. Sumirat Third Secretary, Permanent Mission, Geneva Ms D.E. Sari Sutikno Third Secretary, Permanent Mission, Geneva

Delegate(s) - Délégué(s) Mr M. Zhagiparov Third Secretary, Permanent Mission, Geneva MONACO – MONACO Chief delegate - Chef de délégation M. P. Blanchi Ambassadeur, Représentant permanent, Genève Delegate(s) - Délégué(s) Mlle C. Lanteri Représentant permanent adjoint, Genève M. A. Jahlan Troisième Secrétaire, Mission permanente,

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ Genève MOROCCO – MAROC Chief delegate - Chef de délégation M. M. Loulichki Ambassadeur, Représentant permanent, Genève Delegate(s) - Délégué(s) M. A. Farhane Conseiller, Mission permanente, Genève M. N.-E. Halhoul Deuxième Secrétaire, Mission permanente, Genève MOZAMBIQUE – MOZAMBIQUE Chief delegate - Chef de délégation Delegate(s) - Délégué(s) Professor P.I.A.T. Garrido Minister of Health NEPAL – NEPAL Chief delegate - Chef de délégation Dr N.M. Shrestha Chief Specialist (Focal Point for Tobacco Control), Policy, Planning and International Cooperation Division, Ministry of Health and Population Delegate(s) - Délégué(s) Alternate(s) - Suppléant(s) Mr R. Rajbhandari Under Secretary (Legal Advisor for Tobacco Control), Ministry of Health and Population NICARAGUA – NICARAGUA Chief delegate - Chef de délégation Sra. A. Martín Gallegos Embajadora, Representante Permanente, Ginebra Delegate(s) - Délégué(s) Sr. N. Cruz Toruño Primer Secretario, Misión Permanente, Ginebra REPUBLIC OF MOLDOVA – REPUBLIQUE DE MOLDOVA Chief delegate - Chef de délégation Mr T. Vasiliev Chief Specialist in Narcology, National Coordinator on Problems of Tobacco and Smoking, Ministry of Health and Social Security Mr M. Janczak Third Secretary, Permanent Mission, Geneva Professor W. Zatoński President, Health Promotion Foundation Mr A. Wojtyła Under-Secretary of State, Ministry of Health Deputy chief delegate - Chef adjoint de la Délégation Mr A. Misztal Minister Counsellor, Deputy Permanent Representative, Geneva Delegate(s) - Délégué(s) Ms R. Lemieszewska Counsellor, Permanent Mission, Geneva

92

Sr. N. Somarriba Fonseca Primer Secretario, Misión Permanente, Ginebra PARAGUAY – PARAGUAY Chief delegate - Chef de délégation Sr. R. Gauto Vielman Embajador, Representante Permanente, Ginebra Delegate(s) - Délégué(s) Sra. G. Amarilla Ministra, Misión Permanente, Ginebra POLAND – POLOGNE

93

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ Alternate(s) - Suppléant(s)

Delegate(s) - Délégué(s) Mr E. Revenco Chargé d’Affaires, Permanent Mission, Geneva Mrs M. Zaplitnii First Secretary, Permanent Mission, Geneva ROMANIA – ROUMANIE Chief delegate - Chef de délégation Mr D.R. Costea Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Professor M.A. Bogdan Head of Department, Institute of Pneumophtisiology “Marius Nasta” Mr F. Pironea Second Secretary, Pemanent Mission, Geneva Alternate(s) - Suppléant(s) Dr M. Ciobanu Coordinator, Center for Smoking Cessation RUSSIAN FEDERATION – FEDERATION DE RUSSIE Chief delegate - Chef de délégation Mr I.A. Astakhov Head, International Agreements Unit, Legal Department, Ministry of Foreign Affairs Delegate(s) - Délégué(s) Mr N.N. Sikachev Senior Counsellor, International Organizations Department, Ministry of Foreign Affairs Professor N.P. Napalkov Academician, Member of the Russian Academy of Medical Sciences, and Honorary Director, N.N. Petrov Cancer Research Institute M. B. Godet Ambassadeur, Représentant permanent, Genève Deputy chief delegate - Chef adjoint de la Délégation M. A. von Kessel Section Organisations internationales, Office fédéral de la Santé publique Mr N. Lozinskiy Senior Counsellor, Permanent Mission, Geneva Dr A.V. Pavlov Counsellor, Permanent Mission, Geneva Mr L. Kulikov First Secretary, Permanent Mission, Geneva Mr M. Kochetkov Attaché, Permanent Mission, Geneva SERBIA AND MONTENEGRO – SERBIE ET MONTENEGRO Chief delegate - Chef de délégation Mr D. Sahović Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Mr V. Lazović Second Secretary, Permanent Mission, Geneva SWITZERLAND – SUISSE Chief delegate - Chef de délégation Mr S.V. Akselrod Deputy Head, Department of International Cooperation and Public Relations, Ministry of Health and Social Development Mr V. Zimyanin Senior Counsellor, Permanent Mission, Geneva

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ Delegate(s) - Délégué(s) Mme B. Schaer Bourbeau Deuxième Secrétaire, Mission permanente, Genève Alternate(s) - Suppléant(s) M. T. Schuler Juriste, Division Droit (Programme national tabac), Office fédéral de la Santé publique M. M. Anderegg Collaborateur scientifique, Section Objets usuels, cosmétiques et tabac, Office fédéral de la Santé publique Mme L. Curt-Cavenz Collaboratrice scientifique, Section Tabac, Office fédéral de la Santé publique TUNISIA – TUNISIE Chief delegate - Chef de délégation M. S. Labidi Ambassadur, Représentant permanent, Genève Delegate(s) - Délégué(s) M. H. Landoulsi Conseiller, Mission permanente, Genève TURKMENISTAN – TURKMENISTAN Delegate(s) - Délégué(s) Dr S. Orazberdiyev Ministerial Cabinet, Ministry of Health and Medical Industry UKRAINE – UKRAINE Chief delegate - Chef de délégation Mr Y. Bersheda Ambassador, Permanent Representative, Geneva Delegate(s) - Délégué(s) Ms O. Sydorova Deputy Head, Department of European Integration and International Relations, Ministry of Health Dr G. Kiangi Principal Medical Officer, Head of Health Education Section, Ministry of Health and Social Welfare Delegate(s) - Délégué(s) Mr J.J. Kassaja Minister, Permanent Mission, Geneva Alternate(s) - Suppléant(s) Ms P.M.K. Maganga Principal State Attorney, Ministry of Health and Social Welfare Ms K. Sotulenko First Secretary, Permanent Mission, Geneva UNITED REPUBLIC OF TANZANIA – REPUBLIQUE-UNIE DE TANZANIE Chief delegate - Chef de délégation Mr C.K. Mutalemwa Ambassador, Permanent Representative, Geneva Deputy chief delegate - Chef adjoint de la Délégation

94

Mr I. Lukasevich Chief Specialist of Humanitarian Policy, Department of the Secretariat of the Cabinet of Ministers of Ukraine Alternate(s) - Suppléant(s)

Mr B.H. Luvanda Second Secretary, Permanent Mission, Geneva UNITED STATES OF AMERICA – ETATSUNIS D’AMERIQUE Chief delegate - Chef de délégation Mr D.E. Hohman Health Attaché, Permanent Mission, Geneva Delegate(s) - Délégué(s) Mr J.G. Lankford Assistant to the Health Attaché, Permanent Mission, Geneva

95

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ OBSERVERS INVITED IN ACCORDANCE WITH RESOLUTION WHA27.37 OBSERVATEURS INVITES CONFORMEMENT A LA RESOLUTION WHA27.37 PALESTINE – PALESTINE

Mr C.W. Warren Demographer, Global Surveillance System, Centers for Disease Control and Prevention, Atlanta UZBEKISTAN – OUZBEKISTAN Delegate(s) - Délégué(s) Mr S.K. Khashimov Director, Central Board for Provision of Prevention and Medical Care VENEZUELA (BOLIVARIAN REPUBLIC OF) – VENEZUELA (REPUBLIQUE BOLIVARIENNE DU) Chief delegate - Chef de délégation Sra. R. Poitevien Cabral Embajadora, Encargada de Negocios a.i., Misión Permanente, Ginebra Delegate(s) - Délégué(s) Sr. E. Bitetto Gavilanes Primer Secretario, Misión Permanente, Ginebra Sr. J.F. Ruiz Lugo Jefe, División General de Salud Ambiental y Contraloría Sanitaria, Ministerio de la Salud y Desarrollo Social ZAMBIA – ZAMBIE Chief delegate - Chef de délégation Mr J. Mayeya Mental Health Specialist, Central Board of Health Delegate(s) - Délégué(s)

Dr M. Abu-Koash Ambassador, Permanent Observer, Geneva Mr I. Musa First Secretary, Permanent Observer Mission, Geneva Mr O. Mohammed Counsellor, Permanent Observer Mission, Geneva REPRESENTATIVES OF THE UNITED NATIONS AND RELATED ORGANIZATIONS REPRESENTANTS DE L’ORGANISATION DES NATIONS UNIES ET DES INSTITUTIONS APPARENTEES UNITED NATIONS CHILDREN’S FUND FONDS DES NATIONS UNIES POUR L’ENFANCE Mr K. Oyegbite Senior Programme and Planning Officer, Health Section UNITED NATIONS ENVIRONMENT PROGRAMME PROGRAMME DES NATIONS UNIES POUR L’ENVIRONNEMENT Mr P. Quiblier, Geneva

Mr A. Zulu First Secretary, Permanent Mission, Geneva ZIMBABWE – ZIMBABWE Delegate(s) - Délégué(s) Mrs P. Nyagura Counsellor, Permanent Mission, Geneva

UNITED NATIONS HUMAN SETTLEMENTS PROGRAMME (UN-HABITAT) PROGRAMME DES NATIONS UNIES POUR LES ETABLISSEMENTS HUMAINS Mr A. Abbas Chief, UN-HABITAT Geneva Office

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ UNITED NATIONS RELIEF AND WORKS AGENCY FOR PALESTINE REFUGEES IN THE NEAR EAST OFFICE DE SECOURS ET DE TRAVAUX DES NATIONS UNIES POUR LES REFUGIES DE PALESTINE DANS LE PROCHE-ORIENT Mr M. Burchard Chief, UNRWA Liaison Office in Geneva Ms Y. Burton UNRWA Liaison Office in Geneva UNITED NATIONS INSTITUTE FOR TRAINING AND RESEARCH INSTITUT DE FORMATION ET DE RECHERCHE DES NATIONS UNIES Dr R. Hanskens Director, UNITAR CIFAL Training Centre, Lyon Ms S. Moreira UNITAR CIFAL Training Centre, Lyon SPECIALIZED AGENCIES INSTITUTIONS SPECIALISEES FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS ORGANISATION DES NATIONS UNIES POUR L’ALIMENTATION ET L’AGRICULTURE Mr T.N. Masuku Director, FAO Liaison Office with the United Nations, Geneva Mr P. Konandreas Senior Liaison Officer, FAO Liaison Office with the United Nations, Geneva Mr P. Paredes-Portella Liaison Officer, FAO Liaison Office with the United Nations, Geneva REPRESENTATIVES OF OTHER INTERGOVERNMENTAL ORGANIZATIONS REPRESENTANTS D’AUTRES ORGANISATIONS INTERGOUVERNEMENTALES LEAGUE OF ARAB STATES – LIGUE DES ETATS ARABES

96

M. S. Alfarargi Ambassadeur, Observateur permanent, Genève Dr O. El-Hajje Délégation permanente, Genève M. Y. Tiliouant Premier Attaché, Délégation permanente, Genève AFRICAN UNION – UNION AFRICAINE Mrs K. Masri Ambassador, Permanent Observer, Geneva Mr V. Wege Nzomwita Counsellor, Permanent Delegation, Geneva INTERNATIONAL ORGANIZATION FOR MIGRATION ORGANISATION INTERNATIONALE POUR LES MIGRATIONS Ms M. Grigis Medical Health Physician, Occupational Health Unit, Migration Health Services ORGANIZATION OF THE ISLAMIC CONFERENCE ORGANISATION DE LA CONFERENCE ISLAMIQUE Mr M.A. Jerrari Minister Counsellor, Permanent Observer Mission, Geneva

97

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ REPRESENTATIVES OF NONGOVERNMENTAL ORGANIZATIONS IN OFFICIAL RELATIONS WITH WHO REPRESENTANTS DES ORGANISATIONS NON GOUVERNEMENTALES EN RELATIONS OFFICIELLES AVEC L’OMS FDI WORLD DENTAL FEDERATION FÉDÉRATION DENTAIRE INTERNATIONALE Dr H. Benzian FRAMEWORK CONVENTION ALLIANCE FOR TOBACCO CONTROL FRAMEWORK CONVENTION ALLIANCE FOR TOBACCO CONTROL Ms M. Assunta Mr S. Ahmed Mr A. Randall Ms F. Godfrey Mr W. Lange Ms P. Johns Mr P. Bogui Ms M.A. Càrdenas Ms E. Beguinot Professor G. Dubois Mrs Y. Dimitrova Mrs E. Mahé-Tissot Mr C. Bass Mrs C. de Bérard Mr J. Daver Dr B. Lemaitre Mr G. Bakhturidze Ms L. Salgado Mr S. John Dr G. Heydari

CONSUMERS INTERNATIONAL CONSUMERS INTERNATIONAL Mr S. Ochieng Mr M. Ililonga Ms D. Mwangi Mr B. Misra

CORPORATE ACCOUNTABILITY INTERNATIONAL CORPORATE ACCOUNTABILITY INTERNATIONAL Mr I. Ali Mr Y.F. Dorado Mazorra Mr B. Hirsch Dr E. Adayade Kodjo Ms P. Lynn Ms K. Mulvey Mr A. Oluwafemi Ms J. Omoyeni Mr B. Ramakant Ms M. Rising Ms L. Ruoff

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ Mr F. Odhiambo Mr G.O. Banja Ms F. Machio Ms V. Le Clezio Mr M. Bartal Mr F. Cabo Mr H.L. Shrestha Mr S. Bradbrook Mr B. Rosted Ms N. Solberg Ms A.L. Ryel Dr E. Latif Ms R. Roa Mr J.L. Leonidas Dr M. Limpin Mr O. Gunasekera Ms S. Sánchez Mr P. Diethelm Mr Yibee Huang Mr Song Lih Huang Ms Lin Yuan-wei Mr K. Agbavon Mr N’L. Gbegbeni Ms J. Tumwine Ms E. Lee Ms J. King Ms D. Arnott Dr E. Bianco Ms C. Dougherty Mr R. Hammond Mr R. Daynard Ms R. DeSilva Mr D. Blanke Dr A. Munzer Ms F. Hashemian Mr L. Huber Mr C. Bostic Ms E. Furgurson Ms J. Witzel Ms C. Callard Mr L. Joossens Mr C. Farías Mr D. Hammond Dr J.R. Calvo Dr M. Carballo Dr P. Ko Ms F. Berteletti Mr G. Fong Mr J. Fábregas Ms J. de Boccard Mr J. Pepin Ms L. Sanda Mr M. Asqueta Mr F. Siem Ms C. Wang

98

99

‫ﻗﺎﺌﻤﺔ ﺒﺄﺴﻤﺎﺀ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ‬ INTERNATIONAL ASSOCIATION FOR MATERNAL AND NEONATAL HEALTH ASSOCIATION INTERNATIONALE POUR LA SANTÉ DE LA MÈRE ET DU NOUVEAU-NÉ Dr R. Kulier INTERNATIONAL COUNCIL OF NURSES CONSEIL INTERNATIONAL DES INFIRMIÈRES Dr T. Ghebrehiwet INTERNATIONAL FEDERATION OF BUSINESS AND PROFESSIONAL WOMEN INTERNATIONAL FEDERATION OF BUSINESS AND PROFESSIONAL WOMEN Ms M. Gerber Ms G. Gonzenbach INTERNATIONAL FEDERATION OF GYNECOLOGY AND OBSTETRICS FÉDÉRATION INTERNATIONALE DE GYNÉCOLOGIE ET D’OBSTÉTRIQUE Dr R. Kulier INTERNATIONAL NONGOVERNMENTAL COALITION AGAINST TOBACCO COALITION INTERNATIONALE ANTI TABAC DES ORGANISATIONS NON GOUVERNEMENTALES Ms D. McIntyre INTERNATIONAL UNION AGAINST CANCER UNION INTERNATIONALE CONTRE LE CANCER Dr S. Jones Mr J. Bloom Mr A. Hayes Dr A. Bornhäuser

Ms F. Ndiaye Professor M.S. Gau Mr S. Gordon Mr J.N. Kombila Mr R. Bautista Jr Mr R. Masironi Ms L. Ciaffei Mr H. Muñoz Grandé Dr Lim Thai Pheang Ms J. Radke Ms N. Movsisyan GLOBAL FORUM FOR HEALTH RESEARCH FORUM MONDIAL POUR LA RECHERCHE EN SANTÉ Professor S.A. Matlin Dr A. de Francisco Ms M.A. Burke Dr A. Ghaffar Ms S. Jupp Mr J.-J. Monot Ms S. Olifson Ms L. Sundaram INTERNATIONAL ALLIANCE OF WOMEN ALLIANCE INTERNATIONALE DES FEMMES Ms H. Sackstein Ms M. Pal Ms S.-Y. Yoon

‫ﺍﻟﺩﻭﺭﺓ ﺍﻷﻭﻟﻰ ﻟﻤﺅﺘﻤﺭ ﺍﻷﻁﺭﺍﻑ‬ Mr J. Fábregas Ms J. Corsi Mr R. Cunningham Mr R. Israel Ms J. King Ms E. Lee Mr J. Liberman Dr L. Sanda Ms C. Welch Dr A. Mosavi-Jarrahi Mr R. Wiesli Mr O.A. Opdalshei Ms K. Byrkje Ms C. Hallet Professor N.P. Napalkov Dr Hong Gwan Seo ROTARY INTERNATIONAL - ROTARY INTERNATIONAL Mr G. Coutau

100

WORLD FEDERATION OF PUBLIC HEALTH ASSOCIATIONS FÉDÉRATION MONDIALE DES ASSOCIATIONS DE LA SANTÉ PUBLIQUE Professor T. Abelin Mrs J. Bell WORLD HEART FEDERATION FÉDÉRATION MONDIALE DU CŒUR Mrs J. Voûte Mrs H. Alderson Mrs D. Grizeau-Clemens WORLD SELF-MEDICATION INDUSTRY INDUSTRIE MONDIALE DE L’AUTOMÉDICATION RESPONSABLE Mr D. Graham Ms M. Johnson Ms K. Kemper

______________